<SEC-DOCUMENT>0000275053-23-000007.txt : 20230509
<SEC-HEADER>0000275053-23-000007.hdr.sgml : 20230509
<ACCEPTANCE-DATETIME>20230509171131
ACCESSION NUMBER:		0000275053-23-000007
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230509
DATE AS OF CHANGE:		20230509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURES SUNSHINE PRODUCTS INC
		CENTRAL INDEX KEY:			0000275053
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870327982
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34483
		FILM NUMBER:		23903307

	BUSINESS ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		(801) 341-7900

	MAIL ADDRESS:	
		STREET 1:		2901 WEST BLUEGRASS BLVD.
		STREET 2:		SUITE 100
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMTEC INDUSTRIES INC
		DATE OF NAME CHANGE:	19821108
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>natr-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a,d:aff80d6feba84531aa76e6adafecaf3a--><html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:natr="http://naturessunshine.com/20230331" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>natr-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xLTEtMS0xLTU2NDYy_3002c32a-5f18-4909-add4-831ea1941fb0">0000275053</ix:nonNumeric><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y180LTEtMS0xLTU2NDYy_fd30b4ae-a14f-48fc-8f65-de24a42476f9">false</ix:nonNumeric><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xMi0xLTEtMS01NjQ2Mg_0f565c01-3c51-4732-8225-26c54ede91d3">2023</ix:nonNumeric><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xMy0xLTEtMS01NjQ2Mg_91dd4da1-d32b-4a62-8486-fbaf4dceec36">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGV4dHJlZ2lvbjpkNDQ0YzM5YjZiOGQ0NzgzYjUxOTgyMDkxYmJlMDdkYl8xOQ_2619f8aa-96c6-484c-9328-2379707d01b5">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i9e76d69fab4344eaaeea5f3f8ddae394_D20230101-20230331" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81NS9mcmFnOjI5M2JiN2MxNTliMjQyMzA5MzU4NjZhNmJkNDYyNDkwL3RhYmxlOjM3ZTJiMGMyMDQ1ZDQ5NDQ4NzEzNmQ0MjRjM2U3Njg3L3RhYmxlcmFuZ2U6MzdlMmIwYzIwNDVkNDk0NDg3MTM2ZDQyNGMzZTc2ODdfMS0xLTEtMS01NjQ2Mg_9d3e6694-8483-4c00-bfd4-e45b3ece9c21">1</ix:nonNumeric><ix:nonNumeric contextRef="i1894c4004ad148cea83c9610751c7839_D20230101-20230331" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81NS9mcmFnOjI5M2JiN2MxNTliMjQyMzA5MzU4NjZhNmJkNDYyNDkwL3RhYmxlOjM3ZTJiMGMyMDQ1ZDQ5NDQ4NzEzNmQ0MjRjM2U3Njg3L3RhYmxlcmFuZ2U6MzdlMmIwYzIwNDVkNDk0NDg3MTM2ZDQyNGMzZTc2ODdfMS0yLTEtMS01NjQ2Mg_b0703ee9-1b27-4006-9eb3-73be1b4a686c">1.25</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="natr-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i323367af1eab405e83322a0281dd711b_I20230421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i5013a2410f1f48fe86da71c75ac9b931_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i0eb8c277981f4b25971776c77e8450b0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3756408ac1534f02be1f929758b190ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c5ec96e95bb479aa9317328c85875ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8e99e23cdc04ca3967d8e0cc86c9bc9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic159bd1e6c754fc598df19fee673181b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f1b157582d54aa5b6c76556a72d0fa1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078db4ca9b324f02b4b009b8e5063922_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77345b7632f4c3687707a676a2ecdba_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397792870c944251a9e358f23c5e3f82_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifecfce154349479aaa1ff1d6bfd331aa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id071f960be3f4eddb4fddc539cef8fb2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i118dbcf5a4fc44b8985c21224e382a89_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0691a9d3b51c404f83e92ca13c32ff39_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a92d6d58b6c43fc949181a4738e553c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53dcd0f7b104910a52899f37012afd3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f72f97c01a743d790b5acf8b55c9d24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib40450c215064f9a9f895bc248da7a1e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ce5e44a4ef64052aea959ec0f39d8d8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25cd1edc1c964494bbd0f0f6d41bfd3c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66a7e3f9c206413f8e34219e584092b1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8deaf3592d424474a99cc4c83beafb75_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff00616fa06b404996d8b5bb02df09ce_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id89baad6125140598d815d83ca0cfa3f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3aafe404f0443248657956fd2be506f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e403872b0564650b45c1c4ce25c58da_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b99692a035464f8b8f7f2449d7eccc_I20170711"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-07-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5181311b4b2e46549f7db94eeae94161_I20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="borrowing"><xbrli:measure>natr:borrowing</xbrli:measure></xbrli:unit><xbrli:context id="i576cde29c1fd40f8b8fece1e7aeedef2_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3ae9de4d3934431b85c33730e67cac1d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3b6867cf47247f4968d279e124711d2_D20220623-20220623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-23</xbrli:startDate><xbrli:endDate>2022-06-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bf0ac744d7941f3852747082611c11b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieee06864f03e4d04abae69411c2a8c28_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bad9899385e49ba89421036e841df7e_I20200421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3b0bb7e541c48fbad2bb35bbc0811d0_I20201119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id70a83bdb8dd4e80ac710803192a2c56_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-19</xbrli:startDate><xbrli:endDate>2020-11-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="payment"><xbrli:measure>natr:payment</xbrli:measure></xbrli:unit><xbrli:context id="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad7a3e92766a4588bcf410162f828313_I20210310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9e1feefec641229f8793d60e0ba7a2_I20220308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic119a54e942d4fb496dbaf51f43c3a16_I20121231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17132172a34944c19d1a0af61112f1ff_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice5ff017c4644e0ba536b10add46fcac_D20210505-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-05</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b15fb6f7a54f76a4f03d8f40724290_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148e2e4f78504b7f860c8bb7235cd422_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd667127b304410783b1f535dacef921_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dd6e9c7d1174a5196db741bd9bd6e22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f71d03224964432937c9462c7320fd7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied1fdb1621154a2c992f780e1bfa1706_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7da32705f94942c49d3c710e71c1c4bc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec6bb5c1e51f4f79902860d3143fa47f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib20931e909f04ba3884bbaf616843da2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127289bd16c74b78bcba51e1e0e6b297_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70143db360d648a09df5ae0c19ad6a0c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb089485d284690b3a27c0501d8a380_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia02c469dbbc24747a8b591560a3ee008_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib801a3e8a35c48218f48568d2ed7dda1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01162aa2d194e3182890cbff779a0bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib996c0038abc4f538cb2d29806f221fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie19d15fa8feb4d7fb9e9852fb4440016_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i170c7005fd4e4233977c6c670cb2c2d6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e76d69fab4344eaaeea5f3f8ddae394_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1894c4004ad148cea83c9610751c7839_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>natr:segment</xbrli:measure></xbrli:unit><xbrli:context id="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic89e788790814555baa4f501d838cb1d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide3b537021f84209a36b182180e7beb0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i529b6a830669494b8e359e0f300f1930_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56d1e2e3fada4727b55573a407169196_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ecf051891dc4540bc1a158727bface1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72b2b7d2469d443699c8c1599a668568_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i549144157ff34d2fb598832930efc245_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e4c046cce2249f2aad2d456f289e8b5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3de2700723f44230bd14ea658ce0674b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7865ea6a10c944dd9cf7b4d199be8b36_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704b9d7df3314907a965decd5192d199_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f4f53a1500e4c3d8c20fceb1d303105_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6926d9bdf25244c48c11ee85cac897fc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief991aa102dc4df286a636f2768bf677_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1def7196a1394561a30f23c2f5945836_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ab4170a48ba44688bfbcdb858a32779_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc86721ece64baf808c893cc035d52a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11c371bce764450ac20c60711a22727_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2403b429d1e4d5dbc736ea9f50b2db0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dadec0fe1ce41e581194b370338f5aa_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286bd26b9ba84374854d6dbd57593217_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94c5f48d31de4e58896fadefe80c0fb7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie84001b2ee67469ab6af26eafcb4c8d6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdb780bc72204ed995bb3d5d750aaaa7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie66081dc8a1849988db515744c4a5191_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia242724c2a8d41a2a6629e376281c37d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b0de65c7f04151b172ae37f38db95c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70570a69247e4e4b9228e76f91348f73_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id935bb5a397e4fd5b3068cd551324f0d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0706faf1f08f497a95123914f1ad454c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2e2a755bd504b2d8ab7f427c3ce421e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82ea8fd02a454b32af363f8584558ce2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19eee5983a13470a8e2f0b19460061cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d2601cc29e44ce8a1a4d2e106164fbf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7646bffa476a454e9fff94e8ff089fe7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab2c51f1dcbf45489ce126a589c4fed4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e775b15edf42e0976566b58638008e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd494153a584910be8e82dd4ae90fb8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f3e9061310940c78e07309d597a0c3f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8baa0e541a4e3db131ac25deeece46_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i004051f877df4e358f3020fdd40e15bf_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide005a7559004658904c94d8e1c9d7a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09c2138d4f6448da9af09aa9cad5d832_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c73008cac84edd9bf7a7c951a8ace6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89604f393d1406a9dc613f638bb9282_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c76018a8ad24a3eb01b65729f05e002_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee552623371416a91f53435d09209ff_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idea6fbc78a7e42978d9632750e427515_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife96081680724014b04db995e830f541_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdde04916fb4085909452d7bf0e104b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976cb70b3a6d4224ba518c55b10e68f7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0211468578bd4079b559e74b92be8660_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a725eb7fa624679b58b3693ddec3496_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83bf3f9f69a6453284bd5815b5c518b4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ef4c27b992044b28c84833e4d7a9482_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia27f2c9f8dee4c3ebabd4dd807c88816_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3493146182f54b58b709fb841b93942e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcdd69c0a6834a8f9f59f07e9398c5c4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e831496e7a6437689b1d9ad266655aa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce691f6ab25492fa9195960972e876b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c43ae344d345a98b2a06cdcfe5a28d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0e66a63f3a348c481089b2cedcad2da_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib66f65baeb8548a496f5f643074ca0b6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2774331cf67440fb8010640bd77a71d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4e7456b9664b3bbd2032692ed8e46e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i459e294ae30142cbaa00703fe6880103_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f7ccb539794924835d07e06230787c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb1c7c7993f443cb9775f4cbebcc4b05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if62877c0017f46508b1b76d1b8b631bf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84625c382b684cbd80fa57354e915031_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1edeeda0c4c64b50ada9a9fb45333935_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b69da3bc5f431d8d17902ad62e8a25_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b94b216b4504cbeb1073d1ba015dc60_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d06d946a93b476bb5c22cdc41e56321_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>natr:claim</xbrli:measure></xbrli:unit><xbrli:context id="i278d8bc5355b477b92355f58a24f1d03_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice670056e3d74a568288807e81b6068f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ca42816690450e90028e1c208eecb6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia864dc347810434d8b15fe90be07c05b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc305e5943754b04a7642c1ac05895ad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40f94801a594eb68bcddde4144029a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e88ec88e467480993fa728e6e906f56_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ef804aa7364469e9a21ea865050d6ce_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice92b1b1c68e485b9d90bc7240e9693a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80f04b1608e946ceac0e09928db01466_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c631233fcb545f395609cfbcdaed083_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34db597e9e84e55975f561965ebf581_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida56900bef5d44d6a5e8107f70534e32_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id080f7965727443cb14cd7096debc888_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="product_category"><xbrli:measure>natr:product_category</xbrli:measure></xbrli:unit><xbrli:context id="i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:FraudExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000275053</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:FraudExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iaff80d6feba84531aa76e6adafecaf3a_1"></div><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNTM_0c7930ff-7176-482d-81fe-e22667000ba1">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNzA_51f548f2-b301-44ff-8697-21dcaebf4fb4">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160; QUARTERLY REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yOTc_9eedf71c-beb9-4fa3-adef-37ef119920c8">March&#160;31, 2023</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8zMDg_24891ba2-baa5-4fec-996c-370d8c434b9b">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160; TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV80OTI_a6840f27-397e-4813-a72b-a63d8db8732f">001-34483</ix:nonNumeric></span></div><div style="text-align:center"><img src="natr-20230331_g1.jpg" alt="NS-logo-darkgreen.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:300px"/><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV80OTg_1aafa213-625c-498b-b449-bdb688f848c8">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6OWRkYWJhZDZhZmE3NGNhMDkzYmI4MzU2ODYwYjg4MGMvdGFibGVyYW5nZTo5ZGRhYmFkNmFmYTc0Y2EwOTNiYjgzNTY4NjBiODgwY18wLTAtMS0xLTU2NDYy_ced88f22-1ab1-4020-bf3f-8090b69a6270">Utah</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6OWRkYWJhZDZhZmE3NGNhMDkzYmI4MzU2ODYwYjg4MGMvdGFibGVyYW5nZTo5ZGRhYmFkNmFmYTc0Y2EwOTNiYjgzNTY4NjBiODgwY18wLTItMS0xLTU2NDYy_123fd5b3-89f7-477b-b53b-b9cb573a6b7e">87-0327982</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NjA_14668ad2-91af-4378-97b2-c8d79f5f74d7">2901 Bluegrass Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NjQ_e2c2afa4-930d-4ce5-8eba-ab7e2b032064">Suite&#160;100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81Njc_c3f189d2-9ce0-43e9-8b5b-d5ff03270fa2">Lehi</ix:nonNumeric>, <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NzE_478e6975-3e42-47da-8467-ee1d95772c81">Utah</ix:nonNumeric> <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NzQ_633c1e87-571a-4cfb-a46f-b44aa14ac2d7">84043</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices and zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV82MzQ_f6a52913-8fca-41e9-a5f4-e48721e0f2b3">801</ix:nonNumeric>) <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV82Mzg_a8aa810b-6e66-41da-b39d-9c7e1d4cbffa">341-7900</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTAtMS0xLTU2NDYy_b8ba02aa-de73-4c71-9142-64c07684416f">Common Stock, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTEtMS0xLTU2NDYy_8850eba4-cc60-46e3-acb0-d2c00358ddbf">NATR</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTItMS0xLTU2NDYyL3RleHRyZWdpb246NGEyMzAyZjFiY2RmNGE1M2FmOTk0YmU2ODE0NTIzMDhfNA_4652b7d6-ec61-41e7-bac1-973b75181f66">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant; (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160; <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xMTMy_becd98dd-5fa9-4ec1-ae14-0fdc3082ab69">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNDU4_f3e71189-9eb9-45e4-b6a3-abd575d6dcac">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and an &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N18wLTItMS0xLTU2NDYyL3RleHRyZWdpb246ODE0YmI5MzJiNWFkNDg4ZWIwNDYyMDQ4NzIwYjFhYTVfNQ_5db1047b-9faa-4fb1-a758-a4d778935492">Accelerated filer</ix:nonNumeric>&#160;&#160;&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N18yLTItMS0xLTU2NDYyL3RleHRyZWdpb246ZWIwMDVjNTI3NjA2NDU0MDg1NDlkNzVhOWRjMzI2OGJfMzE_cb228fd2-a066-4d81-b22d-e0b9a5de6a11">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N180LTItMS0xLTU2NDYyL3RleHRyZWdpb246MTc0NmUxOTA3MTEzNGE3NmI4MzE1YzE1ZWFjZDY2MTFfMzA_a2bf061a-f99e-4563-8788-05d8c40f5a0d">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yMzAy_598eafc7-d69c-46a5-8a7b-572d43f7af5d">&#253;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The number of shares of Common Stock, no par value, outstanding on April 21, 2023, was <ix:nonFraction unitRef="shares" contextRef="i323367af1eab405e83322a0281dd711b_I20230421" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yMjkx_e1eccce4-16ad-4311-9ed0-2c56fb1f223d">19,045,405</ix:nonFraction> shares.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarter Ended March&#160;31, 2023 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:77.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.855%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_13">Part&#160;I.&#160;Financial&#160;Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_16">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_22">Condensed Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_22">Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_25">Condensed Consolidated Statements of Comprehensive </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_25">L</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_25">oss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_28">Condensed Consolidated Statement</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_28">s</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_28"> of Changes in Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_76">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_76">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_79">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_79">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_79">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_82">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_82">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_82">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_85">Part&#160;II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_85">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_88">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_88">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_88">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_91">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_91">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_91">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_94">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_94">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_94">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_97">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_97">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_97">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_100">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_100">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_100">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_103">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_103">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_103">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_106">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_106">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_106">33</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information included or incorporated herein by reference in this report may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans, strategies and financial results, including expected improvement in gross profit and gross margin. All statements (other than statements of historical fact) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as &#8220;believe,&#8221; &#8220;hope,&#8221; &#8220;may,&#8221; &#8220;anticipate,&#8221; &#8220;should,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;positioned,&#8221; &#8220;strategy&#8221; and similar expressions, and are based on assumptions and assessments made in light of our experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. For example, information appearing under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; includes forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are more fully described in this report, including the risks set forth under &#8220;Risk Factors&#8221; in Item 1A, and in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022, but include the following:</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">extensive government regulations to which the Company&#8217;s products, business practices and manufacturing activities are subject;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">registration of products for sale in foreign markets, or difficulty or increased cost of importing products into foreign markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">legal challenges to the Company&#8217;s direct selling program or to the classification of its independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">laws and regulations regarding direct selling may prohibit or restrict our ability to sell our products in some markets or require us to make changes to our business model in some markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">liabilities and obligations arising from improper activity by the Company&#8217;s independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">product liability claims;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">impact of anti-bribery laws, including the U.S. Foreign Corrupt Practices Act;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Company&#8217;s ability to attract and retain independent consultants;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the loss of one or more key independent consultants who have a significant sales network;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the Company&#8217;s joint venture for operations in China with Fosun Industrial Co., Ltd.;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the effect of fluctuating foreign exchange rates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">failure of the Company&#8217;s independent consultants to comply with advertising laws;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes to the Company&#8217;s independent consultants compensation plans;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">geopolitical issues and conflicts;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">adverse effects caused by the ongoing coronavirus pandemic;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">negative consequences resulting from difficult economic conditions, including the availability of liquidity or the willingness of the Company&#8217;s customers to purchase products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">risks associated with the manufacturing of the Company&#8217;s products;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">supply chain disruptions, manufacturing interruptions or delays, or the failure to accurately forecast customer demand;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">failure to timely and effectively obtain shipments of products from our manufacturers and deliver products to our independent consultants and customers;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">world-wide slowdowns and delays related to supply chain, ingredient shortages and logistical challenges;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">uncertainties relating to the application of transfer pricing, duties, value-added taxes, and other tax regulations, and changes thereto;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes in tax laws, treaties or regulations, or their interpretation;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">failure to maintain an effective system of internal controls over financial reporting;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">cybersecurity threats and exposure to data loss;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the storage, processing, and use of data, some of which contain personal information, are subject to complex and evolving privacy and data protection laws and regulations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">reliance on information technology infrastructure; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the sufficiency of trademarks and other intellectual property rights.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements speak only as of the date of this report and are expressly qualified in their entirety by the cautionary statements included in or incorporated by reference into this report. Except as is required by law, we expressly disclaim any obligation to publicly release any revisions to forward-looking statements to reflect events after the date of this report.&#160;Throughout this report, we refer to Nature&#8217;s Sunshine Products,&#160;Inc., together with our subsidiaries, as "we," "us," "our," "our Company" or &#8220;the Company.&#8221;</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;I FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINANCIAL STATEMENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMy0xLTEtMS01NjQ2Mg_eedc9b71-77ae-41bc-ae89-0c18d5174986">65,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMy0zLTEtMS01NjQ2Mg_f09bfd88-98d2-4a8b-b81f-68b7ecb5747e">60,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0wLTEtMS01NjQ2Mi90ZXh0cmVnaW9uOjllYWMxMTViMmQ4ZjRhZDY5YWIxOTM1MWE3NDE1MmI1XzY3_766675c6-c073-44c6-8221-a63886183796">122</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0wLTEtMS01NjQ2Mi90ZXh0cmVnaW9uOjllYWMxMTViMmQ4ZjRhZDY5YWIxOTM1MWE3NDE1MmI1Xzc0_0692be04-779a-41dc-80bf-e779063b9ee8">120</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0xLTEtMS01NjQ2Mg_80a4c9f7-5312-467f-841a-0b346f9731fd">10,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0zLTEtMS01NjQ2Mg_07d7560b-c7c4-4309-bf20-40aa53012f61">14,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNy0xLTEtMS01NjQ2Mg_b49de540-76d2-46a2-b56f-dfee9ca21d19">67,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNy0zLTEtMS01NjQ2Mg_95b66977-bdad-47fd-895f-05241a63124e">67,949</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOC0xLTEtMS01NjQ2Mg_d2ae8be1-2879-4b4d-ad67-eef2a169e209">10,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOC0zLTEtMS01NjQ2Mg_d6d047dc-1812-416c-8ea2-4aa1593152d4">7,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOS0xLTEtMS01NjQ2Mg_091b80cc-1e27-4af9-a0f9-87918dca954f">154,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOS0zLTEtMS01NjQ2Mg_feba9238-093a-4003-adf3-77f58cc772f2">149,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTEtMS0xLTEtNTY0NjI_c3eaea10-1ed3-49ff-bfa0-a4f6de20257d">46,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTEtMy0xLTEtNTY0NjI_6c996d58-2a70-466e-92ac-0c44a2264482">46,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTItMS0xLTEtNTY0NjI_a5bc687d-c480-4431-a4c8-7643296a327f">16,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTItMy0xLTEtNTY0NjI_14f66ee0-3c4e-43fc-b3cf-56afb13aef67">16,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTMtMS0xLTEtNTY0NjI_9c4e80a1-132e-4643-b675-98dc439f7328">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:DebtSecuritiesTradingRestricted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTMtMy0xLTEtNTY0NjI_3659192d-b9fb-4e56-8b49-997944b187ec">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTUtMS0xLTEtNTY0NjI_7d6c04df-0559-4f89-ac1d-812fe2934146">6,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTUtMy0xLTEtNTY0NjI_7ff48cae-8344-4d6c-90a6-1fc81811dd04">6,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTYtMS0xLTEtNTY0NjI_cda6d13f-2b9d-4343-b94e-ce6511845add">10,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTYtMy0xLTEtNTY0NjI_7a1d9fed-2979-43cf-b512-99b3d885b7fc">10,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTctMS0xLTEtNTY0NjI_900511f4-c1a7-40b8-aefd-1f43c865b0e8">234,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTctMy0xLTEtNTY0NjI_4c18031a-a659-416d-8bf5-932713303104">229,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjEtMS0xLTEtNTY0NjI_8e78b39f-f015-4bbd-b49d-8b4d5198d3ae">8,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjEtMy0xLTEtNTY0NjI_8b912fd9-0c36-4771-824b-026231b433d1">6,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjItMS0xLTEtNTY0NjI_de5c2bb7-f526-4e67-8732-a45273c65e2b">22,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="natr:AccruedVolumeIncentiveandServiceFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjItMy0xLTEtNTY0NjI_5a787bc7-4a83-499b-a69a-af6da4683ef2">21,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjMtMS0xLTEtNTY0NjI_a2be5684-6ab3-41eb-b7d2-0d6d8efa5028">28,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjMtMy0xLTEtNTY0NjI_a1dd280e-5a79-4135-8c5b-e93053051513">25,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjQtMS0xLTEtNTY0NjI_6a25cc4d-5684-4630-ac1f-6a30c45c3f5e">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjQtMy0xLTEtNTY0NjI_8eefcd5f-f9dc-486b-a971-7711b64dd479">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjctMS0xLTEtNTY0NjI_d724de76-745d-4643-851b-35f4550f0e5b">4,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjctMy0xLTEtNTY0NjI_80469870-3482-4e9c-b909-b166ddcec544">4,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjgtMS0xLTEtNTY0NjI_1840fdec-4ab5-4c3d-b678-75624ed4ef53">4,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjgtMy0xLTEtNTY0NjI_4f1b5528-d448-4e8b-a8ec-6478cd319d3d">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of note payable and revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjktMS0xLTEtNTY0NjI_5a282618-dc88-4b8f-b63e-9d4af1c6442f">1,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjktMy0xLTEtNTY0NjI_30b5e068-02ce-4ed1-a6c6-529d149b68a9">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzAtMS0xLTEtNTY0NjI_cadb4f17-2141-47d4-b2ff-cd4744879d2b">71,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzAtMy0xLTEtNTY0NjI_3c938bf3-0fc4-4e9a-8fe6-35e379c6195e">65,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzItMS0xLTEtNTY0NjI_99469cb5-8c16-4d33-9790-5e23b5792a60">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:LiabilityForUncertainTaxPositionsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzItMy0xLTEtNTY0NjI_2ef3ec32-920c-4905-82ab-930d1b1e8fd0">209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzMtMS0xLTEtNTY0NjI_2bb9b197-be70-4268-88b1-b3217eee28f6">13,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzMtMy0xLTEtNTY0NjI_8de7b064-ae13-4a6f-8357-d1d6b02ba01d">13,745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzYtMS0xLTEtNTY0NjI_24234426-13c4-4d77-9596-e017af3ecb8e">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzYtMy0xLTEtNTY0NjI_4c34dce0-488d-4e83-b4ec-8360c4bb40e1">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzctMS0xLTEtNTY0NjI_dacc6185-acdb-4e32-8385-8887881bea7a">936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzctMy0xLTEtNTY0NjI_97529b13-71f8-4575-b201-2c3ab320187a">1,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzgtMS0xLTEtNTY0NjI_0382fba6-0fc5-4b38-b99e-e5a3ffd7d927">1,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzgtMy0xLTEtNTY0NjI_91121bcc-694b-4539-bfac-2d14ffa6dc1d">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzktMS0xLTEtNTY0NjI_fb5f411e-db09-48c5-add5-aa55827e75f6">87,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzktMy0xLTEtNTY0NjI_59d86024-4e34-4fac-b058-420608552cc7">82,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, <ix:nonFraction unitRef="usdPerShare" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="2" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8xOA_7e121baf-e531-41c6-a7a7-21f5b3d2a95a"><ix:nonFraction unitRef="usdPerShare" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="2" name="us-gaap:CommonStockNoParValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8xOA_976b87a8-a63f-4635-b2fb-0960a3cd1ae9">no</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8zMg_8dcd7a4a-8707-4454-a1e4-e47b11d1b6c2"><ix:nonFraction unitRef="shares" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8zMg_e640dac5-b793-47dc-a130-97c12696f736">50,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl81NA_48cbfba7-258b-4673-bc97-308034a1118a"><ix:nonFraction unitRef="shares" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl81NA_922dfc02-7ebf-49ae-b3c8-671726f6b9ad">19,045</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl82MQ_1b43bdd3-65ba-4886-aee7-f0d0118e5ce4"><ix:nonFraction unitRef="shares" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl82MQ_5994ad79-7cba-402c-9cdd-a9bacb25d396">19,093</ix:nonFraction></ix:nonFraction> shares issued&#160;and outstanding, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMS0xLTEtNTY0NjI_6a1519ec-0f12-47fa-af48-6a2878e06dfc">121,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMy0xLTEtNTY0NjI_b8f06870-f604-411f-9777-529d85f42a58">121,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDUtMS0xLTEtNTY0NjI_dd9403fc-2f1c-44a6-8d28-a253751757c0">35,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDUtMy0xLTEtNTY0NjI_5f09f9a3-7987-4cb0-8418-01b0915689e1">34,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDYtMS0xLTEtNTY0NjI_a648c3ac-e67a-4d92-a41f-df335f2c42b2">4,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDYtMy0xLTEtNTY0NjI_eb07483c-5a83-46d0-931b-58ed8ee43115">4,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDctMS0xLTEtNTY0NjI_28a9a2f1-a10b-419c-b84d-ec8ea62e3dad">14,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDctMy0xLTEtNTY0NjI_eea20b2a-6f9b-42a0-9d74-2ca10de63629">13,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDgtMS0xLTEtNTY0NjI_e71159aa-bd3f-48ef-92b5-c115e1cc0243">146,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDgtMy0xLTEtNTY0NjI_04a58a29-0158-494d-827e-790b15b168c1">147,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDktMS0xLTEtNTY0NjI_e8c111ce-c198-488f-a4ed-0d936c726109">234,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDktMy0xLTEtNTY0NjI_82439728-b774-4eb0-9926-ae3455950d1b">229,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands, except per share information)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMi0xLTEtMS01NjQ2Mg_0e87883c-5655-4b57-b087-881f57584c91">108,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMi0zLTEtMS01NjQ2Mg_eff496f1-dacc-49bc-ae28-9b11a7f4b896">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMy0xLTEtMS01NjQ2Mg_42383e41-0d1a-44a1-9290-36b9feae3092">31,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMy0zLTEtMS01NjQ2Mg_24ab851f-fc00-417f-bb60-99a1d04b2af9">34,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNC0xLTEtMS01NjQ2Mg_e65415bb-15ec-46ef-9632-280dc46e68cf">76,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNC0zLTEtMS01NjQ2Mg_e0e5180e-eed1-44c5-b45f-6ba20331a8ab">76,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNy0xLTEtMS01NjQ2Mg_37611539-a72f-433a-8473-dd8d2a8db129">33,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="natr:VolumeIncentives" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNy0zLTEtMS01NjQ2Mg_9ca06a18-e909-4c15-9a80-f30783089a4e">34,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOC0xLTEtMS01NjQ2Mg_ffbf4f23-8aa7-4708-8d8c-1e73cdb19178">43,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOC0zLTEtMS01NjQ2Mg_014dd347-b1c6-4762-a68e-7781f8a11032">40,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOS0xLTEtMS01NjQ2Mg_dee28a52-ddae-4c36-9d60-03788ea6b40d">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOS0zLTEtMS01NjQ2Mg_aa476035-b804-41c4-92a1-f4de6cfa1a9c">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTAtMS0xLTEtNTY0NjI_337bc55e-016e-448f-bb44-900e202181a6">1,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTAtMy0xLTEtNTY0NjI_0eb11d2d-4083-4245-b247-1e4baac054e7">314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTEtMS0xLTEtNTY0NjI_c41c5470-7b83-4e1a-aec5-20c777a2a7ec">1,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTEtMy0xLTEtNTY0NjI_764bf453-0d2a-4377-9f94-bd7a20bb97ee">995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTItMS0xLTEtNTY0NjI_1c53c0f5-52de-4dc3-935b-c44ea82ba2fd">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTItMy0xLTEtNTY0NjI_a762dd7a-d160-4cc0-bf26-c5ce9042b84d">3,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTMtMS0xLTEtNTY0NjI_44ddf386-03a4-40a1-9c0f-2e5b33ad1086">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTMtMy0xLTEtNTY0NjI_99fa68ad-a87e-4645-8cc7-156bdb288ad7">2,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTQtMS0xLTEtNTY0NjI_eaa7cf8d-38db-429d-96e1-099280399202">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTQtMy0xLTEtNTY0NjI_863b28e4-a24a-470a-95dd-272cd278b58a">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTUtMS0xLTEtNTY0NjI_4759f11b-942f-40c0-b579-eeecc7d0e0ea">860</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTUtMy0xLTEtNTY0NjI_e286afa7-aac7-4479-9b73-8aca492e87c6">2,950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net income (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjItMS0xLTEtNTY0NjI_2e7ee067-7136-4d87-83ae-de5553786a75">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjItMy0xLTEtNTY0NjI_7dfb5fe3-2335-44bb-8561-89d69418b128">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjctMS0xLTEtNTY0NjI_a3f0069b-9ef1-44f5-b0bd-f6a41aa145a8">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjctMy0xLTEtNTY0NjI_7c7ea667-c6ec-4b00-a7c8-d3d754b4313f">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average basic common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjktMS0xLTEtNTY0NjI_5b5e2b21-c079-4292-b39c-b3f458780145">19,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjktMy0xLTEtNTY0NjI_8510c6cb-0b94-4913-ae7d-3ebf17a68320">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMzAtMS0xLTEtNTY0NjI_48c91efb-087d-4516-b871-3a5059d3042b">19,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMzAtMy0xLTEtNTY0NjI_baa6a09d-4d36-4d32-a9ed-a0534ee3a32d">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMi0xLTEtMS01NjQ2Mg_8c7381f1-8294-4824-bf61-70ae709579ee">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMi0zLTEtMS01NjQ2Mg_f9976858-0185-48f3-944b-a8dc387ab571">2,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation loss (net of tax)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMy0xLTEtMS01NjQ2Mg_afd43b07-8cce-43d1-925a-05fd4aa78b0c">1,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMy0zLTEtMS01NjQ2Mg_6f2e4ed3-af08-442c-b29b-b07f0d7277ce">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfNy0xLTEtMS01NjQ2Mg_09795fad-7393-4308-9c96-59e0928b94e2">400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfNy0zLTEtMS01NjQ2Mg_2cca30b2-8659-4bba-9b7e-ce221ff08c9d">3,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3756408ac1534f02be1f929758b190ec_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0xLTEtMS01NjQ2Mg_4bfed6cc-bc60-4c47-b6cb-1ce750b79152">19,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3756408ac1534f02be1f929758b190ec_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0zLTEtMS01NjQ2Mg_11418bc6-3dfb-48c1-aa96-f59b541762f3">121,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c5ec96e95bb479aa9317328c85875ff_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi01LTEtMS01NjQ2Mg_99dcc224-1741-4989-9d86-4f8e36d621ce">34,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8e99e23cdc04ca3967d8e0cc86c9bc9_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi03LTEtMS01NjQ2Mg_927802b2-a3c2-4415-bbdd-fd0db58f4f17">4,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic159bd1e6c754fc598df19fee673181b_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi05LTEtMS01NjQ2Mg_cf272285-8f67-4f28-8f8f-fd19fa24d30e">13,313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0xMS0xLTEtNTY0NjI_75d28ebd-1b3e-44a6-9266-dd65a0b66be6">147,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMy0zLTEtMS01NjQ2Mg_8c6920b6-ef63-4682-a58f-ed699caeffae">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMy0xMS0xLTEtNTY0NjI_9d3164c7-a9af-4a8d-a6cb-234b6be2b859">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0xLTEtMS01NjQ2Mg_003a92cc-da52-4ed3-98ab-7b04df31487d">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0zLTEtMS01NjQ2Mg_6072adb2-04a2-49f5-8890-d0c5a8e144f6">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0xMS0xLTEtNTY0NjI_29ce9af1-7ca1-4e6d-8657-b8b2be5f8fa5">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0xLTEtMS01NjQ2Mg_45e6df45-5dec-43ea-9a49-6e79e6787563">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0zLTEtMS01NjQ2Mg_7b53f89e-8603-4434-9097-7534b58c8448">823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0xMS0xLTEtNTY0NjI_6342bf40-c00c-4ed3-acc4-426a458aa3ba">823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1b157582d54aa5b6c76556a72d0fa1_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi01LTEtMS01NjQ2Mg_8619baf8-99c4-4254-8864-784be1f3434f">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i078db4ca9b324f02b4b009b8e5063922_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi03LTEtMS01NjQ2Mg_657582c8-7002-4615-82b1-d7076eb42462">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi0xMS0xLTEtNTY0NjI_f93e91e4-9f7a-4a99-945c-b3c9d66d4d36">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia77345b7632f4c3687707a676a2ecdba_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNy05LTEtMS01NjQ2Mg_bd75e1e1-f7be-408f-8c90-5c2640807ebf">1,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNy0xMS0xLTEtNTY0NjI_c80a2f8b-c735-423e-b81c-7693aedb0e83">1,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i397792870c944251a9e358f23c5e3f82_I20230331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0xLTEtMS01NjQ2Mg_bf0d7400-f113-4283-9570-d678a28852ea">19,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i397792870c944251a9e358f23c5e3f82_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0zLTEtMS01NjQ2Mg_e5db05d9-1377-43f9-ba1b-3788ae014948">121,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifecfce154349479aaa1ff1d6bfd331aa_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC01LTEtMS01NjQ2Mg_dbf16e0e-3747-4f0a-b5c7-d7d73cb3f3c5">35,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id071f960be3f4eddb4fddc539cef8fb2_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC03LTEtMS01NjQ2Mg_71fbf1dc-2972-4234-9b9d-9bdfac4cc152">4,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i118dbcf5a4fc44b8985c21224e382a89_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC05LTEtMS01NjQ2Mg_a5286204-5115-4849-8b9e-085908118bbe">14,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0xMS0xLTEtNTY0NjI_984c4aae-a037-4408-b345-2d15d17bb08c">146,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:34.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.875%"></td><td style="width:0.1%"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0691a9d3b51c404f83e92ca13c32ff39_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0xLTEtMS01NjQ2Mg_7ef749b4-a051-4e04-99bb-fe8f8a9149fc">19,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0691a9d3b51c404f83e92ca13c32ff39_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0zLTEtMS01NjQ2Mg_2374c0e1-1332-42dd-a1e9-70a863fbf7a5">133,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a92d6d58b6c43fc949181a4738e553c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi01LTEtMS01NjQ2Mg_b9b12ba2-0252-4b4a-95b4-bb7a0f3b3fc1">35,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53dcd0f7b104910a52899f37012afd3_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi03LTEtMS01NjQ2Mg_772bcb17-6b92-4a2d-be1e-d206b647fb75">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f72f97c01a743d790b5acf8b55c9d24_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi05LTEtMS01NjQ2Mg_23070b24-abc0-4472-b0e7-f8a1320e9137">10,205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40450c215064f9a9f895bc248da7a1e_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0xMS0xLTEtNTY0NjI_c43d9ba3-e0f4-4e2f-9e61-947eb6c52aed">161,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMy0zLTEtMS01NjQ2Mg_326195ce-602e-4639-bca0-0595861ebbbb">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMy0xMS0xLTEtNTY0NjI_d478fedf-7712-4fdc-b4a9-d959c6037377">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331" decimals="-3" name="natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0xLTEtMS01NjQ2Mg_7cb7f022-3bf9-4fac-87cd-67cea78b2cec">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0zLTEtMS01NjQ2Mg_53eafc39-98ab-4092-943b-18fc77068caa">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0xMS0xLTEtNTY0NjI_6171ffae-d837-49e4-8bf1-0c4866791e2d">795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0xLTEtMS01NjQ2Mg_050401d3-366f-4bf1-9573-9af4d775cf05">451</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0zLTEtMS01NjQ2Mg_ce062d12-6ca1-4e7f-9448-5bf462f7c37e">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0xMS0xLTEtNTY0NjI_5131a996-b861-4c50-bf78-fd3ac07bc459">7,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ce5e44a4ef64052aea959ec0f39d8d8_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi01LTEtMS01NjQ2Mg_d3c542c2-9e53-4098-93f6-a0cad98913d1">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25cd1edc1c964494bbd0f0f6d41bfd3c_D20220101-20220331" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi03LTEtMS01NjQ2Mg_b656f0ed-e974-49d8-819e-53d9f425e179">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi0xMS0xLTEtNTY0NjI_2fbe6e2f-0069-4d27-a762-73f48f3a16be">2,686</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66a7e3f9c206413f8e34219e584092b1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNy05LTEtMS01NjQ2Mg_70b7ccd7-dac5-43bb-8653-9c184aec6c06">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNy0xMS0xLTEtNTY0NjI_6b0567f8-0d7d-4ea6-8f01-c3bfa59b05cf">975</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8deaf3592d424474a99cc4c83beafb75_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0xLTEtMS01NjQ2Mg_bdfa8e52-974d-41fb-8cd5-fb6d446eab6e">19,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8deaf3592d424474a99cc4c83beafb75_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0zLTEtMS01NjQ2Mg_187f9564-a7a5-455b-97e6-b0f3d8bab719">125,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff00616fa06b404996d8b5bb02df09ce_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC01LTEtMS01NjQ2Mg_6cc11576-a07e-453d-a71f-8870b096aca3">32,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id89baad6125140598d815d83ca0cfa3f_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC03LTEtMS01NjQ2Mg_395092e7-cf8d-4421-8fe6-743258b4e980">3,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3aafe404f0443248657956fd2be506f_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC05LTEtMS01NjQ2Mg_8503dd1c-1845-4fee-a2cd-434b8bbc027e">11,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e403872b0564650b45c1c4ce25c58da_I20220331" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0xMS0xLTEtNTY0NjI_bd14b710-1efb-4740-a9cc-0fdac085f424">149,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Amounts in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMy0xLTEtMS01NjQ2Mg_e1162785-85c1-439d-a7b6-57309734d648">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMy0zLTEtMS01NjQ2Mg_ffb44849-88b2-4c97-a053-21e23636873b">2,686</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNS0xLTEtMS01NjQ2Mg_85eff410-6cc9-4b74-82cd-970587b4cea2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNS0zLTEtMS01NjQ2Mg_079e1473-5d32-4ecc-8bd2-f28be19f3a79">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNi0xLTEtMS01NjQ2Mg_b89ae2f5-8bb8-4931-9e21-9269f29f6953">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNi0zLTEtMS01NjQ2Mg_da3433a7-4453-4514-b250-8071d5488641">2,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNy0xLTEtMS01NjQ2Mg_1a12d05e-82d1-41c9-94c0-ec91f698d155">932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="natr:OperatingLeaseNonCashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNy0zLTEtMS01NjQ2Mg_dd95e683-c3a3-4295-9801-a61e828c9fcb">1,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOC0xLTEtMS01NjQ2Mg_929bd652-feef-4a30-92d5-2666ca615ff6">1,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOC0zLTEtMS01NjQ2Mg_11445214-44b3-41a8-9a7a-f9944e857124">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Loss on sale of property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOS0xLTEtMS01NjQ2Mg_4201c311-ee30-4834-80c3-e60784583b03">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOS0zLTEtMS01NjQ2Mg_77e2c8de-07ec-4173-8dd3-510511662fdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTAtMS0xLTEtNTY0NjI_775996c3-6f32-43a4-8234-c9ab3ed208e4">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTAtMy0xLTEtNTY0NjI_ce8a7dc2-2e28-457b-af7f-2b599c85dbea">3,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchase of trading investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTEtMS0xLTEtNTY0NjI_d536e9eb-1292-4397-a826-3fd2011799b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTEtMy0xLTEtNTY0NjI_f42d7809-65ff-451d-ae07-e17bb3b11732">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from sale of trading investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTItMS0xLTEtNTY0NjI_5ccbbc4d-0419-4005-baa2-ca7ade5a9653">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTItMy0xLTEtNTY0NjI_286eb30f-e971-40d7-97ed-fb969c523e2e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Realized and unrealized (gains) losses on investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTMtMS0xLTEtNTY0NjI_3bc2211b-0956-4861-8561-cb351a259545">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTMtMy0xLTEtNTY0NjI_59adb3aa-1d52-4d8d-b3b9-41a8ecc66990">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Foreign exchange losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTQtMS0xLTEtNTY0NjI_3e6a311b-d9a2-44dd-a768-1673dd0e5d5a">1,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTQtMy0xLTEtNTY0NjI_708329c2-3c43-4ffe-9c79-ce8809e9b834">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTYtMS0xLTEtNTY0NjI_b3d17698-5af2-4264-82ef-f5165822645b">3,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTYtMy0xLTEtNTY0NjI_12c8aa05-00d3-4c17-a9fb-993c47b376d9">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTctMS0xLTEtNTY0NjI_158131bf-3678-4a89-8179-6c288f0c0aa3">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTctMy0xLTEtNTY0NjI_3fde476c-8d9d-4c38-881d-04fea75ccabc">3,489</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTgtMS0xLTEtNTY0NjI_7d191cb9-0551-4ac1-83cf-383570e2fb7b">3,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTgtMy0xLTEtNTY0NjI_6f624b37-8db0-4a62-8e71-9ef5f60dde97">2,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTktMS0xLTEtNTY0NjI_734fe12b-8226-44d3-b46a-900b790ffea3">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTktMy0xLTEtNTY0NjI_005dbf63-2f68-49a4-92c5-28e5c8c1490f">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjAtMS0xLTEtNTY0NjI_d9f2fa02-3fc2-452d-93bd-a342496b914d">2,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjAtMy0xLTEtNTY0NjI_e5225cf5-14eb-4081-971b-d214729b8b02">946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued volume incentives and service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjEtMS0xLTEtNTY0NjI_6d04061f-424b-49d7-86a7-781ec35493ca">781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjEtMy0xLTEtNTY0NjI_28edff1c-ff5f-445c-8747-f4c8974389bc">464</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjItMS0xLTEtNTY0NjI_90d90bd3-b1b4-49db-b8d6-060fcd358cdd">2,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjItMy0xLTEtNTY0NjI_3adbe3dc-b100-4876-9720-c5611d0f31ba">5,386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjMtMS0xLTEtNTY0NjI_a1c901b0-d1b2-4b40-bff5-8815dd17d0c2">1,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjMtMy0xLTEtNTY0NjI_24bba76f-2d29-4541-8a29-bb76e7d425bf">1,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjQtMS0xLTEtNTY0NjI_2e8999fb-e232-46da-b3a6-c4f511e88cd5">900</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="natr:IncreaseDecreaseInOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjQtMy0xLTEtNTY0NjI_f9d85d16-2592-48ae-8bec-2ee6b27fa540">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjUtMS0xLTEtNTY0NjI_74a0c07e-8da3-40f4-9f76-04f9e8a6c72c">586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjUtMy0xLTEtNTY0NjI_d312a782-4682-4754-8713-bf95eacf638d">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Liability related to unrecognized tax benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjYtMS0xLTEtNTY0NjI_f637c542-0734-4aab-96fe-8d732ff15754">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjYtMy0xLTEtNTY0NjI_bfe1de6e-ba54-4fab-8e8e-b048dbc54c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred compensation payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjctMS0xLTEtNTY0NjI_3cb491a7-595e-4289-bad6-8a645ccd63af">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjctMy0xLTEtNTY0NjI_014a0c28-1152-4f6e-9168-f1b3f7081796">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjgtMS0xLTEtNTY0NjI_e7053351-7e89-446a-a639-1dec960ec97b">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjgtMy0xLTEtNTY0NjI_b9fd040d-4b47-47d8-9beb-3c7b95777ee4">7,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzAtMS0xLTEtNTY0NjI_577d4a70-9a8d-4573-a851-cf8b6940ec33">2,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzAtMy0xLTEtNTY0NjI_3abac890-0561-4f47-9415-1f88894274ad">1,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzQtMS0xLTEtNTY0NjI_8c2b383c-82cc-47ab-b79e-b4d56065b32d">2,325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzQtMy0xLTEtNTY0NjI_4537dc46-60e4-4e8c-9321-c462dbef1f1d">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzctMS0xLTEtNTY0NjI_de4fc6b2-3d59-462c-b536-a4b4e82a5721">318</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfOtherLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzctMy0xLTEtNTY0NjI_de83acae-4ad0-4d93-80e0-7bb03c6a0baf">308</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzgtMS0xLTEtNTY0NjI_f9c7f019-c1f2-4c31-9914-0e264f66910f">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzgtMy0xLTEtNTY0NjI_4b57f57d-27b3-41f5-ae8d-6a3e452dbf18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of revolving credit facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzktMS0xLTEtNTY0NjI_41ebff81-4574-4eb5-96e9-ada08841e74f">283</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzktMy0xLTEtNTY0NjI_6bbc56bf-9d23-4c71-8800-571ba5702beb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Principal payments of related party borrowing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDEtMS0xLTEtNTY0NjI_023da8fb-e3a9-43c3-b14c-ca293d76c962">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDEtMy0xLTEtNTY0NjI_eec4d9f1-56f0-445f-ae3a-b7a965f19622">300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Payments related to tax withholding for net-share settled equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDMtMS0xLTEtNTY0NjI_e11b2460-2d61-4e91-ae92-3043d14ed54d">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDMtMy0xLTEtNTY0NjI_d75ac47c-8521-4582-b169-24471a36e8ca">795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDUtMS0xLTEtNTY0NjI_897f6e63-e382-4ff0-89a2-509e3571717b">823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDUtMy0xLTEtNTY0NjI_fd4615cf-8ff1-46c3-be94-756d450b918d">7,971</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDYtMS0xLTEtNTY0NjI_addb4e51-bf7a-4b4b-b43f-fb6a4a298c6b">1,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDYtMy0xLTEtNTY0NjI_f5080a1f-2e14-4c1a-8281-7760e5c9af8f">9,374</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Effect of exchange rates on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDctMS0xLTEtNTY0NjI_81718f6b-0bf7-4cc2-b059-ebd32bec01b5">156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDctMy0xLTEtNTY0NjI_64966fe9-a309-49c2-8ee8-5158cc848017">827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDgtMS0xLTEtNTY0NjI_d1ed3d83-bf4c-4fbb-a008-19a6b2c0a46f">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDgtMy0xLTEtNTY0NjI_4201f8da-85a3-41cf-9b1a-1a3eea5ee56c">19,643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the beginning of the period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDktMS0xLTEtNTY0NjI_c2537fdc-4642-4d9b-849f-5d0447bfc139">60,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40450c215064f9a9f895bc248da7a1e_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDktMy0xLTEtNTY0NjI_125756d2-a036-4147-98ac-cf7ab7c4b3d8">86,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at the end of the period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTAtMS0xLTEtNTY0NjI_378408fe-dcff-4391-9f94-21b84eb9b75a">65,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e403872b0564650b45c1c4ce25c58da_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTAtMy0xLTEtNTY0NjI_3a567a76-e824-406d-8ef1-b784a88a0414">66,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTItMS0xLTEtNTY0NjI_b6ab73ac-2c6a-4c1a-b3ae-af8b04604f8e">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTItMy0xLTEtNTY0NjI_7b6d64e7-8490-4851-be33-e91afca41a09">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTMtMS0xLTEtNTY0NjI_bb3dd75a-972d-47b9-b28a-a068db05c7eb">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTMtMy0xLTEtNTY0NjI_92387514-74b1-4a0d-beaa-e83e3a32f796">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU1OQ_e24b1d86-d58d-443c-be70-4671ad43e323" continuedAt="i237a1012e16f46afa3f43e8d092a4c3a" escape="true"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU2NA_fcfb68b4-2b32-4ba3-a873-5221b20e9597" continuedAt="i4f4fef44dfe64d0e948697c0b6813c67" escape="true">Basis of Presentation</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i4f4fef44dfe64d0e948697c0b6813c67"><ix:continuation id="i237a1012e16f46afa3f43e8d092a4c3a"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU4MA_786a713e-67f5-423d-b00b-e8e2acba9f04" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2023, and for the three-month periods ended March&#160;31, 2023 and 2022. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.</span></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU3Mw_222b1e25-497a-46e3-833a-b3f5ac40633c" continuedAt="i42551dd0f155412e962599a648812206" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i42551dd0f155412e962599a648812206">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</ix:continuation> </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzAxMg_c178c62f-291e-4363-88a8-983da6e310ea">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-5" name="us-gaap:MinorityInterestPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMTY0OTI2NzQ0NjMwMQ_1c1cf980-d67f-4ffd-a7c2-260d5f814622">0.3</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, noncontrolling interests were $<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzI0Mw_794a1ee6-c2db-4082-ab78-78b51a0c7372">4.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-5" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzI1MA_afc9d594-c380-4d69-9ccc-3a2b90633b3a">4.1</ix:nonFraction> million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU1Mg_b67e8129-d468-4697-b31c-4d7101866362" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective during the three months ended March&#160;31, 2023, had, or is expected to have, a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RleHRyZWdpb246MGFhMmRkODc0NDFjNGRjMGI1ZmYxNjY4NDdhNGM2Y2NfMTEw_ddcfb547-2ecf-452a-a6c5-8d9c112169e0" continuedAt="ie3ddbb53e23c40cd87d947735aeed726" escape="true">Inventories</ix:nonNumeric></span></div><ix:continuation id="ie3ddbb53e23c40cd87d947735aeed726"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RleHRyZWdpb246MGFhMmRkODc0NDFjNGRjMGI1ZmYxNjY4NDdhNGM2Y2NfMTA2_2fd542f0-8e50-4a20-b0f0-9be3b2ce920d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMS0xLTEtMS01NjQ2Mg_a2f5282d-d654-4711-b04d-712924a6b255">22,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMS0zLTEtMS01NjQ2Mg_34cfd828-fb16-419d-a888-82c2570feaca">23,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMi0xLTEtMS01NjQ2Mg_1b4eb6c2-2f91-45c5-b666-25982cd6d0a8">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMi0zLTEtMS01NjQ2Mg_c87648cc-17c3-47e9-b9c7-d84aeb9e661c">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMy0xLTEtMS01NjQ2Mg_f8fe1982-fc0a-4c5b-ab3f-4cd5cf9d3212">43,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMy0zLTEtMS01NjQ2Mg_5d15b9d4-dd68-4400-86a6-9db1682a4113">43,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfNC0xLTEtMS01NjQ2Mg_f85e1948-de1c-43cc-8fec-ea6b2f7b4d74">67,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfNC0zLTEtMS01NjQ2Mg_7991a0ea-1105-49e4-97b6-7867c11e913d">67,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMjc3_ea29424c-8da7-4605-9b49-eb4c4b355e97" continuedAt="if53f97f5c3244838a35c14ec717b095c" escape="true">Investment Securities - Trading</ix:nonNumeric></span></div><ix:continuation id="if53f97f5c3244838a35c14ec717b095c"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trading securities portfolio totaled $<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfODQ_e940aa49-0c00-466b-a6ec-c83ee55a90fe">0.7</ix:nonFraction> million at March&#160;31, 2023, and $<ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-5" name="us-gaap:DebtSecuritiesTradingRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfOTg_dd747dda-4e60-49b6-a5bb-8f4e39e3f749">0.7</ix:nonFraction> million at December&#160;31, 2022, and generated gains of $<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMTMy_babf91a7-0df6-4b5a-9f33-eb475d8eb54b">47,000</ix:nonFraction> and losses of $<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesTradingRealizedGainLoss" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMTM5_61430a8f-fa9e-49de-aa2e-813154992bce">58,000</ix:nonFraction> for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMjEwMA_7082023e-b0e3-4910-a2c1-96eac637043e" continuedAt="ife71961e5d6a42f78438669c8e4e72d6" escape="true">Revolving Credit Facility and Other Obligations</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ife71961e5d6a42f78438669c8e4e72d6"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$<ix:nonFraction unitRef="usd" contextRef="i43b99692a035464f8b8f7f2449d7eccc_I20170711" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTc1_889ebc6b-0d81-4511-ba79-b9dd6d8b508a">25.0</ix:nonFraction> million (the &#8220;Credit Agreement&#8221;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $<ix:nonFraction unitRef="usd" contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzM5_e4165706-6abb-4bbb-8629-8971448569d4">25.0</ix:nonFraction>&#160;million or up to <ix:nonFraction unitRef="borrowing" contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623" decimals="INF" name="natr:LineOfCreditFacilityNumberOfSeparateIncreases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzUx_ab0af69b-9953-48df-b9b4-f3c697658d7d">three</ix:nonFraction> separate increases of no less than $<ix:nonFraction unitRef="usd" contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623" decimals="-5" name="natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzg5_555046d8-ed8b-4ea1-b97c-6f3a61071942">5.0</ix:nonFraction>&#160;million each, subject to the lender's due diligence. The amendment to the Credit Agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;<ix:nonFraction unitRef="number" contextRef="i576cde29c1fd40f8b8fece1e7aeedef2_D20220623-20220623" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjMw_73c8c47e-6845-4fca-aa26-fb442a3d2581">1.50</ix:nonFraction> percent&#160;(<ix:nonFraction unitRef="number" contextRef="i3ae9de4d3934431b85c33730e67cac1d_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjM0_87bf62b8-3fc5-461c-9fd6-8fbfad8962b1">6.39</ix:nonFraction> percent as of March&#160;31, 2023), and an annual commitment fee of&#160;<ix:nonFraction unitRef="number" contextRef="if3b6867cf47247f4968d279e124711d2_D20220623-20220623" decimals="4" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjgw_7761cf73-63fe-4dda-aef4-fbb158d6154d">0.25</ix:nonFraction> percent&#160;on the unused portion of the commitment. As of March&#160;31, 2023 and December&#160;31, 2022 we had outstanding balances under the Credit Agreement $<ix:nonFraction unitRef="usd" contextRef="i4bf0ac744d7941f3852747082611c11b_I20230331" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY0OTI2NzQ0Mzk3Mg_3893715b-4927-4e9b-9039-80a01b435ed9">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ieee06864f03e4d04abae69411c2a8c28_I20221231" decimals="-5" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY0OTI2NzQ0Mzk4NA_d7635397-b1a1-45f3-a5a1-3a2af94fb661">0</ix:nonFraction>, respectively, included in current portion of note payable within our Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2023, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $<ix:nonFraction unitRef="usd" contextRef="i5bad9899385e49ba89421036e841df7e_I20200421" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTU1Mw_22509866-3217-4d2f-8366-0b95485359d7">6.0</ix:nonFraction>&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $<ix:nonFraction unitRef="usd" contextRef="ic3b0bb7e541c48fbad2bb35bbc0811d0_I20201119" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY2OQ_e59aecbb-c650-44e8-a88e-7b5cd9d51e0d">3.7</ix:nonFraction>&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of <ix:nonFraction unitRef="number" contextRef="id70a83bdb8dd4e80ac710803192a2c56_I20230331" decimals="2" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTc2MQ_315156a6-74f3-4747-8a24-2c0680708b63">3.00</ix:nonFraction> percent and are required to settle our borrowings under the Capital Credit Agreement in <ix:nonFraction unitRef="payment" contextRef="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119" decimals="INF" name="natr:DebtInstrumentNumberOfMonthlyPayments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTg1Mg_06cf80c8-4a25-46b6-86c8-39c030eea6f3">36</ix:nonFraction> monthly payments of $<ix:nonFraction unitRef="usd" contextRef="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTg3NQ_6d17019b-5586-489a-8414-3262b40aa17e">0.1</ix:nonFraction>&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTk5OA_663025b4-fc39-4880-8a59-415b9ac70abc">0.9</ix:nonFraction>&#160;million outstanding balance under the Capital Credit Agreement, of which $<ix:nonFraction unitRef="usd" contextRef="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331" decimals="-5" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMjA2Ng_171295c7-cf21-41e0-a5b8-22c8badc1ede">0.9</ix:nonFraction>&#160;million was classified as current.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTc2Ng_2884168b-1020-4cd8-bf7a-b220d637b3ff" continuedAt="i749ef7fa4c8141cfa149c14ace5cf6e0" escape="true">Net Income (loss) Per Share</ix:nonNumeric></span></div><ix:continuation id="i749ef7fa4c8141cfa149c14ace5cf6e0" continuedAt="ia34f16ada64940f6a0d4042343965363"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="ia34f16ada64940f6a0d4042343965363"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTc2OA_f591d5a0-6e93-43d7-a833-f97207644f03" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNS0xLTEtMS01NjQ2Mg_b8351f4c-0a35-4445-aafe-8b62b5457bda">860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNS0zLTEtMS01NjQ2Mg_bac058bf-c32f-4a31-8517-633d4f4d22ae">2,950</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNy0xLTEtMS01NjQ2Mg_60ad4b2c-d9f0-41f2-97d1-84cca67215b0">19,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNy0zLTEtMS01NjQ2Mg_8b6cb30a-397c-49a2-90a7-421365cd4167">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTItMS0xLTEtNTY0NjI_b1a789f8-b252-455c-891d-f13a2b6246a1">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTItMy0xLTEtNTY0NjI_6b504b6b-ea99-40ae-b1b0-de15b0828af9">0.15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTUtMS0xLTEtNTY0NjI_f0b47c37-3cef-4340-bed3-26090d61365c">19,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTUtMy0xLTEtNTY0NjI_48703483-7fe5-4186-bcd6-84a527f0e3ac">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTYtMS0xLTEtNTY0NjI_7b429351-09b4-4086-83d1-756f577c42e5">372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTYtMy0xLTEtNTY0NjI_ed64da79-d6a1-46f8-9586-c4f52f0135e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTctMS0xLTEtNTY0NjI_eda8933c-0f72-44f8-9103-3b2966201f74">19,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTctMy0xLTEtNTY0NjI_2901683b-eb83-456b-a752-ce643029b022">19,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjItMS0xLTEtNTY0NjI_32773862-8ff9-436d-9158-e909e7a957d5">0.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjItMy0xLTEtNTY0NjI_31ff7b76-65a4-45e0-ad54-236d6b4a29d8">0.15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjUtMS0xLTEtNTY0NjI_41bd7677-5d33-467e-a5fc-920f1f1c751e">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="natr:DilutiveSecuritiesExcludedfromComputationofEarnings" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjUtMy0xLTEtNTY0NjI_3ede83e2-c90e-47ce-849b-fa759f5717fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjgtMS0xLTEtNTY0NjI_45310afe-34e7-4f7b-a66b-f2d622c06375">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjgtMy0xLTEtNTY0NjI_97a7f87d-74fc-44a8-8e82-f7e62cd2ff6e">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, <ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfOTE0_aab16e74-9251-4c59-bdb2-1ff8f1418caf">no</ix:nonFraction> potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include <ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTEzNg_59f1b6ee-d932-4369-b508-25ded64ec6f2">282</ix:nonFraction> restricted stock units.</span></div></ix:nonNumeric><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg0NA_af558679-b0e4-42bb-a1c0-88b6540b7a98" continuedAt="i4aec9a4711c34cf381e5251269e6f3e0" escape="true">Capital Transactions</ix:nonNumeric></span></div><ix:continuation id="i4aec9a4711c34cf381e5251269e6f3e0" continuedAt="if7c81e9a135d4c7bb383b44d7152dbb3"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $<ix:nonFraction unitRef="usd" contextRef="iad7a3e92766a4588bcf410162f828313_I20210310" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTEzNA_305708c9-01aa-4887-a60f-309cfa1a51ad">15.0</ix:nonFraction>&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $<ix:nonFraction unitRef="usd" contextRef="iec9e1feefec641229f8793d60e0ba7a2_I20220308" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTI4Ng_568afba9-0735-4508-9396-4f09427e1598">30.0</ix:nonFraction>&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2023, we repurchased <ix:nonFraction unitRef="shares" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTQ3OA_a2e309a5-6bdd-47ea-8ad9-79743152c0a8">90,000</ix:nonFraction> shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTUxOQ_c1a638bf-437c-47d3-ae87-98e8066d97b7">0.8</ix:nonFraction>&#160;million. For the three months ended March 31, 2022, we repurchased <ix:nonFraction unitRef="shares" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ2Mjk2Mw_50eeabcf-26bd-4b70-bde1-e6c945d8c4ed">451,000</ix:nonFraction> shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ2Mjk3Mg_9a0d3f1a-9c10-416c-a072-cea6e1944144">8.0</ix:nonFraction>&#160;million. At March&#160;31, 2023, the remaining balance available for repurchases under the program was $<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTYyMQ_57276082-7427-4011-bd5a-71b44a7811f2">23.2</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="if7c81e9a135d4c7bb383b44d7152dbb3" continuedAt="i48e7f180a68a4080afe23ae7dd851c8f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of <ix:nonFraction unitRef="shares" contextRef="ic119a54e942d4fb496dbaf51f43c3a16_I20121231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjMyOQ_c723d4f6-f9f7-4db8-ab5d-87cd6dd800c5">1,500,000</ix:nonFraction> shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="i17132172a34944c19d1a0af61112f1ff_D20150101-20151231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjU5NA_9e6db81d-274f-42ac-8ae8-62b083e26fad">1,500,000</ix:nonFraction> shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by <ix:nonFraction unitRef="shares" contextRef="ice5ff017c4644e0ba536b10add46fcac_D20210505-20210505" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjgwMQ_9f2f1b73-070d-4e00-a040-28c5b2caceb4">2,000,000</ix:nonFraction> shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to <ix:nonNumeric contextRef="i60b15fb6f7a54f76a4f03d8f40724290_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzIzMQ_46c94eca-349c-4e0b-a418-f1812a72eb74">48</ix:nonNumeric> months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of <ix:nonFraction unitRef="number" contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM2OA_e8571d74-b644-4bd4-8f9e-ee7d51fb4192">six</ix:nonFraction>, <ix:nonFraction unitRef="number" contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM3Mg_77d4cfeb-f3c2-43d5-89d7-f64f2388a609">eight</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM3OQ_d996d8d5-aa7b-48ee-b1f2-0cf54570a717">ten</ix:nonFraction> percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg1MQ_10990a9b-6d86-4480-8081-a030a10a94fd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS0xLTEtMS01NjQ2Mg_afa8facc-4ed1-44e2-b563-673a49488026">143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS0zLTEtMS01NjQ2Mg_abc475f9-092d-426d-9b47-2a125ac9e158">12.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS01LTEtMS01NjQ2Mg_9ee6f5a6-b2bd-4d96-b341-be55541c6774">5.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi0xLTEtMS01NjQ2Mg_6cd13ada-7e5b-4baf-bcc5-61dd26e333da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi0zLTEtMS01NjQ2Mg_48df4eb1-cf5c-429a-8120-661da7b209d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi01LTEtMS01NjQ2Mg_7a416aae-23aa-43b3-81a1-3c286e86af19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy0xLTEtMS01NjQ2Mg_35637067-e789-4a0e-93de-aed0545aa70d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy0zLTEtMS01NjQ2Mg_6f1668fe-dfbd-447a-9c9a-22972064156c">11.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy01LTEtMS01NjQ2Mg_4f5efca6-310d-4c4e-a3c9-76d53f73b6a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC0xLTEtMS01NjQ2Mg_fdbedb0b-f8fb-4240-a0ad-b259b3669fe4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC0zLTEtMS01NjQ2Mg_43bfff9c-1b9a-49d9-a2ce-af630dc4a8d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="2" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC01LTEtMS01NjQ2Mg_1e87dda5-b059-4299-b970-59e6205a9735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS0xLTEtMS01NjQ2Mg_91a6b44f-bd06-490e-b3b6-d91a79ccd44c">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS0zLTEtMS01NjQ2Mg_0d18c108-41d5-4ba1-a919-c529d82d0df1">12.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS01LTEtMS01NjQ2Mg_f56ccc99-eec7-4465-8c77-c2629ac1acea">5.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_529d1146-5f86-4190-90f5-177618c94ff8"><ix:nonFraction unitRef="usd" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_869d712e-95b7-4855-aabd-2bced28f2aac"><ix:nonFraction unitRef="usd" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_9c5b02f5-b4db-4cba-8dd2-967528570517"><ix:nonFraction unitRef="usd" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_a6897db6-fd2c-47de-9522-86fdf06d264c">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> share-based compensation expense from stock options for the three- month periods ended March&#160;31, 2023 and 2022. As of March&#160;31, 2023 and December&#160;31, 2022, there was <ix:nonFraction unitRef="usd" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzcyMw_1cf8b7ef-a5c1-4043-8957-2d03f1d41c09"><ix:nonFraction unitRef="usd" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzcyMw_31445fc5-bb67-490e-9180-982fee2c83d3">no</ix:nonFraction></ix:nonFraction> unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the aggregate intrinsic value of outstanding and exercisable stock options to purchase <ix:nonFraction unitRef="shares" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzkwNg_be367e44-ae9a-4e88-ad97-84b916ef3e9f">127,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="icd667127b304410783b1f535dacef921_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzkzNg_11383a46-8c0c-4c6c-976a-474a9efac935">0</ix:nonFraction>. At December&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable options to purchase <ix:nonFraction unitRef="shares" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDAyOA_d9a98b07-bb98-4003-8bc6-9b60808f2d23">143,000</ix:nonFraction> shares of common stock was $<ix:nonFraction unitRef="usd" contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDA1OA_d0641b1a-d819-441d-96b9-3f2e1b32e1ff">0</ix:nonFraction>.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three-month period ended March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ1NjY3NQ_a9f390ed-a864-4f21-91f1-c62e54124902">no</ix:nonFraction> shares of common stock were issued upon the exercise of stock options. For the three months ended March&#160;31, 2022, we issued <ix:nonFraction unitRef="shares" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDEyMg_311bfe0d-9e24-46d8-87bf-d763f2cc3417">29,000</ix:nonFraction> shares of common stock upon the exercise of stock options at an average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDIyMg_0cae716f-9eb8-4bdf-b582-c38f8b88fd46">9.17</ix:nonFraction> per share. The aggregate intrinsic value of options exercised during the three-month periods ended March&#160;31, 2023 and 2022, was $<ix:nonFraction unitRef="usd" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjc0ODc3OTA4NjkwNQ_f327e63e-af1a-4713-a96a-667e3c684448">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDM1Nw_df2e1b67-ef40-47e2-9a7f-9fef00deaf49">0.3</ix:nonFraction> million, respectively. For the three-month periods ended March&#160;31, 2023 and 2022, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDQ0MA_23de8bdf-9217-4645-a49d-3325deda03de">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDQ0Nw_be4ef960-558f-4db6-9a10-4d08ee4d54e9">0.1</ix:nonFraction> million of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, we did <ix:nonFraction unitRef="shares" contextRef="i9dd6e9c7d1174a5196db741bd9bd6e22_I20221231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDU0MQ_e800bec7-282e-4c7d-949a-227a07908d30"><ix:nonFraction unitRef="shares" contextRef="i9f71d03224964432937c9462c7320fd7_I20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDU0MQ_ea064cb1-2b32-447a-ad5d-a07a436160e1">no</ix:nonFraction></ix:nonFraction>t have any unvested stock options outstanding.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from <ix:nonNumeric contextRef="ied1fdb1621154a2c992f780e1bfa1706_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDc0Ng_ec276eeb-2d33-436e-9861-61e5e19f2df8">12</ix:nonNumeric> months to up to <ix:nonNumeric contextRef="i7da32705f94942c49d3c710e71c1c4bc_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDc1OA_62db5665-461f-489c-87d4-b4fe601db25f">36</ix:nonNumeric> months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until <ix:nonNumeric contextRef="iec6bb5c1e51f4f79902860d3143fa47f_D20230101-20230331" name="natr:RestrictionPeriodForIssuanceOfShares" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTAzNQ_92ab85bd-ad56-4955-a8a7-beaa9be258f4">two years</ix:nonNumeric> after vesting. At March&#160;31, 2023 and December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ib20931e909f04ba3884bbaf616843da2_I20230331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTA3OA_0ed198dd-8ea1-4713-9e50-06700bdbabb8">106,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i127289bd16c74b78bcba51e1e0e6b297_I20221231" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTA4NQ_553115b2-5cc0-4512-a0d3-54b0ac75d3d1">94,000</ix:nonFraction> vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="i48e7f180a68a4080afe23ae7dd851c8f" continuedAt="i64766c1bad7a4904a3f2fd5b6afc49c8"><div style="text-indent:27pt"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg2MQ_92bb777d-3a31-42dd-87df-b44c7adee3c4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i70143db360d648a09df5ae0c19ad6a0c_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMS0xLTEtMS01NjQ2Mg_568f9ff4-01cd-4180-99a1-1d76d5dc14ae">1,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70143db360d648a09df5ae0c19ad6a0c_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMS0zLTEtMS01NjQ2Mg_a0e5e311-6dcc-4f24-b8f7-81e572d8003c">10.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMi0xLTEtMS01NjQ2Mg_7bf06202-73c2-4d8d-90df-dfc7f9e018fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMi0zLTEtMS01NjQ2Mg_d73008b4-7c90-4db0-8ad4-2b0786856ddf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMy0xLTEtMS01NjQ2Mg_1de27cdb-6dbf-4612-ab09-fa71b5f4da14">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMy0zLTEtMS01NjQ2Mg_6058f460-16e3-4e7e-8ede-3c815da547d8">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNC0xLTEtMS01NjQ2Mg_6d5cd9ff-6ce5-4793-9afd-ef8d14444415">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNC0zLTEtMS01NjQ2Mg_dfa3da7b-e320-4f54-95e5-e9ee28721a22">12.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iceb089485d284690b3a27c0501d8a380_I20230331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNS0xLTEtMS01NjQ2Mg_7a6e5239-cf96-4580-b328-3d3386eceadb">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iceb089485d284690b3a27c0501d8a380_I20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNS0zLTEtMS01NjQ2Mg_1d525e8e-6fe4-4107-9bbf-064e2c5fdea2">11.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three-month period ended March&#160;31, 2023, <ix:nonFraction unitRef="shares" contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTM3NQ_91ab5318-bf56-47aa-9c97-c6a9da4d860b">no</ix:nonFraction> RSUs were granted under the 2012 Incentive Plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was approximately $<ix:nonFraction unitRef="usd" contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzM2MQ_ec822452-402b-462f-a8a3-210520b2de38">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzM2OA_1436745f-430d-4a41-ad5b-80d1811368ba">0.5</ix:nonFraction> million, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $<ix:nonFraction unitRef="usd" contextRef="ia02c469dbbc24747a8b591560a3ee008_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzY4NQ_77718954-306e-4a0c-bd49-4e7ec42827e9">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib801a3e8a35c48218f48568d2ed7dda1_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzY5Mg_96e3972e-d3e6-47f0-8389-46b9e3f3a792">3.0</ix:nonFraction> million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately <ix:nonNumeric contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzgyNA_6aa02a83-1923-456a-96cf-9e0a0c062e47">1.5</ix:nonNumeric> years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was $<ix:nonFraction unitRef="usd" contextRef="ia01162aa2d194e3182890cbff779a0bf_D20230101-20230331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzk0Ng_df046b1e-7f19-4193-a57b-3d7a7c02a516">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib996c0038abc4f538cb2d29806f221fb_D20220101-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzk1Mw_52ec7f1b-569e-4cf7-9454-cca65eb9eff8">0.3</ix:nonFraction> million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $<ix:nonFraction unitRef="usd" contextRef="ie19d15fa8feb4d7fb9e9852fb4440016_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODIxMQ_5fe43aa6-6bed-4bf3-aa00-8d1ca42722ce">4.5</ix:nonFraction> million of potential share-based compensation expense. We currently expect to recognize an additional $<ix:nonFraction unitRef="usd" contextRef="i170c7005fd4e4233977c6c670cb2c2d6_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjc0ODc3OTA4NjI3MA_e184ef8d-6d69-4a22-a511-7f962856ad31">2.2</ix:nonFraction> million of that potential share based compensation expense. </span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64766c1bad7a4904a3f2fd5b6afc49c8">The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was <ix:nonFraction unitRef="shares" contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODQ3NA_c3e8b8f1-77c8-4c23-bf30-69a3da4fe71d">15,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331" decimals="INF" name="natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODQ4MQ_0f448963-c16f-4e9d-83f9-b21e4b3fe174">60,000</ix:nonFraction> shares for the three-month periods ended March&#160;31, 2023 and 2022, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</ix:continuation>&#160;</span></div><div><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4MQ_2bf3334d-c230-413f-bb17-cd7aa87db56c" continuedAt="ia9b0cff120d54a72b7661efe3a892b57" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="ia9b0cff120d54a72b7661efe3a892b57" continuedAt="ia00b653da9ff4f3c9318eb7d8135c776"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMzk_a2ed756c-bce7-407d-beac-f889fd06ffe9">four</ix:nonFraction> business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="ia00b653da9ff4f3c9318eb7d8135c776" continuedAt="i6bf918a5a8f4414b86eb56a1b5b7f169"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4Mg_5e96bd07-8cf9-4ebb-93a1-62c1124f121c" continuedAt="i0125cbc8a1f342fa80faa7ad04344020" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMy0xLTEtMS01NjQ2Mg_c94b3124-49e4-4d8d-b817-0f3f310af78f">46,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMy0zLTEtMS01NjQ2Mg_919c3dc6-d881-4402-9c3b-3e12f2e94477">46,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNC0xLTEtMS01NjQ2Mg_d5f8ab97-c409-40ad-a33b-e7ebd8e587ea">21,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNC0zLTEtMS01NjQ2Mg_b53f98dc-f1be-4b59-aa93-6f26c373e836">21,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNS0xLTEtMS01NjQ2Mg_29766de6-2e5e-4724-9f22-d1bd9a124591">34,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNS0zLTEtMS01NjQ2Mg_47e30e3a-3f4c-460b-b175-9cbd46cd9923">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNi0xLTEtMS01NjQ2Mg_de5370ab-a17d-4c46-854c-48c13d30b460">6,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNi0zLTEtMS01NjQ2Mg_6ba61c6d-1c4c-4d9f-8a8e-18a7b297de30">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNy0xLTEtMS01NjQ2Mg_f9281f3c-b44e-46e8-85e7-4ff27bf5b9bb">108,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNy0zLTEtMS01NjQ2Mg_8e757514-6157-481e-83ec-d16ef9b367ba">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTAtMS0xLTEtNTY0NjI_3e78cb36-3878-452d-b138-363c03f0c3ef">21,951</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTAtMy0xLTEtNTY0NjI_0b23e619-cb03-4681-a7aa-43c52f82964c">21,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTEtMS0xLTEtNTY0NjI_f11c1b8c-ca9d-450e-a0d5-8defb7f8d788">6,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTEtMy0xLTEtNTY0NjI_411eb8f7-04a8-4f22-8c03-af0b5f9fe034">4,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTItMS0xLTEtNTY0NjI_e7a0b92b-88f2-4b2c-a9f8-08b9855513c9">12,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTItMy0xLTEtNTY0NjI_211101a2-bf5c-4b7b-934c-56270944a2c7">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTMtMS0xLTEtNTY0NjI_88f74a66-1b0b-4731-a4e9-6ba004a20163">2,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTMtMy0xLTEtNTY0NjI_3b2bd557-dc29-4162-b87b-f1c4c825d5c1">2,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTQtMS0xLTEtNTY0NjI_b1a662c7-cd99-420c-b277-4b7fe03f66a0">43,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="natr:ContributionMargin" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTQtMy0xLTEtNTY0NjI_6a81a7d0-a566-4aac-b665-e8dd94f14f4a">41,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTYtMS0xLTEtNTY0NjI_3f2faa26-9110-453c-83fd-46c27ea68bb2">43,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTYtMy0xLTEtNTY0NjI_e4397737-7dab-4f9c-9694-1326a159fb8f">40,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTctMS0xLTEtNTY0NjI_42d04bdc-6323-49dd-bc66-b6d8032a2032">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTctMy0xLTEtNTY0NjI_181cb37c-e69a-458a-b0d6-207d36070bb1">1,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTktMS0xLTEtNTY0NjI_8e956c18-fefc-4b58-bde6-de68465e9389">1,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTktMy0xLTEtNTY0NjI_c1716939-275b-4ea1-8a3b-621ade47bc43">314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMjAtMS0xLTEtNTY0NjI_8f34c5f2-b56b-46b7-bc53-0788936d5fd7">1,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMjAtMy0xLTEtNTY0NjI_51c239ea-f9ff-41ea-9988-acd781b9c9f6">995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div></ix:nonNumeric><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0125cbc8a1f342fa80faa7ad04344020">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $<ix:nonFraction unitRef="usd" contextRef="i1ecf051891dc4540bc1a158727bface1_D20230101-20230331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTE2Nw_add5415e-331e-495d-9a22-a57624e7ca53">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i72b2b7d2469d443699c8c1599a668568_D20220101-20220331" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTY0OTI2NzQ0MzY2Ng_b767e885-8dfd-4b2e-b108-dc7866c1f273">4.9</ix:nonFraction> million for the three-month periods ended March&#160;31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses.</ix:continuation> </span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk3Ng_23495025-4e9f-4534-a4b7-79802004b59a" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March&#160;31, 2023 and 2022, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549144157ff34d2fb598832930efc245_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfMy0xLTEtMS01NjQ2Mg_4357ace6-e2d4-4e5e-bbfa-31747602a838">31,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e4c046cce2249f2aad2d456f289e8b5_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfMy0zLTEtMS01NjQ2Mg_176de013-08c5-4462-a59f-17e13528c8ae">33,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de2700723f44230bd14ea658ce0674b_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNS0xLTEtMS01NjQ2Mg_81197a9f-8cb3-4a57-b6b7-3d61c242aaa9">14,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7865ea6a10c944dd9cf7b4d199be8b36_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNS0zLTEtMS01NjQ2Mg_b5457669-4a1c-4dfc-a83c-faa498e98cc8">9,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704b9d7df3314907a965decd5192d199_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0xLTEtMS02MDEyMg_a70d3fb5-76e8-4e20-909c-ca953cc87883">11,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f4f53a1500e4c3d8c20fceb1d303105_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0zLTEtMS02MDEyMg_b277e3a1-594a-4202-9ddb-3e6dc966d451">13,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6926d9bdf25244c48c11ee85cac897fc_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0xLTEtMS01NjQ2Mg_b777a9d3-0782-4015-99af-7d79396e723c">51,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief991aa102dc4df286a636f2768bf677_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0zLTEtMS01NjQ2Mg_1eec1aaf-07f0-4cc7-8e8f-42e0cdb1fb19">53,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNy0xLTEtMS01NjQ2Mg_35cc49a6-751c-472b-bcc9-aac2da845ac3">108,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNy0zLTEtMS01NjQ2Mg_64e6eafb-6c32-42e8-9dd3-1d31f8fbf45d">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="i6bf918a5a8f4414b86eb56a1b5b7f169" continuedAt="i86cf14a39c064ea5b6c64bbd7286ab92"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk2OQ_b28fde80-5ee7-4f47-aa54-a55e445e1283" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1def7196a1394561a30f23c2f5945836_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMy0xLTEtMS01NjQ2Mg_204b8b15-fb47-4f1e-8ccf-cc22252fa4f8">13,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab4170a48ba44688bfbcdb858a32779_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMy0zLTEtMS01NjQ2Mg_03b46df0-1901-4f44-ad1b-dc10ac669270">12,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc86721ece64baf808c893cc035d52a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNC0xLTEtMS01NjQ2Mg_cf4269d0-72a5-4f45-a43e-d4d86b70e8eb">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11c371bce764450ac20c60711a22727_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNC0zLTEtMS01NjQ2Mg_41bd24e1-bd32-47ca-8a5c-959d3823e835">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2403b429d1e4d5dbc736ea9f50b2db0_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNS0xLTEtMS01NjQ2Mg_e6d06572-69f7-40b5-aee4-0e66cac551c0">14,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dadec0fe1ce41e581194b370338f5aa_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNS0zLTEtMS01NjQ2Mg_135a9a97-8bd8-4645-be48-59c066f7955d">13,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bd26b9ba84374854d6dbd57593217_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNi0xLTEtMS01NjQ2Mg_99f84843-4394-4cf1-afe0-c4775313a93e">9,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c5f48d31de4e58896fadefe80c0fb7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNi0zLTEtMS01NjQ2Mg_5e843f85-8c55-40c3-a8f5-47bc5fa8e42c">9,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84001b2ee67469ab6af26eafcb4c8d6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNy0xLTEtMS01NjQ2Mg_4129c539-cbc3-40c8-8388-2f78ac6d1166">1,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdb780bc72204ed995bb3d5d750aaaa7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNy0zLTEtMS01NjQ2Mg_c9a012e0-1347-47d8-9072-7b6f54ddbb5d">2,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66081dc8a1849988db515744c4a5191_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOC0xLTEtMS01NjQ2Mg_2c4c7126-9b63-495a-bca0-85413a361348">6,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia242724c2a8d41a2a6629e376281c37d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOC0zLTEtMS01NjQ2Mg_3c82e0f1-fd1b-4c17-afad-89d5b7258963">6,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOS0xLTEtMS01NjQ2Mg_b15755e8-23fa-43b9-96d4-0fc368e58e15">46,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOS0zLTEtMS01NjQ2Mg_bb902cbd-3796-4285-b991-49e7d434ac94">46,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b0de65c7f04151b172ae37f38db95c_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTEtMS0xLTEtNTY0NjI_4f265ab5-2237-4b53-857e-7bcf5472bf0f">9,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70570a69247e4e4b9228e76f91348f73_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTEtMy0xLTEtNTY0NjI_50bc46d3-67e4-4381-9a84-2b813ff78949">9,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id935bb5a397e4fd5b3068cd551324f0d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTItMS0xLTEtNTY0NjI_54836eeb-6843-4ff0-9769-00bc229ce374">2,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0706faf1f08f497a95123914f1ad454c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTItMy0xLTEtNTY0NjI_7f4656f0-9598-4258-a664-97089878ed4f">2,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2e2a755bd504b2d8ab7f427c3ce421e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTMtMS0xLTEtNTY0NjI_2b416507-c6ad-4a7e-a826-c6a1d47173f0">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82ea8fd02a454b32af363f8584558ce2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTMtMy0xLTEtNTY0NjI_083ac4f6-cf29-4752-874e-52d369e61770">2,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19eee5983a13470a8e2f0b19460061cc_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTQtMS0xLTEtNTY0NjI_58f5bad7-857a-466d-ab98-8279320cc928">5,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d2601cc29e44ce8a1a4d2e106164fbf_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTQtMy0xLTEtNTY0NjI_5be49316-f4c8-4d1d-a9f3-7db20c51aa2e">5,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7646bffa476a454e9fff94e8ff089fe7_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTUtMS0xLTEtNTY0NjI_e28a3e00-ab51-47ac-bba3-6f12bd178f5f">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab2c51f1dcbf45489ce126a589c4fed4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTUtMy0xLTEtNTY0NjI_3993538d-8e96-4941-bae0-0aadeb7193ea">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e775b15edf42e0976566b58638008e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTYtMS0xLTEtNTY0NjI_93999a0d-a4e0-4193-9685-6eedd90de2a5">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd494153a584910be8e82dd4ae90fb8_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTYtMy0xLTEtNTY0NjI_782eba0c-b861-4f8f-87b0-387322e453ef">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTctMS0xLTEtNTY0NjI_9118522f-4c44-4999-9e3f-3b20569d8b51">21,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTctMy0xLTEtNTY0NjI_f971a88e-77cb-42e3-b7bb-d356db634a74">21,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3e9061310940c78e07309d597a0c3f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTktMS0xLTEtNTY0NjI_ba4d5fd4-9f86-4301-ad74-7ab07e202aaa">15,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8baa0e541a4e3db131ac25deeece46_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTktMy0xLTEtNTY0NjI_9dfb932f-fab6-4435-a6c0-0953fb3d7cc7">15,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i004051f877df4e358f3020fdd40e15bf_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjAtMS0xLTEtNTY0NjI_51a195e6-c722-4928-a5cb-5e1a5c1f8f5d">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide005a7559004658904c94d8e1c9d7a3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjAtMy0xLTEtNTY0NjI_39b3e382-822e-43a4-80a8-86682c272a80">4,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c2138d4f6448da9af09aa9cad5d832_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjEtMS0xLTEtNTY0NjI_51eb0595-74d4-4777-915d-b2ae1dece84d">3,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31c73008cac84edd9bf7a7c951a8ace6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjEtMy0xLTEtNTY0NjI_6d817307-2103-4e51-b07b-be2edcd16985">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if89604f393d1406a9dc613f638bb9282_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjItMS0xLTEtNTY0NjI_bfc535a1-004a-4c02-a1a9-d18609960163">8,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c76018a8ad24a3eb01b65729f05e002_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjItMy0xLTEtNTY0NjI_1e34d9b5-0ee0-45e4-9d1f-2f012b3546bb">8,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee552623371416a91f53435d09209ff_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjMtMS0xLTEtNTY0NjI_d2c282dd-058b-436b-ba6c-064f0258e0be">1,464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea6fbc78a7e42978d9632750e427515_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjMtMy0xLTEtNTY0NjI_241f233d-efc6-4ad8-9805-3c629dc378c5">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife96081680724014b04db995e830f541_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjQtMS0xLTEtNTY0NjI_6a65f1b0-2b39-4885-9a65-ac9ce1e9e740">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cdde04916fb4085909452d7bf0e104b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjQtMy0xLTEtNTY0NjI_5403e69d-96c9-4435-babe-82c8931f833d">1,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjUtMS0xLTEtNTY0NjI_7f9ff2ab-797f-41d9-849d-c06e8a7e5f00">34,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjUtMy0xLTEtNTY0NjI_77fdb295-ce21-472c-947a-f2360f71ee00">35,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976cb70b3a6d4224ba518c55b10e68f7_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjctMS0xLTEtNTY0NjI_c0419b5e-d9ee-47ac-b281-e63bc52a2596">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0211468578bd4079b559e74b92be8660_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjctMy0xLTEtNTY0NjI_be20a214-d9ac-4116-b3fb-968e27a06ba1">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a725eb7fa624679b58b3693ddec3496_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjgtMS0xLTEtNTY0NjI_e27e73dd-e1f1-4912-a53a-f0350392f734">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83bf3f9f69a6453284bd5815b5c518b4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjgtMy0xLTEtNTY0NjI_f9ca4b7b-ad29-4ca3-a1c6-2da647a0a94f">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ef4c27b992044b28c84833e4d7a9482_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjktMS0xLTEtNTY0NjI_f8f56380-e1c2-4584-9d15-e56f9f5af11a">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27f2c9f8dee4c3ebabd4dd807c88816_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjktMy0xLTEtNTY0NjI_6e45c99f-a7ec-42c8-8c96-4d810b7de13d">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3493146182f54b58b709fb841b93942e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzAtMS0xLTEtNTY0NjI_cc6a6006-8dbc-4741-b4b6-af07571f8029">2,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcdd69c0a6834a8f9f59f07e9398c5c4_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzAtMy0xLTEtNTY0NjI_1c4ef774-13f5-4125-882a-50bebf03ed5a">2,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e831496e7a6437689b1d9ad266655aa_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzEtMS0xLTEtNTY0NjI_c61c883c-ff22-4552-a15c-aa72c4b9476a">351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icce691f6ab25492fa9195960972e876b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzEtMy0xLTEtNTY0NjI_2a155584-2fb4-46ec-96ea-cdff1b4812da">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c43ae344d345a98b2a06cdcfe5a28d_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzItMS0xLTEtNTY0NjI_d6f0519c-dc18-476c-81c8-6043704978c6">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0e66a63f3a348c481089b2cedcad2da_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzItMy0xLTEtNTY0NjI_481e0d08-ddf7-4d58-ad7c-0398315f46f7">208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzMtMS0xLTEtNTY0NjI_9b148bf5-f141-4500-8df5-fb052ed23741">6,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzMtMy0xLTEtNTY0NjI_f1c6b6cc-af22-4170-9022-91857f3b5626">6,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzQtMS0xLTEtNTY0NjI_40da9d53-b1ef-4810-b529-47c2f5de4e7d">108,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzQtMy0xLTEtNTY0NjI_7501ca2b-efa2-44eb-9a25-7d4d8643ea7c">110,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk3MA_908916c9-3a2c-43a7-ab8d-0ffc2fdb92b6" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib66f65baeb8548a496f5f643074ca0b6_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMi0xLTEtMS01NjQ2Mg_f4d4b067-3a5c-4e3a-a4f3-7340aa1e8747">42,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2774331cf67440fb8010640bd77a71d6_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMi0zLTEtMS01NjQ2Mg_405712c1-84e0-4d84-8556-0e3e1b232868">42,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4e7456b9664b3bbd2032692ed8e46e_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMy0xLTEtMS01NjQ2Mg_ccf1b2c6-d9e4-4507-bce8-b92bd996141c">3,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i459e294ae30142cbaa00703fe6880103_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMy0zLTEtMS01NjQ2Mg_a8d6d6db-90e0-4f8e-b4db-872825cd642a">3,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfNC0xLTEtMS01NjQ2Mg_20e94fba-5e31-42c7-8e8f-dcf398b87396">46,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfNC0zLTEtMS01NjQ2Mg_72cd8f02-47cd-4c11-a1af-ca838bbaa3c1">46,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="i86cf14a39c064ea5b6c64bbd7286ab92"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4MA_500aa869-2b71-4326-a40a-ba7b77ef4b6a" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f7ccb539794924835d07e06230787c_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMi0xLTEtMS01NjQ2Mg_3cd708c7-0206-4f0e-a3d8-12cb05e4f038">100,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1c7c7993f443cb9775f4cbebcc4b05_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMi0zLTEtMS01NjQ2Mg_35d09580-2dfd-49e3-a8e7-022343d19ddf">95,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if62877c0017f46508b1b76d1b8b631bf_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMy0xLTEtMS01NjQ2Mg_88746fc8-b8e6-4c2b-ad4c-2f7e4ebb81a6">18,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84625c382b684cbd80fa57354e915031_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMy0zLTEtMS01NjQ2Mg_5ceb5c5d-6b0d-4330-bcae-f05ea6e92af1">15,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1edeeda0c4c64b50ada9a9fb45333935_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNC0xLTEtMS01NjQ2Mg_a6fc884f-d25c-4632-85b1-0f066da018f6">107,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b69da3bc5f431d8d17902ad62e8a25_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNC0zLTEtMS01NjQ2Mg_59bc537c-7d3c-4a81-8738-1d506015da90">112,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b94b216b4504cbeb1073d1ba015dc60_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNS0xLTEtMS01NjQ2Mg_1ef648b5-0d97-42ba-98dc-20891395465d">7,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d06d946a93b476bb5c22cdc41e56321_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNS0zLTEtMS01NjQ2Mg_6479e2a0-9b2c-4271-ad60-2e8e8baba99a">6,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNi0xLTEtMS01NjQ2Mg_7ff9e5e1-78ee-4490-9124-798c820cc962">234,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNi0zLTEtMS01NjQ2Mg_7f9f2924-4cb9-40a8-ac9f-ad57259660d0">229,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMjE5Ng_035c692f-33a4-4cc4-9fa1-0d55348006b7" continuedAt="i5732b537669f4dfeae5f4eea5ec53251" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i5732b537669f4dfeae5f4eea5ec53251"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, our provision for income taxes, as a percentage of income before income taxes was <ix:nonFraction unitRef="number" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTQ0_f19dc501-f436-4802-b97e-caeb621304c8">25.7</ix:nonFraction> percent and <ix:nonFraction unitRef="number" contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTUx_a4f17406-4bcc-44a6-b716-1bf2df9b69f2">369.9</ix:nonFraction> percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2023, was primarily attributed to an increase in tax liability related to foreign operations which are treated as a branch for US tax purposes and current year foreign losses that presently do not provide future tax benefit, partially offset by favorable adjustments to deferred tax assets and foreign tax credits.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three months ended March&#160;31, 2023 compared to March&#160;31, 2022 is primarily caused by recording a valuation allowance in the prior period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2019 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2017 through 2022.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, we have accrued $<ix:nonFraction unitRef="usd" contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTU1Nw_6aaa5797-913b-48c7-aa28-ecefb8d50445">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTU2NA_dc1c5b5d-da7e-4b67-99d9-321b6c5a7399">0.2</ix:nonFraction> million, respectively, related to unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div></ix:continuation><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY4OQ_e4d96c32-f409-440c-8d86-9baf2eb6b149" continuedAt="if168ea12eb3d42479d79b08cd4bb0a63" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="if168ea12eb3d42479d79b08cd4bb0a63" continuedAt="iea94121f23c6432e86e7a3c3b1cff20c"><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;<ix:nonFraction unitRef="claim" contextRef="i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331" decimals="INF" name="natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfODc2_01d73d05-288b-4c90-b164-208b7ffde994">one</ix:nonFraction> or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><ix:continuation id="iea94121f23c6432e86e7a3c3b1cff20c" continuedAt="i6250d8150a1d48c586a6b635e24527a6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="i278d8bc5355b477b92355f58a24f1d03_I20230331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMTcyMw_76ec9ae8-7eb8-4891-b7b3-99cf3ca427ba">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ice670056e3d74a568288807e81b6068f_I20221231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMTczMA_ea21c01f-12f0-4e27-9687-91fc97077314">0.3</ix:nonFraction> million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i99ca42816690450e90028e1c208eecb6_I20230331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjAzNw_729ec385-4c77-4b12-92f7-c3782e78eb1f">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="ia864dc347810434d8b15fe90be07c05b_I20230331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjA1Nw_43276dd8-fac6-4d7c-b5de-b701d7b48f3b">2.9</ix:nonFraction> million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6250d8150a1d48c586a6b635e24527a6">We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $<ix:nonFraction unitRef="usd" contextRef="idc305e5943754b04a7642c1ac05895ad_I20230331" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjIzNQ_f4807465-da47-446d-b942-f59abd0a401e">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if40f94801a594eb68bcddde4144029a2_I20221231" decimals="-5" name="us-gaap:LossContingencyAccrualAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjI0Mg_fe479fb1-3797-40cf-8f65-8bdb9d55644f">0.6</ix:nonFraction> million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, <ix:nonFraction unitRef="usd" contextRef="i7e88ec88e467480993fa728e6e906f56_D20230101-20230331" decimals="INF" name="us-gaap:LossContingencyLossInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjU1Mg_2ea36a2a-d35a-434f-834c-ef84003d15f3">no</ix:nonFraction> provision for losses has been provided.&#160;We believe future payments related to these matters could range from $<ix:nonFraction unitRef="usd" contextRef="i8ef804aa7364469e9a21ea865050d6ce_I20230331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY2NA_b21ae80e-5d0c-476c-b707-95853c896571">0</ix:nonFraction> to approximately $<ix:nonFraction unitRef="usd" contextRef="ice92b1b1c68e485b9d90bc7240e9693a_I20230331" decimals="-5" name="us-gaap:LossContingencyEstimateOfPossibleLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY4NA_a16bd101-33f1-46f9-b2a0-e0e1cfe2221e">0.4</ix:nonFraction> million.</ix:continuation> </span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10)&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RleHRyZWdpb246NzNlNjMyMjBkN2NhNDc2ODg4MDMyNzIzZGU4ZTJjZmJfMjE2Nw_5fc72024-02e4-438b-bf9d-607d3432804c" continuedAt="i945397865a25424d89ee6c13d13f7f45" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i945397865a25424d89ee6c13d13f7f45" continuedAt="i320a00704c95459ea58ba3e39e763f8b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RleHRyZWdpb246NzNlNjMyMjBkN2NhNDc2ODg4MDMyNzIzZGU4ZTJjZmJfMjE2OA_d1e07351-d51c-40c0-9c0d-b8fb3c55c8dc" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2023 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi0xLTEtMS01NjQ2Mg_87af8fea-aa44-4182-a9db-011052b709a3">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f04b1608e946ceac0e09928db01466_I20230331" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi0zLTEtMS01NjQ2Mg_f2bd0d13-70c2-45fd-bccb-c45ba68099b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c631233fcb545f395609cfbcdaed083_I20230331" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi01LTEtMS01NjQ2Mg_59c1253f-ab77-44d8-81fd-e539eddbb61f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34db597e9e84e55975f561965ebf581_I20230331" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi03LTEtMS01NjQ2Mg_5d4a28c1-cb38-40df-9d08-946df8963489">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy0xLTEtMS01NjQ2Mg_ddd15714-1b5d-482d-857c-6405d1f72c1b">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f04b1608e946ceac0e09928db01466_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy0zLTEtMS01NjQ2Mg_dd3a6582-5e0c-47ba-b28d-f284490050f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c631233fcb545f395609cfbcdaed083_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy01LTEtMS01NjQ2Mg_50592f13-291e-439e-a6d6-0447a85f0c5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34db597e9e84e55975f561965ebf581_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy03LTEtMS01NjQ2Mg_b5e0a738-a890-4219-b345-56fdc2c49717">718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2022 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:46.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida56900bef5d44d6a5e8107f70534e32_I20221231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC0xLTEtMS01NjQ2Mg_27978eda-dee0-43be-b3df-39387f1821a6">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC0zLTEtMS01NjQ2Mg_f9ad07e4-a901-4710-b759-4c0acb21e4b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id080f7965727443cb14cd7096debc888_I20221231" decimals="-3" name="us-gaap:TradingSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC01LTEtMS01NjQ2Mg_1358d489-9d9e-46ed-bec7-eca057b810c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231" decimals="-3" name="us-gaap:TradingSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC03LTEtMS01NjQ2Mg_f4d1947f-ca4b-4f7b-a71d-472f00d3dad1">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida56900bef5d44d6a5e8107f70534e32_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS0xLTEtMS01NjQ2Mg_ba36ac20-b8dc-4801-9159-e575988cf56a">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS0zLTEtMS01NjQ2Mg_5a37beb8-469e-4058-a8fd-6e33e5348171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id080f7965727443cb14cd7096debc888_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS01LTEtMS01NjQ2Mg_6782b2b6-0664-4511-b07c-cadd3761619d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS03LTEtMS01NjQ2Mg_04027465-6e4e-4a62-b71f-9be4583153b8">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and for the year ended December&#160;31, 2022, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i320a00704c95459ea58ba3e39e763f8b">The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2023 and 2022, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</ix:continuation></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMzUyNw_81472f80-3933-4e3c-a5a8-d5d7875ffd35" continuedAt="i9250330aa4e84a44a3a13b660e6a089d" escape="true">Revenue Recognition</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><ix:continuation id="i9250330aa4e84a44a3a13b660e6a089d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within <ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="natr:RevenuefromContractwithCustomerRefundPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMTQxMg_c71bc13c-478f-4344-96df-3fc24777e6cc">ninety days</ix:nonNumeric> of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amounts billed to customers for shipping and handling are reported as a component of net sales. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into <ix:nonFraction unitRef="product_category" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="INF" name="natr:NumberofPrincipalCategoriesofProducts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMjU3OQ_07a25f54-e657-4913-a7cc-cc88f01f0f28">six</ix:nonFraction> principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have <ix:nonFraction unitRef="segment" contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMjcwMA_1917b44f-275a-4690-8c0a-7c619c6cb9b4">four</ix:nonFraction> business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div></ix:continuation><div style="text-indent:27pt"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_1063"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV81NDk3NTU4MTc1NjE_8b6f1882-9d1b-4cc6-8763-d6e01bc5370a" continuedAt="i6a7fb682e33a4e958857bd82e84d18ce" escape="true">Synergy Japan Loss</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6a7fb682e33a4e958857bd82e84d18ce" continuedAt="icd1155f2a89244bc8936126f0e9001c5">On February 17, 2023, we became aware that Synergy Worldwide Japan G.K., a Japan entity and wholly owned subsidiary of the Company (&#8220;Synergy Japan&#8221;), was the victim of a criminal scheme involving employee impersonation and fraudulent requests targeting Synergy Japan. The criminal scheme resulted in a series of fraudulently induced wire transfers between February 1, 2023, and February 17, 2023 totaling $<ix:nonFraction unitRef="usd" contextRef="i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217" decimals="-5" name="us-gaap:LossContingencyLossInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDU4_a8547c46-d52f-4988-b137-030954171614">4.8</ix:nonFraction> million. We promptly launched an investigation, led by an independent third party, to determine the full extent of the fraud scheme and related potential exposure. We self-discovered this fraudulent activity and promptly initiated contact with our bank as well as appropriate law enforcement authorities in an effort to, among other things, recover the transferred funds. To date, we have not found any evidence of additional fraudulent activity and do not believe the incident resulted in any unauthorized access to confidential consumer information or other data maintained by the Company.  </ix:continuation></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icd1155f2a89244bc8936126f0e9001c5">As a result of this matter, we incurred investigation and other professional fees of $<ix:nonFraction unitRef="usd" contextRef="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331" decimals="-5" name="us-gaap:ProfessionalFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDUy_61723ac0-8472-4652-aa91-6af8b0eab80a">1.0</ix:nonFraction> million, which along with the initial $<ix:nonFraction unitRef="usd" contextRef="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331" decimals="-5" name="us-gaap:LossContingencyLossInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDc1_a40768e4-9277-4c2c-b0ab-9d8d2e528fce">4.8</ix:nonFraction> million loss, were recorded in Selling, General and Administrative expense for the three months ended March&#160;31, 2023. We do not expect this incident to otherwise have a material impact on our business.</ix:continuation> </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included in this report, as well as the consolidated financial statements, the notes thereto, and management&#8217;s discussion and analysis included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022, and our other reports filed since the date of such Form&#160;10-K.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who resell our products to consumers.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent consultants market and sell our products to customers and sponsor other independent consultants who also market our products to customers. Because a significant amount of revenue is generated through the sales of our independent consultants, our revenue can be impacted by the number and productivity of our independent consultants. We seek to motivate and provide incentives to our independent consultants by offering high quality products, product support, training seminars, and financial incentives, among other considerations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COVID-19</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In or about December 2019, a novel strain of coronavirus, SARS-CoV-2 &#8220;COVID-19&#8221;, began aggressively spreading throughout the world, including all the primary markets where we conduct business. As COVID-19 has spread throughout the world, it has impacted our markets differently. At various times during the course of the pandemic and throughout our markets, governments have issued orders and restrictions that have limited the ability of our consultants to meet with consumers, put downward pressure on our sales in many of our markets and added substantial uncertainties to our global supply chain. Different variants of COVID-19 continue to arise and spread in various places around the world. We continue to take actions to mitigate the effects COVID-19 may have on our business, such actions may ultimately be insufficient to avoid substantial impact on the consolidated financial statement or material health of the Company. At this time, the duration of any business disruption and related financial impact cannot be reasonably estimated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eastern Europe</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, Russian forces launched significant military action against Ukraine. There continues to be sustained conflict and disruption in the region, which is expected to endure for the foreseeable future. Our consultants in our Russia and Other market, a market within our Europe business segment that includes </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Russia, Ukraine, Belarus and other Common Independent States in the region</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, continue to operate their independent businesses, albeit at a reduced level than prior to the start of the conflict. For the three months ended March&#160;31, 2023 and 2022, we recorded a pretax charge of $0 and $3.1 million, respectively, primarily related to the impairment of inventory, as well as accruals for contractual obligations related to Russian operations. We expect that this will continue to impact our business for the foreseeable future. We will continue monitoring the social, political, regulatory and economic environment in Ukraine and Russia, and will consider further actions as appropriate.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Russia and Other for the three months ended March&#160;31, 2023 and 2022, were $14.5 million. Operating income related to Russia and Other for the three months ended March&#160;31, 2023 and 2022, was $0.5 million and $1.2 million, respectively, prior to the charges noted above. As of March&#160;31, 2023, Russia and Other had assets of $6.8 million, net of working capital reserves related to inventories. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More broadly, there could be additional negative impacts to our net sales, earnings and cash flows should the situation escalate beyond its current scope, including, among other potential impacts, economic recessions in certain neighboring countries or globally due to inflationary pressures and supply chain cost increases or the geographic proximity of the war relative to the rest of Europe. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Inflation</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like many other companies, we are facing significant inflationary pressures in the global economy. Our operations have been, and may continue to be, adversely impacted by inflation, primarily from higher costs of raw materials, labor, production, distribution and transportation costs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">First Quarter Performance</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we experienced a decrease in our consolidated net sales of 1.7 percent (or an increase of 2.4 percent in local currencies) compared to the same period in 2022. Asia net sales increased approximately 0.5 percent (or 9.1 percent in local currencies) compared to the same period in 2022. Europe net sales decreased approximately 1.7 percent (or increased 0.3 percent in local currencies) compared to the same period in 2022. North America net sales decreased approximately 3.7 percent (or 3.2 percent in local currencies) compared to the same period in 2022. Latin America and Other net sales decreased approximately 5.9 percent (or 6.2 percent in local currencies) compared to the same period in 2022. The strengthening of the U.S. dollar versus the local currencies, primarily in our Asian and European markets, resulted in an approximate 4.1 percent, or $4.6 million, decrease of our net sales during the quarter.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $2.8 million during the three months ended March&#160;31, 2023, compared to the same period in 2022, and as a percentage of net sales were 29.2 percent and 31.2 percent for the three months ended March&#160;31, 2023 and 2022, respectively. The decrease in cost of sales percentage is primarily due to prior-year inventory valuation reserves taken as a result of the conflict between Russia and Ukraine, partially offset by increases related to inflation and unfavorable foreign currency exchange.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In absolute terms, selling, general and administrative expenses increased $3.0 million during the three months ended March&#160;31, 2023, compared to the same period in 2022, and as a percentage of net sales were 40.2 percent and 36.8 percent for the three months ended March&#160;31, 2023 and 2022, respectively. The increase was primarily related to a one-time pre-tax charge of $5.8 million related to a criminal scheme directed at one of our wholly owned subsidiaries and related investigation costs. See further discussion in Note 12, &#8220;Synergy Japan Loss,&#8221; to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report. That increase was partially offset by lower service fees that resulted from a decline in China's net sales and lower compensation expense.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an international business, we have significant sales and costs denominated in currencies other than the U.S. Dollar. We expect foreign markets with functional currencies other than the U.S. Dollar will continue to represent a substantial portion of our overall sales and related operating expenses. Accordingly, changes in foreign currency exchange rates could materially affect sales and costs or the comparability of sales and costs from period to period as a result of translating foreign markets financial statements into our reporting currency.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our unaudited consolidated operating results from continuing operations in U.S. dollars and as a percentage of net sales for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:28.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent&#160;of<br/>net sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volume incentives</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,137)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (loss), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income&#160;taxes</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,686)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International operations have provided, and are expected to continue to provide, a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the U.S. dollar against foreign currencies. In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, in addition to comparing the percent change in net sales from one period to another in U.S. dollars, we present net sales excluding the impact of foreign exchange fluctuations. We compare the percentage change in net sales from one period to another period by excluding the effects of foreign currency exchange as shown below. Net sales excluding the impact of foreign exchange fluctuations is not a U.S. GAAP financial measure and removes from net sales in U.S. dollars the impact of changes in exchange rates between the U.S. dollar and the functional currencies of our foreign subsidiaries, by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting the impact of foreign currency fluctuations is useful to investors because it allows a more meaningful comparison of net sales of our foreign operations from period to period. However, net sales excluding the impact of foreign currency fluctuations should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP. Throughout the last five years, foreign currency exchange rates have fluctuated significantly. See Item 3.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in net sales by operating segment with a reconciliation to net sales excluding the impact of currency fluctuations for the three months ended March&#160;31, 2023 and 2022 (dollar amounts in thousands):&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.815%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net&#160;Sales&#160;by&#160;Operating&#160;Segment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Impact&#160;of<br/>Currency<br/>Exchange</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent<br/>Change<br/>Excluding<br/>Impact&#160;of<br/>Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(445)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,567)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated net sales for the three months ended March&#160;31, 2023 and 2022, were $108.6 million and $110.5 million, respectively, which represents a decrease of 1.7 percent. The decrease was primarily related to product sales declines in our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North America operating segment. Excluding the impact of foreign currency exchange rate fluctuations, consolidated net sales for the three months ended March&#160;31, 2023, increased 2.4 percent from the same period in 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asia</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Asia for the three months ended March&#160;31, 2023 and 2022, were $46.3 million and $46.1 million, respectively, or an increase of 0.5 percent. In local currency, net sales for the three months ended March&#160;31, 2023, increased 9.1 percent, compared to the same periods in 2022. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notable activity in the following markets contributed to the results of Asia:</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our South Korea market, net sales decreased $2.4 million, or 17.7 percent, for the three months ended March&#160;31, 2023, compared to the same period in 2022. In local currency, net sales for the three months ended March&#160;31, 2023, decreased 12.9 percent, compared to the same period in 2022. The decrease in net sales was primarily the result of residual effects of government restrictions intended to slow the spread of COVID-19 as well as customer sensitivity due to inflationary pressures, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Taiwan market, net sales increased $4.4 million, or 45.4 percent, for the three months ended March&#160;31, 2023, compared to the same period in 2022. In local currencies, net sales for the three months ended March&#160;31, 2023, increased 58.0 percent, compared to the same period in 2022. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Japan market, net sales increased $0.6 million, or 6.0 percent, for the three months ended March&#160;31, 2023, compared to the same period in 2022. In local currencies, net sales for the three months ended March&#160;31, 2023, increased 20.8 percent, compared to the same period in 2022. We attribute the growth in net sales primarily to product promotions intended to stimulate activity as well as an increase in demand for nutritional supplements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our China market, net sales decreased $2.7 million, or 22.5 percent, for the three months ended March&#160;31, 2023, compared to the same period in 2022. In local currencies, net sales for the three months ended March&#160;31, 2023, decreased 17.3 percent, compared to the same period in 2022. The decrease in net sales was primarily the result of residual effects of government restrictions intended to slow the spread of COVID-19, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Europe</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Europe for the three months ended March&#160;31, 2023 and 2022, were $21.4 million and $21.8 million, respectively, or decrease of 1.7 percent. In local currency, net sales for the three months ended March&#160;31, 2023, increased 0.3 percent, compared to the same period in 2022. The functional currency for many of these markets is the U.S. Dollar which reduces the effect from foreign currency fluctuations. Fluctuations in foreign exchange rates had unfavorable impacts on net sales of $0.4 million for the three months ended March&#160;31, 2023. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">North America</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to North America for the three months ended March&#160;31, 2023 and 2022, were $34.6 million and $36.0 million, respectively, or a decrease of 3.7 percent. In local currency, net sales for the three months ended March&#160;31, 2023, decreased 3.2 percent, compared to the same periods in 2022. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, net sales decreased $1.2 million, or 3.7 percent, for the three months ended March&#160;31, 2023, compared to the same period in 2022. The decrease in sales was due primarily to a reduction in the average order size attributed to customer sensitivity due to inflationary pressures, among other factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Latin America and Other</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales related to Latin America and Other markets for the three months ended March&#160;31, 2023 and 2022, were $6.2 million and $6.6 million, respectively, or a decrease of 5.9 percent. In local currency, net sales for the three months ended March&#160;31, 2023, decreased 6.2 percent. Fluctuations in foreign currency had negligible impacts on net sales for the three months ended March&#160;31, 2023. The decrease in sales was due primarily to a reduction in the average order size attributed to customer sensitivity due to inflationary pressures, among other factors.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further information related to our Asia, Europe, North America, and Latin America and Other business segments is set forth in Note 7 to the Unaudited Condensed Consolidated Financial Statements in Part&#160;1,&#160;Item 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Sales</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales as a percent of net sales was 29.2 percent and 31.2 percent for the three months ended March&#160;31, 2023 and 2022, respectively. The decrease in cost of sales percentage is primarily due to $3.1 million in prior-year inventory valuation reserves taken as a result of the conflict between Russia and Ukraine, partially offset by increases related to inflation and unfavorable foreign currency exchange.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Volume Incentives</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives expense as a percent of net sales was 30.5 percent and 30.9 percent for the three months ended March&#160;31, 2023 and 2022, respectively. These payments are designed to provide incentives for reaching certain sales levels. Volume incentives vary slightly, on a percentage basis, by product due to pricing policies and commission plans in place in our various operations. We do not pay volume incentives in China, instead we pay independent service fees which are included in selling, general and administrative expenses. Volume incentives as a percentage of net sales can fluctuate based on promotional activity and mix of sales by market.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses represent operating expenses, components of which include labor and benefits, sales events, professional fees, travel and entertainment, marketing, occupancy costs, communications costs, bank fees, depreciation and amortization, independent services fees paid in China, and other miscellaneous operating expenses.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased by $3.0 million, to $43.6 million for the three months ended March&#160;31, 2023, respectively, compared to the same period in 2022. Selling, general and administrative expenses were 40.2 percent and 36.8 percent of net sales for the three months ended March&#160;31, 2023 and 2022, respectively. The increase was primarily related to a one-time pre-tax charge of $5.8 million related to a criminal scheme directed at one of our wholly owned subsidiaries and related investigation costs. See further discussion in Note 12, &#8220;Synergy Japan Loss,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report. That increase was partially offset by lower service fees that resulted from a decline in China's net sales and lower compensation expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Loss), Net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (loss), net, for the three months ended March&#160;31, 2023 and 2022, were income of $1.5 million and losses of $0.3 million, respectively. Other income, net for the three months ended March&#160;31, 2023 primarily consisted of foreign exchange gains as a result of net changes in foreign currencies primarily in Asia, Europe and Latin America.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, our provision for income taxes, as a percentage of income before income taxes was 25.7 percent and 369.9 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2023, was primarily attributed to an increase in tax liability related to foreign operations which are treated as a branch for US tax purposes and current year foreign losses that presently do not provide future tax benefit, partially offset by favorable adjustments to deferred tax assets and foreign tax credits.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three months ended March&#160;31, 2023 compared to March&#160;31, 2022 is primarily caused by recording a valuation allowance in the prior period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2019 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions that have open tax years from 2017 through 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, we have accrued $0.2&#160;million and $0.2&#160;million, respectively, related to unrecognized tax positions. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Categories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our line of over 800 products includes several different product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. We purchase herbs and other raw materials in bulk and, after quality control testing, we formulate, encapsulate, tablet or concentrate them, label and package them for shipment. Most of our products are manufactured at our facility in Spanish Fork, Utah. Contract manufacturers produce some of our products in accordance with our specifications and standards. We have implemented quality control procedures to verify that our contract manufacturers have complied with our specifications and standards.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 7, Segment Information, for a summary of the U.S. dollar amounts from the sale of general health, immune, cardiovascular, digestive, personal care and weight management products for the three months ended March&#160;31, 2023 and 2022, by business segment.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Distribution and Marketing</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our products primarily through our network of independent consultants, who market our products to customers through direct selling techniques and sponsor other independent consultants who also market our products to customers. We seek to motivate and provide incentives to our independent consultants by offering high quality products and providing independent consultants with product support, training seminars, sales conventions, travel programs and financial incentives.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products sold in the United States are shipped directly from our manufacturing and warehouse facilities located in Spanish Fork, Utah, as well as from our regional warehouses located in Georgia, Ohio and Texas. Many of our international operations maintain warehouse facilities and inventory to supply their independent consultants. However, in foreign markets where we do not maintain warehouse facilities, we have contracted with third-parties to distribute our products and provide support services to our force of independent consultants.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, we generally sell our products on a cash or credit card basis. From time to time, our U.S. operations extend short-term credit associated with product promotions. For certain of our international operations, we use independent distribution centers and offer credit terms that are generally consistent with industry standards within each respective country.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay sales commissions, or &#8220;volume incentives&#8221; to our independent consultants based upon their own product sales and the product sales of their sales organization. As an exception, in China, we do not pay volume incentives; rather, we pay independent service fees, which are included in selling, general and administrative expenses. These volume incentives are recorded as an expense in the year earned. The amounts of volume incentives that we expensed during the quarters ended March&#160;31, 2023 and 2022, are set forth in the Condensed Consolidated Financial Statements in Item 1 of this report. In addition to the opportunity to receive volume incentives, independent consultants who attain certain levels of monthly product sales are eligible for additional incentive programs including automobile allowances, sales convention privileges and travel awards.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal use of cash is to pay for operating expenses, including volume incentives, inventory and raw material purchases, capital assets and funding of international expansion. As of March&#160;31, 2023, working capital was $82.8 million, compared to $83.9 million as of December&#160;31, 2022. At March&#160;31, 2023, we had $65.7 million in cash, of which $4.7 million was held in the U.S. and $61.0 million was held in foreign markets and may be subject to various withholding taxes and other restrictions related to repatriation before becoming available to be used along with the normal cash flows from operations to fund any unanticipated shortfalls in future cash flows.</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net consolidated cash inflows (outflows) are as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:64.492%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.737%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.739%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,924)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,374)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operating Activities </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, operating activities provided cash of $9.3 million, compared to using cash of $7.9 million in the same period in 2022. Operating cash flows increased primarily due to improved net income, the timing of payments for accrued liabilities and accounts payable, reduced inventory purchases, and timing of receipts of accounts receivable.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Investing Activities</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, investing activities used $2.3 million, compared to $1.5 million for the same period in 2022, which consisted of capital expenditures related to the purchase of equipment, computer systems and software. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financing Activities</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023, financing activities used $1.2 million, compared to $9.4 million in cash for the same period in 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we used cash to repurchase 90,000 shares of our common stock under the share repurchase program for $0.8 million. At March&#160;31, 2023, the remaining balance available for repurchases under the program was $23.2&#160;million.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a revolving credit agreement with Bank of America, N.A (the &#8220;Credit Agreement&#8221;), as well as a credit agreement with Banc of America Leasing and Capital, LLC (the "Capital Credit Agreement"). At March&#160;31, 2023, there was $0.2 million outstanding balance under the Credit Agreement. During the three months ended March&#160;31, 2023 we made monthly payments of $0.1&#160;million pursuant to the Capital Credit Agreement. As of March&#160;31, 2023, there was $0.9&#160;million outstanding balance under the Capital Credit Agreement, $0.9&#160;million of which was classified as current. Our debt obligations are discussed in greater detail in Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving Credit Facility and Other Obligations,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that cash generated from operations, along with available cash and cash equivalents, will be sufficient to fund our normal operating needs, including capital expenditures, on both a short- and long-term basis.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other things such as a prolonged economic downturn, a decrease in demand for our products, an unfavorable settlement of our unrecognized tax positions or non-income tax contingencies could adversely affect our long-term liquidity.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with U.S. GAAP and form the basis for the following discussion and analysis on critical accounting policies and estimates. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On a regular basis, we evaluate our estimates and assumptions. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations. We have discussed the development, selection and disclosure of these estimates with the Board of Directors and our Audit Committee.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is provided in Note 1 of the Notes to Consolidated Financial Statements in Item 8 of the Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022. We believe the critical accounting policies and estimates described below reflect our more significant estimates and assumptions used in the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">preparation of the consolidated financial statements. The impact and any associated risks on our business that are related to these policies are also discussed throughout this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; where such policies affect reported and expected financial results.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue recognition practices are discussed in Note 11, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue Recognition,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Consolidated Financial Statements in Item 1, Part 1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inventories</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are adjusted to lower of cost and net realizable value, using the first-in, first-out method. The components of inventory cost include raw materials, labor and overhead. To estimate any necessary adjustments, various assumptions are made in regard to excess or slow-moving inventories, non-conforming inventories, expiration dates, current and future product demand, production planning and market conditions. If future demand and market conditions are less favorable than our assumptions, additional inventory adjustments could be required.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Trip Accrual</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for expenses associated with our direct sales program, which rewards independent consultants with paid attendance for incentive trips, including our conventions and meetings. Expenses associated with incentive trips are accrued over qualification periods as they are earned. We specifically analyze incentive trip accruals based on historical and current sales trends as well as contractual obligations when evaluating the adequacy of the incentive trip accrual. Actual results could generate liabilities more or less than the amounts recorded.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in certain legal proceedings and disputes. When a loss is considered probable in connection with litigation or non-income tax contingencies and when such loss can be reasonably estimated with a range, we record our best estimate within the range related to the contingency. If there is no best estimate, we record the minimum of the range. As additional information becomes available, we assess the potential liability related to the contingency and revise the estimates. Revision in estimates of the potential liabilities could materially affect our results of operations in the period of adjustment. Our contingencies are discussed in further detail in Note 9, &#8220;Commitments and Contingencies&#8221;, to the Notes of our Condensed Consolidated Financial Statements, of Item 1, Part&#160;1 of this report.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income taxes, deferred tax assets and liabilities and contingent reserves reflect management&#8217;s best assessment of estimated future taxes to be paid. We are subject to income taxes in both the United States and numerous foreign jurisdictions. Significant judgments and estimates are required in determining our consolidated provision for income taxes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes arise from temporary differences between the tax and financial statement recognition of revenue and expense. In evaluating our ability to recover our deferred tax assets, management considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, we develop assumptions including the amount of future state, federal and foreign pretax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment about the forecasts of future taxable income, and are consistent with the plans and estimates that we are using to manage the underlying businesses. Valuation allowances are recorded as reserves against net deferred tax assets by us when it is determined that net deferred tax assets are not likely to be realized in the foreseeable future.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Management is not aware of any such changes that would have a material effect on our results of operations, cash flows or financial position.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across our global operations. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business in several countries and intend to grow our international operations. Net sales, operating income and net income are affected by fluctuations in currency exchange rates, interest rates and other uncertainties inherent in doing business and selling product in more than one currency. In addition, our operations are exposed to risks associated with changes in social, political and economic conditions inherent in international operations, including changes in the laws and policies that govern international investment in countries where we have operations, as well as, to a lesser extent, changes in U.S. laws and regulations relating to international trade and investment. For further information, see Part II, Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CONTROLS AND PROCEDURES</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures (as defined in Rule&#160;13a-15(e)&#160;under the Exchange Act) are designed to provide reasonable assurance that the information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules&#160;and forms adopted by the SEC, and that such information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosures. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision and with the participation of the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March&#160;31, 2023. Based on this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of March&#160;31, 2023, due to the material weakness in internal controls over financial reporting described below. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management, with the participation of our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework set forth in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Internal Control&#8212;Integrated Framework (2013)&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on management&#8217;s assessment under this framework, management has concluded that our internal control over financial reporting were not effective as of March&#160;31, 2023, due to the material weakness in internal controls over financial reporting described below.&#160;</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weakness</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in our Current Report on Form 8-K filed on February 24, 2023, we determined that Synergy Worldwide Japan G.K., a Japan entity and wholly owned subsidiary of the Company (&#8220;Synergy Japan&#8221;), was the victim of a criminal scheme involving employee impersonation and fraudulent requests targeting Synergy Japan. The criminal scheme resulted in a series of fraudulently induced unauthorized wire transfers between February 1, 2023, and February 17, 2023, totaling $4.8 million. We determined that our internal controls were not properly designed to prevent or timely detect unauthorized wire transfers by Synergy Japan. This material weakness in our controls resulted in the inability to prevent and timely detect this misappropriation of our cash assets in Synergy Japan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's independent registered public accounting firm, Deloitte &amp; Touche LLP, has audited the effectiveness of the Company's internal control over financial reporting as of December&#160;31, 2022 and expressed an adverse opinion, which is disclosed in Item 9A. of the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 16, 2023.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan of Remediation of Material Weakness</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the incident, we initiated a reassessment of our processes and controls related to wire transfers and developed an action plan to remediate this matter, which included the following control enhancements:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhancing the design of approval requirements for wire transfers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhancing the design of controls within online banking platforms;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing the centralization and review processes associated with cash management; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing internal communication to heighten awareness and emphasize the importance of exercising professional skepticism and judgment.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These remediation efforts are still in process and have not yet been completed. A material weakness in internal control over financial reporting is a matter that may require an extended period to correct. We will continue to evaluate, design and implement policies and procedures to address this material weakness. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the ongoing remediation efforts related to the material weakness described above, there were no changes in our internal controls over financial reporting (as defined in Rule&#160;13a-15(f)&#160;under the Exchange Act) during the quarter ended March&#160;31, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II OTHER INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RISK FACTORS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the information set forth in this report, you should carefully consider the risks discussed under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022, which could have a material adverse effect on our business or consolidated financial statements, results of operations, and cash flows. Additional risks not currently known, or risks that are currently believed to be not material, may also impair business operations.&#160;There have been no material changes to our risk factors since the filing of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022, except as set forth below. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal controls, we may not be able to report our financial results accurately, may make a material misstatement in our financial statements, or may experience a financial loss. Any inability to report and file our financial results accurately and timely could harm our business and adversely affect the value of our business.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to establish and maintain internal controls over financial reporting and disclosure controls and procedures and to comply with other requirements of the Sarbanes-Oxley Act and the rules promulgated by the SEC. Even when such controls are implemented, management, including our Chief Executive Officer and Chief Financial Officer, cannot guarantee that our internal controls and disclosure controls and procedures will prevent all possible errors or loss. Because of the inherent limitations in all control systems, no system of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company or perpetrated against us will be prevented or have been detected. These inherent limitations include the possibility that judgments in decision-making can be faulty and subject to simple error or mistake. Furthermore, controls can be circumvented by individual acts of some persons, by collusion of two or more persons, or by management override of the controls. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, measures of control may become inadequate because of changes in conditions, new fraudulent schemes, or the deterioration of compliance with policies or procedures. Because of inherent limitations in a cost-effective control system, financial loss or misstatements due to error or fraud may occur and/or may not be detected.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accuracy of our financial reporting and safeguarding of our assets depends on the effectiveness of our internal control over financial reporting. Internal control over financial reporting can provide only reasonable assurance with respect to the preparation and fair presentation of financial statements and may not prevent or detect financial loss or misstatements. Failure to maintain effective internal control over financial reporting, or lapses in disclosure controls and procedures, could undermine the ability to provide accurate disclosure (including with respect to financial information) on a timely basis or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prevent or timely detect unauthorized wire transfers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which could cause investors to lose confidence in our internal controls (including with respect to financial information), require significant resources to remediate the lapse or deficiency, and expose us to legal or regulatory proceedings. In the first quarter of 2023, we identified a material weakness in internal controls over financial reporting related to the prevention and timely detection of unauthorized wire transfers. Because the material weakness </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in the inability to prevent and timely detect misappropriation of cash assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our management concluded that at March 31, 2023, the Company&#8217;s internal control over financial reporting was ineffective.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate, design and work through the process of implementing controls and procedures under a remediation plan designed to address this material weakness, but there can be no assurance that we will be able to remediate this material weakness in a timely manner or at all. If our remediation measures are insufficient to address the material weaknesses, or if additional material weaknesses or significant deficiencies in our internal control are discovered or occur in the future, our financial statements may contain material misstatements, we could experience another financial loss, or we could be required to restate our financial results, which could lead to substantial additional costs for accounting and legal fees and stockholder litigation.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any failure to maintain such internal control could adversely impact our ability to report our financial position and results from operations on a timely and accurate basis, and result in unauthorized access to our assets, including through unauthorized wire transfers. If such unauthorized transfers are not prevented or detected in a timely manner, our financial position could be adversely affected. Ineffective internal controls could also cause investors to lose confidence in our reported </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">financial information, which could have a negative effect on the trading price of our stock. In addition, we may face potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from any restatement and material weaknesses in our internal controls over financial reporting. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.</span></div><div style="text-indent:27pt"><span><br/></span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the purchases of our common stock during the fiscal quarter ended March&#160;31, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Periods</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased <br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs<br/>&#160;(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2023 to January 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023 to February 28, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2023 to March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,181&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;On March 10, 2021, we announced a $15.0 million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0 million shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. We purchased 90,000 shares of our common stock during the quarter ended March&#160;31, 2023 under the terms of this Board approved plan.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual timing, number, and value of common shares repurchased under our board-approved plan will be determined at our discretion and will depend on a number of factors, including, among others, general market and business conditions, the trading price of common shares, and applicable legal requirements. We have no obligation to repurchase any common shares under the authorization, and the repurchase plan may be suspended, discontinued, or modified at any time for any reason.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DEFAULTS UPON SENIOR SECURITIES</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MINE SAFETY DISCLOSURES</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="iaff80d6feba84531aa76e6adafecaf3a_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EXHIBITS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Index to Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Item&#160;No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex311.htm">Certification of Chief Executive Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex312.htm">Certification of Chief Financial Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex313.htm">Certification of Chief </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex313.htm">Accounting</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex313.htm"> Officer under SEC Rule&#160;13a-14(a)/15d-14(a)&#160;promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex321.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350 Chief Executive Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex322.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section&#160;1350 Financial Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.3(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex323.htm">Certification of Chief </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex323.htm">Accounting</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="natr2023331-ex323.htm"> Officer pursuant to 18 U.S.C. Section&#160;1350 Financial Officer pursuant to 18 U.S.C. Section&#160;1350</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page Interactive Data File (the cover page XBRL tags are embedded within iXBRL (Inline Extensible Business Reporting Language) document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Filed currently herewith.</span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="iaff80d6feba84531aa76e6adafecaf3a_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#iaff80d6feba84531aa76e6adafecaf3a_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nature</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">s Sunshine Products, Inc.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Terrence O. Moorehead</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ L. Shane Jones</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L. Shane Jones, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jonathan D. Lanoy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>natr2023331-ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic419917d9f554284896e545ae75ac5a8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Terrence O. Moorehead, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (&#8220;the registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>natr2023331-ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i61934fd0049f400882e86280640c8e0e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, L. Shane Jones, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; L. Shane Jones</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L. Shane Jones</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer </font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.3
<SEQUENCE>4
<FILENAME>natr2023331-ex313.htm
<DESCRIPTION>EX-31.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1921efc62e6f47aa996c70f1bf8f9bf2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jonathan D. Lanoy, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have reviewed this Quarterly Report on Form&#160;10-Q of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f)&#160;and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>natr2023331-ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9275698b1e904c06a90b8f2859aa84d5_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Terrence O. Moorehead, President and Chief Executive Officer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrence O. Moorehead</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>natr2023331-ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if523e3ac972d451f92694a69e9e92e73_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, L. Shane Jones, Executive Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; L. Shane Jones</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">L. Shane Jones</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Chief Financial Officer and Treasurer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.3
<SEQUENCE>7
<FILENAME>natr2023331-ex323.htm
<DESCRIPTION>EX-32.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i003387767b604bb58d4215bb3b6b3057_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.3</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION&#160;1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Nature&#8217;s Sunshine Products,&#160;Inc. (the &#8220;Company&#8221;) on Form&#160;10-Q for the period ended March&#160;31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;),&#160;I, Jonathan D. Lanoy, Senior Vice President and Chief Accounting Officer of the Company, certify, pursuant to 18.U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge&#58;</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Report fully complies with the requirements of Section&#160;13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jonathan D. Lanoy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>natr-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:natr="http://naturessunshine.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://naturessunshine.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="natr-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://naturessunshine.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://naturessunshine.com/role/BasisofPresentation">
        <link:definition>0000008 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://naturessunshine.com/role/Inventories">
        <link:definition>0000009 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTrading" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading">
        <link:definition>0000010 - Disclosure - Investment Securities - Trading</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligations" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations">
        <link:definition>0000011 - Disclosure - Revolving Credit Facility and Other Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelossPerShare" roleURI="http://naturessunshine.com/role/NetIncomelossPerShare">
        <link:definition>0000012 - Disclosure - Net Income (loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactions" roleURI="http://naturessunshine.com/role/CapitalTransactions">
        <link:definition>0000013 - Disclosure - Capital Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://naturessunshine.com/role/SegmentInformation">
        <link:definition>0000014 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://naturessunshine.com/role/IncomeTaxes">
        <link:definition>0000015 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://naturessunshine.com/role/CommitmentsandContingencies">
        <link:definition>0000016 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://naturessunshine.com/role/FairValueMeasurements">
        <link:definition>0000017 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://naturessunshine.com/role/RevenueRecognition">
        <link:definition>0000018 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SynergyJapanLoss" roleURI="http://naturessunshine.com/role/SynergyJapanLoss">
        <link:definition>0000019 - Disclosure - Synergy Japan Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationPolicies" roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies">
        <link:definition>0000020 - Disclosure - Basis of Presentation (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://naturessunshine.com/role/InventoriesTables">
        <link:definition>0000021 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelossPerShareTables" roleURI="http://naturessunshine.com/role/NetIncomelossPerShareTables">
        <link:definition>0000022 - Disclosure - Net Income (loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsTables" roleURI="http://naturessunshine.com/role/CapitalTransactionsTables">
        <link:definition>0000023 - Disclosure - Capital Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://naturessunshine.com/role/SegmentInformationTables">
        <link:definition>0000024 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables">
        <link:definition>0000025 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetails" roleURI="http://naturessunshine.com/role/BasisofPresentationDetails">
        <link:definition>0000026 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://naturessunshine.com/role/InventoriesDetails">
        <link:definition>0000027 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentSecuritiesTradingDetails" roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails">
        <link:definition>0000028 - Disclosure - Investment Securities - Trading (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevolvingCreditFacilityandOtherObligationsDetails" roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails">
        <link:definition>0000029 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomelossPerShareDetails" roleURI="http://naturessunshine.com/role/NetIncomelossPerShareDetails">
        <link:definition>0000030 - Disclosure - Net Income (loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsNarrativeDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails">
        <link:definition>0000031 - Disclosure - Capital Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsStockOptionActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails">
        <link:definition>0000032 - Disclosure - Capital Transactions - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalTransactionsRSUActivityDetails" roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails">
        <link:definition>0000033 - Disclosure - Capital Transactions - RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://naturessunshine.com/role/SegmentInformationDetails">
        <link:definition>0000034 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://naturessunshine.com/role/IncomeTaxesDetails">
        <link:definition>0000035 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails">
        <link:definition>0000036 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails">
        <link:definition>0000037 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>0000038 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SynergyJapanLossDetails" roleURI="http://naturessunshine.com/role/SynergyJapanLossDetails">
        <link:definition>0000039 - Disclosure - Synergy Japan Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="natr_BankofAmericaCreditAgreementMember" abstract="true" name="BankofAmericaCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_PersonalCareProductsMember" abstract="true" name="PersonalCareProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" abstract="true" name="BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IndicativeIndexMember" abstract="true" name="IndicativeIndexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_EuropeSegmentMember" abstract="true" name="EuropeSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_LatinAmericaAndOtherSegmentMember" abstract="true" name="LatinAmericaAndOtherSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ContributionMargin" abstract="false" name="ContributionMargin" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedfromComputationofEarnings" abstract="false" name="DilutiveSecuritiesExcludedfromComputationofEarnings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" abstract="false" name="MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_FraudExpenseMember" abstract="true" name="FraudExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" abstract="true" name="AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_LineOfCreditFacilityNumberOfSeparateIncreases" abstract="false" name="LineOfCreditFacilityNumberOfSeparateIncreases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_NonIncomeTaxMember" abstract="true" name="NonIncomeTaxMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_GeneralHealthProductsMember" abstract="true" name="GeneralHealthProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ImmunityProductsMember" abstract="true" name="ImmunityProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_A2012IncentivePlanMember" abstract="true" name="A2012IncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_VolumeIncentives" abstract="false" name="VolumeIncentives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_AsiaSegmentMember" abstract="true" name="AsiaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" abstract="false" name="IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_WeightManagementProductsMember" abstract="true" name="WeightManagementProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_RestrictionPeriodForIssuanceOfShares" abstract="false" name="RestrictionPeriodForIssuanceOfShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_ContributionMarginAbstract" abstract="true" name="ContributionMarginAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_AccruedVolumeIncentiveandServiceFees" abstract="false" name="AccruedVolumeIncentiveandServiceFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" abstract="true" name="DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_DebtInstrumentNumberOfMonthlyPayments" abstract="false" name="DebtInstrumentNumberOfMonthlyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_NumberofPrincipalCategoriesofProducts" abstract="false" name="NumberofPrincipalCategoriesofProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="natr_CardiovascularProductsMember" abstract="true" name="CardiovascularProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="natr_TimeBasedStockOptionsMember" abstract="true" name="TimeBasedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_OperatingLeaseNonCashLeaseExpense" abstract="false" name="OperatingLeaseNonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" abstract="true" name="PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_RevenuefromContractwithCustomerRefundPeriod" abstract="false" name="RevenuefromContractwithCustomerRefundPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" abstract="false" name="IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" abstract="true" name="ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_NorthAmericaSegmentMember" abstract="true" name="NorthAmericaSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_PerformanceBasedRestrictedStockUnitsRSUsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_DigestiveProductsMember" abstract="true" name="DigestiveProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" abstract="false" name="ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>natr-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e8afc28-0861-43ee-ab76-5ded727fb683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_35a366f0-f36f-41c2-aacf-3be9df9bbf15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e8afc28-0861-43ee-ab76-5ded727fb683" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_35a366f0-f36f-41c2-aacf-3be9df9bbf15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_01eb8d1a-8456-47de-acac-499627a5e7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e8afc28-0861-43ee-ab76-5ded727fb683" xlink:to="loc_us-gaap_MinorityInterest_01eb8d1a-8456-47de-acac-499627a5e7d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b272f80-82c2-469c-8e8d-f7f26ea17f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e8afc28-0861-43ee-ab76-5ded727fb683" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8b272f80-82c2-469c-8e8d-f7f26ea17f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0f7ef271-f4b3-4114-ac79-929796f69584" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5e8afc28-0861-43ee-ab76-5ded727fb683" xlink:to="loc_us-gaap_CommonStockValue_0f7ef271-f4b3-4114-ac79-929796f69584" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b110f540-7588-480c-b382-4c81a45e3d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_AccountsPayableCurrent_b110f540-7588-480c-b382-4c81a45e3d9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_f5ad7154-7950-4e35-b017-d505636880ec" xlink:href="natr-20230331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_f5ad7154-7950-4e35-b017-d505636880ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f512eafd-dcc4-4dbd-91a0-ce1026914030" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f512eafd-dcc4-4dbd-91a0-ce1026914030" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b26ea89d-fe4e-44f0-b22f-41b7f244c4ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_b26ea89d-fe4e-44f0-b22f-41b7f244c4ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_e3ff536b-540e-4cbe-b3ad-10578da2341a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_e3ff536b-540e-4cbe-b3ad-10578da2341a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_300fb318-624d-4c1b-b69e-6e5e41d93d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_300fb318-624d-4c1b-b69e-6e5e41d93d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_53a948d9-7f03-4021-a863-ec1b69136e54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_52df158a-ebc5-46ac-b7d2-1a0287b51b9e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_53a948d9-7f03-4021-a863-ec1b69136e54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8340030f-7fe0-4bd4-b435-3f9d1def87b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_467b8c3a-3cdc-4f62-a45a-91c49b19695f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8340030f-7fe0-4bd4-b435-3f9d1def87b8" xlink:to="loc_us-gaap_Liabilities_467b8c3a-3cdc-4f62-a45a-91c49b19695f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07ce6028-b2a2-4a15-a0b1-375f1e7224b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8340030f-7fe0-4bd4-b435-3f9d1def87b8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_07ce6028-b2a2-4a15-a0b1-375f1e7224b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8e4f209b-d20d-40e8-bf9d-2a027b082f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8e4f209b-d20d-40e8-bf9d-2a027b082f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_8d0b6945-29e0-4a85-90ce-5dfd5c1f087c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_LiabilitiesCurrent_8d0b6945-29e0-4a85-90ce-5dfd5c1f087c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6573bb36-2020-422a-b696-6ebd78080829" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_6573bb36-2020-422a-b696-6ebd78080829" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_24ebd439-be40-404c-a833-f75e5562e257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_24ebd439-be40-404c-a833-f75e5562e257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2eb48ca5-49be-4eec-afd7-6300cc01ec67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2eb48ca5-49be-4eec-afd7-6300cc01ec67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1838c4bf-49e5-4378-b7d2-be2d598bfa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_4678b492-ace6-4d45-b521-129c65bfdd0a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1838c4bf-49e5-4378-b7d2-be2d598bfa3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b05c5486-cde1-4e7f-b01a-396591e0eb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_AssetsCurrent_b05c5486-cde1-4e7f-b01a-396591e0eb66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_874b99bd-b87a-41e4-b4bb-42d7db107504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_874b99bd-b87a-41e4-b4bb-42d7db107504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_00829bd9-0690-4f1d-8ea0-48d27dc55697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_00829bd9-0690-4f1d-8ea0-48d27dc55697" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_ad469a0e-4a81-4657-a039-63ef5c0342b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_ad469a0e-4a81-4657-a039-63ef5c0342b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7bda38bb-b758-40e5-b472-3a78a3e4d320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7bda38bb-b758-40e5-b472-3a78a3e4d320" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5de131a8-3c8f-4fa7-88d6-3cbe0cd33cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dd2e782b-e680-41b4-a984-bdd3d22d7f89" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5de131a8-3c8f-4fa7-88d6-3cbe0cd33cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_06344720-09b6-45e7-a2be-9bda440e6b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f469b4eb-1401-4178-b512-eaf5e91015bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_06344720-09b6-45e7-a2be-9bda440e6b20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f469b4eb-1401-4178-b512-eaf5e91015bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b1aac3dc-72cb-4124-860f-360485de5373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_06344720-09b6-45e7-a2be-9bda440e6b20" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b1aac3dc-72cb-4124-860f-360485de5373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9c4d08b9-8c5c-4f34-a8ee-9b8933904463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_06344720-09b6-45e7-a2be-9bda440e6b20" xlink:to="loc_us-gaap_InventoryNet_9c4d08b9-8c5c-4f34-a8ee-9b8933904463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8b05d5db-6858-4ef0-8f84-3b3a42e503bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_06344720-09b6-45e7-a2be-9bda440e6b20" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8b05d5db-6858-4ef0-8f84-3b3a42e503bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ed7ba07b-a027-4254-bab1-15e3b966f02a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf91a69d-12f5-408f-b465-5930c415b1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ed7ba07b-a027-4254-bab1-15e3b966f02a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bf91a69d-12f5-408f-b465-5930c415b1b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_287aa4a4-1269-4b18-8d46-27a066558d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ed7ba07b-a027-4254-bab1-15e3b966f02a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_287aa4a4-1269-4b18-8d46-27a066558d17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_affe2945-708b-4449-8d46-fc5ca63d359d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12b7ba4-cbf0-458e-9df9-b47a501a8021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_affe2945-708b-4449-8d46-fc5ca63d359d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d12b7ba4-cbf0-458e-9df9-b47a501a8021" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_573dff27-ae6d-445c-bbd4-61ec0e76b242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_affe2945-708b-4449-8d46-fc5ca63d359d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_573dff27-ae6d-445c-bbd4-61ec0e76b242" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0d573a6-0a5a-4324-8efc-251d99caeb97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9375d09-67ed-4541-a499-bdcba8749461" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e0d573a6-0a5a-4324-8efc-251d99caeb97" xlink:to="loc_us-gaap_ProfitLoss_c9375d09-67ed-4541-a499-bdcba8749461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_74a2259c-8374-497f-a23c-ca2701277ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e0d573a6-0a5a-4324-8efc-251d99caeb97" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_74a2259c-8374-497f-a23c-ca2701277ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a5897970-eeb7-4c20-b201-c9d8f3cb5aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e6ed8e3f-3160-4cb9-a866-c7e44d9e1432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a5897970-eeb7-4c20-b201-c9d8f3cb5aa2" xlink:to="loc_us-gaap_GrossProfit_e6ed8e3f-3160-4cb9-a866-c7e44d9e1432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_e961c41f-7b3d-4049-a478-e33f9695d752" xlink:href="natr-20230331.xsd#natr_VolumeIncentives"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a5897970-eeb7-4c20-b201-c9d8f3cb5aa2" xlink:to="loc_natr_VolumeIncentives_e961c41f-7b3d-4049-a478-e33f9695d752" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ed3f4c8b-d46b-4c8a-8ca3-cf352e7942c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a5897970-eeb7-4c20-b201-c9d8f3cb5aa2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ed3f4c8b-d46b-4c8a-8ca3-cf352e7942c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90159740-5de3-49c1-a395-c838d885ce0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c51d2d99-7052-45c1-a3f4-0efb74390075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90159740-5de3-49c1-a395-c838d885ce0e" xlink:to="loc_us-gaap_OperatingIncomeLoss_c51d2d99-7052-45c1-a3f4-0efb74390075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ead7bec8-9dfc-4583-9b5d-571a6de1613e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90159740-5de3-49c1-a395-c838d885ce0e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ead7bec8-9dfc-4583-9b5d-571a6de1613e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dcdcecc3-1f55-4f99-a013-e70cfe2a0328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ff96b62a-be45-4211-ba8e-334f3ea08d31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dcdcecc3-1f55-4f99-a013-e70cfe2a0328" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_ff96b62a-be45-4211-ba8e-334f3ea08d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2c62151f-c5e8-491c-987d-80ca8d0eb491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_dcdcecc3-1f55-4f99-a013-e70cfe2a0328" xlink:to="loc_us-gaap_ProfitLoss_2c62151f-c5e8-491c-987d-80ca8d0eb491" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_2b1b5c03-1005-4586-a574-0abc9644888f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_2b1b5c03-1005-4586-a574-0abc9644888f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_f422e71f-4d78-4e5b-a7d0-29d9441cc663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_f422e71f-4d78-4e5b-a7d0-29d9441cc663" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_218688f5-031c-4c58-ac08-b9a76f9dc6ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_218688f5-031c-4c58-ac08-b9a76f9dc6ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_688c685a-7815-4e7c-b504-b3292fd252f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_688c685a-7815-4e7c-b504-b3292fd252f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f8d28624-267b-4b49-8a00-3df18d0a8e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f8d28624-267b-4b49-8a00-3df18d0a8e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92775731-37bd-4410-98df-f685a9247b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2f25cc82-9b72-46d0-984d-0592251aebab" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_92775731-37bd-4410-98df-f685a9247b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dd1fd035-2dce-4b79-9462-82c07aa68780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8880363c-30b5-4443-a096-165b751e122b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dd1fd035-2dce-4b79-9462-82c07aa68780" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8880363c-30b5-4443-a096-165b751e122b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04f6e4d-3eb2-49e4-8498-e4ed39aab603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26f84ad8-b259-42b5-953d-f27d36e2efd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04f6e4d-3eb2-49e4-8498-e4ed39aab603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_26f84ad8-b259-42b5-953d-f27d36e2efd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b9c80970-e6be-4b3f-86b0-b22941e20d68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04f6e4d-3eb2-49e4-8498-e4ed39aab603" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b9c80970-e6be-4b3f-86b0-b22941e20d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eef61aa-c4f5-4acf-a9f6-9f26c6fa36a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04f6e4d-3eb2-49e4-8498-e4ed39aab603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0eef61aa-c4f5-4acf-a9f6-9f26c6fa36a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b7fb0b5-bc82-4e6f-b979-b689b8caa944" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a04f6e4d-3eb2-49e4-8498-e4ed39aab603" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9b7fb0b5-bc82-4e6f-b979-b689b8caa944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_12472bd2-e4e7-4529-90b8-af6330dd6e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_ProfitLoss_12472bd2-e4e7-4529-90b8-af6330dd6e0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_3811f93b-101d-49e8-a664-485268c4a989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_3811f93b-101d-49e8-a664-485268c4a989" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_91bb5c6c-a086-40af-b1c8-ac68314ebcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_91bb5c6c-a086-40af-b1c8-ac68314ebcd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_997c06ee-51b6-4974-a857-3945d068fea3" xlink:href="natr-20230331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_997c06ee-51b6-4974-a857-3945d068fea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9aa61bb0-f3bf-496a-a4c9-cbb1a148ba64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_ShareBasedCompensation_9aa61bb0-f3bf-496a-a4c9-cbb1a148ba64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b5fcc1ad-38a7-4ee1-ae20-a6c8de5b0184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_b5fcc1ad-38a7-4ee1-ae20-a6c8de5b0184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_acc8b749-1a59-44cd-8ef9-7868f4e9b3da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_acc8b749-1a59-44cd-8ef9-7868f4e9b3da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_2f64b46f-66c5-4e54-a7b1-624781690ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_2f64b46f-66c5-4e54-a7b1-624781690ac3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_773378fd-8320-41ac-a6dd-70e7bfd4a085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_773378fd-8320-41ac-a6dd-70e7bfd4a085" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b8ce4710-2f9a-4b9f-b5cf-b4458500fd99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_GainLossOnInvestments_b8ce4710-2f9a-4b9f-b5cf-b4458500fd99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_9a91f7f2-292f-4f88-b1b9-8d4b511c145d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_9a91f7f2-292f-4f88-b1b9-8d4b511c145d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8e74a13f-2f43-4670-960b-5bdd7f9ffeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_8e74a13f-2f43-4670-960b-5bdd7f9ffeb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_a31b2321-c03e-4042-b640-5b9b10602570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_a31b2321-c03e-4042-b640-5b9b10602570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e7f80ec-b280-42de-95a2-af8d180c51f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8e7f80ec-b280-42de-95a2-af8d180c51f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3664c72b-a802-4f45-989d-c2f07c21aedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_3664c72b-a802-4f45-989d-c2f07c21aedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3b131ac3-91cc-4637-8706-7cd227f03b20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3b131ac3-91cc-4637-8706-7cd227f03b20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_9645824b-c4e0-4771-a80d-3e63b0a17b19" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_9645824b-c4e0-4771-a80d-3e63b0a17b19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccffc0d8-0c93-4b0b-a529-fd2aafbac9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_ccffc0d8-0c93-4b0b-a529-fd2aafbac9cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c1852323-5629-4e6f-8c4a-7201c8934a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c1852323-5629-4e6f-8c4a-7201c8934a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_9a2f817c-67d4-403c-915d-a1a5e675519a" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_9a2f817c-67d4-403c-915d-a1a5e675519a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7ac9996e-1c17-42ef-a581-1b2692b3a5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_7ac9996e-1c17-42ef-a581-1b2692b3a5b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_b4a8a0de-d469-4f20-9e37-e3a947226215" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_b4a8a0de-d469-4f20-9e37-e3a947226215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_fe741b55-d673-4dec-9026-7a548213f0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="23" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2985c9ba-1d40-4cef-b49c-00956e105b49" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_fe741b55-d673-4dec-9026-7a548213f0c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_27e771dc-56dc-41b1-9db9-7d21b334310a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_429eeb6b-8279-4617-aa69-e50abd4e58d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_27e771dc-56dc-41b1-9db9-7d21b334310a" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_429eeb6b-8279-4617-aa69-e50abd4e58d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7d7c6a07-76d4-4967-acda-974c3fe2519f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_27e771dc-56dc-41b1-9db9-7d21b334310a" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_7d7c6a07-76d4-4967-acda-974c3fe2519f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9cd7b1c8-e5c1-4b67-a076-3691ec66f748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_27e771dc-56dc-41b1-9db9-7d21b334310a" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9cd7b1c8-e5c1-4b67-a076-3691ec66f748" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomelossPerShareDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#NetIncomelossPerShareDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/NetIncomelossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbb9c0e0-e1a4-42e8-a89f-a057a1b23f63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_616851c3-05f5-4c8a-b686-c61c71c411f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbb9c0e0-e1a4-42e8-a89f-a057a1b23f63" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_616851c3-05f5-4c8a-b686-c61c71c411f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6627b23c-04b4-4a1a-a539-bec721efc104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_dbb9c0e0-e1a4-42e8-a89f-a057a1b23f63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6627b23c-04b4-4a1a-a539-bec721efc104" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_34a9e44c-c36d-49a3-80df-30fa8655e27c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_f2efdabd-0d5d-4787-a29a-2beb408d56e0" xlink:href="natr-20230331.xsd#natr_ContributionMargin"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_34a9e44c-c36d-49a3-80df-30fa8655e27c" xlink:to="loc_natr_ContributionMargin_f2efdabd-0d5d-4787-a29a-2beb408d56e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3129a349-b9a7-4bd0-bf7b-42a3664e020a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_34a9e44c-c36d-49a3-80df-30fa8655e27c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3129a349-b9a7-4bd0-bf7b-42a3664e020a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_88dadc99-1c57-42f4-87c4-d32a9dda65fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c00b63af-f6a6-4001-ab6b-780c1e31f690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_88dadc99-1c57-42f4-87c4-d32a9dda65fd" xlink:to="loc_us-gaap_TradingSecurities_c00b63af-f6a6-4001-ab6b-780c1e31f690" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>natr-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended" id="i394980b8ec434598b53288bb40a1f505_CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_10c7c845-3169-441e-a4e4-d4e75f144f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_CommonStockSharesIssued_10c7c845-3169-441e-a4e4-d4e75f144f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78487426-9fe7-40aa-b134-d328e1616eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78487426-9fe7-40aa-b134-d328e1616eea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_c824c5d8-7359-4b7a-99f2-3f79880a2424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_c824c5d8-7359-4b7a-99f2-3f79880a2424" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_97754427-29d7-4811-b243-8f529127699a" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_97754427-29d7-4811-b243-8f529127699a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_41ee38db-645f-4250-b0b0-5fce51eaaed9" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_41ee38db-645f-4250-b0b0-5fce51eaaed9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0cfb39d5-82c2-4579-8e80-8f54441f79e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0cfb39d5-82c2-4579-8e80-8f54441f79e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ca579b65-34bf-437c-9fae-8adc14d8cd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ca579b65-34bf-437c-9fae-8adc14d8cd7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_43b7478c-ba02-430e-b5ec-022af7aa55f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_ProfitLoss_43b7478c-ba02-430e-b5ec-022af7aa55f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f12a04fe-1be9-4388-9802-30b374b1ca9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f12a04fe-1be9-4388-9802-30b374b1ca9d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e3e09f74-df13-4121-962b-093388d66017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53fb9b48-bc49-49a1-9d56-88e6f37e507a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:to="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_afd41326-3238-4984-9bc3-cbfaaca36835_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:to="loc_us-gaap_EquityComponentDomain_afd41326-3238-4984-9bc3-cbfaaca36835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:to="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_34d52b82-1738-434d-b6eb-4ed73dd261a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_CommonStockMember_34d52b82-1738-434d-b6eb-4ed73dd261a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f912656b-9c5c-449b-915c-221793afe22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_RetainedEarningsMember_f912656b-9c5c-449b-915c-221793afe22b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5b1136b2-89a4-4b58-a847-1d6657b489a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5b1136b2-89a4-4b58-a847-1d6657b489a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b9858d76-0eeb-4b0a-8c7f-378e90591913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b9858d76-0eeb-4b0a-8c7f-378e90591913" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended" id="ied2034d32b624b6f8a18a77e6e57fa27_RevolvingCreditFacilityandOtherObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e776dd5d-5f93-4f8b-93e1-f69c7050ccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e776dd5d-5f93-4f8b-93e1-f69c7050ccaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_f3b4d5b7-251a-4b72-aecf-d37df825390b" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_f3b4d5b7-251a-4b72-aecf-d37df825390b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_560d98a9-69ca-4fc6-882e-4fff9a30373d" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_560d98a9-69ca-4fc6-882e-4fff9a30373d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_7b68c214-44f8-41ee-999c-0db969c813c4" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_7b68c214-44f8-41ee-999c-0db969c813c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_58da9825-efa8-4914-8653-2cf16be57de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_58da9825-efa8-4914-8653-2cf16be57de2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_54c9ecb5-8f12-4546-8768-e58c075dbbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_54c9ecb5-8f12-4546-8768-e58c075dbbd3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e895a560-edbb-4308-b763-0b2e9100883d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e895a560-edbb-4308-b763-0b2e9100883d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_30f7391f-7b31-4ff9-886c-fa52db7175db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCredit_30f7391f-7b31-4ff9-886c-fa52db7175db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_0bb23463-b5d1-476b-8900-e39fa10826fb" xlink:href="natr-20230331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_0bb23463-b5d1-476b-8900-e39fa10826fb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_febd9f97-fe68-443e-b876-548706082ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_febd9f97-fe68-443e-b876-548706082ca7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_e3858bf6-f72b-47a9-8ad5-708b10293189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LinesOfCreditCurrent_e3858bf6-f72b-47a9-8ad5-708b10293189" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:to="loc_us-gaap_CreditFacilityDomain_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:to="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0dee1f28-198e-4efd-8307-cfd70cd83deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0dee1f28-198e-4efd-8307-cfd70cd83deb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_410ec325-7eb8-410a-b75f-ffb087584296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:to="loc_us-gaap_LineOfCreditMember_410ec325-7eb8-410a-b75f-ffb087584296" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2e1e5965-e852-450d-8508-9b90b184a50a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:to="loc_us-gaap_VariableRateDomain_2e1e5965-e852-450d-8508-9b90b184a50a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:to="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6f09d87c-30b1-4b5d-8585-925bb9ebf5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6f09d87c-30b1-4b5d-8585-925bb9ebf5f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_dc041b15-bf7d-43d3-814f-f79e77fabff2" xlink:href="natr-20230331.xsd#natr_IndicativeIndexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:to="loc_natr_IndicativeIndexMember_dc041b15-bf7d-43d3-814f-f79e77fabff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1626718b-5b34-4533-8659-2af14f786c4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1626718b-5b34-4533-8659-2af14f786c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_20f3cf8c-959f-48e1-8fff-00c9338a176e" xlink:href="natr-20230331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_20f3cf8c-959f-48e1-8fff-00c9338a176e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e69e0b13-3e2b-4aeb-98fc-7493499e0542" xlink:href="natr-20230331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e69e0b13-3e2b-4aeb-98fc-7493499e0542" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended" id="i83e490588add446494a4d69c78383403_CapitalTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b6efc806-b99b-42b1-a588-0794e5128581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b6efc806-b99b-42b1-a588-0794e5128581" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_06c507b2-0d6a-43dc-8d93-b30b03db8d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_06c507b2-0d6a-43dc-8d93-b30b03db8d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4ba4b171-1cfe-4704-8e36-f3d06f23f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4ba4b171-1cfe-4704-8e36-f3d06f23f046" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_59e928fe-5be7-4664-a000-ccaf6a75675e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_59e928fe-5be7-4664-a000-ccaf6a75675e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ec00f4c9-61bd-48cb-8047-86646c9388de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ec00f4c9-61bd-48cb-8047-86646c9388de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0f60b5a1-cf81-44c6-946c-e36a9deefa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0f60b5a1-cf81-44c6-946c-e36a9deefa3b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bff95d62-279e-4d92-99b4-45013c8bf500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bff95d62-279e-4d92-99b4-45013c8bf500" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_5b6bdecd-3b71-44c2-8ffc-1c9ada9702c1" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_5b6bdecd-3b71-44c2-8ffc-1c9ada9702c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_1fa43acc-3a97-4abc-9eb6-01f9d1b5a3c9" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_1fa43acc-3a97-4abc-9eb6-01f9d1b5a3c9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_5c3ede1f-3b8e-45d0-a914-1c0a9ef7d581" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_5c3ede1f-3b8e-45d0-a914-1c0a9ef7d581" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_77c47958-7447-455f-bd1b-12da9104f2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_77c47958-7447-455f-bd1b-12da9104f2c0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_625d6018-47b3-4f90-a0f5-7d516cd76e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_625d6018-47b3-4f90-a0f5-7d516cd76e2a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20a77884-e105-42e6-aecb-c2d31dd6a904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20a77884-e105-42e6-aecb-c2d31dd6a904" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21e58737-9668-4358-af67-a6feec7ec4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21e58737-9668-4358-af67-a6feec7ec4dd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c7e8b27e-d81d-481e-91f1-56e2289f6021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c7e8b27e-d81d-481e-91f1-56e2289f6021" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe8d2ad-b82d-4569-a963-e15e4ec162ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe8d2ad-b82d-4569-a963-e15e4ec162ab" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b6d7ab11-c095-4129-a940-9584d9d6b71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b6d7ab11-c095-4129-a940-9584d9d6b71c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2ba8da42-ec8b-4bc9-bcfe-0733c689d901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2ba8da42-ec8b-4bc9-bcfe-0733c689d901" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_823a1cd8-5da3-4711-8365-aab6c8a6502d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_823a1cd8-5da3-4711-8365-aab6c8a6502d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_4fd44da8-731d-452a-8c76-eadf88f811be" xlink:href="natr-20230331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_4fd44da8-731d-452a-8c76-eadf88f811be" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_c7be40db-8aee-4327-9d6d-63de0aed6b89" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_c7be40db-8aee-4327-9d6d-63de0aed6b89" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a27f1c4a-4996-47d4-a991-bee8d26da9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a27f1c4a-4996-47d4-a991-bee8d26da9c4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc35ab6c-6779-49d6-8dcb-4a1165648507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc35ab6c-6779-49d6-8dcb-4a1165648507" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6f77f5-c1c6-49d0-a21c-d7ca85058b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6f77f5-c1c6-49d0-a21c-d7ca85058b00" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_f7013ca2-213e-4520-9fd9-37761c5a1525" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_f7013ca2-213e-4520-9fd9-37761c5a1525" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_383fad46-5928-4079-b8e4-6ff3692f56bd" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_383fad46-5928-4079-b8e4-6ff3692f56bd" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_7950275c-ffdc-4cb7-8c7b-0ab04a5875e6" xlink:href="natr-20230331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:to="loc_natr_TimeBasedStockOptionsMember_7950275c-ffdc-4cb7-8c7b-0ab04a5875e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_e0b393e0-068e-4dd3-925d-20ede88a6e67" xlink:href="natr-20230331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_e0b393e0-068e-4dd3-925d-20ede88a6e67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_23af279f-97c3-4dfc-bd7e-7e7e440020c8" xlink:href="natr-20230331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_23af279f-97c3-4dfc-bd7e-7e7e440020c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9e23747d-e191-4620-9dc9-412e641dcfd6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9e23747d-e191-4620-9dc9-412e641dcfd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c289813d-9baa-45ab-b687-72b6177ab369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:to="loc_srt_DirectorMember_c289813d-9baa-45ab-b687-72b6177ab369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e0b8b439-4c4e-4b1f-939a-dfa7414034b6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:to="loc_srt_RangeMember_e0b8b439-4c4e-4b1f-939a-dfa7414034b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:to="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8de9416-25a3-4de8-84be-768554d65e78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:to="loc_srt_MinimumMember_b8de9416-25a3-4de8-84be-768554d65e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_41dedf40-acd5-410e-bb59-fbfef02b0f23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:to="loc_srt_MaximumMember_41dedf40-acd5-410e-bb59-fbfef02b0f23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1b674aa7-33b2-4547-bb05-6becf980130b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:to="loc_us-gaap_PlanNameDomain_1b674aa7-33b2-4547-bb05-6becf980130b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:to="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_8b6b95d3-3182-4388-b081-a200377800b0" xlink:href="natr-20230331.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:to="loc_natr_A2012IncentivePlanMember_8b6b95d3-3182-4388-b081-a200377800b0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended" id="i1058a8f4b0bb4ccf883feb77922ae48d_CapitalTransactionsStockOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df47c786-7747-4de7-8e7f-14375a4edd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df47c786-7747-4de7-8e7f-14375a4edd5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4f319b61-e5a7-4ab2-b42f-e76a4257994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4f319b61-e5a7-4ab2-b42f-e76a4257994a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_782615c2-7e0c-4bf7-a1c6-deef6dfbbd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_782615c2-7e0c-4bf7-a1c6-deef6dfbbd07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7c5e67f7-bed9-4954-a15b-d455aa7a03a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7c5e67f7-bed9-4954-a15b-d455aa7a03a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7d849c0f-19a3-403a-8fcf-2790162915b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10368038-4750-4ce7-baa1-c773ebe2bc61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10368038-4750-4ce7-baa1-c773ebe2bc61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aee12bf8-12e1-4389-aa22-cdb2c49b922f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aee12bf8-12e1-4389-aa22-cdb2c49b922f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_028e36c9-fab7-4473-a952-220337ca8c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_028e36c9-fab7-4473-a952-220337ca8c9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_822f0cbb-04d7-4532-836d-b5dbdd69bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_822f0cbb-04d7-4532-836d-b5dbdd69bea4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0af1f4d-d55b-47c1-824c-a55be19f48a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_4d5947fb-3108-4753-8ef7-c600e8596683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_4d5947fb-3108-4753-8ef7-c600e8596683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1b401da1-f35c-4e92-a292-cbe3b5756739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1b401da1-f35c-4e92-a292-cbe3b5756739" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_78c9819e-d88a-47b9-a767-5b2677f9cb46" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_78c9819e-d88a-47b9-a767-5b2677f9cb46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_c0449d86-3108-489b-8aed-b1700be9ed88" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_c0449d86-3108-489b-8aed-b1700be9ed88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_712d18e3-8c9e-489f-bd4a-5f98055b38b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:to="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cb26655-cc41-482d-a20f-c99afb112ac3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7cb26655-cc41-482d-a20f-c99afb112ac3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d8309780-b9f8-4f9f-8ecd-ce5a090ca5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d8309780-b9f8-4f9f-8ecd-ce5a090ca5ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended" id="ie483ff51419d4fc5bdbc148a4ce4b0dc_CapitalTransactionsRSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfb406e3-00b6-4b98-b85e-636ecfd8278d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfb406e3-00b6-4b98-b85e-636ecfd8278d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1490b996-203f-4903-a1ef-22219a097385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1490b996-203f-4903-a1ef-22219a097385" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3dec84bf-7b21-4583-a9c5-a11e15320469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3dec84bf-7b21-4583-a9c5-a11e15320469" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f4f8715b-2744-477d-bd34-7c37836646e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f4f8715b-2744-477d-bd34-7c37836646e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db796c76-1ec8-409d-a72b-388360d19c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b579475c-55d9-4dac-8f84-c75cba373c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b579475c-55d9-4dac-8f84-c75cba373c21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3eba4566-d36b-4390-a5aa-d512c691e600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3eba4566-d36b-4390-a5aa-d512c691e600" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_724b7aa6-8b60-4545-96df-0b0b6ded84ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_724b7aa6-8b60-4545-96df-0b0b6ded84ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a7d6f6d9-e6fe-4402-9e09-4dd294b1fc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a7d6f6d9-e6fe-4402-9e09-4dd294b1fc30" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d9e8e626-b666-4c63-a6c1-5732b5cb6c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:to="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8883e430-aefd-42f7-8061-9d5784f061c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:to="loc_us-gaap_PlanNameDomain_8883e430-aefd-42f7-8061-9d5784f061c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:to="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_0edbec7b-9f43-4245-bcee-5472eb4e00a4" xlink:href="natr-20230331.xsd#natr_A2012IncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:to="loc_natr_A2012IncentivePlanMember_0edbec7b-9f43-4245-bcee-5472eb4e00a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:to="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_304f7627-dbcd-4008-866e-069b9e27324b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_304f7627-dbcd-4008-866e-069b9e27324b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a93aede7-6cc5-4ef1-9165-11dde4e05e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a93aede7-6cc5-4ef1-9165-11dde4e05e1f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended" id="if1234a63d6b7499bb3cdd6d05202126f_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_861a9b32-71a0-4cb3-a115-5cd9fb340c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_NumberOfReportableSegments_861a9b32-71a0-4cb3-a115-5cd9fb340c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b7280b2a-f9b7-4109-983d-c339bd2acb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b7280b2a-f9b7-4109-983d-c339bd2acb5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:href="natr-20230331.xsd#natr_ContributionMarginAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_196fd201-91de-4b34-87ee-a12f02fc4b79" xlink:href="natr-20230331.xsd#natr_ContributionMargin"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:to="loc_natr_ContributionMargin_196fd201-91de-4b34-87ee-a12f02fc4b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1ff563c-1b2c-4a42-9214-b7efccbb3395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1ff563c-1b2c-4a42-9214-b7efccbb3395" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ef21df46-0c99-4a6a-9a8b-7d03689911af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_OperatingIncomeLoss_ef21df46-0c99-4a6a-9a8b-7d03689911af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8557bc6e-c199-4e1f-8393-b8f540f39a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8557bc6e-c199-4e1f-8393-b8f540f39a5e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3aaa3c-8c51-47b2-bf7f-9f1bc3d9764d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3aaa3c-8c51-47b2-bf7f-9f1bc3d9764d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78bcd3c5-fe4b-4865-942e-496df8572476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78bcd3c5-fe4b-4865-942e-496df8572476" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2c980b25-a808-4193-b669-86e67783b680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_Assets_2c980b25-a808-4193-b669-86e67783b680" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ce623a81-8ed6-438e-928d-8851e2b8ed08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:to="loc_us-gaap_SegmentDomain_ce623a81-8ed6-438e-928d-8851e2b8ed08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:to="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_7f848156-c18f-46ba-a554-7f618c06362b" xlink:href="natr-20230331.xsd#natr_AsiaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_AsiaSegmentMember_7f848156-c18f-46ba-a554-7f618c06362b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_052a8eb6-2923-4cfe-b1dd-670ed8bb41f0" xlink:href="natr-20230331.xsd#natr_EuropeSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_EuropeSegmentMember_052a8eb6-2923-4cfe-b1dd-670ed8bb41f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_9573c71c-81b3-421b-9a91-2fc2f57e2eef" xlink:href="natr-20230331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_NorthAmericaSegmentMember_9573c71c-81b3-421b-9a91-2fc2f57e2eef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_3f09f198-3182-4e4a-a6f7-850719841130" xlink:href="natr-20230331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_3f09f198-3182-4e4a-a6f7-850719841130" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_679359fd-0136-4a7d-b619-5deda1faa275_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:to="loc_srt_SegmentGeographicalDomain_679359fd-0136-4a7d-b619-5deda1faa275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:to="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_ca6b2707-60a8-487d-9485-a06030fd6da9" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_CN_ca6b2707-60a8-487d-9485-a06030fd6da9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a23cd47b-7587-4f45-9232-0b68b9f7f648" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_US_a23cd47b-7587-4f45-9232-0b68b9f7f648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_788f47eb-fb2c-436e-9665-a2e3a2463e02" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_TW_788f47eb-fb2c-436e-9665-a2e3a2463e02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_7b0d1b75-9a47-4085-8169-c597ac5f9db5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_KR_7b0d1b75-9a47-4085-8169-c597ac5f9db5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_379cb391-c13a-434f-b69e-8c4dfbacabd0" xlink:href="natr-20230331.xsd#natr_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_natr_OtherCountriesMember_379cb391-c13a-434f-b69e-8c4dfbacabd0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c9378859-3072-4b38-9e57-6c59cf8fb62a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:to="loc_srt_ProductsAndServicesDomain_c9378859-3072-4b38-9e57-6c59cf8fb62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:to="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_4eb06441-87b2-4eb8-a94c-634ba2af2073" xlink:href="natr-20230331.xsd#natr_GeneralHealthProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_GeneralHealthProductsMember_4eb06441-87b2-4eb8-a94c-634ba2af2073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_0e1d3e92-735f-4f1b-8a12-598627e2a088" xlink:href="natr-20230331.xsd#natr_ImmunityProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_ImmunityProductsMember_0e1d3e92-735f-4f1b-8a12-598627e2a088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_734d1b99-0af7-4ab4-b5ec-fe04d555f66c" xlink:href="natr-20230331.xsd#natr_CardiovascularProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_CardiovascularProductsMember_734d1b99-0af7-4ab4-b5ec-fe04d555f66c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_61d84ed6-5a77-4cc5-9373-28d09aab09d6" xlink:href="natr-20230331.xsd#natr_DigestiveProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_DigestiveProductsMember_61d84ed6-5a77-4cc5-9373-28d09aab09d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_77bbbbef-26be-4a48-98fe-ed2a5b6c285e" xlink:href="natr-20230331.xsd#natr_PersonalCareProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_PersonalCareProductsMember_77bbbbef-26be-4a48-98fe-ed2a5b6c285e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_0a2582b6-2ef4-4a6f-9e4f-032a4ba6fd9b" xlink:href="natr-20230331.xsd#natr_WeightManagementProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_WeightManagementProductsMember_0a2582b6-2ef4-4a6f-9e4f-032a4ba6fd9b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i57551a7e59384ccfb873d4e040c16720_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_dcb67299-5daa-4fc4-a95f-72c5f07973aa" xlink:href="natr-20230331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_dcb67299-5daa-4fc4-a95f-72c5f07973aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0cf97f31-94b7-447b-9f7f-e8f9abecbb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0cf97f31-94b7-447b-9f7f-e8f9abecbb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_524bf609-a69e-428c-864a-2524634d2d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_524bf609-a69e-428c-864a-2524634d2d73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_93b228e5-a197-4104-92f1-2edf118780c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_93b228e5-a197-4104-92f1-2edf118780c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_a51b7b5c-1010-4023-867e-9e3d0c129908_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:to="loc_us-gaap_LitigationStatusDomain_a51b7b5c-1010-4023-867e-9e3d0c129908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:to="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_11464d08-1060-4fde-9fcd-0721fc3644b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:to="loc_us-gaap_PendingLitigationMember_11464d08-1060-4fde-9fcd-0721fc3644b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f75e46c-a8e6-4d8b-ade2-6e222672f144_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:to="loc_srt_RangeMember_6f75e46c-a8e6-4d8b-ade2-6e222672f144_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:to="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_86d0829c-d7bd-4caa-9b06-66e5b7256b3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:to="loc_srt_MinimumMember_86d0829c-d7bd-4caa-9b06-66e5b7256b3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ab4b0c0-1d6b-45e6-866f-aa5be6141df9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:to="loc_srt_MaximumMember_1ab4b0c0-1d6b-45e6-866f-aa5be6141df9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_7708384f-f8b7-4aeb-bdb4-dd4972f840a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_7708384f-f8b7-4aeb-bdb4-dd4972f840a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_79e3ca7b-5385-4b75-a4d3-623959c1ab55" xlink:href="natr-20230331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_79e3ca7b-5385-4b75-a4d3-623959c1ab55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_6e3fa6ac-99c1-446c-a417-acbf2907cbc6" xlink:href="natr-20230331.xsd#natr_NonIncomeTaxMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:to="loc_natr_NonIncomeTaxMember_6e3fa6ac-99c1-446c-a417-acbf2907cbc6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i259993aecf9540e4baa83644a25bc1eb_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f6f4714b-3528-49e5-9636-c938ca2962cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:to="loc_us-gaap_TradingSecurities_f6f4714b-3528-49e5-9636-c938ca2962cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d08fd28f-2b80-4a66-aeee-3f033cb6341c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d08fd28f-2b80-4a66-aeee-3f033cb6341c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9933e5f0-2350-413f-862f-9ddb651d53bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9933e5f0-2350-413f-862f-9ddb651d53bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7566525d-2a9c-43c5-a721-3f08761998b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7566525d-2a9c-43c5-a721-3f08761998b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe72790-ed81-4221-aa7a-396c63108661_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_efe72790-ed81-4221-aa7a-396c63108661_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3d590780-5f3e-4b98-9101-3bb5e589264f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3d590780-5f3e-4b98-9101-3bb5e589264f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c4c90ecb-868c-4a26-a08f-750f98dfa5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c4c90ecb-868c-4a26-a08f-750f98dfa5c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_909274b3-2ee9-41de-994f-31764b06a048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_909274b3-2ee9-41de-994f-31764b06a048" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a2d7f0f0-ef78-45e7-b7b1-f1809105f066_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_a2d7f0f0-ef78-45e7-b7b1-f1809105f066_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_770982b0-82e5-4b70-a574-9bb507169296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_770982b0-82e5-4b70-a574-9bb507169296" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SynergyJapanLossDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#SynergyJapanLossDetails"/>
  <link:definitionLink xlink:role="http://naturessunshine.com/role/SynergyJapanLossDetails" xlink:type="extended" id="i480839775eb542699b0a7a0b21965e9d_SynergyJapanLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_e776f21b-df6b-4bac-a913-10604d2b400e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_e776f21b-df6b-4bac-a913-10604d2b400e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_678cb4af-7e2b-447a-954f-98201ae7dc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:to="loc_us-gaap_ProfessionalFees_678cb4af-7e2b-447a-954f-98201ae7dc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:to="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_5307de83-eb95-46ac-a2cd-87279d496e41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:to="loc_us-gaap_LossContingencyNatureDomain_5307de83-eb95-46ac-a2cd-87279d496e41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FraudExpenseMember_e43a2dcf-7add-43ff-bcfa-726a615ebad3" xlink:href="natr-20230331.xsd#natr_FraudExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:to="loc_natr_FraudExpenseMember_e43a2dcf-7add-43ff-bcfa-726a615ebad3" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>natr-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_70e07972-41e6-419a-aac1-aa98210f5dfd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_1d72d96e-f4f8-4202-ae56-613cf65fc354_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_009d99f5-2b8d-4400-a788-5172bc34e21e_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_documentation_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:href="natr-20230331.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:to="lab_natr_DilutiveSecuritiesExcludedfromComputationofEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ed014e7b-a85e-4c22-925a-081a928f5009_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d64114c0-279d-4162-a4ef-a2dffa794920_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_8de165d8-3e17-4bc2-953d-f81930befbb1_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_ebe65434-0ccf-4cb9-8636-542fae98b7dc_terseLabel_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value-added tax assessments and other civil litigation</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_label_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Added Tax Assessments And Other Civil Litigation [Member]</link:label>
    <link:label id="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_documentation_en-US" xlink:label="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:href="natr-20230331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:to="lab_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AsiaSegmentMember_e2727b41-54fd-4629-b7ef-e776590dea63_terseLabel_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_label_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:label id="lab_natr_AsiaSegmentMember_documentation_en-US" xlink:label="lab_natr_AsiaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember" xlink:href="natr-20230331.xsd#natr_AsiaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AsiaSegmentMember" xlink:to="lab_natr_AsiaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a5137c84-5975-421f-9732-e98c58eaa744_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cb1ffc3b-7578-4dc8-83f2-9e7823010b67_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_f3b9ba5d-1f14-4d7c-86cf-79c83c15bb19_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_b69e950e-012e-44d6-a518-184277a555b5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_ef595bf2-2bb4-4292-9cea-2cf10909ff2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_548b984e-1e8a-407f-9c80-100c1b65d4d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_28a6c1e8-8b1b-4f77-97e8-dce31dc9924e_terseLabel_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America and Other</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_label_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:label id="lab_natr_LatinAmericaAndOtherSegmentMember_documentation_en-US" xlink:label="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America And Other Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:href="natr-20230331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LatinAmericaAndOtherSegmentMember" xlink:to="lab_natr_LatinAmericaAndOtherSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_29d745f9-2a33-4720-93e6-21fbb3866bdb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6fae2cb4-0182-43dd-b454-3b05f1671854_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_61233a5b-8eb2-467b-a301-e2638f4a2347_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities - trading</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PersonalCareProductsMember_3eb8f625-0ff7-493b-a222-bfaacf3933ad_terseLabel_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal care</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_label_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Care Products [Member]</link:label>
    <link:label id="lab_natr_PersonalCareProductsMember_documentation_en-US" xlink:label="lab_natr_PersonalCareProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to personal care products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember" xlink:href="natr-20230331.xsd#natr_PersonalCareProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PersonalCareProductsMember" xlink:to="lab_natr_PersonalCareProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e1cefe1b-2e32-4068-aa89-b76ac1092896_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic values of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_b70b964f-ec1d-417c-9945-d2e84750eeeb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_1b82c216-f515-470a-9e15-eb2ecb6f7974_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_32b3d84f-f52d-4679-a788-56b17dbf6081_terseLabel_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of principal categories of products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_label_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:label id="lab_natr_NumberofPrincipalCategoriesofProducts_documentation_en-US" xlink:label="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Principal Categories of Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:href="natr-20230331.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NumberofPrincipalCategoriesofProducts" xlink:to="lab_natr_NumberofPrincipalCategoriesofProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b79c57ab-8855-4d30-a262-daefe0ada179_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average diluted common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_529d5773-fa6d-492e-949b-e1f17a4f6344_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NonIncomeTaxMember_f8b823fe-9ee0-427a-aca3-1dab51d62d06_terseLabel_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Income Tax Contingencies</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_label_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Income Tax [Member]</link:label>
    <link:label id="lab_natr_NonIncomeTaxMember_documentation_en-US" xlink:label="lab_natr_NonIncomeTaxMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to non-income tax matters, including value-added taxes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember" xlink:href="natr-20230331.xsd#natr_NonIncomeTaxMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NonIncomeTaxMember" xlink:to="lab_natr_NonIncomeTaxMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_1e71a5ed-dd27-4eb7-a8e3-3ff06472fefb_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized and unrealized (gains) losses on investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_59a0da7c-9c97-4089-a8ed-749594535adb_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_0db86713-778d-4933-87c5-d4776c9dc552_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of composition of inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_b47c42e8-fcfb-4796-805c-2bbf6a60046c_terseLabel_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of monthly payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_label_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:label id="lab_natr_DebtInstrumentNumberOfMonthlyPayments_documentation_en-US" xlink:label="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Monthly Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:href="natr-20230331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:to="lab_natr_DebtInstrumentNumberOfMonthlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_306a4058-8e15-4513-a16f-ec00851d8a71_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_3323c871-5c0c-4606-9643-21860e05f299_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0358dc67-e52d-4b6b-9044-62f124f4edf0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_804ba1f7-61e4-49d6-aa43-31ef6ae6f3ad_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_8e06b73a-6d88-4824-a5ca-6acea0fdd792_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of note payable and revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_ccda37d5-659b-4e3a-ba05-dcb1e3c855cf_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for losses</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_b7cba0c3-7f14-448f-90a2-9e113186d3ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation loss (net of tax)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ae53f20e-0a77-45ce-beda-e2ee7af43ff5_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value, 50,000 shares authorized, 19,045 and 19,093 shares issued&#160;and outstanding, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_d639e60a-237f-43ed-83e0-a3ffefb581f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_db0e36b3-0892-4be4-93ff-144d7b9ab11e_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_8032b47d-f510-4fc4-8ba8-c0ec046d57c1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_8731fe55-60d1-40fe-811f-90b432d459b7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1e8a684d-1f73-4606-a262-73611d81ea03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_79333111-d15b-4cdb-b0da-0912608cd056_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_GeneralHealthProductsMember_5ce6015f-70ca-4ced-99f7-7b93d05aff42_terseLabel_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General health</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_label_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Health Products [Member]</link:label>
    <link:label id="lab_natr_GeneralHealthProductsMember_documentation_en-US" xlink:label="lab_natr_GeneralHealthProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to general health products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember" xlink:href="natr-20230331.xsd#natr_GeneralHealthProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_GeneralHealthProductsMember" xlink:to="lab_natr_GeneralHealthProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9ed6acf8-b5af-4807-aa19-b5976c0eae79_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5e1fe9ef-b591-4ab8-9b5d-cab16ca158ac_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_96068dbd-6799-410d-8005-51692238d11b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Uncertainty in Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:to="lab_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_A2012IncentivePlanMember_10f78b01-0d4c-4e3a-be0d-d7c58a1f6741_terseLabel_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Stock Incentive Plan</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_label_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2012 Incentive Plan [Member]</link:label>
    <link:label id="lab_natr_A2012IncentivePlanMember_documentation_en-US" xlink:label="lab_natr_A2012IncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to 2012 incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember" xlink:href="natr-20230331.xsd#natr_A2012IncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_A2012IncentivePlanMember" xlink:to="lab_natr_A2012IncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_a85398b7-f4e5-4fe4-8cfb-a2fef2239227_terseLabel_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_label_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:label id="lab_natr_OperatingLeaseNonCashLeaseExpense_documentation_en-US" xlink:label="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:href="natr-20230331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OperatingLeaseNonCashLeaseExpense" xlink:to="lab_natr_OperatingLeaseNonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_f3cb7cd8-39e2-4788-99a6-b6de0b4f1927_terseLabel_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction period for issuance of shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_label_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restriction Period for Issuance of Shares</link:label>
    <link:label id="lab_natr_RestrictionPeriodForIssuanceOfShares_documentation_en-US" xlink:label="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the restriction period before shares will be issued related to a share-based compensation plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:href="natr-20230331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RestrictionPeriodForIssuanceOfShares" xlink:to="lab_natr_RestrictionPeriodForIssuanceOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2e7c5686-c683-4547-ae9b-59514dc6510b_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_92911af4-b63c-4764-928c-d0e70b0fe9e9_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_32e2ea66-d632-490f-9666-d5994fca3701_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of trading investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Purchase of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ab50ebd-0398-422c-8684-4253a60447e9_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1ccee44b-5349-42e2-949d-d9e5e9320052_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d9d1ae88-8dda-44b9-801b-81f2fd4e7cd2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_30bf0736-ae10-46cb-8972-43b8dcd58807_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_faee49e6-9ff2-491b-af9b-2c3b3d8d956e_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_natr_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_b5d79f5e-aa83-42d8-9f2b-f3af161fdd87_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_label_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Volume Incentives and Service Fees</link:label>
    <link:label id="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:to="lab_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_651a6efb-1f47-40b6-855e-f323f37eba35_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_28bb9392-d477-43d6-a86e-dc1312152b41_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_35632c31-3b16-40f0-a218-9d5b1881b465_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_95d0ecf5-1bae-417b-a0a8-1f91baa99a70_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ca096627-6ab8-4947-9ce9-a75ba6bcd396_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_93833f56-7f39-49f9-90ed-263854bb6dfe_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum withholding requirements (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bdf94049-a220-442e-ab81-578356ff82a5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_26aac40d-5bde-46f3-a312-8c1cace77ba5_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_1f9c78fd-7272-4ee6-9a9d-6ab1b4c3ad0e_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0f042639-7910-4226-8445-7ada4649ebaa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e2c3834b-856b-4ff6-83c4-27543070c117_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_37e30160-0eed-4623-bf12-111e104e4c76_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3b93198-7003-420a-974f-1532993a4920_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_64854503-dbaa-45f0-a496-45d15f53ce74_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investigation and other professional fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_3c9b6ffd-49a0-4751-a06a-542687a0f687_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of related party borrowing</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="lab_us-gaap_RepaymentsOfRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_country_KR_bfc09c8f-7868-4deb-bc47-59cc746113de_terseLabel_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Korea</link:label>
    <link:label id="lab_country_KR_label_en-US" xlink:label="lab_country_KR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KOREA, REPUBLIC OF</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_KR" xlink:to="lab_country_KR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_afd304ae-ad07-4029-8d48-11256ff70b93_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_5f04f4c9-df5e-4596-9705-95ac51baac15_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested subject to restriction period (in shares)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8ec5cf51-302c-4970-91a8-26e169ade14f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_f7293f5c-ebde-4f55-be27-53fe03bd2779_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6685af93-9666-4566-b905-2ff32174cf42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reportable business segment information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_bb6315cf-a5e3-4709-b734-76aa24b0f52e_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_760bc43a-7e69-4564-a80e-c5c2474ce2b8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_50c3bc65-58a4-435d-9bb2-f44a6664fc63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_47a29a1d-e677-4adc-9c29-b7d67cfba2fc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities - trading</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_ef838cc0-b48a-49ab-ae70-58474c8d0536_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities portfolio</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRestricted_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRestricted" xlink:to="lab_us-gaap_DebtSecuritiesTradingRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_263f1e35-ef33-4e43-98bd-86a3bc5df851_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_85bd6a91-691c-46f8-a9c9-fa02586184ec_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of separate increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Number Of Separate Increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:to="lab_natr_LineOfCreditFacilityNumberOfSeparateIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_d45a873d-67d2-4cc8-8d3c-9cf9ec1a53b0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_b71d7ab2-9b33-4c72-8b60-c1428f706243_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales:</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_f9588f40-b5e8-4ea6-a3f4-51c66bf2044d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual commitment fee</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_d61e8f94-21c9-4b81-ae5c-f3954a9105c2_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation potential compensation expense to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_e41882cd-5d9e-4073-b845-adf08479269b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_e11a0fef-bbe8-478f-b8c5-56a726ceeba0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_66a5a1bb-c3d7-4559-b56e-9ac63dc2b8a6_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_58dd47f4-0020-463c-b046-86039c44f038_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b3409ef8-fc92-487f-83f7-dbac0ffcf235_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 - Quoted Prices in Active Markets for Identical Assets</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_b48b143d-b6e1-4db0-b6f6-cf0912d3f145_terseLabel_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:href="natr-20230331.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:to="lab_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a18c0d47-5620-4886-92ea-f22de3e7ddba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30339127-4207-4ee8-af6d-c9f664b8c338_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c88eb865-e327-4cdc-b177-4b4e4309aabc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_0e626ab5-1793-4e83-8ec2-2ed835c58b2b_terseLabel_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from diluted-per-share amounts:</link:label>
    <link:label id="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_label_en-US" xlink:label="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:href="natr-20230331.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:to="lab_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_feccc64d-a52f-47d2-ae9b-e77188aa5fd5_terseLabel_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of assets per segment</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_label_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1 [Table Text Block]</link:label>
    <link:label id="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_documentation_en-US" xlink:label="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:href="natr-20230331.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:to="lab_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_0424f9a2-d492-419b-b80d-6118d6a32073_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_315d24a5-9193-4a13-8ded-574208be54ff_terseLabel_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_label_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised</link:label>
    <link:label id="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_documentation_en-US" xlink:label="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:to="lab_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a64778f-3568-40bd-9e31-13be5ecfebf0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_039e1839-8731-489d-b6bf-310f0787b47a_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_9cecd1b6-9d5d-406a-9332-59b3ee21da78_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9268149f-76d7-43c5-9153-3b6031e300cb_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_bcab7b06-f916-4c18-9553-6ade51a998e3_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9f357ca9-3a08-4352-8e5d-8fa6266617c2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1cbec3a8-10bb-44b2-b8be-ca70e4a890aa_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e5ca8564-383c-40c7-b25f-77aa58827fec_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMargin_53492c49-b573-4813-a24f-ceedf5b3aaea_terseLabel_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total contribution margin</link:label>
    <link:label id="lab_natr_ContributionMargin_label_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin</link:label>
    <link:label id="lab_natr_ContributionMargin_documentation_en-US" xlink:label="lab_natr_ContributionMargin" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin" xlink:href="natr-20230331.xsd#natr_ContributionMargin"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMargin" xlink:to="lab_natr_ContributionMargin" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0cc06965-44d5-48b4-9ce5-d539bf206977_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_VolumeIncentives_6a7c54a0-7409-4d62-bad3-b5d9cfcac9be_terseLabel_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_label_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volume Incentives</link:label>
    <link:label id="lab_natr_VolumeIncentives_documentation_en-US" xlink:label="lab_natr_VolumeIncentives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives" xlink:href="natr-20230331.xsd#natr_VolumeIncentives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_VolumeIncentives" xlink:to="lab_natr_VolumeIncentives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e42077e3-2c22-4eb1-a492-d8d70df385c7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_e1eea1a2-afb1-4156-bf04-731eedc8192c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e7dce9d9-321f-4a9e-bd8c-023319a9cc17_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3e8817cc-9380-4255-9a5e-575929b3d19c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_d49bf646-9bcd-4cf1-a69f-54cd25e6baa7_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_420cd92e-7b3d-41f3-a88a-105525e616bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other loss, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_32f857ed-d5c4-417d-9019-b7de9833c5d5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b7f0accd-a8d3-4e21-b855-aec2eb40b140_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_671eaf21-995f-40f8-9100-48779fca0641_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_DigestiveProductsMember_58c0b628-9ecb-4ff8-accc-3b6fe27928df_terseLabel_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_label_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Digestive Products [Member]</link:label>
    <link:label id="lab_natr_DigestiveProductsMember_documentation_en-US" xlink:label="lab_natr_DigestiveProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to digestive products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember" xlink:href="natr-20230331.xsd#natr_DigestiveProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_DigestiveProductsMember" xlink:to="lab_natr_DigestiveProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a2121135-92c5-4497-9c23-e1f520d06f24_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_d23fe7c6-9b13-4422-a625-6e0220c110dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_4cd8983d-2b13-42bb-add2-95f48a51a0dc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d97963cb-1082-464a-b947-e0c742b63ae9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_f7d09e60-5bda-4c3a-8d1e-40b22d45dd40_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5e8cb2bf-da77-410f-8ebd-57aad1814411_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_fd7d23a1-2d59-4bc2-bfe4-a1069e2e7240_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of revenue generated by each of the Company's product lines</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_58e69eb5-c729-4ccc-a64c-7ee4c37c7800_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_5e9833ba-6214-424e-a827-bcb7067f7bec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated net sales revenue by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_446e84db-a088-41ff-a2cb-cfa9a75c52db_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4c73684c-3104-4d65-936a-9017a3ac10dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_759957d5-7803-4bf3-acba-2d9ddfa14ac2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_e0f0ceb3-5675-418a-b117-443bd143578c_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2ece9005-5664-47fa-b139-f169b7b58594_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_b7734726-1b58-40e3-a029-d0ff3bd6b08e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_7f52703c-709c-4884-926b-cec9fbb73b0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3854fcda-fc85-4c54-b13e-1006a1533975_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_6bc4fd96-26de-4155-8eb7-499021635fc7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_48213c6b-25c6-40f3-a548-333572d8a05b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Exercise Price&#160;Per&#160;Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_b7834eb9-7700-4159-9a7b-b7353cb0b68f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:to="lab_us-gaap_MinorityInterestPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d4c6146c-9cec-426f-9625-1588409e5158_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_dcce033d-0f94-48b6-b6c5-8c523dc77831_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_f44228df-667c-4c37-b446-a15c8bc66d5a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility and Other Obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_8c5d979f-72ce-462e-b04b-dfe65c6e9c0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_07b28b97-776d-452c-bab4-b50645624c87_terseLabel_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_label_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Liability Related to Unrecognized Tax Positions</link:label>
    <link:label id="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_documentation_en-US" xlink:label="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:to="lab_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_e7847445-74ce-4981-beaa-31298f307cd8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_a20be895-558c-440d-95b7-56cf3a4a6c32_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_6bc4c099-a678-4058-9775-45961026c68b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2e06ff4e-ce12-44a1-879d-84b1f3393870_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e2a771d0-0455-4605-b8a6-a5353cb2cc3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_0d182a77-463f-4157-8098-4e50060deeee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of the company's hierarchy for assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0d290a02-6e2b-4b4e-b20d-6e344b07b098_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_683be5b3-63cb-415d-9305-57b243a33b82_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_ef2c9840-8dcd-4729-8063-ff2e373450c4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_5edc3b09-b15f-4046-aab7-cbdfa05d0c38_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c1c7379b-928b-4b03-9860-1c332a28bf8d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ImmunityProductsMember_995e11d8-d3b6-4fe1-98c2-21c2fbae4a5f_terseLabel_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immune</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_label_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunity Products [Member]</link:label>
    <link:label id="lab_natr_ImmunityProductsMember_documentation_en-US" xlink:label="lab_natr_ImmunityProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to immunity products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember" xlink:href="natr-20230331.xsd#natr_ImmunityProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ImmunityProductsMember" xlink:to="lab_natr_ImmunityProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1fa21244-8bd2-4236-95d3-fe973bea6cf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number&#160;of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_950d2b00-90dc-4013-894d-0a05292fc4cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fe215e3f-d775-42bf-9f9b-095415e38f56_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_8afce893-e2d3-4818-8a79-ff992eebb44e_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_1a91665b-dea5-4211-93da-2e7a3bc2874e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a327b247-1285-4e9a-bc81-4d48d12acae4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c5c7bb14-247b-4026-af8d-4e46305f1c71_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_08353aa4-9110-44e2-abcc-dac90efeebf8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_1f12c7c9-4157-4dd8-a75b-a9f1ef121106_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5b95f2ed-8c36-4638-a1d9-9ee0daf6ef27_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_e27ec2d2-4de8-4a86-98fe-7cabb97bc5d8_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, three (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the three operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_90e43f3b-d636-4562-9e2f-1a2053d6f5cd_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_349b4407-d3df-4701-9a5b-98b8cf6bfa91_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3a78b476-ffd5-44a0-a222-0ffdc290bd52_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5c0cf3d5-941b-49a4-9bfd-a38c7b7c5890_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_fd897ad8-5d7a-49a9-a7b2-2e6bb16fb03b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted net income (loss) per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_0697c6be-f2b6-40ce-9274-25cd1f71d802_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, one (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the first operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_029e5d5b-f80d-4230-97c9-b96ac1a3893d_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_b2e579bc-2320-4715-aebc-72a04b75accf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, trading, realized gains (losses)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesTradingRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_b1897da9-dfbf-4b6d-81d9-609568fc0883_terseLabel_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income margin, two (as a percent)</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_label_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two</link:label>
    <link:label id="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_documentation_en-US" xlink:label="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the second operating margin percentage to be achieved for the vesting of stock options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:to="lab_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d63c87d0-ef05-4739-8a9a-414e601c9c11_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d4978178-b34d-482d-bbf4-85b77170711f_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_8a56fddd-b946-464f-b92d-d8e4802d1938_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ad809506-69fd-4828-ac3a-51f25b83850f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_062691a0-c912-401d-ab65-c3ee806d497a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_f269ce41-618b-4d87-af25-c1a8c220beae_terseLabel_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued volume incentives and service fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_label_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Volume Incentive and Service Fees</link:label>
    <link:label id="lab_natr_AccruedVolumeIncentiveandServiceFees_documentation_en-US" xlink:label="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the liability that is related to incentives that are payable, due to volume sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:href="natr-20230331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_AccruedVolumeIncentiveandServiceFees" xlink:to="lab_natr_AccruedVolumeIncentiveandServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_810c5bd6-616a-4b74-9833-281c19547bee_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f4d8ffdc-21b3-4437-84b5-e7f701c595ba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_193ce1c2-2fcb-4aeb-a51e-35dadaa5ce1c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e1e9d2f6-d4fa-4fb0-8dd3-7c50f2b00954_terseLabel_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital Credit Agreement</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_label_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Banc of America Leasing and Capital, LLC, Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:href="natr-20230331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:to="lab_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_4caf0c27-51f3-4451-ab06-e0c4b1366165_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b5ca33f1-56ea-4388-a138-a1c86fc3401b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4c75c10c-c57d-4a46-979c-92b1a45acd3e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_dfe07c2d-dc5f-43ff-bead-aba67949eebd_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_NorthAmericaSegmentMember_3ec85a4f-8a5f-41b3-8a58-136b69f62497_terseLabel_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_label_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:label id="lab_natr_NorthAmericaSegmentMember_documentation_en-US" xlink:label="lab_natr_NorthAmericaSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North America Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember" xlink:href="natr-20230331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_NorthAmericaSegmentMember" xlink:to="lab_natr_NorthAmericaSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_145e762f-b772-48ae-988b-1d716a96e3bf_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c37196df-0dc2-4ef4-85fe-1a00b7490f24_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_47d039fe-a81d-4677-8fc9-4a2111d7ba0c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1d1176be-9f59-43e7-9e66-c5fddfe97cec_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_6700b576-4660-4a7a-97f5-4f01afec18da_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1f47c4ad-5d48-4c28-98cb-e5b79d4b747b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_f1c000e6-b174-43bc-ac6a-d67751ca39fe_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9eea574c-7b36-4f0a-ba24-8ffc874bc56e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_f9442c48-bc56-4d0b-b559-fcbf3733a9f1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_EuropeSegmentMember_795b0241-a7ae-431b-be76-0c7884f206c9_terseLabel_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_label_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:label id="lab_natr_EuropeSegmentMember_documentation_en-US" xlink:label="lab_natr_EuropeSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember" xlink:href="natr-20230331.xsd#natr_EuropeSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_EuropeSegmentMember" xlink:to="lab_natr_EuropeSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_2834212e-c3bf-4c50-aab5-8de113f1b490_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation payable</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6539101a-0ed5-4f93-9984-8bc0f9f0b894_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d7f64e94-240d-4b1b-9dc4-93eff0a160ab_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_6f86d550-7dd3-4fcd-8172-7fe32865d896_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance based stock options operating income margins</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the performance based stock options, which vest upon achieving operating income margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:href="natr-20230331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:to="lab_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c996a897-c2cb-4a69-9435-1b3c7dde8d46_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9fe3a3f7-692c-4209-a167-716dfd928566_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_99c1748d-0cba-4e92-86bd-a907d41717e2_netLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a78187e9-e2fb-4610-bb4e-a1a87d8d2ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_3ec310ea-0c92-4009-b2ba-f56f86653cb4_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_10d8458a-da51-48eb-a7d7-646ba3d03cfb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period over which the remaining compensation cost is expected to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_95993351-1e94-4e43-a8cc-6a6daa58e71e_terseLabel_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_label_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:label id="lab_natr_BankofAmericaCreditAgreementMember_documentation_en-US" xlink:label="lab_natr_BankofAmericaCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank of America Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember" xlink:href="natr-20230331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_BankofAmericaCreditAgreementMember" xlink:to="lab_natr_BankofAmericaCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_IndicativeIndexMember_27f33899-a3c6-4ae1-9e05-2781e6c86e16_terseLabel_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_label_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index [Member]</link:label>
    <link:label id="lab_natr_IndicativeIndexMember_documentation_en-US" xlink:label="lab_natr_IndicativeIndexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indicative Index</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember" xlink:href="natr-20230331.xsd#natr_IndicativeIndexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_IndicativeIndexMember" xlink:to="lab_natr_IndicativeIndexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_b43aa8a9-bb1b-4648-851a-819440f1b76d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a0eb85d8-e850-4a3e-b66a-91e948740250_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_3c3ff857-af39-4ead-b01a-b5312dff541e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_2b7e01e3-99bc-46ff-9b26-511dd98a07fb_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c83c948e-4881-4b2f-9d9a-884c8bc44931_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e9403948-9144-4824-94cf-eacf98fbc057_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6bf6d92-5fa6-4952-bec5-3e4fe5d75328_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_2d3df991-7fcb-4067-adfb-dedf1a321143_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_6a01907e-f424-44dd-bc90-9bad7ce5f3ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of consolidated property, plant and equipment by geographical locations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9791ccc8-dc18-4edf-b7ae-6b0a99aed1f8_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f9cd1018-bf80-45bb-b4a5-79847ce46346_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net sales revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_18914de2-fff8-436a-a823-f52b5494fd7d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b4b34205-c542-4ba2-abb7-d031b570a8fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_e131fc63-ecdf-41b7-8f80-5ad9045b8fd7_terseLabel_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_label_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Number of Claims Companies Insurance Coverage May Not Cover</link:label>
    <link:label id="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_documentation_en-US" xlink:label="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:href="natr-20230331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:to="lab_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a6617f36-69c9-4c33-97b8-e6ccf1e8f5bc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_e477109f-7c36-4d06-aec6-f91b0ec8abce_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_448b718f-556b-4aca-bf19-3d2c92c293fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_770c57a8-8ae7-4aee-acff-efeafc9e1c54_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ecbefc6f-0ef4-4093-bf20-9eb53efb2289_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_225ab501-f8ef-42b5-b2f5-ac1fcfb9fc0a_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_668f5174-c61f-4dc7-998d-0fd21ee4d2b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 - Significant Unobservable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_8dc0fd51-b02e-4541-b53f-4e5a20f1bb30_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_TW_ddbc0b1f-437b-44d3-b263-fc6f3d677043_terseLabel_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taiwan</link:label>
    <link:label id="lab_country_TW_label_en-US" xlink:label="lab_country_TW" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TAIWAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TW" xlink:to="lab_country_TW" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_43fd7471-10b9-4a95-b8ba-3e680f6c7061_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_f6bf72af-bf11-433c-b282-8a2bfaa9e8b6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_f9cb0741-4f4e-496e-af47-77d556eeaad2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_72381a40-e911-402f-991a-ba191f6b56bc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_fcd14b2f-b772-462d-82bb-b7704a8cc96f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_03078770-1203-41d9-b114-d50cca9ebcb3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d18b22b4-4687-418e-beca-c6d5e1dfcd39_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_cc8b2642-4937-42ac-b2fb-c36cc02ff40f_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_47d0ef25-1432-49a5-b898-805036bc6931_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding at the beginning of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_0dfde109-85e0-426c-b5b5-bd93f166b0b5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_1c932f6e-e6fe-414f-8e7c-566b71e8f525_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea3faa52-bdf5-4487-bb88-4d899a141064_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_6cafc980-75b8-47dc-9188-e4abece319fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_e3d9b223-6c48-46ef-88e9-4c09292a4033_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ab265984-bc8d-41cd-bb77-31744af8a723_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments related to tax withholding for net-share settled equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_42172ddf-5558-46d1-96d5-aa21fca6980c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_95773d73-c3ea-4918-b705-113efaa0eabf_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_640083ba-8d47-496d-a25d-e04d9bb00d1c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_e2f08f25-af5f-4139-8e0d-b6804527a671_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange losses</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c727867c-a21f-42de-9b07-b9ca35b488ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0570f451-0104-44b0-87ab-479a3ed3ad26_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_eea8d8d2-b827-4ea3-8d3c-8d20a7e15cd6_terseLabel_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time-based stock options</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_label_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time Based Stock Options [Member]</link:label>
    <link:label id="lab_natr_TimeBasedStockOptionsMember_documentation_en-US" xlink:label="lab_natr_TimeBasedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the time-based stock options, which vest over differing periods.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember" xlink:href="natr-20230331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_TimeBasedStockOptionsMember" xlink:to="lab_natr_TimeBasedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_315e48fb-68d8-4b3b-8818-0962a3ed41f7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5e53ec05-4c23-4224-b4e9-62fdf0fdbcf8_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d3449bda-0642-4bf8-9c49-99f1776ae9e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 - Significant Other Observable Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_ea9310a4-444c-4c58-9cfd-7159f1bd499c_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a1884570-60bc-4efc-b90e-9d8b4b639910_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_69f71412-8c0e-4751-9e8e-45b7f0a7fb3a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_72637e97-689c-48b3-9e23-526fc0f5cb67_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes, as a percentage of income before income taxes</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3c77d398-4790-4394-a3e9-2234ebec0298_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_49a71a28-55ea-4adf-92fa-6d0437f5f8e7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6c787b09-80c7-4258-948f-05af2099265c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_2c54dea6-7560-4338-a21c-cd7d226963ae_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3d9eceb-f112-4665-ba74-1c5c963b52ef_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_82e1ce16-a9e1-4a79-bb27-9bc802cea76c_terseLabel_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_label_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_documentation_en-US" xlink:label="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:href="natr-20230331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:to="lab_natr_PerformanceBasedRestrictedStockUnitsRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_34852ec4-ef04-4517-9a46-a67fca01928c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_83527b37-f11c-4a2b-a660-d71dc52ba81d_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_707ba7e9-ad66-4c86-aa30-6d946862841a_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d310a777-c0d3-44a2-91e6-61aedcf01386_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2bf137bc-9fae-4a6b-877e-778e702e947a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_5f0189e8-6bb6-4332-9262-306a82463480_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities - Trading</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_517f0714-7b2f-4c99-9308-194ba6674af4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d8609338-3752-42b6-bff0-ebbca81e39d8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c4f0c1c6-30fe-46b5-8e48-2a2f77e5e013_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_90303611-211a-4bc5-a7f1-ecdcccf58196_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_ef770664-14e7-4db3-83bb-1532960e4757_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of restricted stock unit activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3f1f6e88-f8ee-4c73-ba29-10f813e6ec2f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_721c00a5-1c47-4df6-825d-5b66f3db8e73_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_ContributionMarginAbstract_84e22990-6be4-4ec4-bb00-94346e475e9a_terseLabel_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution margin:</link:label>
    <link:label id="lab_natr_ContributionMarginAbstract_label_en-US" xlink:label="lab_natr_ContributionMarginAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution Margin [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract" xlink:href="natr-20230331.xsd#natr_ContributionMarginAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_ContributionMarginAbstract" xlink:to="lab_natr_ContributionMarginAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_9e5abc83-8ef9-46c2-9f8e-e2652705b6e1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b0cc2718-470c-47a7-9b5b-71db382b7a86_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_69b23440-69c0-41ec-a0d6-bdcb29192236_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_7519e667-a97b-4b25-bc2c-4299faa04fb7_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_f5fcb7e6-208d-4cfc-80f9-11863544867e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_97b518d5-565c-4e5a-b186-aaba4c1c40c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_ded11331-02ad-4aa8-9b62-029e79462f32_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_019ed221-e872-4cfb-b7e6-6ed95e81cc2e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_bb33c063-c29e-47d5-b010-2028181fb85f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Transactions</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9ee93a8d-7a89-475b-a4dc-f83abf400d14_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_e9af0fc0-8976-4841-ad08-bd702d24dcf3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_c7fce0b1-c968-4f5a-80e2-980e01314a95_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_4764a3ed-c0d1-4160-840c-bd3f48ad2622_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c4e751b0-8a77-49af-8bb5-ebb4730bf34e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_be299db9-effe-4af5-b9d5-6233817e9440_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_a631bdb0-d792-4933-97d7-cf8f758f1570_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_1e60f2b4-c51a-433f-8a0b-c1b8aef85333_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_6d69c3b1-251e-458f-9b6b-45eb40c67ec9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_05e93ea6-d20b-481c-80b5-4cde342cbbb8_terseLabel_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase in maximum borrowing capacity, per occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_label_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:label id="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_documentation_en-US" xlink:label="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:to="lab_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3da30c53-3d49-4e9e-99f2-ff2b0c9e74ac_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_6dbe6929-92ce-43f4-bd99-efa615f4403f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6f63b98a-ce27-437e-9a34-8213ecfbc739_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares authorized under the plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4d8800f3-cc2d-4d7c-ad32-8a56636bd147_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d4ac873f-6ae8-4310-9886-783c5b57fc06_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_69679318-70c9-4ab2-a629-61f284470c6e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ea067cb8-2fd2-4ba3-a1fe-1f746d2b744f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_49131ca5-ad21-42f8-a81c-dd2f0924fb95_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_368a84ce-0b9e-466d-ac4c-1ca76f112e17_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d23f666c-5203-4101-b654-e8091e02d227_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_49504f60-08b1-414c-87d9-731167b3cbc0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ff24c702-2ebe-48d9-86dd-9395babbac18_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_59503be2-a34d-46ae-acf7-931a37a218ed_terseLabel_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_label_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:label id="lab_natr_RevenuefromContractwithCustomerRefundPeriod_documentation_en-US" xlink:label="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Refund Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:href="natr-20230331.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:to="lab_natr_RevenuefromContractwithCustomerRefundPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_005f55b8-c6ae-458b-ae66-d7cddd61564c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_91628aee-973f-409d-8f99-5ab536a2e671_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_43f34764-e188-4e39-8e76-54c50fdf40b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of trading investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Securities, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNoParValue_1578ebd4-742c-4afb-b9dd-df710b389b9c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, no par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockNoParValue_label_en-US" xlink:label="lab_us-gaap_CommonStockNoParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, No Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNoParValue" xlink:to="lab_us-gaap_CommonStockNoParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_fda1d967-66fd-4338-bc0e-37f9ff082570_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bafc2fda-2712-4cdb-8ed7-1c34941e6f47_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_OtherCountriesMember_09578f36-507b-4017-a6ee-99f287a0cd32_terseLabel_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_natr_OtherCountriesMember_label_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_natr_OtherCountriesMember_documentation_en-US" xlink:label="lab_natr_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information related to all other international countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember" xlink:href="natr-20230331.xsd#natr_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_OtherCountriesMember" xlink:to="lab_natr_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_4938ffbe-9c6b-4003-af77-1e6e5ec93152_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares included in the calculation of diluted earnings per share</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_52ffd6d5-6c8d-459b-8f07-1e3593edff12_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f10abf56-eb5d-4cd4-9a9c-e1bbafb74b8a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $122 and $120, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_dfb53244-fa56-45c0-bcd7-14ff6515daad_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f71aa507-d350-4b9d-863f-e3036e088b05_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1c90c5c8-5cc4-4297-b7e2-8511d8259c8a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f0a2ec42-ce45-413e-8647-5f0a37ba1dfc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6abd2128-f94e-4159-88b6-49746735a1e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted&#160;Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3ed59155-0a91-446f-8b70-65256f4be825_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fa477674-634d-460d-bd0d-bbf120927ae1_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_0ddea578-4a90-4d36-b51a-ba9ee6eaab12_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_FraudExpenseMember_2a19dda8-25c6-4be2-904a-d37e39733c4f_terseLabel_en-US" xlink:label="lab_natr_FraudExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fraud Expense</link:label>
    <link:label id="lab_natr_FraudExpenseMember_label_en-US" xlink:label="lab_natr_FraudExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fraud Expense [Member]</link:label>
    <link:label id="lab_natr_FraudExpenseMember_documentation_en-US" xlink:label="lab_natr_FraudExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fraud Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FraudExpenseMember" xlink:href="natr-20230331.xsd#natr_FraudExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_FraudExpenseMember" xlink:to="lab_natr_FraudExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_51195a94-bcf2-47c5-abc0-c0ccf7b7c6e0_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1b59bee9-9eab-403d-ba6d-fa3ea38276e5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ca0039ea-9eb9-4ac2-b9bc-752cf92d4b70_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_39c73a38-82e3-46f4-a771-a48f89a95b34_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_74ee969a-c2e7-4253-a70b-1c41e6c0f503_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4e2d9865-543b-4485-9a8d-e54514aa78f2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_c5566684-9f63-496c-a9d8-31586ddb7e47_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ff62e3c4-343c-4563-a3d6-28ef374abd51_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_b5d02135-a878-4fcd-b655-dc8a8d54f029_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d1305576-20fa-446c-81b0-201e2ca828cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_b76d5611-83ee-4069-8062-deced003c678_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, outstanding, current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7ce9e935-7d8e-4188-9846-68cffa60c1e5_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_bf6624ea-77fe-4abf-93dc-0612fd7771e6_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_18c299d9-4618-42c0-9482-3dd62e7fa009_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b9fc2ea8-69b5-49a4-b9a9-6252faeb629b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_1d7e5683-ef0e-4d19-a7d6-6b47d41fe725_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_bcc9617e-f5f0-401d-8d61-255cec274dd4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_01407e72-4a54-41f0-9a8a-e1d2ba84c35b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dd8355ac-e33e-4d9e-ac45-ab02c1664d07_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_dc5df64b-235a-45ad-8cba-651660aa7767_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Synergy Japan Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_WeightManagementProductsMember_68f7c2f2-9bfa-4065-9789-a7adc3d4181d_terseLabel_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight management</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_label_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight Management Products [Member]</link:label>
    <link:label id="lab_natr_WeightManagementProductsMember_documentation_en-US" xlink:label="lab_natr_WeightManagementProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to weight management products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember" xlink:href="natr-20230331.xsd#natr_WeightManagementProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_WeightManagementProductsMember" xlink:to="lab_natr_WeightManagementProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2127256d-6769-4680-b4de-02f1268e026e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a172a47b-2be5-492d-9417-939c4d469d04_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_ddbbf68e-1913-4bb3-9631-67a587eefebb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_7a675ce2-aba4-476f-8a26-9dc5e593ec9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5f24daca-69f5-4d6c-84c2-4cc04b2d396a_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d8776581-84cc-4cf2-8c90-4e0e154eed79_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9e32a567-9da4-4532-be95-52c38c86dade_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1c6ffae9-edd1-487a-a963-e373b60583a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9381c45b-96c5-45ef-87f1-6801ddf87069_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_cfcc4a3b-1853-419a-a102-83e2c8746b34_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_20e467cc-9b3a-4c85-91f2-a686618f9c90_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_8c6d52f3-4f24-469f-856d-1e01030517be_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_09233e2c-88ae-4349-93a2-a5657b2df5ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_natr_CardiovascularProductsMember_61e4efac-6ee0-4312-abbf-31df5471bb1c_terseLabel_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_label_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular Products [Member]</link:label>
    <link:label id="lab_natr_CardiovascularProductsMember_documentation_en-US" xlink:label="lab_natr_CardiovascularProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to cardiovascular products of the entity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember" xlink:href="natr-20230331.xsd#natr_CardiovascularProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_natr_CardiovascularProductsMember" xlink:to="lab_natr_CardiovascularProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_30734f7d-1d17-442d-8a8a-1c25bab8c29f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_00a7e3bd-faec-4ce6-acb7-4f064e52b2ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>natr-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b97fc173-22e4-4888-b858-1b8ba6d424bb,g:c9f7516e-bbd4-4af1-82a6-c5d334c50b5a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://naturessunshine.com/role/CoverPage" xlink:type="simple" xlink:href="natr-20230331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6bbeb447-82a7-4986-9459-b02f9712bbca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentType_6bbeb447-82a7-4986-9459-b02f9712bbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9ff34231-682e-4193-bef8-05fb7b947cd8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentQuarterlyReport_9ff34231-682e-4193-bef8-05fb7b947cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_24925849-8efa-436f-b211-00d478da375a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentPeriodEndDate_24925849-8efa-436f-b211-00d478da375a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_4c43d45f-6b21-408e-b66e-8d8285da888b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentTransitionReport_4c43d45f-6b21-408e-b66e-8d8285da888b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3b49ad40-243b-4cf3-9b2c-2a24ca7720a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityFileNumber_3b49ad40-243b-4cf3-9b2c-2a24ca7720a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c016bfc1-688a-4022-9d75-763c4e486dbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityRegistrantName_c016bfc1-688a-4022-9d75-763c4e486dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f672653a-03fa-4e1e-a4c3-7aaf413fae27" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f672653a-03fa-4e1e-a4c3-7aaf413fae27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_eb06ef86-902e-495e-9de7-75df926e757f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityTaxIdentificationNumber_eb06ef86-902e-495e-9de7-75df926e757f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_0dc9cf59-c62d-4f77-8b76-6c1d6ddf9346" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityAddressAddressLine1_0dc9cf59-c62d-4f77-8b76-6c1d6ddf9346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_82450d8b-86e5-48a3-83e0-9eabf55105a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityAddressAddressLine2_82450d8b-86e5-48a3-83e0-9eabf55105a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_99912f79-93d3-4c95-a52c-85e61efd0bcc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityAddressCityOrTown_99912f79-93d3-4c95-a52c-85e61efd0bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1224091e-d4ab-4479-bc07-a082e543ac9d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityAddressStateOrProvince_1224091e-d4ab-4479-bc07-a082e543ac9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d9e478ce-b1b2-482a-bb22-311ec07d7d8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityAddressPostalZipCode_d9e478ce-b1b2-482a-bb22-311ec07d7d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bcc2c905-6438-442c-af02-008d9650a175" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_CityAreaCode_bcc2c905-6438-442c-af02-008d9650a175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_29d3df9a-14c7-49c5-85d1-a18fd0cdde14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_LocalPhoneNumber_29d3df9a-14c7-49c5-85d1-a18fd0cdde14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_17096804-d8f9-441b-a358-661604c0da5e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_Security12bTitle_17096804-d8f9-441b-a358-661604c0da5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4e8e089a-72b0-48f2-8e31-6b72656f5038" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_TradingSymbol_4e8e089a-72b0-48f2-8e31-6b72656f5038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_17fa0306-30b1-4b18-b63f-02e281b20cf4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_SecurityExchangeName_17fa0306-30b1-4b18-b63f-02e281b20cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_07a8e573-21bb-4e08-a3fc-28bbea21b386" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityCurrentReportingStatus_07a8e573-21bb-4e08-a3fc-28bbea21b386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_3f1792f9-c2cd-4a04-981c-709ea229b433" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityInteractiveDataCurrent_3f1792f9-c2cd-4a04-981c-709ea229b433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_7dfc1d62-3a7b-4d73-b2f2-841b631eb8bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityFilerCategory_7dfc1d62-3a7b-4d73-b2f2-841b631eb8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ec2cdd1e-3bf7-4a00-bea6-ea9872bca1a0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntitySmallBusiness_ec2cdd1e-3bf7-4a00-bea6-ea9872bca1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a5253ab8-c117-46bf-a97e-dbb6775e1f74" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityEmergingGrowthCompany_a5253ab8-c117-46bf-a97e-dbb6775e1f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f60f3b38-b549-4591-9901-f3f2f8928943" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityShellCompany_f60f3b38-b549-4591-9901-f3f2f8928943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0eab9716-fd0b-4c23-b097-18b3428ed663" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0eab9716-fd0b-4c23-b097-18b3428ed663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_146b9291-3eb9-405e-8ce8-c6125ae36807" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_EntityCentralIndexKey_146b9291-3eb9-405e-8ce8-c6125ae36807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1571ae73-fc75-4675-88ad-391cc4c2138d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_AmendmentFlag_1571ae73-fc75-4675-88ad-391cc4c2138d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_98cafa47-3b60-4dc0-988c-3a0865de55c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentFiscalYearFocus_98cafa47-3b60-4dc0-988c-3a0865de55c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_9a115dda-14a1-4c2d-8747-08181aaa5036" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_DocumentFiscalPeriodFocus_9a115dda-14a1-4c2d-8747-08181aaa5036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_da0feca4-a199-4a22-826c-4212b0713fbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_49d22e6c-52ab-4785-aea1-545218836591" xlink:to="loc_dei_CurrentFiscalYearEndDate_da0feca4-a199-4a22-826c-4212b0713fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_408f1ded-4bff-4e16-ae41-12402c6eaf15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_408f1ded-4bff-4e16-ae41-12402c6eaf15" xlink:to="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8ac2d826-f8b5-4568-a7a4-11529a962cbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8ac2d826-f8b5-4568-a7a4-11529a962cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_aa54a548-47f0-4e56-8dfa-1f6fc344d0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_aa54a548-47f0-4e56-8dfa-1f6fc344d0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7b41d14d-0f3c-4f02-938f-b79cfc7f30a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:to="loc_us-gaap_InventoryNet_7b41d14d-0f3c-4f02-938f-b79cfc7f30a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_40a9e89a-dff7-4e46-8e5c-26974a72a6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_40a9e89a-dff7-4e46-8e5c-26974a72a6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b21149c4-129f-4cdb-ba4b-32683619c66c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f7c425d5-8838-4744-b6a4-a05b625f55d6" xlink:to="loc_us-gaap_AssetsCurrent_b21149c4-129f-4cdb-ba4b-32683619c66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9ce8ec86-16ca-40f9-adda-91cf8d0c1aea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9ce8ec86-16ca-40f9-adda-91cf8d0c1aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a84598b1-dcef-4c15-a65e-698f8cd7532e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a84598b1-dcef-4c15-a65e-698f8cd7532e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_8c32cfa5-8b6e-4195-951f-35b1f65fdfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_8c32cfa5-8b6e-4195-951f-35b1f65fdfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_96238b59-7a1d-4d03-9390-29a715ac7d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_96238b59-7a1d-4d03-9390-29a715ac7d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_770cdcc7-f15a-4f0b-8b61-4236bd643c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_770cdcc7-f15a-4f0b-8b61-4236bd643c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_53c878ff-741a-4803-a894-cf786dd02bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_74f96bb2-5911-4ed9-b09d-5be58d92a0e1" xlink:to="loc_us-gaap_Assets_53c878ff-741a-4803-a894-cf786dd02bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_408f1ded-4bff-4e16-ae41-12402c6eaf15" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_037d0204-37b5-47cb-a505-8b57116ce912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_AccountsPayableCurrent_037d0204-37b5-47cb-a505-8b57116ce912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AccruedVolumeIncentiveandServiceFees_7149f799-32c8-4e3f-949b-811faf8f600a" xlink:href="natr-20230331.xsd#natr_AccruedVolumeIncentiveandServiceFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_natr_AccruedVolumeIncentiveandServiceFees_7149f799-32c8-4e3f-949b-811faf8f600a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_17cc82b8-e684-4620-af4b-d2dec0bd8c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_17cc82b8-e684-4620-af4b-d2dec0bd8c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6f6b5a71-7436-422c-a505-74f2bd48a524" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_6f6b5a71-7436-422c-a505-74f2bd48a524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_ec285006-2b4d-4aad-a1ef-c8c86df756ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_ec285006-2b4d-4aad-a1ef-c8c86df756ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_01b094e0-cf76-4ec1-bc89-3db5fecc8e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_01b094e0-cf76-4ec1-bc89-3db5fecc8e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1213409a-67bd-4605-ad6d-c7c3782d4d87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_1213409a-67bd-4605-ad6d-c7c3782d4d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6f6f342f-8a4d-4213-8c76-a281cb0bf48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_85b32ea5-e25c-4b55-993a-145386b9ab1e" xlink:to="loc_us-gaap_LiabilitiesCurrent_6f6f342f-8a4d-4213-8c76-a281cb0bf48e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8eec69c1-e34e-4159-ac29-110156fe8fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUncertainTaxPositionsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent_8eec69c1-e34e-4159-ac29-110156fe8fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ca82ccb-280b-46eb-89ad-0ed95d61d73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_4ca82ccb-280b-46eb-89ad-0ed95d61d73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efe0a3bd-dbf4-4ba4-b5fc-3eb1c1d31c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_efe0a3bd-dbf4-4ba4-b5fc-3eb1c1d31c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a51a0055-af47-4ac6-b58c-728961d1ca88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a51a0055-af47-4ac6-b58c-728961d1ca88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_56131322-a059-4c77-b886-3cc8fad330a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_56131322-a059-4c77-b886-3cc8fad330a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_09305052-61b2-4f00-80d0-33ee4e8bee64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_Liabilities_09305052-61b2-4f00-80d0-33ee4e8bee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_09fd86b5-7b31-4cab-a8ab-af56a607c46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:to="loc_us-gaap_CommonStockValue_09fd86b5-7b31-4cab-a8ab-af56a607c46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31c8bb47-ac63-4f65-afb1-cf50b3a87451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_31c8bb47-ac63-4f65-afb1-cf50b3a87451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c9079373-66c9-4fce-87c6-4056fd777e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:to="loc_us-gaap_MinorityInterest_c9079373-66c9-4fce-87c6-4056fd777e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3ba6f149-4a94-409a-a6ee-7b0b5fdd9feb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3ba6f149-4a94-409a-a6ee-7b0b5fdd9feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a7518c0-2dc8-4feb-b4a9-6e66cf9a36da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_cae841c8-a803-450f-b03f-bf40b0ba7ef1" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2a7518c0-2dc8-4feb-b4a9-6e66cf9a36da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc2e83bd-622b-4bd1-8041-b5b0ab21ddb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b86a19f1-5fc7-4a15-977b-5c94177ac9a8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cc2e83bd-622b-4bd1-8041-b5b0ab21ddb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b2fb4e80-d039-49d2-aab0-188824b29eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b2fb4e80-d039-49d2-aab0-188824b29eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNoParValue_50ad7794-e182-4a3a-bad8-28b169fb483e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockNoParValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:to="loc_us-gaap_CommonStockNoParValue_50ad7794-e182-4a3a-bad8-28b169fb483e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9023b925-7470-4488-8ee4-683ed9348ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9023b925-7470-4488-8ee4-683ed9348ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c158b0be-8aa3-452e-b5de-e6d45167a5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c158b0be-8aa3-452e-b5de-e6d45167a5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_624de459-9650-4968-be15-26f4cb22028d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e666667e-236a-4cf4-a069-98d9923d5484" xlink:to="loc_us-gaap_CommonStockSharesIssued_624de459-9650-4968-be15-26f4cb22028d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b925c295-709d-4c3e-b154-4f4ebd3d7b18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b925c295-709d-4c3e-b154-4f4ebd3d7b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4487e0a1-741d-48a4-a039-458fcc82a22d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4487e0a1-741d-48a4-a039-458fcc82a22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_1b134d88-180c-44d4-9eae-01f87af365bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_GrossProfit_1b134d88-180c-44d4-9eae-01f87af365bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_VolumeIncentives_bf18995f-996d-427b-8452-d2139f004afd" xlink:href="natr-20230331.xsd#natr_VolumeIncentives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_natr_VolumeIncentives_bf18995f-996d-427b-8452-d2139f004afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d65f37e8-e0c0-4a48-a48b-18ab5702ba22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d65f37e8-e0c0-4a48-a48b-18ab5702ba22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_181633df-dd3b-41d5-8370-5bce04922bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_us-gaap_OperatingIncomeLoss_181633df-dd3b-41d5-8370-5bce04922bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_11a66d4f-f5b9-41a4-9ffc-54c1b74b7107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_11a66d4f-f5b9-41a4-9ffc-54c1b74b7107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b0ca290-0429-405f-9146-c7c69b74fddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b0ca290-0429-405f-9146-c7c69b74fddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3ac0d216-c012-4001-a0ed-fc8052107cce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_0bdbb193-f149-4f30-a97b-c1d9acaf4405" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3ac0d216-c012-4001-a0ed-fc8052107cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7cd69374-cc9a-47c7-af0e-719e04513858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_ProfitLoss_7cd69374-cc9a-47c7-af0e-719e04513858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ed326fb-2728-462a-a858-428621a70491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8ed326fb-2728-462a-a858-428621a70491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_381e105c-ff24-4453-a71c-005fb79367c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_NetIncomeLoss_381e105c-ff24-4453-a71c-005fb79367c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_af3d2a03-c86f-4027-af11-725d775e6683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_EarningsPerShareAbstract_af3d2a03-c86f-4027-af11-725d775e6683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4279d33b-4929-45bf-8258-ab544639131c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af3d2a03-c86f-4027-af11-725d775e6683" xlink:to="loc_us-gaap_EarningsPerShareBasic_4279d33b-4929-45bf-8258-ab544639131c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2d46f5d4-50d9-47af-aeac-ee356cdb455b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_af3d2a03-c86f-4027-af11-725d775e6683" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2d46f5d4-50d9-47af-aeac-ee356cdb455b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_873ea381-11ae-48ef-8a3b-71d2de363ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_873ea381-11ae-48ef-8a3b-71d2de363ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ceb7103-0d8d-40e5-88c7-cfc2ef106140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_202a4eb7-62e5-4ad4-83a6-7ec3d97ebe63" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6ceb7103-0d8d-40e5-88c7-cfc2ef106140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d0b63ea-2901-407a-9bcf-4ae874e62933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ae95255f-c96e-4c62-ac51-73e4bdbe2eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d0b63ea-2901-407a-9bcf-4ae874e62933" xlink:to="loc_us-gaap_ProfitLoss_ae95255f-c96e-4c62-ac51-73e4bdbe2eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2ba7a6a6-7132-44d7-82e9-c33a3ea7de7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d0b63ea-2901-407a-9bcf-4ae874e62933" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2ba7a6a6-7132-44d7-82e9-c33a3ea7de7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1a600360-e048-42da-b5b4-b30dbe435340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d0b63ea-2901-407a-9bcf-4ae874e62933" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1a600360-e048-42da-b5b4-b30dbe435340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_15e88237-d483-4873-b274-ad6191f33767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_15e88237-d483-4873-b274-ad6191f33767" xlink:to="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_afd41326-3238-4984-9bc3-cbfaaca36835" xlink:to="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_34d52b82-1738-434d-b6eb-4ed73dd261a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_CommonStockMember_34d52b82-1738-434d-b6eb-4ed73dd261a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f912656b-9c5c-449b-915c-221793afe22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_RetainedEarningsMember_f912656b-9c5c-449b-915c-221793afe22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_5b1136b2-89a4-4b58-a847-1d6657b489a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_NoncontrollingInterestMember_5b1136b2-89a4-4b58-a847-1d6657b489a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b9858d76-0eeb-4b0a-8c7f-378e90591913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_06d52528-4704-419c-a9fd-9325449edeab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b9858d76-0eeb-4b0a-8c7f-378e90591913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ba075189-8a33-4268-957d-5ac8a304a6f5" xlink:to="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e4acb408-28d2-480a-a009-ddab54810459" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_10c7c845-3169-441e-a4e4-d4e75f144f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_CommonStockSharesIssued_10c7c845-3169-441e-a4e4-d4e75f144f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78487426-9fe7-40aa-b134-d328e1616eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78487426-9fe7-40aa-b134-d328e1616eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_c824c5d8-7359-4b7a-99f2-3f79880a2424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross_c824c5d8-7359-4b7a-99f2-3f79880a2424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_97754427-29d7-4811-b243-8f529127699a" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised_97754427-29d7-4811-b243-8f529127699a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_41ee38db-645f-4250-b0b0-5fce51eaaed9" xlink:href="natr-20230331.xsd#natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised_41ee38db-645f-4250-b0b0-5fce51eaaed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0cfb39d5-82c2-4579-8e80-8f54441f79e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0cfb39d5-82c2-4579-8e80-8f54441f79e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_ca579b65-34bf-437c-9fae-8adc14d8cd7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_ca579b65-34bf-437c-9fae-8adc14d8cd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_43b7478c-ba02-430e-b5ec-022af7aa55f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_ProfitLoss_43b7478c-ba02-430e-b5ec-022af7aa55f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f12a04fe-1be9-4388-9802-30b374b1ca9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f12a04fe-1be9-4388-9802-30b374b1ca9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e3e09f74-df13-4121-962b-093388d66017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_CommonStockSharesIssued_e3e09f74-df13-4121-962b-093388d66017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53fb9b48-bc49-49a1-9d56-88e6f37e507a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fd85f2eb-0d2d-4bba-809f-3ab57fbf7106" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_53fb9b48-bc49-49a1-9d56-88e6f37e507a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="natr-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2b6385c3-bfba-4891-9ae5-18a77c903c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:to="loc_us-gaap_ProfitLoss_2b6385c3-bfba-4891-9ae5-18a77c903c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_f5a45127-d2f8-4c92-a3c7-f95f46b072bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_f5a45127-d2f8-4c92-a3c7-f95f46b072bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0d15d260-d2e4-42b0-9ac7-fb5f6edf4520" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0d15d260-d2e4-42b0-9ac7-fb5f6edf4520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OperatingLeaseNonCashLeaseExpense_f6e89e5b-c0ff-4242-9636-4b7eb6575e36" xlink:href="natr-20230331.xsd#natr_OperatingLeaseNonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_natr_OperatingLeaseNonCashLeaseExpense_f6e89e5b-c0ff-4242-9636-4b7eb6575e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_131891bd-241d-4d27-a393-bbf449dc3aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_ShareBasedCompensation_131891bd-241d-4d27-a393-bbf449dc3aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_22c8ad0d-4ee5-4a14-9b3e-a254ea34db78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_22c8ad0d-4ee5-4a14-9b3e-a254ea34db78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b6c07e00-d2f2-499d-bce4-a141a713c4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b6c07e00-d2f2-499d-bce4-a141a713c4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_4aa72d73-73e5-4a5c-b68f-9a410d5efb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities_4aa72d73-73e5-4a5c-b68f-9a410d5efb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_3880ebc3-ee81-42cf-8c23-208c8c5eb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities_3880ebc3-ee81-42cf-8c23-208c8c5eb6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_6ec1b2ee-0ef5-41b3-97eb-8a9f51eb80c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_GainLossOnInvestments_6ec1b2ee-0ef5-41b3-97eb-8a9f51eb80c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84dd5ffc-9a05-48b4-8ea3-18f8b92269a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cddb7486-4a45-46c8-8821-6f3a5f317f04" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_84dd5ffc-9a05-48b4-8ea3-18f8b92269a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dad32212-6076-4bf4-b9ab-bb2ecadc47d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dad32212-6076-4bf4-b9ab-bb2ecadc47d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_71ef03fa-697b-457e-89d1-1181fad5b456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_71ef03fa-697b-457e-89d1-1181fad5b456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cfdb67e0-5dc5-4ba9-a8b4-24d76195cd34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cfdb67e0-5dc5-4ba9-a8b4-24d76195cd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7e26280c-2183-4a6c-8e5b-87908536eb36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_7e26280c-2183-4a6c-8e5b-87908536eb36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2221df39-fdf7-4cb2-8d46-5af229f156ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_2221df39-fdf7-4cb2-8d46-5af229f156ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_0ba67402-e3e8-47bf-82cb-47d7a2e4d853" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees_0ba67402-e3e8-47bf-82cb-47d7a2e4d853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3efaf5ce-593d-4226-bc65-f28d0479fb08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3efaf5ce-593d-4226-bc65-f28d0479fb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dc6a2cb4-8dcb-4e75-b716-577aa99b7fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dc6a2cb4-8dcb-4e75-b716-577aa99b7fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_4a7b4c00-b22b-4649-ba5c-2b6d8aac0ffb" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_natr_IncreaseDecreaseInOperatingLeaseLiabilities_4a7b4c00-b22b-4649-ba5c-2b6d8aac0ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ee7c665f-0135-4e1f-8d83-ab5e10ffeb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_ee7c665f-0135-4e1f-8d83-ab5e10ffeb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_acd6d6ae-0386-4eaf-bcf3-182e36069a77" xlink:href="natr-20230331.xsd#natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions_acd6d6ae-0386-4eaf-bcf3-182e36069a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_6917a3aa-369a-4ba9-8fae-0752630e7f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_34a8a778-0acd-439d-bf2c-5a79f68dbf4b" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_6917a3aa-369a-4ba9-8fae-0752630e7f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c38e8a5-40a0-468d-86ec-b4a63a6adeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8a02d152-d276-486d-abc2-5578ae6b2f25" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2c38e8a5-40a0-468d-86ec-b4a63a6adeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b00e5a16-36f8-431c-b290-8aaf676954e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b00e5a16-36f8-431c-b290-8aaf676954e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3c70535a-f2db-437a-a2b3-0c96584010a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b00e5a16-36f8-431c-b290-8aaf676954e8" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3c70535a-f2db-437a-a2b3-0c96584010a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a40a1aa6-d921-4e1a-bf5c-f567c5aa0d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b00e5a16-36f8-431c-b290-8aaf676954e8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a40a1aa6-d921-4e1a-bf5c-f567c5aa0d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherLongTermDebt_f2678a2b-3d2f-4245-b947-62769a24bd06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_RepaymentsOfOtherLongTermDebt_f2678a2b-3d2f-4245-b947-62769a24bd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_7e27214a-fd4c-4a8e-8191-6a91600faf36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_7e27214a-fd4c-4a8e-8191-6a91600faf36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d1e8ada4-fbc1-4e89-b506-4cd7c0c9e040" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d1e8ada4-fbc1-4e89-b506-4cd7c0c9e040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfRelatedPartyDebt_9a005710-1a0b-4281-944a-1e5dc0c6a608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfRelatedPartyDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_RepaymentsOfRelatedPartyDebt_9a005710-1a0b-4281-944a-1e5dc0c6a608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d7b9fd12-f49e-4c65-bc19-e4dc4754419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d7b9fd12-f49e-4c65-bc19-e4dc4754419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8ee10cb1-a842-4eb6-ab6d-5cede6ce8a14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8ee10cb1-a842-4eb6-ab6d-5cede6ce8a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2de7ce5d-7d84-4d4b-93ce-2770fa31d31f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_629fb971-d342-4a63-8f50-abe7809fda72" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2de7ce5d-7d84-4d4b-93ce-2770fa31d31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3da4e26-3e0d-479f-98ef-56cc3d08c1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3da4e26-3e0d-479f-98ef-56cc3d08c1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eceb08da-1b14-4fd9-9dc2-771c79a4f35f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_eceb08da-1b14-4fd9-9dc2-771c79a4f35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fa3e8191-1b33-4bdf-9122-2d0715d1ee8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_fa3e8191-1b33-4bdf-9122-2d0715d1ee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cc70902-7a8e-4f34-97d2-a78c1530f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8cc70902-7a8e-4f34-97d2-a78c1530f89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_28dd3637-f541-4896-80f0-f88a9f9a2974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5c0a0df5-641d-453e-83c3-12eec3327d05" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_28dd3637-f541-4896-80f0-f88a9f9a2974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_3d6e9cbe-1fe4-4f99-94ed-48e55d82d491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28dd3637-f541-4896-80f0-f88a9f9a2974" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_3d6e9cbe-1fe4-4f99-94ed-48e55d82d491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_a7d3552d-a2b7-4ec1-a576-5b5e18a6a410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_28dd3637-f541-4896-80f0-f88a9f9a2974" xlink:to="loc_us-gaap_InterestPaidNet_a7d3552d-a2b7-4ec1-a576-5b5e18a6a410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentation" xlink:type="simple" xlink:href="natr-20230331.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_487a4e61-af5e-4356-bac0-cf405d092a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_901e8d05-d665-4c67-953f-ce0189e40b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_487a4e61-af5e-4356-bac0-cf405d092a46" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_901e8d05-d665-4c67-953f-ce0189e40b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/Inventories" xlink:type="simple" xlink:href="natr-20230331.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6d776203-8c41-4e02-9976-983a7295477f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_9c1a5929-54d2-41e8-bf09-fdb7fd64f2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6d776203-8c41-4e02-9976-983a7295477f" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_9c1a5929-54d2-41e8-bf09-fdb7fd64f2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="simple" xlink:href="natr-20230331.xsd#InvestmentSecuritiesTrading"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTrading" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b8a40a75-1091-4e87-bfb2-0f077825b87f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2b4e8fc2-ef98-44a0-8f8a-c6402e29be76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b8a40a75-1091-4e87-bfb2-0f077825b87f" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2b4e8fc2-ef98-44a0-8f8a-c6402e29be76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="simple" xlink:href="natr-20230331.xsd#RevolvingCreditFacilityandOtherObligations"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7c501877-416c-4f38-b65d-546b49ad00c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_f497a524-5ac0-4873-94d2-b2bc6d4135e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7c501877-416c-4f38-b65d-546b49ad00c4" xlink:to="loc_us-gaap_LongTermDebtTextBlock_f497a524-5ac0-4873-94d2-b2bc6d4135e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomelossPerShare" xlink:type="simple" xlink:href="natr-20230331.xsd#NetIncomelossPerShare"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomelossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_71752fd4-4aeb-4061-a129-1955e0d1f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_4108781b-5b6d-40fa-892f-f43f27aa9072" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_71752fd4-4aeb-4061-a129-1955e0d1f9c4" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_4108781b-5b6d-40fa-892f-f43f27aa9072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactions" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactions"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b80b4e78-548c-4788-b3d7-30fa0a9e7cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_8af770f8-57cb-459c-bc24-b8d967081d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b80b4e78-548c-4788-b3d7-30fa0a9e7cc5" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_8af770f8-57cb-459c-bc24-b8d967081d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformation" xlink:type="simple" xlink:href="natr-20230331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4427a1f0-24f5-4eaa-82ac-0596ab00230e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d97e7997-7261-4ef3-a642-7439ce9fdafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4427a1f0-24f5-4eaa-82ac-0596ab00230e" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d97e7997-7261-4ef3-a642-7439ce9fdafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxes" xlink:type="simple" xlink:href="natr-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fe1b03fc-c5dd-4b8e-ba46-123cb8a6d14a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f9f14df-7f7a-4013-b07d-ec69e7ea4954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe1b03fc-c5dd-4b8e-ba46-123cb8a6d14a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8f9f14df-7f7a-4013-b07d-ec69e7ea4954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="natr-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5e63e61-42d5-4c40-8783-1f31b3805670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_be044fcb-c372-471c-ac13-c8f00e3fb4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a5e63e61-42d5-4c40-8783-1f31b3805670" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_be044fcb-c372-471c-ac13-c8f00e3fb4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="natr-20230331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f6f6f765-15dc-4303-a86c-47bdf9b50cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_474ea13e-6e23-413e-8cf6-50742e616ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f6f6f765-15dc-4303-a86c-47bdf9b50cbe" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_474ea13e-6e23-413e-8cf6-50742e616ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognition" xlink:type="simple" xlink:href="natr-20230331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_34fc96b4-13e3-4a82-b70c-fe39ad6988cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0ecc219b-6f2b-496e-bde4-3e68dd1b5aca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_34fc96b4-13e3-4a82-b70c-fe39ad6988cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0ecc219b-6f2b-496e-bde4-3e68dd1b5aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SynergyJapanLoss" xlink:type="simple" xlink:href="natr-20230331.xsd#SynergyJapanLoss"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SynergyJapanLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67fe32fc-f247-4857-b2c3-694e2a2771e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_8760eb49-ccc9-4939-973a-bf0d65001b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_67fe32fc-f247-4857-b2c3-694e2a2771e5" xlink:to="loc_us-gaap_LossContingencyDisclosures_8760eb49-ccc9-4939-973a-bf0d65001b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="simple" xlink:href="natr-20230331.xsd#BasisofPresentationPolicies"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b17961f2-ec1d-4c85-b419-7258f0aa92f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d00e70d2-c1c0-41e1-a15e-ba9992ddbc71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b17961f2-ec1d-4c85-b419-7258f0aa92f9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_d00e70d2-c1c0-41e1-a15e-ba9992ddbc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_86e369e5-c3f5-4618-b8c3-e0ce503b84c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b17961f2-ec1d-4c85-b419-7258f0aa92f9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_86e369e5-c3f5-4618-b8c3-e0ce503b84c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_4b352f6f-2c3a-47a8-bb38-601cf96d25ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b17961f2-ec1d-4c85-b419-7258f0aa92f9" xlink:to="loc_us-gaap_UseOfEstimates_4b352f6f-2c3a-47a8-bb38-601cf96d25ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a2ffc327-34eb-4fa4-a863-435143eb067a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b17961f2-ec1d-4c85-b419-7258f0aa92f9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a2ffc327-34eb-4fa4-a863-435143eb067a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesTables" xlink:type="simple" xlink:href="natr-20230331.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_48e67c18-c7a5-4ee7-9417-c4baabd6d95b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f25e344d-51ca-4fe3-916a-44aea1366a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_48e67c18-c7a5-4ee7-9417-c4baabd6d95b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f25e344d-51ca-4fe3-916a-44aea1366a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomelossPerShareTables" xlink:type="simple" xlink:href="natr-20230331.xsd#NetIncomelossPerShareTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomelossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fa0c9b72-cc4e-4106-93d6-a5d629076d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0b9dc5b8-4171-4742-a53f-bec2ad82aa7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fa0c9b72-cc4e-4106-93d6-a5d629076d08" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0b9dc5b8-4171-4742-a53f-bec2ad82aa7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c32e2e2b-ea42-4e96-bf19-d6488c2ba123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_49d50178-9b60-4a0e-b091-df4f7b8aef74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c32e2e2b-ea42-4e96-bf19-d6488c2ba123" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_49d50178-9b60-4a0e-b091-df4f7b8aef74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_bfebca6f-99ab-4456-82fb-0c78e407551f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c32e2e2b-ea42-4e96-bf19-d6488c2ba123" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_bfebca6f-99ab-4456-82fb-0c78e407551f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="natr-20230331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4e657de3-14d3-42cd-a75a-b0199d819ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4e657de3-14d3-42cd-a75a-b0199d819ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_e57efdec-58e2-44ef-9032-b3b59a0514a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_e57efdec-58e2-44ef-9032-b3b59a0514a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_4312e459-71a2-4889-ad6e-1347bb8b121d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_4312e459-71a2-4889-ad6e-1347bb8b121d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_eb1dff4a-0ddd-4186-a7da-d9a2700d219d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_eb1dff4a-0ddd-4186-a7da-d9a2700d219d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_60c1f962-a147-4294-90cc-6585070befb1" xlink:href="natr-20230331.xsd#natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b8426afa-9592-44c5-92d3-d12cfd1b6a38" xlink:to="loc_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock_60c1f962-a147-4294-90cc-6585070befb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="natr-20230331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ac7f241b-0000-4824-ac1b-27a9caa9523f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_09402c42-ce08-4d0f-aa6b-4a1c2f81c8b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ac7f241b-0000-4824-ac1b-27a9caa9523f" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_09402c42-ce08-4d0f-aa6b-4a1c2f81c8b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#BasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/BasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a3ed24d1-7710-4ad9-8ed6-fac346545834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_9366e432-bb8e-4106-83b9-d9030d26b519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a3ed24d1-7710-4ad9-8ed6-fac346545834" xlink:to="loc_us-gaap_MinorityInterestPeriodIncreaseDecrease_9366e432-bb8e-4106-83b9-d9030d26b519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d03bf991-df98-4a2e-bf8c-2fee1dd041d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a3ed24d1-7710-4ad9-8ed6-fac346545834" xlink:to="loc_us-gaap_MinorityInterest_d03bf991-df98-4a2e-bf8c-2fee1dd041d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InventoriesDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b67fd3f8-7668-4353-9c6b-6a2fa52252bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7b858da0-69f1-43b8-9fbb-c4d0b5e91cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b67fd3f8-7668-4353-9c6b-6a2fa52252bc" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7b858da0-69f1-43b8-9fbb-c4d0b5e91cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d798e554-255a-4713-a91c-e780caed548a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b67fd3f8-7668-4353-9c6b-6a2fa52252bc" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d798e554-255a-4713-a91c-e780caed548a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ab80c70e-23c4-4acb-94b2-c131c4b54726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b67fd3f8-7668-4353-9c6b-6a2fa52252bc" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_ab80c70e-23c4-4acb-94b2-c131c4b54726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2d46005f-87fd-4f99-8756-ffd4a9090e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b67fd3f8-7668-4353-9c6b-6a2fa52252bc" xlink:to="loc_us-gaap_InventoryNet_2d46005f-87fd-4f99-8756-ffd4a9090e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#InvestmentSecuritiesTradingDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e2ac6652-8525-49bd-a3ae-31ca3d1afe20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRestricted_39416547-3909-4892-86a2-3c4d938d8c74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRestricted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e2ac6652-8525-49bd-a3ae-31ca3d1afe20" xlink:to="loc_us-gaap_DebtSecuritiesTradingRestricted_39416547-3909-4892-86a2-3c4d938d8c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_eef7a567-c2d1-4ae0-85da-7ef839ba2d16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesTradingRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e2ac6652-8525-49bd-a3ae-31ca3d1afe20" xlink:to="loc_us-gaap_DebtSecuritiesTradingRealizedGainLoss_eef7a567-c2d1-4ae0-85da-7ef839ba2d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#RevolvingCreditFacilityandOtherObligationsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e35f890c-32d5-4af6-8715-59f85ec2b5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e35f890c-32d5-4af6-8715-59f85ec2b5ad" xlink:to="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_f63a5ea7-7e29-4ab5-9eb8-6d5e2495f331" xlink:to="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_0dee1f28-198e-4efd-8307-cfd70cd83deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_0dee1f28-198e-4efd-8307-cfd70cd83deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_410ec325-7eb8-410a-b75f-ffb087584296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_ffae30c5-1917-47ee-b1a3-c6a7b90a4882" xlink:to="loc_us-gaap_LineOfCreditMember_410ec325-7eb8-410a-b75f-ffb087584296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2e1e5965-e852-450d-8508-9b90b184a50a" xlink:to="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6f09d87c-30b1-4b5d-8585-925bb9ebf5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_6f09d87c-30b1-4b5d-8585-925bb9ebf5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_IndicativeIndexMember_dc041b15-bf7d-43d3-814f-f79e77fabff2" xlink:href="natr-20230331.xsd#natr_IndicativeIndexMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_a6141f4d-fdfa-45e8-ab9f-4fe408f94293" xlink:to="loc_natr_IndicativeIndexMember_dc041b15-bf7d-43d3-814f-f79e77fabff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1626718b-5b34-4533-8659-2af14f786c4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BankofAmericaCreditAgreementMember_20f3cf8c-959f-48e1-8fff-00c9338a176e" xlink:href="natr-20230331.xsd#natr_BankofAmericaCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:to="loc_natr_BankofAmericaCreditAgreementMember_20f3cf8c-959f-48e1-8fff-00c9338a176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e69e0b13-3e2b-4aeb-98fc-7493499e0542" xlink:href="natr-20230331.xsd#natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b7811774-a45d-49e8-8af5-10fcf3ac166d" xlink:to="loc_natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember_e69e0b13-3e2b-4aeb-98fc-7493499e0542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a1e5d83d-11a6-47e1-87e2-ea83d92d19e1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e776dd5d-5f93-4f8b-93e1-f69c7050ccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e776dd5d-5f93-4f8b-93e1-f69c7050ccaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_f3b4d5b7-251a-4b72-aecf-d37df825390b" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings_f3b4d5b7-251a-4b72-aecf-d37df825390b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_560d98a9-69ca-4fc6-882e-4fff9a30373d" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityNumberOfSeparateIncreases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityNumberOfSeparateIncreases_560d98a9-69ca-4fc6-882e-4fff9a30373d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_7b68c214-44f8-41ee-999c-0db969c813c4" xlink:href="natr-20230331.xsd#natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence_7b68c214-44f8-41ee-999c-0db969c813c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_58da9825-efa8-4914-8653-2cf16be57de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_58da9825-efa8-4914-8653-2cf16be57de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_54c9ecb5-8f12-4546-8768-e58c075dbbd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_54c9ecb5-8f12-4546-8768-e58c075dbbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e895a560-edbb-4308-b763-0b2e9100883d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_e895a560-edbb-4308-b763-0b2e9100883d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_30f7391f-7b31-4ff9-886c-fa52db7175db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LineOfCredit_30f7391f-7b31-4ff9-886c-fa52db7175db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DebtInstrumentNumberOfMonthlyPayments_0bb23463-b5d1-476b-8900-e39fa10826fb" xlink:href="natr-20230331.xsd#natr_DebtInstrumentNumberOfMonthlyPayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_natr_DebtInstrumentNumberOfMonthlyPayments_0bb23463-b5d1-476b-8900-e39fa10826fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_febd9f97-fe68-443e-b876-548706082ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_febd9f97-fe68-443e-b876-548706082ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_e3858bf6-f72b-47a9-8ad5-708b10293189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_21161c23-e195-446f-a3f6-91c05a80cac2" xlink:to="loc_us-gaap_LinesOfCreditCurrent_e3858bf6-f72b-47a9-8ad5-708b10293189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/NetIncomelossPerShareDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#NetIncomelossPerShareDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/NetIncomelossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9d1733d5-4165-4732-906a-b8a3fce9444a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_9d1733d5-4165-4732-906a-b8a3fce9444a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_541e08d1-bb24-46bf-b085-dbefff5e6c12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_541e08d1-bb24-46bf-b085-dbefff5e6c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b90228a2-a433-4cac-beea-bdd3900ce8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_us-gaap_EarningsPerShareBasic_b90228a2-a433-4cac-beea-bdd3900ce8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa1c54eb-04b7-447f-83e8-93ea41715b3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa1c54eb-04b7-447f-83e8-93ea41715b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_db1f8650-7836-41dc-b771-30dd0e07cdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa1c54eb-04b7-447f-83e8-93ea41715b3f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_db1f8650-7836-41dc-b771-30dd0e07cdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4bac9b16-fb5a-42a6-a3e0-f7cc56c58ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa1c54eb-04b7-447f-83e8-93ea41715b3f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4bac9b16-fb5a-42a6-a3e0-f7cc56c58ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c9a533b5-ec60-4252-820f-dc0b6c1d25be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_aa1c54eb-04b7-447f-83e8-93ea41715b3f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c9a533b5-ec60-4252-820f-dc0b6c1d25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2eea59e1-5feb-4926-a7ea-59e2f92c6077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2eea59e1-5feb-4926-a7ea-59e2f92c6077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_0ca26514-4564-4855-95a2-1f10155bd3a8" xlink:href="natr-20230331.xsd#natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_0ca26514-4564-4855-95a2-1f10155bd3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_a2b8d459-e9ab-4e88-b31f-3804d7a02e83" xlink:href="natr-20230331.xsd#natr_DilutiveSecuritiesExcludedfromComputationofEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract_0ca26514-4564-4855-95a2-1f10155bd3a8" xlink:to="loc_natr_DilutiveSecuritiesExcludedfromComputationofEarnings_a2b8d459-e9ab-4e88-b31f-3804d7a02e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_209aaaea-7d29-4e48-9aab-e2c7631cdad3" xlink:href="natr-20230331.xsd#natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5f7c9643-59ee-486f-a52a-ae18a6740c63" xlink:to="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_209aaaea-7d29-4e48-9aab-e2c7631cdad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0166354c-692d-4045-bb01-e79f25cacf4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_209aaaea-7d29-4e48-9aab-e2c7631cdad3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0166354c-692d-4045-bb01-e79f25cacf4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cbf01b7b-eaad-4ee3-b7d0-bb3fa5051a24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract_209aaaea-7d29-4e48-9aab-e2c7631cdad3" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_cbf01b7b-eaad-4ee3-b7d0-bb3fa5051a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_879d3712-c0c9-4520-a1bd-cc7ef2467d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_879d3712-c0c9-4520-a1bd-cc7ef2467d5a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d082c0a5-f729-4fbe-a4ea-da9f9bbf42ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:to="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_TimeBasedStockOptionsMember_7950275c-ffdc-4cb7-8c7b-0ab04a5875e6" xlink:href="natr-20230331.xsd#natr_TimeBasedStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:to="loc_natr_TimeBasedStockOptionsMember_7950275c-ffdc-4cb7-8c7b-0ab04a5875e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_e0b393e0-068e-4dd3-925d-20ede88a6e67" xlink:href="natr-20230331.xsd#natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOptionMember_31aa24a7-1c4e-40ec-924e-59aec071ae1a" xlink:to="loc_natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember_e0b393e0-068e-4dd3-925d-20ede88a6e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2425b847-5e30-4db1-bc57-2b7897671faa" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_23af279f-97c3-4dfc-bd7e-7e7e440020c8" xlink:href="natr-20230331.xsd#natr_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_36c3ca36-d35d-4da6-b613-b2fbd1935fbb" xlink:to="loc_natr_PerformanceBasedRestrictedStockUnitsRSUsMember_23af279f-97c3-4dfc-bd7e-7e7e440020c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_9e23747d-e191-4620-9dc9-412e641dcfd6" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_c289813d-9baa-45ab-b687-72b6177ab369" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_9c8c91a0-24e1-4b48-bcd2-84887a10658b" xlink:to="loc_srt_DirectorMember_c289813d-9baa-45ab-b687-72b6177ab369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e0b8b439-4c4e-4b1f-939a-dfa7414034b6" xlink:to="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b8de9416-25a3-4de8-84be-768554d65e78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:to="loc_srt_MinimumMember_b8de9416-25a3-4de8-84be-768554d65e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_41dedf40-acd5-410e-bb59-fbfef02b0f23" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8826fd47-0acc-4c3a-a742-d678ea6cd16c" xlink:to="loc_srt_MaximumMember_41dedf40-acd5-410e-bb59-fbfef02b0f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1b674aa7-33b2-4547-bb05-6becf980130b" xlink:to="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_8b6b95d3-3182-4388-b081-a200377800b0" xlink:href="natr-20230331.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f0a9b286-db69-4008-893a-170dc9780cf8" xlink:to="loc_natr_A2012IncentivePlanMember_8b6b95d3-3182-4388-b081-a200377800b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cb8be7ce-5e2d-42ec-88af-502b3377e8ed" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b6efc806-b99b-42b1-a588-0794e5128581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b6efc806-b99b-42b1-a588-0794e5128581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_06c507b2-0d6a-43dc-8d93-b30b03db8d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_06c507b2-0d6a-43dc-8d93-b30b03db8d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4ba4b171-1cfe-4704-8e36-f3d06f23f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4ba4b171-1cfe-4704-8e36-f3d06f23f046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_59e928fe-5be7-4664-a000-ccaf6a75675e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_59e928fe-5be7-4664-a000-ccaf6a75675e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ec00f4c9-61bd-48cb-8047-86646c9388de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_ec00f4c9-61bd-48cb-8047-86646c9388de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0f60b5a1-cf81-44c6-946c-e36a9deefa3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_0f60b5a1-cf81-44c6-946c-e36a9deefa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bff95d62-279e-4d92-99b4-45013c8bf500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bff95d62-279e-4d92-99b4-45013c8bf500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_5b6bdecd-3b71-44c2-8ffc-1c9ada9702c1" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne_5b6bdecd-3b71-44c2-8ffc-1c9ada9702c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_1fa43acc-3a97-4abc-9eb6-01f9d1b5a3c9" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo_1fa43acc-3a97-4abc-9eb6-01f9d1b5a3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_5c3ede1f-3b8e-45d0-a914-1c0a9ef7d581" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree_5c3ede1f-3b8e-45d0-a914-1c0a9ef7d581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_77c47958-7447-455f-bd1b-12da9104f2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_77c47958-7447-455f-bd1b-12da9104f2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_625d6018-47b3-4f90-a0f5-7d516cd76e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_625d6018-47b3-4f90-a0f5-7d516cd76e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20a77884-e105-42e6-aecb-c2d31dd6a904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20a77884-e105-42e6-aecb-c2d31dd6a904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21e58737-9668-4358-af67-a6feec7ec4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_21e58737-9668-4358-af67-a6feec7ec4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c7e8b27e-d81d-481e-91f1-56e2289f6021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c7e8b27e-d81d-481e-91f1-56e2289f6021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe8d2ad-b82d-4569-a963-e15e4ec162ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_cfe8d2ad-b82d-4569-a963-e15e4ec162ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b6d7ab11-c095-4129-a940-9584d9d6b71c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b6d7ab11-c095-4129-a940-9584d9d6b71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2ba8da42-ec8b-4bc9-bcfe-0733c689d901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_2ba8da42-ec8b-4bc9-bcfe-0733c689d901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_823a1cd8-5da3-4711-8365-aab6c8a6502d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_823a1cd8-5da3-4711-8365-aab6c8a6502d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RestrictionPeriodForIssuanceOfShares_4fd44da8-731d-452a-8c76-eadf88f811be" xlink:href="natr-20230331.xsd#natr_RestrictionPeriodForIssuanceOfShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_RestrictionPeriodForIssuanceOfShares_4fd44da8-731d-452a-8c76-eadf88f811be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_c7be40db-8aee-4327-9d6d-63de0aed6b89" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber_c7be40db-8aee-4327-9d6d-63de0aed6b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a27f1c4a-4996-47d4-a991-bee8d26da9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a27f1c4a-4996-47d4-a991-bee8d26da9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc35ab6c-6779-49d6-8dcb-4a1165648507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fc35ab6c-6779-49d6-8dcb-4a1165648507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6f77f5-c1c6-49d0-a21c-d7ca85058b00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ca6f77f5-c1c6-49d0-a21c-d7ca85058b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_f7013ca2-213e-4520-9fd9-37761c5a1525" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements_f7013ca2-213e-4520-9fd9-37761c5a1525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_383fad46-5928-4079-b8e4-6ff3692f56bd" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_48d4a5d5-347a-4f8b-a137-e1c78d3a3a73" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_383fad46-5928-4079-b8e4-6ff3692f56bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e8c4987c-9ab2-43fa-ae0d-f7b808110f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e8c4987c-9ab2-43fa-ae0d-f7b808110f5a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:to="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7cb26655-cc41-482d-a20f-c99afb112ac3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d8309780-b9f8-4f9f-8ecd-ce5a090ca5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f040f941-71a9-47f9-9260-58b873f0b2d9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d8309780-b9f8-4f9f-8ecd-ce5a090ca5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d61dac1-86fd-4adf-951f-144b37ee0b4f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df47c786-7747-4de7-8e7f-14375a4edd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_df47c786-7747-4de7-8e7f-14375a4edd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4f319b61-e5a7-4ab2-b42f-e76a4257994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4f319b61-e5a7-4ab2-b42f-e76a4257994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_782615c2-7e0c-4bf7-a1c6-deef6dfbbd07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_782615c2-7e0c-4bf7-a1c6-deef6dfbbd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7c5e67f7-bed9-4954-a15b-d455aa7a03a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7c5e67f7-bed9-4954-a15b-d455aa7a03a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7d849c0f-19a3-403a-8fcf-2790162915b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f022512-0546-49b1-b981-786b809806f8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7d849c0f-19a3-403a-8fcf-2790162915b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10368038-4750-4ce7-baa1-c773ebe2bc61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_10368038-4750-4ce7-baa1-c773ebe2bc61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aee12bf8-12e1-4389-aa22-cdb2c49b922f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_aee12bf8-12e1-4389-aa22-cdb2c49b922f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_028e36c9-fab7-4473-a952-220337ca8c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_028e36c9-fab7-4473-a952-220337ca8c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_822f0cbb-04d7-4532-836d-b5dbdd69bea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_822f0cbb-04d7-4532-836d-b5dbdd69bea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0af1f4d-d55b-47c1-824c-a55be19f48a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_23f66d91-b93e-44a0-ada1-617660e12777" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c0af1f4d-d55b-47c1-824c-a55be19f48a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_75091cce-4e71-45e1-925f-e5154f7fbe8f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_4d5947fb-3108-4753-8ef7-c600e8596683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_4d5947fb-3108-4753-8ef7-c600e8596683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1b401da1-f35c-4e92-a292-cbe3b5756739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1b401da1-f35c-4e92-a292-cbe3b5756739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_78c9819e-d88a-47b9-a767-5b2677f9cb46" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue_78c9819e-d88a-47b9-a767-5b2677f9cb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_c0449d86-3108-489b-8aed-b1700be9ed88" xlink:href="natr-20230331.xsd#natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue_c0449d86-3108-489b-8aed-b1700be9ed88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_712d18e3-8c9e-489f-bd4a-5f98055b38b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_84dd05a6-b8c6-4d63-b3af-bd54b8b83858" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_712d18e3-8c9e-489f-bd4a-5f98055b38b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CapitalTransactionsRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f1059872-3025-40ca-94e2-cb4fc40b0b61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f1059872-3025-40ca-94e2-cb4fc40b0b61" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:to="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8883e430-aefd-42f7-8061-9d5784f061c3" xlink:to="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_A2012IncentivePlanMember_0edbec7b-9f43-4245-bcee-5472eb4e00a4" xlink:href="natr-20230331.xsd#natr_A2012IncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9a0cae7c-e572-4e1d-84fb-a0255f2a2303" xlink:to="loc_natr_A2012IncentivePlanMember_0edbec7b-9f43-4245-bcee-5472eb4e00a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:to="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_304f7627-dbcd-4008-866e-069b9e27324b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a93aede7-6cc5-4ef1-9165-11dde4e05e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2e898ab7-341a-4bb8-b290-930ea3351358" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a93aede7-6cc5-4ef1-9165-11dde4e05e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_369717db-0353-4b20-a425-e2c8f4572357" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfb406e3-00b6-4b98-b85e-636ecfd8278d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfb406e3-00b6-4b98-b85e-636ecfd8278d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1490b996-203f-4903-a1ef-22219a097385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1490b996-203f-4903-a1ef-22219a097385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3dec84bf-7b21-4583-a9c5-a11e15320469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3dec84bf-7b21-4583-a9c5-a11e15320469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f4f8715b-2744-477d-bd34-7c37836646e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f4f8715b-2744-477d-bd34-7c37836646e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db796c76-1ec8-409d-a72b-388360d19c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_395fbd07-b2fb-4b8f-ae16-66b972e357d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db796c76-1ec8-409d-a72b-388360d19c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_092d5d8e-38bd-4b16-9b64-af3d50997d80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b579475c-55d9-4dac-8f84-c75cba373c21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b579475c-55d9-4dac-8f84-c75cba373c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3eba4566-d36b-4390-a5aa-d512c691e600" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3eba4566-d36b-4390-a5aa-d512c691e600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_724b7aa6-8b60-4545-96df-0b0b6ded84ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_724b7aa6-8b60-4545-96df-0b0b6ded84ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a7d6f6d9-e6fe-4402-9e09-4dd294b1fc30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a7d6f6d9-e6fe-4402-9e09-4dd294b1fc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d9e8e626-b666-4c63-a6c1-5732b5cb6c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5902922d-70d1-4b7f-b323-fb9a7f80cb47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d9e8e626-b666-4c63-a6c1-5732b5cb6c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_450bd2bd-a70f-48c2-8385-8a36a640e11b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_450bd2bd-a70f-48c2-8385-8a36a640e11b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ce623a81-8ed6-438e-928d-8851e2b8ed08" xlink:to="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_AsiaSegmentMember_7f848156-c18f-46ba-a554-7f618c06362b" xlink:href="natr-20230331.xsd#natr_AsiaSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_AsiaSegmentMember_7f848156-c18f-46ba-a554-7f618c06362b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_EuropeSegmentMember_052a8eb6-2923-4cfe-b1dd-670ed8bb41f0" xlink:href="natr-20230331.xsd#natr_EuropeSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_EuropeSegmentMember_052a8eb6-2923-4cfe-b1dd-670ed8bb41f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NorthAmericaSegmentMember_9573c71c-81b3-421b-9a91-2fc2f57e2eef" xlink:href="natr-20230331.xsd#natr_NorthAmericaSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_NorthAmericaSegmentMember_9573c71c-81b3-421b-9a91-2fc2f57e2eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_LatinAmericaAndOtherSegmentMember_3f09f198-3182-4e4a-a6f7-850719841130" xlink:href="natr-20230331.xsd#natr_LatinAmericaAndOtherSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_40b312e0-da5d-49da-a37f-14783f049b5f" xlink:to="loc_natr_LatinAmericaAndOtherSegmentMember_3f09f198-3182-4e4a-a6f7-850719841130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_679359fd-0136-4a7d-b619-5deda1faa275" xlink:to="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_ca6b2707-60a8-487d-9485-a06030fd6da9" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_CN_ca6b2707-60a8-487d-9485-a06030fd6da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a23cd47b-7587-4f45-9232-0b68b9f7f648" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_US_a23cd47b-7587-4f45-9232-0b68b9f7f648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_TW_788f47eb-fb2c-436e-9665-a2e3a2463e02" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_TW"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_TW_788f47eb-fb2c-436e-9665-a2e3a2463e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_KR_7b0d1b75-9a47-4085-8169-c597ac5f9db5" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_KR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_country_KR_7b0d1b75-9a47-4085-8169-c597ac5f9db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_OtherCountriesMember_379cb391-c13a-434f-b69e-8c4dfbacabd0" xlink:href="natr-20230331.xsd#natr_OtherCountriesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3ef5fd7a-2dd2-4d9a-b7ad-746d7153a441" xlink:to="loc_natr_OtherCountriesMember_379cb391-c13a-434f-b69e-8c4dfbacabd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c9378859-3072-4b38-9e57-6c59cf8fb62a" xlink:to="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_GeneralHealthProductsMember_4eb06441-87b2-4eb8-a94c-634ba2af2073" xlink:href="natr-20230331.xsd#natr_GeneralHealthProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_GeneralHealthProductsMember_4eb06441-87b2-4eb8-a94c-634ba2af2073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ImmunityProductsMember_0e1d3e92-735f-4f1b-8a12-598627e2a088" xlink:href="natr-20230331.xsd#natr_ImmunityProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_ImmunityProductsMember_0e1d3e92-735f-4f1b-8a12-598627e2a088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_CardiovascularProductsMember_734d1b99-0af7-4ab4-b5ec-fe04d555f66c" xlink:href="natr-20230331.xsd#natr_CardiovascularProductsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_CardiovascularProductsMember_734d1b99-0af7-4ab4-b5ec-fe04d555f66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_DigestiveProductsMember_61d84ed6-5a77-4cc5-9373-28d09aab09d6" xlink:href="natr-20230331.xsd#natr_DigestiveProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_DigestiveProductsMember_61d84ed6-5a77-4cc5-9373-28d09aab09d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_PersonalCareProductsMember_77bbbbef-26be-4a48-98fe-ed2a5b6c285e" xlink:href="natr-20230331.xsd#natr_PersonalCareProductsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_PersonalCareProductsMember_77bbbbef-26be-4a48-98fe-ed2a5b6c285e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_WeightManagementProductsMember_0a2582b6-2ef4-4a6f-9e4f-032a4ba6fd9b" xlink:href="natr-20230331.xsd#natr_WeightManagementProductsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_c2331fcf-65cd-47bb-b6c6-18117d550460" xlink:to="loc_natr_WeightManagementProductsMember_0a2582b6-2ef4-4a6f-9e4f-032a4ba6fd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_42cfab4a-4da0-4f3e-babb-048ceda09ce7" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_861a9b32-71a0-4cb3-a115-5cd9fb340c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_NumberOfReportableSegments_861a9b32-71a0-4cb3-a115-5cd9fb340c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b7280b2a-f9b7-4109-983d-c339bd2acb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_e71e0a94-7242-4c51-bbd9-c1aa92dda077" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b7280b2a-f9b7-4109-983d-c339bd2acb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:href="natr-20230331.xsd#natr_ContributionMarginAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ContributionMargin_196fd201-91de-4b34-87ee-a12f02fc4b79" xlink:href="natr-20230331.xsd#natr_ContributionMargin"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_natr_ContributionMarginAbstract_1dc70ad1-29c6-4eba-a46b-39fe558ac29c" xlink:to="loc_natr_ContributionMargin_196fd201-91de-4b34-87ee-a12f02fc4b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1ff563c-1b2c-4a42-9214-b7efccbb3395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d1ff563c-1b2c-4a42-9214-b7efccbb3395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ef21df46-0c99-4a6a-9a8b-7d03689911af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_OperatingIncomeLoss_ef21df46-0c99-4a6a-9a8b-7d03689911af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8557bc6e-c199-4e1f-8393-b8f540f39a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8557bc6e-c199-4e1f-8393-b8f540f39a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3aaa3c-8c51-47b2-bf7f-9f1bc3d9764d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_be3aaa3c-8c51-47b2-bf7f-9f1bc3d9764d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_78bcd3c5-fe4b-4865-942e-496df8572476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_78bcd3c5-fe4b-4865-942e-496df8572476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2c980b25-a808-4193-b669-86e67783b680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_0d46b2e1-2fa2-44da-8249-d6089f8878dc" xlink:to="loc_us-gaap_Assets_2c980b25-a808-4193-b669-86e67783b680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_43bc78c2-0fbe-462e-adb4-400e7b1e8098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98d8392e-225b-4fa5-a199-d3181ec07f08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43bc78c2-0fbe-462e-adb4-400e7b1e8098" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98d8392e-225b-4fa5-a199-d3181ec07f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_230213e0-53b4-4e3f-a8ee-fb401da1362c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_43bc78c2-0fbe-462e-adb4-400e7b1e8098" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_230213e0-53b4-4e3f-a8ee-fb401da1362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2e0e23b6-f4d4-4dcd-9dce-fe1839a3c485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2e0e23b6-f4d4-4dcd-9dce-fe1839a3c485" xlink:to="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_a51b7b5c-1010-4023-867e-9e3d0c129908" xlink:to="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_11464d08-1060-4fde-9fcd-0721fc3644b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_9a5fd11a-4b33-4c68-b5aa-eec46b96032e" xlink:to="loc_us-gaap_PendingLitigationMember_11464d08-1060-4fde-9fcd-0721fc3644b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6f75e46c-a8e6-4d8b-ade2-6e222672f144" xlink:to="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_86d0829c-d7bd-4caa-9b06-66e5b7256b3d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:to="loc_srt_MinimumMember_86d0829c-d7bd-4caa-9b06-66e5b7256b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1ab4b0c0-1d6b-45e6-866f-aa5be6141df9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9c3efdab-10ea-434b-9abe-bcfe4bacd7df" xlink:to="loc_srt_MaximumMember_1ab4b0c0-1d6b-45e6-866f-aa5be6141df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_7708384f-f8b7-4aeb-bdb4-dd4972f840a1" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_79e3ca7b-5385-4b75-a4d3-623959c1ab55" xlink:href="natr-20230331.xsd#natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:to="loc_natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember_79e3ca7b-5385-4b75-a4d3-623959c1ab55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NonIncomeTaxMember_6e3fa6ac-99c1-446c-a417-acbf2907cbc6" xlink:href="natr-20230331.xsd#natr_NonIncomeTaxMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f75932d8-a8ce-4370-880c-a212b8fc3705" xlink:to="loc_natr_NonIncomeTaxMember_6e3fa6ac-99c1-446c-a417-acbf2907cbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d0e60627-93bd-483f-b3b5-d260916b2ed2" xlink:to="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_dcb67299-5daa-4fc4-a95f-72c5f07973aa" xlink:href="natr-20230331.xsd#natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover_dcb67299-5daa-4fc4-a95f-72c5f07973aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0cf97f31-94b7-447b-9f7f-e8f9abecbb11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_0cf97f31-94b7-447b-9f7f-e8f9abecbb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_524bf609-a69e-428c-864a-2524634d2d73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_524bf609-a69e-428c-864a-2524634d2d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_93b228e5-a197-4104-92f1-2edf118780c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f17029ea-4e51-4c61-aef8-6e3c51a121fa" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_93b228e5-a197-4104-92f1-2edf118780c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_66e0982b-3dac-4e8f-bd83-6f2244edc813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_66e0982b-3dac-4e8f-bd83-6f2244edc813" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_9933e5f0-2350-413f-862f-9ddb651d53bf" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7566525d-2a9c-43c5-a721-3f08761998b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_88b16d27-8e02-4d65-bbc7-d728b7a4799e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7566525d-2a9c-43c5-a721-3f08761998b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_efe72790-ed81-4221-aa7a-396c63108661" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3d590780-5f3e-4b98-9101-3bb5e589264f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3d590780-5f3e-4b98-9101-3bb5e589264f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c4c90ecb-868c-4a26-a08f-750f98dfa5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c4c90ecb-868c-4a26-a08f-750f98dfa5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_909274b3-2ee9-41de-994f-31764b06a048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f885bc59-3569-4e4b-8e46-ae340c23d5fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_909274b3-2ee9-41de-994f-31764b06a048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_a2d7f0f0-ef78-45e7-b7b1-f1809105f066" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_512dd997-2fff-449a-bffb-8bf221cb599c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_770982b0-82e5-4b70-a574-9bb507169296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_42c14891-cae4-4e1e-ba18-656687294eba" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_770982b0-82e5-4b70-a574-9bb507169296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8ede9dc7-87df-449a-a608-3fc528dc5b58" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_f6f4714b-3528-49e5-9636-c938ca2962cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:to="loc_us-gaap_TradingSecurities_f6f4714b-3528-49e5-9636-c938ca2962cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_d08fd28f-2b80-4a66-aeee-3f033cb6341c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_7aa01b0b-cb25-4ba2-b7f3-3ae73693e197" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_d08fd28f-2b80-4a66-aeee-3f033cb6341c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99ea2eaa-95ca-45ba-af9d-a71383e43b88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_RevenuefromContractwithCustomerRefundPeriod_d1c65fb7-2410-46cf-be6d-4e04b3174202" xlink:href="natr-20230331.xsd#natr_RevenuefromContractwithCustomerRefundPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99ea2eaa-95ca-45ba-af9d-a71383e43b88" xlink:to="loc_natr_RevenuefromContractwithCustomerRefundPeriod_d1c65fb7-2410-46cf-be6d-4e04b3174202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_NumberofPrincipalCategoriesofProducts_c3c64fec-7c6f-411f-bcad-f5e4f96e969a" xlink:href="natr-20230331.xsd#natr_NumberofPrincipalCategoriesofProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99ea2eaa-95ca-45ba-af9d-a71383e43b88" xlink:to="loc_natr_NumberofPrincipalCategoriesofProducts_c3c64fec-7c6f-411f-bcad-f5e4f96e969a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_fd6c9b3f-3330-4598-bbed-ad8e539b4346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_99ea2eaa-95ca-45ba-af9d-a71383e43b88" xlink:to="loc_us-gaap_NumberOfReportableSegments_fd6c9b3f-3330-4598-bbed-ad8e539b4346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://naturessunshine.com/role/SynergyJapanLossDetails" xlink:type="simple" xlink:href="natr-20230331.xsd#SynergyJapanLossDetails"/>
  <link:presentationLink xlink:role="http://naturessunshine.com/role/SynergyJapanLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dd2ee69a-9b1a-4e07-9f3e-1d0456cfe258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dd2ee69a-9b1a-4e07-9f3e-1d0456cfe258" xlink:to="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_5307de83-eb95-46ac-a2cd-87279d496e41" xlink:to="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_natr_FraudExpenseMember_e43a2dcf-7add-43ff-bcfa-726a615ebad3" xlink:href="natr-20230331.xsd#natr_FraudExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_b5bfe58f-16cb-45a4-84c1-042fe57766d0" xlink:to="loc_natr_FraudExpenseMember_e43a2dcf-7add-43ff-bcfa-726a615ebad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_79904f64-9ede-47c1-940b-5dee8d454edd" xlink:to="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_e776f21b-df6b-4bac-a913-10604d2b400e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_e776f21b-df6b-4bac-a913-10604d2b400e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_678cb4af-7e2b-447a-954f-98201ae7dc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_30e6c7d5-bcad-49ff-9e2c-b7ddd68b2389" xlink:to="loc_us-gaap_ProfessionalFees_678cb4af-7e2b-447a-954f-98201ae7dc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>natr-20230331_g1.jpg
<DESCRIPTION>LOGO
<TEXT>
begin 644 natr-20230331_g1.jpg
M_]C_X1((17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    A    <@$R  (    4
M    DX=I  0    !    J    -0 "OR    G$  *_(   "<0061O8F4@4&AO
M=&]S:&]P(#(Q+C @*$UA8VEN=&]S:"D ,C R,#HP,3HR-2 P.#HQ,CHP,P
M  .@ 0 #     0 !  "@ @ $     0  !+"@ P $     0   5@
M!@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H  ,    !
M  (   (!  0    !   !,@("  0    !   0S@        !(     0   $@
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M_OMG&+E&<JCI6* .T?TBYW7\KIF+TJZSJM9MPG;:[6!I?H]S6!VT?N.]^_\
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M+C  .$))300E       0                     #A"24T$.@      Y0
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M;G,    7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
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M;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D
M   08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N
M9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H
M=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0
M $@    !  $ 2     $  3A"24T$)@      #@             _@   .$))
M300-       $    6CA"24T$&0      !    !XX0DE- _,       D
M      $ .$))32<0       *  $          3A"24T#]0      2  O9F8
M 0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M     0 U     0 M    !@       3A"24T#^       <   ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@     ____________________
M_________P/H   X0DE-!         (  3A"24T$ @      !      X0DE-
M!#        (! 3A"24T$+0      !@ !     CA"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -)    !@
M           !6   !+     * %4 ;@!T &D = !L &4 9  M #0    !
M                      $             !+    %8
M      $                         $     $       !N=6QL     @
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M      !,969T;&]N9P          0G1O;6QO;F<   %8     %)G:'1L;VYG
M   $L     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I
M9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4
M>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG   !6     !29VAT;&]N9P  !+     #=7)L5$58
M5     $       !N=6QL5$585     $       !-<V=E5$585     $
M  9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (
M8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E
M2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI
M8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    1
M15-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M      IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M       +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M       X0DE-!!0       0    #.$))300,     !#J     0   *     N
M   !X   5D   !#. !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4 9(
M   !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,
M# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.
M#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,
M# S_P  1"  N * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$
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ME<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$
M/P#U1SFM:7.(:UHDDZ  +DG]9ZW]9,BS&^K[AA]-I=LNZF\2YWBW':?Y/O\
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ML]OZ1$ZEU?"Z8[%;E.(.9<W'JB-'._/?N+?T3?SW_P M8'^+8$="N!Y&4_\
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M62]@SO1<_>&^W<UY9_-S^Z%>Z#]8<;K73W7U17DTB,B@F2Q\:?UJK(_1/_\
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M &\ <    !0 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #
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M1E0     245#('-21T(               $  /;6  $     TRU(4" @
M                                                           1
M8W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0
M   4<EA96@   A@    49UA96@   BP    48EA96@   D     49&UN9
M E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M
M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,
M9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I
M(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-2
M1T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M     %A96B        #S40 !     1;,6%E:(                     !8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N
M8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                9&5S8P
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO
M=7(@<W!A8V4@+2!S4D="                             &1E<V,
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@
M245#-C$Y-C8M,BXQ                                  !V:65W
M   3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4
M %<?YVUE87,          0                        */     G-I9R
M    0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M #( -P [
M $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D
MK@"R +< O #! ,8 RP#0 -4 VP#@ .4 ZP#P /8 ^P$! 0<!#0$3 1D!'P$E
M 2L!,@$X 3X!10%, 5(!60%@ 6<!;@%U 7P!@P&+ 9(!F@&A :D!L0&Y <$!
MR0'1 =D!X0'I ?(!^@(# @P"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A *.
M I@"H@*L K8"P0++ M4"X +K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R WX#
MB@.6 Z(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@2H
M!+8$Q 33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&
M!@86!B<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'= >&
M!YD'K >_!]('Y0?X" L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$ DE"3H)
M3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W KS"PL+(@LY
M"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U #5H-
M= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/
M#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02
MA!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56
M%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA &&48
MBABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:
M' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'ND?$Q\^'VD?
ME!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F
M(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHG
MJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@JFRK/*P(K-BMI*YTKT2P%
M+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0P
MVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"
M-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[
M+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B0"- 9$"F
M0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519I%WD8B1F=&
MJT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ
M30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C%2?%+'4Q-3
M7U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'
M6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8 5@5V"J8/QA
M3V&B8?5B26*<8O!C0V.78^MD0&249.EE/6629>=F/6:29NAG/6>39^EH/VB6
M:.QI0VF::?%J2&J?:O=K3VNG:_]L5VRO;0AM8&VY;A)N:V[$;QYO>&_1<"MP
MAG#@<3IQE7'P<DMRIG,!<UUSN'04='!TS'4H=85UX78^=IMV^'=6=[-X$7AN
M>,QY*GF)>>=Z1GJE>P1[8WO"?"%\@7SA?4%]H7X!?F)^PG\C?X1_Y8!'@*B!
M"H%K@<V",(*2@O2#5X.ZA!V$@(3CA4>%JX8.AG*&UX<[AY^(!(AIB,Z),XF9
MB?Z*9(K*BS"+EHO\C&.,RHTQC9B-_XYFCLZ/-H^>D :0;I#6D3^1J)(1DGJ2
MXY--D[:4()2*E/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<
MG(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF
M&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[
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M],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X
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M/ZG?]#<?\XY_^72T[_D1>?\ 5#'\KE[E_P!%W97^KQ^1_4[_ *&X_P"<<_\
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M+/\ H;C_ )QS_P#+I:=_R(O/^J&'\KE[D?Z+NRO]7C\C^IW_ $-Q_P XY_\
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M0OT0#:[%78J[%78J[%6.><69/*/FET8HZ:1?,CJ:$$6[D$$9*',.-K#6"?\
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MM>6\C12QL.C(Z$,I]P<2+90G*!$HD@CJ'VQ^37_.<_YF>09[32_/DTOYC>5
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M'_./ODQ(63R1'YHOH@.6H>8I&U O3^:W?C;?=$,PYZO)+K7N>WT7L;V9I?\
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M_P#^39R[3_WD?>Z3VE_XS-1_4/W/YT<WS\YNQ5^C_P#S[=_Y3[\Q?_ ?M_\
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M4=U?QMU8[%(B* ;O4_"NMU6K_AA\WU7V2]C14=5K(^<8'_=2'W1^?<_48
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M9FF?<W8J[%78J[%78JP+\T?/VF_EA^7_ )J\]ZKQ:W\NV+SPV['CZ]RU([:
M'QEE94^G)XX&<A$=7 [4U\-!I9YY\H"_>>@^)H/YM==UK4O,FM:OYAUFY:\U
M;7+R>_U*Z;K)/<.9)&^EF.=!$ "@_-F?///DEDF;E(DD^9W*586I]N?\X)?E
M5_CK\VQYOU&V]70/RVC346+"J/J4I9;%/FA5YJCH47QS#UN7AA74O;^PG97Y
MO7>-(>C%O_G'Z?EO+X)9_P YO_E3_P J[_.&[U_3[;T?+OYC+)K-D5%$2^Y
M7\0]_482^PD [8='EXX5U#5[<=D_DM><D1Z,OJ'];^(?/?\ SGQMF6\:B]/O
M[S2K^RU/3KA[/4-.GCNK&[C-'BFA8/&ZGL58 C$B]F>/)+'(2B:(-@^8?T@?
MDO\ F19_FS^6?E/SU:E$GU>S5=7M4Z07\!]*ZBIU $JGC7JI![YS^;'X<S%^
MD.Q>TH]HZ3'G'.0W\I#:0^?V/4<K=H[%78J[%78J[%78JP7\T/\ R6GYB?\
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M^)=_T.C_ ,XS_P#ES4_[A.K_ /9%C^4R]WW+_HT[(_U;_8S_ .)=_P!#H_\
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M[%7R7_SFS-YL3_G'_P QVOE33[C4#J5Y9VWF$VJ,\L.F<S)-)Q0$\2\:(_\
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MS$UW]W\7M?8#_C3']27Z'[CYIGW)V*NQ5V*NQ5V*NQ5^2_\ S\H_Y2+\J?\
MMFZI_P GK?-IV?RD^2_\$K^]P?U9?>'YEYL'S)V*OWJ_YPA_]9J\A?\ &?6/
M^ZI=9I=9_>GX?<^]^P__ !DXO?+_ '<GUEF*]8[%78J[%78J_%C_ )^*?^3P
M\O?^ 78_]1^H9M]!_=GW_J?%?^"+_P :,/\ A0_W4GP5F:\$[%7]%/\ SC-_
MY('\I?\ P'+3_B)S0ZC^\E[WZ*]F?^,S!_4#W/*7>NQ5V*L*_,G_ ,EUY^_\
M!S5?^H27)X_J'O<+M+_%<O\ 4E]Q?S,9T+\RNQ5V*NQ5V*NQ5V*NQ54@@FN9
MH;:VA>XN+AUC@@C4N[NYHJJHJ2230 8IC$R-#<E^L'_.)?\ SAO<Z%=Z9^:'
MYN:<(M5MBEUY4\E3J"UK(*-'=WRG82+U2(_8/Q/\8XKK-5J[],/F^L>R7L:<
M4HZK5CU#>,#T_I2\^X=.N^P^G&:Y].=BKL5=BKL5>(_\Y)_^2$_-O_P&;_\
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MLI_.8N_["[S_ $$]K_ZC_LX?\4[_ *$I_P"<FO\ RVG_ '.=&_[+L?SF+O\
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MNK]"?^A#/^<>?^K/K/\ W%)LP?SN1]"_T!=E_P V7^F+O^A#/^<>?^K/K/\
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MXAEPR$HGK^@]Q\BRO(N6[%78J[%78J[%78J[%78J[%78J[%78J[%78J_&?\
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MJVEO-0O)#1(H($,DDC'P55).$"S089<L<4#.1J,023W <W\WGYP_F-??FO\
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M?^2T_,3_ ,!C5_\ J"ER>/ZA[W![4_Q3-_4E_N2_F=SH7YF=BK[5_P"<!/\
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M??1?S^_F-^7?FG\K/-VJ>3/-]@;+5M,?X9%J8;F!B?3N+=R!SCD J#\P0&!
MWF/()BP_/_:79V;L_/+#F%2'R(Z$>1_&[!\FX+L5=BK[0_YP(_\ 6A--_P"V
M'J?_ ";7,36_W?Q>T]@?^-0?U9/W,S3/N;L5=BKL5?!'_.??YL?X0_+:S_+S
M2[GT];_,20K?A#\<6DVK*TU:;CUI.$8_F7U!F;H<7%+B/1X'V_[6_+:0:>)]
M67G_ %!S^9H>ZWXM9MWQ9V*NQ5V*NQ5V*NQ5V*NQ5V*OV6_Y]^_FO_B?\O\
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MT/Z.6(M*UZ;D$,94<"@@VH.^8NJU!Q50YO7^R?LYB[8EE&24HB'#RK?BOO\
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M_P",&C_]TNUS=Z/^Z'Q^]\$]N/\ C6R^Z/\ N(OD[,EY-%6/^]MG_P 9X_\
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M\EI^8G_@,:O_ -04N3Q_4/>X/:G^*9OZDO\ <E_,[G0OS,[%7VK_ ,X"?^M
MVO\ VP-3_5'F)KO[OXO:^P'_ !IC^I+]#]Q\TS[D[%78J[%78J[%78J[%7Q?
M_P YA_\ ..+?G)Y8B\T^5;56_,7RE XLH10'4[$$N]F3_.I):(G;D67]NJY>
MDU'AFCR+Q?MC[-_RGA\7$/WT!M_2C_-]_6/RZOPXG@GM9YK6ZADMKFVD:*XM
MY5*/&Z'BRLK4(((H0<W+X;*)B2"*(4L4.Q5V*NQ5V*NQ5V*O6?R8_)_S1^=?
MG6P\H^7(6B@)6;7M;="T&GV8-'FDI2I[(M:LU!MN15FRC'&R[;L7L?-VIJ!A
MQ\OXCTC'O/Z!U+^A;R+Y)T#\NO*6A>2_+%K]4T70+9;>U0T+N:EI)9" .3R.
M2[FF[$YHIS,R2>K]#:#18M%@C@Q"HQ%#]9\R=RRW(N6[%78J[%6%?F3_ .2Z
M\_?^ YJO_4)+D\?U#WN%VE_BN7^I+[B_F8SH7YE=BK[E_P"??'_D^;S_ ,!7
M4/\ D_:YAZ[^[^+W/_ ]_P"-(_\ "Y??%^V^:=]N=BKL5>-_GY^5=K^<?Y6^
M9?);J@U2:'ZYY:NGH!#J5L"UNW(_9#FL;G^1FRW!E\.8+INW^RAVGHYX/XN<
M?*0Y?J/D2_G/O+.ZT^[NK"^MWM+VQF>WO+652KQRQ,5=&4[@JP((S?@V_.<X
M&$C&0HC8H?%B]%_*;\QM6_*?\P?+7GO2"SRZ)=!KVS#<1=6<GP7-NW;]Y&2
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M$G8&-D?'B%_)+/\ HFE/_P"7FC_\)\_]Y+#_ "A_1^W]C5_R;0_\I/\ L/\
MC[V3\DO^<%O+'Y5^<M/\[Z_YPE\\:GH;^OH-D+!;"U@N *+/(IGN&D9.J;J
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MD9/PJ\B7T2N0.I"+7P&;$=H?T?M?,<G_  - 9'AU%#I<+/SXA]P0O_1-*?\
M\O-'_P"$^?\ O)8_RA_1^W]C#_DVA_Y2?]A_Q]]&?\XY?\XA:3^0GF/5?-MQ
MYPF\WZ[>V+:;9,+(6$%O!*Z22GT_7N"[L8U /( "NQK7*-1JCE%50>C]G/9"
M'9&668Y/$D10VX0!M?4V=GV/F(]D[%78J[%7EWYQ_E3H/YS^0M5\BZ_*]G%>
MM'<:=JL2*\MG=P&L4Z*U :5*L*BJLRU%:Y9BRG'+B#J^V>R<?:>FE@R;7N#U
MB1R/XZ6_/T_\^TIJFGYS)3M7R\?^\EF=_*']'[?V/GW_ ";0_P#*3_L/^/N_
MZ)I3_P#EYH__  GS_P!Y+'^4/Z/V_L7_ )-H?^4G_8?\?>X?D%_SA3IGY*^>
MK?S]?^>YO-NIZ;;W$.CVD>GC3X87N8VADDD)N;@R'TW8 ?"!6N^4Y]8<D>&J
M=YV![%0[+U(U$LO'( T.'A L43SE>S[CS#>Y=BKL5=BK&O.7E;3//'E3S%Y/
MUDRC2_,VG7&FWSPL%E6.XC*%XR00&6M14$5ZC)0D8D$='&UFEAJL$\,_IF"#
M\7YJS?\ /M)C+(8/SE"PECZ2R:!R8+V#$:B 2/&@S8?RA_1^W]CYH?\ @:;[
M:C;^I_Q]3_Z)I3_^7FC_ /"?/_>2Q_E#^C]O[$?\FT/_ "D_[#_C[O\ HFE/
M_P"7FC_\)\_]Y+'^4/Z/V_L7_DVA_P"4G_8?\?=_T32G_P#+S1_^$^?^\EC_
M "A_1^W]B_\ )M#_ ,I/^P_X^[_HFE/_ .7FC_\ "?/_ 'DL?Y0_H_;^Q?\
MDVA_Y2?]A_Q]W_1-*?\ \O-'_P"$^?\ O)8_RA_1^W]B_P#)M#_RD_[#_C[O
M^B:4_P#Y>:/_ ,)\_P#>2Q_E#^C]O[%_Y-H?^4G_ &'_ !]W_1-*?_R\T?\
MX3Y_[R6/\H?T?M_8O_)M#_RD_P"P_P"/KX_^?:3^HGK?G*#$&'J!/+]&*]P"
M=1(!^C'^4/Z/V_L2/^!IOOJ/]A_Q]^DOD7R?I?Y?^3O+?DK16EDTSRS80V%I
M-.0TL@B6ADD( ')VJQH *G8 9KYS,Y$GJ^DZ'1PT>"&"'TP  OFRO(N6[%78
MJ\._YR _)#3?S[\C0^3K_7)_+LUAJ46JZ9JT,*W CN(HI8:20L\?-"DS;!U-
M:&NU#=@S'%*^;H_:#L.':^F&&4C B0D#5[@$;C:Q1/4/AW_HFE/_ .7FC_\
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M.JV<6H:9J<$EKJ%A.H>*:&52CQNIV(9201A!(-AAEQ1RP,)BXD40>H+\"O\
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MECY"7,P]_?'[1YC9^Q%C?6>IV=KJ.G7<-_87T27%E>V[K)%-%(H9)(W4D,K
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M\XXZ4J?6/)]WKDJ=)M0U2]J3XE;>6%#_ ,#E)UF4]7=8?8;LK'SQF7OE+]!
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MV*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\
M_]?[P^9M L/-?ES7O+&JIZFF^8M/N=-OT'4PW431/2O>C;9*,N$@CHT:G3QU
M&*>*?TS!!]Q%/YG/-/EW4?*/F77_ "KJ\?I:GY<U"YTV_6E!ZMM(T3$5[$K4
M'N,Z&,A( CJ_,VJTT]-FGBG]4"0?@:2'"T/L?_G![\S5\@_G38:+?W'I:)^8
M<(T.ZY&B+>,W.QD([DR_NA_QD.8FLQ\<+ZA[+V'[3_)]H"$CZ<HX3_6_A^W;
M_.?NKFF?=78J[%78JT0"""*@[$'%7Q3^>7_.$WY>?F:EYKGDV.#\O_.LG*3U
M[6.FF7DAWI<VJ4"%CUDB .Y+*YS,PZR4-CN'B>W?8G2ZX&>&L63R^D^^/3WC
MX@OQY_,?\L/.WY3^89O+/GG1)=(U!:O:3'X[:[B!H)K:8?#(A]MP=F :HS:X
M\D<@N+X]VEV7J.S\OA9X\)Z=Q'>#U'X+ ,FZ]V*ON3_G$G_G*J\_*?4[7R)Y
MXO)+O\M-4GXV]U(2[Z+/*V\T?4F!F-9$'3[:[\@^'JM-X@XH\_O>Y]D?:N79
M\Q@SF\)/^D/?_5[Q\1UO[9V]Q!=P0W5K-'<VUS&LMO<1,'CDC<!E=&6H((-0
M1US3OML9"0!!L%5Q2[%7X]?\YW?\X_KY4UP?G#Y4LO3\O>9[D1>;[2%?AM-3
MDW6YH.B7._+PD[_O ,VNBS\0X#S')\>]O/9_\OD_.8AZ)GUCNEW^Z7^Z][\Z
M,SWSEV*OV_\ ^<'?SJ;\Q_RW/DS7+SU_-GY=I%:%Y&K)<Z6PXVDV^[&/B8F^
M2$FKYI]9AX)6.1?</8;MK\[I/!F?WF+;WP_A/P^D_#O?;N8;V[L5=BKL5=BK
MR7\W_P Z?(WY)^7&U_SCJ'&><,NBZ#;E7O;^51]B&,D;"HY.U%7N:D VXL,L
MAH.H[8[:TW9>+Q,QW/*(^J1\A]YY!^'OYY_\Y'>?_P ]-59M;NCI'E2UE+Z-
MY-LW;ZK#399)CL9Y:=78;;\%4&F;C#IXXAMS[WP_MWVDU/:T_6>'&.4!R'O_
M )Q\S\*?/^7O/NQ5P!)  J3L ,5?6_Y2_P#.&'YP_F>MMJ5]IZ^0O+$]&&L:
MXCI/+&?VK>R%)7VW!?@A'1\Q<NKA#S+UW9/L7K]?4I#PH'K+G\(\S\:'F_2'
M\M/^<(/R3\AK;W>M:9)^8>N14+WNNT:T#=_3L$I#Q/A+ZA]\P,FLR2Y;!]([
M,]A^S])1G'Q9=\N7^EY?.WUU96-EIEK!8Z=9P:?8VRA+:SMHUBBC4=%1$ 51
M[ 9BDV]=#'&$1&(  Z#8(K S=BKL5=BKL5?AI_SGQ*LG_.0>H(IWAT/3$?YE
M';]3#-SHO[OXOAGM\;[4/]6+XNS+>+>Z_P#.,:<_^<@/RF%:4\PVS?\  U/\
M,IU']W+W.]]F!?:>#^N']$^:%^BG8J[%78J[%78J[%78J[%78J\V\]?G#^6'
MY:+_ ,[SYWTKR_.5YKI\TWJ7C*?VDM(0\[#W"99#%.?TBW6Z[MC1Z'^_RQB>
MZ]_]*+/V/F?6O^?@?Y"Z9*\=A'YE\QJIHL]AIT<:-[CZY<6S4^:YD#0Y#W!Y
MG-_P0>S<9J/'/W1_XHQ8[#_S\:_)YI.,WE#SC%$3_>+;Z>Y^97Z\OZ\E^0GW
MAQA_P1M!>^/)\H_\4].\L?\ .;O_ #CQYDDC@F\UW/EFYE("0ZU8SPK4_P T
MT(FA7YLXRN6CR#I;M-+[;]EYS1R&!_I C[18^U].:%YC\O\ FFPCU7RUKFG^
M8=,EVCU#3;F*ZA)ZT$D3,M?:N8THF)HBGI\&IQ:B/'BD)1[P01]B<X&YV*NQ
M5V*N) %3L!U.*OGR^_YRL_YQYTZ\N;&Y_-/2?K%I(T4WHK<3Q\E-#QEBB=&%
M>ZL1EXTV0]'GI^U?9<)&)SQL>\_:!2%_Z&X_YQS_ /+I:=_R(O/^J&'\KE[F
M/^B[LK_5X_(_J>O^2O/OD[\Q=&_Q!Y(\PVGF32!,UO)>6C$^G,@!:.1&"LC
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M_P!4,O\ RN7N='_HN[*_U>/R/ZER?\Y:_P#..DCI&OYIZ8&<A06ANU6I\6:
M #W)Q_*Y?YJCVM[*/^7C\C^I]!VEW:W]I:W]C<Q7ME>Q)/9WD#B2*6*10R2(
MZDAE92""#0C,<BGH83C.(E$V#N".H1&+)V*NQ5V*NQ5Y;Y\_.O\ *K\LKVTT
MSSUYVT_R]J5]#]8MM/F,DDYAJ5$ACA21E4D$ L "0:=#ED,,Y[Q%NKU_;>BT
M,A'/E$2=ZZU[A;!/^AN/^<<__+I:=_R(O/\ JAEGY7+W.!_HN[*_U>/R/ZF:
M>1_ST_*3\R=4ET3R1YZT[7M7BA-PVFQ^I%,T2T#,B3)&7"UWXUIWR$\,X"R'
M-T/;NAUT^#!E$I5=;@_;3UG*G;.Q5V*NQ5X]YS_YR _)O\O=:D\N^<//^FZ-
MKD$:27&F-ZLTL2R ,GJB".3@64A@&H:$'H1EL,$YBP-G3ZWV@T&CR>'FRQC(
M=-R1[Z!IB?\ T-Q_SCG_ .72T[_D1>?]4,G^5R]SB?Z+NRO]7C\C^IZ'Y"_.
M'\LOS0DOX/(7G&P\R7.F*LE]:0%TFC1C0.8I51RM=N0%*[5RN>*4/J%.QT';
M&CUY(T^03(Y@<_D7I65NR=BKL5=BKX;\Q_\ .?OY.>7?-6I^6FT;S)J<.D7S
MV-WKEI;VQMF>)S'(\2R7*2,BD&A*@GL.F9D=#,B]GAM3[?Z##FEBX9GA-&0
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MS+^7GGQE)5E\NZH58;$$6DM"#D\?U#WN%VE_BN7^I+[B_F6SH7YE=BK]>?\
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MZ4#AU&RYH]3A\.7D>3] ^RW;@[5T@E+^\AM/W])?YWWV.CZ4S'>E=BK\WO\
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M,\Q_\_'OS$N[I&\J>0] T2Q5P6BU.2YU&9U!Z>I$]FHKW^#,J.@CU)>2U/\
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MGRG>1^0Z >08+DW 1FG:;J.KWMMIFDV%SJFI7CB.ST^TB>>>5ST6..,,S'V
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M;[,;6?W1^'WO5>Q/_&OA_P __<2?OKFD??78J[%78J_G:_YR?_\ 6@?S8_\
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MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MT,[A7<^+?\$+L_P=;'.!MECO_6CL?LX7P-F:\"GWE7S#>^4O,_EWS3IQI?\
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MZEYCECJW8J[%7V=_S@O^7,_G/\[-.\Q7%H\FA?E_;R:M=7)0F(WC PV<1:E
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MJ[%7\[7_ #D__P"M _FQ_P"!!<?J7-]IO[N/N?G;VH_XT\_]<O",N="^Y?\
MGWQ_Y/F\_P# 5U#_ )/VN8>N_N_B]S_P/?\ C2/_  N7WQ?MOFG?;G8J[%78
MJ_F'\Y?\I?YK_P"VQ??]1#YT4/I#\PZW^_R?UC]Y8WDG&=BKL5?I3_SAQ_SE
MG_AR33?RE_,W4_\ G7I66V\F^9[E_P#>!B:)9W+M_N@G:-S_ '9^$_NZ<-?J
M]+?JCSZOI7L;[6^ 8Z352]'*$C_#_1/]'N/3ERY?7/-6^NNQ5V*ODW_G-[_U
MFKS[_P 9]'_[JEKF5H_[T?'[GD_;C_C)R^^/^[B_!7-T^".Q5_0]_P XM?\
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MTP/"G4_YIVE^WWBWO&4.^=BKL5=BKL5=BKL5?%W_ #GO_P"L]ZC_ -MS3/\
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M*'?NQ5V*OS__ .?C/_DF?*7_ (&EI_W3M0S.T'UGW?J?/_\ @C?XAC_X:/\
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M_P 4/MY][TW_ )S>_P#6:O/O_&?1_P#NJ6N5Z/\ O1\?N=I[<?\ &3E]\?\
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M5_1=_P XV?\ DA/RD_\  9L/^38S0ZC^\E[WZ,]FO^,S3_U!]SV[*7=O!/\
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M]1_[;FF?\G&S+T7]Y\'B_;[_ (RS_6B_#3-R^&.Q5_1=_P XV?\ DA/RD_\
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M*OZ'O^<6O_6>_P J/^V''_R<?-%J?[R7O?HCV6_XR\']5[]E#OW8J[%7Y_\
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M!$DAL)$GE*)(:(\[PQR) K=C*RBF_3+88)S%@;.GUW;^AT.48L^41D>FY^=
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MVVDL[)J?1,X_XQ^^;+0X?XS\'RS_ ((/;G+0XSW&?^]C_OC_ )K\P-(UC5=
MU*SUG0]2N='U;3Y!-8ZE9RO!/"XZ,DB$,I^1S8D BB^7X<T\,Q.!,9#D0:(?
MHW^3O_/PC6](CM=%_.+1G\QVB4C7S=I2QQ7RKTK<6IX12^[(4-/V6.8&70@[
MPV?1^Q_^"%DQ@0UD>,?SH_5\8\C\*]Q?HCY(_/S\G?S$ABD\J_F#I%W<3 $:
M5<3BSO0>X-K<^G+MTJ%(]\P)X)PYA]$T/;^@UHO%EB3W$U+_ $IHO3-2UO1M
M&LVU#6-7LM*L$7D]]>7$<$(4=S)(RJ!].5@$\G9Y<^/%'BG(1'>2 'YL?\Y7
M?\YD^6+CRSK'Y:?E-JBZY?Z["]CYB\WVU?JEO:2#C-!:2;>J\JDJ77X%4GB2
MQ^'8:;2&^*7R?-O:OVRPG#+3:27$9"I2'(#J(GJ3W\@.6_+Y.YLWR9V*OT\_
MY]Q>0+B75O/7YG74!6TM+5/+FCS,-I)IG2ZN^/O&L<0_V>:[7SV$?B^G_P#
MX[/)GEU1&P' />:,OE4?F_6#-8^L.Q5V*OSL_P"<_?R6G\T^5M._-G0+0SZO
MY*A-KYFBC6KRZ2[%UFVW/U:1B3_D.S'9<S]#FX3PGJ^=>W_8IU&$:O&+EC%2
M_J=_^:?L)/1^.V;5\==BKW;\E/\ G(G\Q?R,U"63RO>I?:!?2"35O*=_RDLI
MVH 9%"D-%)04YH16@Y!@*93FP1RC?F[[L3VBU79,OW1N!YQ/TG]1\Q\;?I3Y
M1_Y^'?E)JUM$/-N@Z[Y0U&@^L+'&FHV@/^1-$R2GZ81FOGH)CD07TK2?\$30
MY!^^C*!_TP^8W_V+*M5_YSX_YQ]T^W::SO\ 7-<E JMI9:8Z.33I6Z:!/^&R
M T60]SE9?;[LN N)E+R$?^*I\6_G1_SGEYX\^65YY=_+W3F_+[0;M6BNM4$W
MJZM/&=B%E4*MN&!W].K>$G;,S#HHQWEN7B^VO;W4:N)QZ<>% \S=S/Q_A^&_
MF^""22234G<DYFO NQ5](_\ .+7Y+W'YS_FEI>GW5JTGE#RX\>J><;@C]V;>
M-JQVI/3E<N.%*UX\V'V<Q]3F\.'F>3TGLMV*>T]9&)'[N'JG[OYO^<=O=9Z/
MZ"E4* J@*JBBJ-@ .PS1OT&WBKL5=BKY(_YSC_\ 6;?.O_,7I'_=1M\RM'_>
MAY'VY_XR<GOC_N@_!K-T^#.Q5_1=_P XV?\ DA/RD_\  9L/^38S0ZC^\E[W
MZ,]FO^,S3_U!]SV[*7=NQ5V*NQ5^>_\ SF+_ ,XJ+Y_M+S\T/R[TX#SS81<_
M,6AVZT.KP1K_ 'D:CK<QJ.G611Q^T%!SM)J>#TRY?<^>^V/LI^<B=5IQ^]'U
M ?QCO'](?:/.GXV,K(S(ZE64D,I%"".H(S;/C1%-8J]=_P"<?_\ R>?Y0?\
M@8Z+_P!1L659_P"[E[B[?V?_ .-'3_\ #(?[H/Z/\T#](.Q5V*L)_,?SYHGY
M8^2?,7GGS!)QTWR_:-.800'GE-$AMXZ_MRR,J+[G?;)XX&<A$=7![2U^/0:>
M>?)RB+]YZ#WD[/YP_//G+6_S"\W>8/.GF*?ZQK'F*\>[NV%>*<MDBC!K1(T
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MK_UGO\J/^V''_P G'S1:G^\E[WZ(]EO^,O!_5>_90[]V*NQ5^?\ _P _&?\
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ML:A)J?F'RU; FXNXA$4CFB0;R&"K'@-R&J 2M,S-%DC"6_5XCVZ[-U6LT<?
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MJ]^RAW[L5=BK\_\ _GXS_P"29\I?^!I:?]T[4,SM!]9]WZGS_P#X(W^(8_\
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MPQ^41?VV^5<R7E7TA_SB-Y<7S/\ \Y$?EI:2Q\X--OY=7F-*A3IMO+=Q$_\
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M0Y1'TCW_ ,[W<O>_1I555"J JJ**HV  [#,!]';Q5V*NQ5\B?\YPZ%J^O?\
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M\L<__(MOZ8VOAR[BF.D>6O,&O:G8:-HVC7FHZIJ<Z6]A8P0N\DDDAHJJ /'
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M(?RZ\]+>6$]OH5QKT5SHM[(I6.XF:W$=UZ9/V@@BC!(VKMVS5Z^N(=]/KG_
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9L5=BKL5=BKL5=BKL5=BKL5=BKL5=BK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642677360480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 21, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NATURE&#8217;S SUNSHINE PRODUCTS,&#160;INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0327982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2901 Bluegrass Boulevard<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite&#160;100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lehi<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84043<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">341-7900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NATR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,045,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000275053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642675313328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 65,720<span></span>
</td>
<td class="nump">$ 60,032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $122 and $120, respectively</a></td>
<td class="nump">10,474<span></span>
</td>
<td class="nump">14,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">67,524<span></span>
</td>
<td class="nump">67,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">10,702<span></span>
</td>
<td class="nump">7,420<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">154,420<span></span>
</td>
<td class="nump">149,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">46,080<span></span>
</td>
<td class="nump">46,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">16,152<span></span>
</td>
<td class="nump">16,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Investment securities - trading</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">6,965<span></span>
</td>
<td class="nump">6,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">10,249<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">234,584<span></span>
</td>
<td class="nump">229,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,775<span></span>
</td>
<td class="nump">6,349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_AccruedVolumeIncentiveandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="nump">22,611<span></span>
</td>
<td class="nump">21,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">28,730<span></span>
</td>
<td class="nump">25,591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="nump">2,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">4,654<span></span>
</td>
<td class="nump">4,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">4,671<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of note payable and revolving credit facility</a></td>
<td class="nump">1,007<span></span>
</td>
<td class="nump">1,174<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">71,576<span></span>
</td>
<td class="nump">65,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">215<span></span>
</td>
<td class="nump">209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of operating lease liabilities</a></td>
<td class="nump">13,382<span></span>
</td>
<td class="nump">13,745<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation payable</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax liabilities</a></td>
<td class="nump">936<span></span>
</td>
<td class="nump">1,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">1,040<span></span>
</td>
<td class="nump">1,054<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">87,867<span></span>
</td>
<td class="nump">82,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, no par value, 50,000 shares authorized, 19,045 and 19,093 shares issued&#160;and outstanding, respectively</a></td>
<td class="nump">121,653<span></span>
</td>
<td class="nump">121,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">35,495<span></span>
</td>
<td class="nump">34,635<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">4,535<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(14,966)<span></span>
</td>
<td class="num">(13,313)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">146,717<span></span>
</td>
<td class="nump">147,047<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 234,584<span></span>
</td>
<td class="nump">$ 229,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AccruedVolumeIncentiveandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the liability that is related to incentives that are payable, due to volume sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AccruedVolumeIncentiveandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUncertainTaxPositionsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for uncertainty in income taxes classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUncertainTaxPositionsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642675514832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNoParValue', window );">Common stock, no par value (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">19,045<span></span>
</td>
<td class="nump">19,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">19,045<span></span>
</td>
<td class="nump">19,093<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNoParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount per share of no-par value common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNoParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642675164688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net sales</a></td>
<td class="nump">$ 108,634<span></span>
</td>
<td class="nump">$ 110,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">31,692<span></span>
</td>
<td class="nump">34,460<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">76,942<span></span>
</td>
<td class="nump">76,034<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_VolumeIncentives', window );">Volume incentives</a></td>
<td class="nump">33,128<span></span>
</td>
<td class="nump">34,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">43,642<span></span>
</td>
<td class="nump">40,623<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (loss), net</a></td>
<td class="nump">1,514<span></span>
</td>
<td class="num">(314)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">1,686<span></span>
</td>
<td class="nump">995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">3,681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="num">(2,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">264<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="nump">$ 860<span></span>
</td>
<td class="num">$ (2,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Basic and diluted net income (loss) per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic common shares outstanding (in shares)</a></td>
<td class="nump">19,061<span></span>
</td>
<td class="nump">19,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average diluted common shares outstanding (in shares)</a></td>
<td class="nump">19,433<span></span>
</td>
<td class="nump">19,573<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_VolumeIncentives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_VolumeIncentives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672575360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,253<span></span>
</td>
<td class="num">$ (2,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation loss (net of tax)</a></td>
<td class="num">(1,653)<span></span>
</td>
<td class="num">(975)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive loss</a></td>
<td class="num">$ (400)<span></span>
</td>
<td class="num">$ (3,661)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642675466656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Noncontrolling Interest</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 161,404<span></span>
</td>
<td class="nump">$ 133,382<span></span>
</td>
<td class="nump">$ 35,025<span></span>
</td>
<td class="nump">$ 3,202<span></span>
</td>
<td class="num">$ (10,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">$ 801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">$ (795)<span></span>
</td>
<td class="num">$ (795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(451)<span></span>
</td>
<td class="num">(451)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (7,971)<span></span>
</td>
<td class="num">$ (7,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(2,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,950)<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(975)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(975)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 149,778<span></span>
</td>
<td class="nump">$ 125,417<span></span>
</td>
<td class="nump">32,075<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
<td class="num">(11,180)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">19,093<span></span>
</td>
<td class="nump">19,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 147,047<span></span>
</td>
<td class="nump">$ 121,583<span></span>
</td>
<td class="nump">34,635<span></span>
</td>
<td class="nump">4,142<span></span>
</td>
<td class="num">(13,313)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross', window );">Share-based compensation expense</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised', window );">Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax</a></td>
<td class="num">$ (165)<span></span>
</td>
<td class="num">$ (165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">$ (823)<span></span>
</td>
<td class="num">$ (823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">860<span></span>
</td>
<td class="nump">393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">$ (1,653)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,653)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">19,045<span></span>
</td>
<td class="nump">19,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 146,717<span></span>
</td>
<td class="nump">$ 121,653<span></span>
</td>
<td class="nump">$ 35,495<span></span>
</td>
<td class="nump">$ 4,535<span></span>
</td>
<td class="num">$ (14,966)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672040480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 1,253<span></span>
</td>
<td class="num">$ (2,686)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,805<span></span>
</td>
<td class="nump">2,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_OperatingLeaseNonCashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">932<span></span>
</td>
<td class="nump">1,173<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on sale of property, plant and equipment</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(631)<span></span>
</td>
<td class="nump">3,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities', window );">Purchase of trading investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities', window );">Proceeds from sale of trading investment securities</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Realized and unrealized (gains) losses on investments</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Foreign exchange losses</a></td>
<td class="num">(1,477)<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">3,649<span></span>
</td>
<td class="nump">1,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">457<span></span>
</td>
<td class="num">(3,489)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(3,266)<span></span>
</td>
<td class="num">(2,518)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,391<span></span>
</td>
<td class="num">(946)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees', window );">Accrued volume incentives and service fees</a></td>
<td class="nump">781<span></span>
</td>
<td class="num">(464)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">2,759<span></span>
</td>
<td class="num">(5,386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(1,142)<span></span>
</td>
<td class="num">(1,632)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="num">(900)<span></span>
</td>
<td class="num">(1,031)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">586<span></span>
</td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Deferred compensation payable</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">9,325<span></span>
</td>
<td class="num">(7,924)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(2,325)<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,325)<span></span>
</td>
<td class="num">(1,518)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Principal payments of long-term debt</a></td>
<td class="num">(318)<span></span>
</td>
<td class="num">(308)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">433<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Principal payments of revolving credit facility</a></td>
<td class="num">(283)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Principal payments of related party borrowing</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments related to tax withholding for net-share settled equity awards</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(795)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(823)<span></span>
</td>
<td class="num">(7,971)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,156)<span></span>
</td>
<td class="num">(9,374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rates on cash and cash equivalents</a></td>
<td class="num">(156)<span></span>
</td>
<td class="num">(827)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="num">(19,643)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the beginning of the period</a></td>
<td class="nump">60,032<span></span>
</td>
<td class="nump">86,184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at the end of the period</a></td>
<td class="nump">65,720<span></span>
</td>
<td class="nump">66,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">1,991<span></span>
</td>
<td class="nump">1,809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_OperatingLeaseNonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_OperatingLeaseNonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642680242400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2023, and for the three-month periods ended March&#160;31, 2023 and 2022. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.4 million and $0.3 million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, noncontrolling interests were $4.5 million and $4.1 million, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective during the three months ended March&#160;31, 2023, had, or is expected to have, a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI https://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681412512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681403552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investment Securities - Trading</a></td>
<td class="text">Investment Securities - Trading<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our trading securities portfolio totaled $0.7 million at March&#160;31, 2023, and $0.7 million at December&#160;31, 2022, and generated gains of $47,000 and losses of $58,000 for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681503024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Revolving Credit Facility and Other Obligations</a></td>
<td class="text">Revolving Credit Facility and Other Obligations<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#8220;Credit Agreement&#8221;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $25.0&#160;million or up to three separate increases of no less than $5.0&#160;million each, subject to the lender's due diligence. The amendment to the Credit Agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;1.50 percent&#160;(6.39 percent as of March&#160;31, 2023), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. As of March&#160;31, 2023 and December&#160;31, 2022 we had outstanding balances under the Credit Agreement $0.2 million and $0, respectively, included in current portion of note payable within our Condensed Consolidated Balance Sheets. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2023, we were in compliance with the debt covenants set forth in the Credit Agreement.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2023, there was $0.9&#160;million outstanding balance under the Capital Credit Agreement, of which $0.9&#160;million was classified as current.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681446864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (loss) Per Share</a></td>
<td class="text">Net Income (loss) Per Share<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per common share (&#8220;Basic EPS&#8221;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#8220;Diluted EPS&#8221;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681563632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Capital Transactions</a></td>
<td class="text">Capital Transactions<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2023, we repurchased 90,000 shares of our common stock for $0.8&#160;million. For the three months ended March 31, 2022, we repurchased 451,000 shares of our common stock for $8.0&#160;million. At March&#160;31, 2023, the remaining balance available for repurchases under the program was $23.2&#160;million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#8217;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no share-based compensation expense from stock options for the three- month periods ended March&#160;31, 2023 and 2022. As of March&#160;31, 2023 and December&#160;31, 2022, there was no unrecognized share-based compensation expense related to the grants described above.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2023, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 127,000 shares of common stock was $0. At December&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable options to purchase 143,000 shares of common stock was $0.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three-month period ended March&#160;31, 2023, no shares of common stock were issued upon the exercise of stock options. For the three months ended March&#160;31, 2022, we issued 29,000 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 per share. The aggregate intrinsic value of options exercised during the three-month periods ended March&#160;31, 2023 and 2022, was $0 and $0.3 million, respectively. For the three-month periods ended March&#160;31, 2023 and 2022, the Company recognized $0 and $0.1 million of tax benefits from the exercise of stock options, respectively.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, we did not have any unvested stock options outstanding.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock Units</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our outstanding restricted stock units (&#8220;RSUs&#8221;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At March&#160;31, 2023 and December&#160;31, 2022, there were 106,000 and 94,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three-month period ended March&#160;31, 2023, no RSUs were granted under the 2012 Incentive Plan. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to time-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was approximately $0.8 million and $0.5 million, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $2.2 million and $3.0 million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately 1.5 years.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to performance-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was $0.3 million and $0.3 million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $4.5 million of potential share-based compensation expense. We currently expect to recognize an additional $2.2 million of that potential share based compensation expense. </span></div>The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 15,000 and 60,000 shares for the three-month periods ended March&#160;31, 2023 and 2022, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642677359168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Service fees in China totaled $3.7 million and $4.9 million for the three-month periods ended March&#160;31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March&#160;31, 2023 and 2022, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681563632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022, our provision for income taxes, as a percentage of income before income taxes was 25.7 percent and 369.9 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2023, was primarily attributed to an increase in tax liability related to foreign operations which are treated as a branch for US tax purposes and current year foreign losses that presently do not provide future tax benefit, partially offset by favorable adjustments to deferred tax assets and foreign tax credits.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the effective tax rate for the three months ended March&#160;31, 2023 compared to March&#160;31, 2022 is primarily caused by recording a valuation allowance in the prior period against deferred tax assets for which we do not expect to receive a benefit.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. federal income tax returns for 2019 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2017 through 2022.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, we have accrued $0.2&#160;million and $0.2 million, respectively, related to unrecognized tax positions.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681558032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Income Tax Contingencies</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recorded for probable losses at management&#8217;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $0.3 million and $0.3 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $2.9 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Litigation</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $0.5 million and $0.6 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.4 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681444864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted market prices in active markets for identical assets or liabilities.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are not corroborated by market data.</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2023 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2022 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment securities - trading</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and for the year ended December&#160;31, 2022, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div>The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2023 and 2022, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681498544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amounts billed to customers for shipping and handling are reported as a component of net sales. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. </span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#8217;s Sunshine Products and Synergy WorldWide&#174; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Practical Expedients and Exemptions</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681558032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Synergy Japan Loss<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Synergy Japan Loss</a></td>
<td class="text">Synergy Japan LossOn February 17, 2023, we became aware that Synergy Worldwide Japan G.K., a Japan entity and wholly owned subsidiary of the Company (&#8220;Synergy Japan&#8221;), was the victim of a criminal scheme involving employee impersonation and fraudulent requests targeting Synergy Japan. The criminal scheme resulted in a series of fraudulently induced wire transfers between February 1, 2023, and February 17, 2023 totaling $4.8 million. We promptly launched an investigation, led by an independent third party, to determine the full extent of the fraud scheme and related potential exposure. We self-discovered this fraudulent activity and promptly initiated contact with our bank as well as appropriate law enforcement authorities in an effort to, among other things, recover the transferred funds. To date, we have not found any evidence of additional fraudulent activity and do not believe the incident resulted in any unauthorized access to confidential consumer information or other data maintained by the Company.  As a result of this matter, we incurred investigation and other professional fees of $1.0 million, which along with the initial $4.8 million loss, were recorded in Selling, General and Administrative expense for the three months ended March&#160;31, 2023. We do not expect this incident to otherwise have a material impact on our business.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642677415232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2023, and for the three-month periods ended March&#160;31, 2023 and 2022. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2023.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.</span></div>The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No new accounting pronouncement issued or effective during the three months ended March&#160;31, 2023, had, or is expected to have, a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642677233808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of composition of inventories</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of inventories is as follows (dollar amounts in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,713&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,524&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,949&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681503024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.116%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) attributable to common shareholders</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">860&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,950)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic weighted average shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted-average shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,573&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share attributable to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-dilutive shares excluded from diluted-per-share amounts:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681435632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of stock option activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Exercise<br/>Price&#160;Per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited or canceled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of restricted stock unit activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock unit activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted&#160;Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Units outstanding at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642671836512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of reportable business segment information</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reportable business segment information is as follows (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net sales</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution margin (1):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,951&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,939&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution margin</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expenses (2)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,642&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,309&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other loss, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(314)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,686&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________</span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.</span></div>(2)&#160;&#160;&#160;&#160;Service fees in China totaled $3.7 million and $4.9 million for the three-month periods ended March&#160;31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Schedule of consolidated net sales revenue by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March&#160;31, 2023 and 2022, as follows (dollar amounts in thousands):</span></div><div style="text-indent:29.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Korea</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,862&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of revenue generated by each of the Company's product lines</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,405&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,777&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,648&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,981&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immune</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cardiovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Digestive</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Personal care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weight management</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,634&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,494&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Schedule of consolidated property, plant and equipment by geographical locations</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,080&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock', window );">Schedule of assets per segment</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets per segment is set forth below (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">North America</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,584&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,778&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Segment Reporting Information, by Segment1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681376368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of the company's hierarchy for assets measured at fair value on a recurring basis</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2023 (dollar amounts in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2022 (dollar amounts in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in&#160;Active<br/>Markets&#160;for<br/>Identical&#160;Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities - trading</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">702&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672037632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestPeriodIncreaseDecrease', window );">Increase (decrease) in noncontrolling interest</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">$ 4,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642676714048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 22,183<span></span>
</td>
<td class="nump">$ 23,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in progress</a></td>
<td class="nump">1,614<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">43,727<span></span>
</td>
<td class="nump">43,103<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 67,524<span></span>
</td>
<td class="nump">$ 67,949<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672043232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment Securities - Trading (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRestricted', window );">Trading securities portfolio</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss', window );">Debt securities, trading, realized gains (losses)</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="num">$ (58)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesTradingRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=127002003&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesTradingRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642671780880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revolving Credit Facility and Other Obligations (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 23, 2022 </div>
<div>USD ($) </div>
<div>borrowing</div>
</th>
<th class="th">
<div>Nov. 19, 2020 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 21, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 11, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings', window );">Potential increase in maximum borrowing capacity</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases', window );">Number of separate increases | borrowing</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence', window );">Potential increase in maximum borrowing capacity, per occurrence</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Annual commitment fee</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | LIBOR | Bank of America Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Long-term line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DebtInstrumentNumberOfMonthlyPayments', window );">Number of monthly payments | payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit, outstanding, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Indicative Index | Banc of America Leasing and Capital Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Long-term debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DebtInstrumentNumberOfMonthlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Monthly Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DebtInstrumentNumberOfMonthlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_LineOfCreditFacilityNumberOfSeparateIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Number Of Separate Increases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_LineOfCreditFacilityNumberOfSeparateIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BankofAmericaCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=natr_IndicativeIndexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=natr_IndicativeIndexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642677168512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income (loss) attributable to common shareholders</a></td>
<td class="nump">$ 860<span></span>
</td>
<td class="num">$ (2,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">19,061<span></span>
</td>
<td class="nump">19,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.05<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Diluted shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,061<span></span>
</td>
<td class="nump">19,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock-based awards (in shares)</a></td>
<td class="nump">372<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average shares outstanding (in shares)</a></td>
<td class="nump">19,433<span></span>
</td>
<td class="nump">19,573<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)</a></td>
<td class="nump">$ 0.04<span></span>
</td>
<td class="num">$ (0.15)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract', window );"><strong>Dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings', window );">Stock options (in shares)</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract', window );"><strong>Anti-dilutive shares excluded from diluted-per-share amounts:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options (in shares)</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Potentially dilutive shares included in the calculation of diluted earnings per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_DilutiveSecuritiesExcludedfromComputationofEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_DilutiveSecuritiesExcludedfromComputationofEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642670998880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 05, 2021</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Mar. 10, 2021</div></th>
<th class="th"><div>Dec. 31, 2012</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,000<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 823,000<span></span>
</td>
<td class="nump">$ 7,971,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember', window );">2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized under the plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional number of shares authorized under the plan (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic values of options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Tax benefit from the exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember', window );">Time-based stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne', window );">Operating income margin, one (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo', window );">Operating income margin, two (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree', window );">Operating income margin, three (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested stock options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember', window );">Performance based stock options operating income margins | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period over which the remaining compensation cost is expected to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements', window );">Minimum withholding requirements (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Minimum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Maximum | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Director | 2012 Stock Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_RestrictionPeriodForIssuanceOfShares', window );">Restriction period for issuance of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber', window );">Nonvested subject to restriction period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share based compensation potential compensation expense to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember', window );">Performance-Based Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share based compensation potential compensation expense to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RestrictionPeriodForIssuanceOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the restriction period before shares will be issued related to a share-based compensation plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RestrictionPeriodForIssuanceOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the first operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the three operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the second operating margin percentage to be achieved for the vesting of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_TimeBasedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=natr_PerformanceBasedRestrictedStockUnitsRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672304048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - Stock Option Activity (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the beginning of the period (in shares)</a></td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited or canceled (in shares)</a></td>
<td class="num">(16,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(29,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding at the end of the period (in shares)</a></td>
<td class="nump">127,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted&#160;Average Exercise Price&#160;Per&#160;Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 12.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">11.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 9.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">12.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted&#160;Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">5.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue', window );">Forfeited or canceled (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Options outstanding at the beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 5.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642671903872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Transactions - RSU Activity (Details) - 2012 Stock Incentive Plan - RSUs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number&#160;of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">1,091,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(45,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="num">(57,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted Stock Units outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">989,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160;Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">2.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">12.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted Stock Units outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=natr_A2012IncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642670512096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">$ 108,634<span></span>
</td>
<td class="nump">$ 110,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">43,814<span></span>
</td>
<td class="nump">41,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">43,642<span></span>
</td>
<td class="nump">40,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">172<span></span>
</td>
<td class="nump">1,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss, net</a></td>
<td class="nump">1,514<span></span>
</td>
<td class="num">(314)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">1,686<span></span>
</td>
<td class="nump">995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">46,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,162<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">234,584<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CN', window );">CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="nump">4,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">31,986<span></span>
</td>
<td class="nump">33,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">42,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,389<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_TW', window );">Taiwan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,175<span></span>
</td>
<td class="nump">9,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_KR', window );">South Korea</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">11,240<span></span>
</td>
<td class="nump">13,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">51,233<span></span>
</td>
<td class="nump">53,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property, plant and equipment, net</a></td>
<td class="nump">3,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">46,345<span></span>
</td>
<td class="nump">46,110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">21,951<span></span>
</td>
<td class="nump">21,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">100,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,362<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">13,764<span></span>
</td>
<td class="nump">12,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">1,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">14,895<span></span>
</td>
<td class="nump">13,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">9,422<span></span>
</td>
<td class="nump">9,036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,341<span></span>
</td>
<td class="nump">2,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember', window );">Asia | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">6,461<span></span>
</td>
<td class="nump">6,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">21,405<span></span>
</td>
<td class="nump">21,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">6,536<span></span>
</td>
<td class="nump">4,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">18,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">9,174<span></span>
</td>
<td class="nump">9,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,284<span></span>
</td>
<td class="nump">2,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,519<span></span>
</td>
<td class="nump">2,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">5,738<span></span>
</td>
<td class="nump">5,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,177<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember', window );">Europe | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">34,648<span></span>
</td>
<td class="nump">35,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">12,861<span></span>
</td>
<td class="nump">12,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">107,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,319<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">15,534<span></span>
</td>
<td class="nump">15,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">4,320<span></span>
</td>
<td class="nump">4,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">3,588<span></span>
</td>
<td class="nump">3,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">8,731<span></span>
</td>
<td class="nump">8,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,464<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember', window );">North America | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">1,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">6,236<span></span>
</td>
<td class="nump">6,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMarginAbstract', window );"><strong>Contribution margin:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_ContributionMargin', window );">Total contribution margin</a></td>
<td class="nump">2,466<span></span>
</td>
<td class="nump">2,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | General health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">1,637<span></span>
</td>
<td class="nump">1,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Immune</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">744<span></span>
</td>
<td class="nump">761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Cardiovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">466<span></span>
</td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Digestive</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">2,885<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Personal care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember', window );">Latin America and Other | Weight management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Net sales:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net sales revenue</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMargin">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMargin</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_ContributionMarginAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_ContributionMarginAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_TW">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_TW</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_KR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_KR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=natr_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=natr_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_AsiaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_GeneralHealthProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_ImmunityProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_ImmunityProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_CardiovascularProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_CardiovascularProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_DigestiveProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_DigestiveProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_PersonalCareProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_PersonalCareProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=natr_WeightManagementProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=natr_WeightManagementProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_EuropeSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_NorthAmericaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=natr_LatinAmericaAndOtherSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642671924496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Provision (benefit) for income taxes, as a percentage of income before income taxes</a></td>
<td class="nump">25.70%<span></span>
</td>
<td class="nump">369.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Liability related to unrecognized tax benefits</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642671814208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember', window );">Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover', window );">Minimum number of claims that the Company's insurance coverage may not be sufficient to cover | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Provision for losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember', window );">Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Value-added tax assessments and other civil litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Non-Income Tax Contingencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liabilities</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_NonIncomeTaxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672291696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Recurring basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 - Quoted Prices in Active Markets for Identical Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">702<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 - Significant Other Observable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3 - Significant Unobservable Inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Investment securities - trading</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642681629232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>segment </div>
<div>product_category</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_RevenuefromContractwithCustomerRefundPeriod', window );">Refund period</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_natr_NumberofPrincipalCategoriesofProducts', window );">Number of principal categories of products | product_category</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of business segments | segment</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_NumberofPrincipalCategoriesofProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Principal Categories of Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_NumberofPrincipalCategoriesofProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_natr_RevenuefromContractwithCustomerRefundPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer, Refund Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">natr_RevenuefromContractwithCustomerRefundPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>natr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139642672445104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Synergy Japan Loss (Details) - Fraud Expense - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 17, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Commitments and contingencies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Provision for losses</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Investigation and other professional fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.2(a),(b),(c),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433917&amp;loc=SL114874205-224268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_FraudExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=natr_FraudExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>natr-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:natr="http://naturessunshine.com/20230331"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="natr-20230331.xsd" xlink:type="simple"/>
    <context id="i037da2db44724416a7e87967f0045ef9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i323367af1eab405e83322a0281dd711b_I20230421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2023-04-21</instant>
        </period>
    </context>
    <context id="i5013a2410f1f48fe86da71c75ac9b931_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0eb8c277981f4b25971776c77e8450b0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3756408ac1534f02be1f929758b190ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c5ec96e95bb479aa9317328c85875ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8e99e23cdc04ca3967d8e0cc86c9bc9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic159bd1e6c754fc598df19fee673181b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2f1b157582d54aa5b6c76556a72d0fa1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i078db4ca9b324f02b4b009b8e5063922_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia77345b7632f4c3687707a676a2ecdba_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i397792870c944251a9e358f23c5e3f82_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifecfce154349479aaa1ff1d6bfd331aa_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id071f960be3f4eddb4fddc539cef8fb2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i118dbcf5a4fc44b8985c21224e382a89_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0691a9d3b51c404f83e92ca13c32ff39_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a92d6d58b6c43fc949181a4738e553c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib53dcd0f7b104910a52899f37012afd3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f72f97c01a743d790b5acf8b55c9d24_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib40450c215064f9a9f895bc248da7a1e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ce5e44a4ef64052aea959ec0f39d8d8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i25cd1edc1c964494bbd0f0f6d41bfd3c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i66a7e3f9c206413f8e34219e584092b1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8deaf3592d424474a99cc4c83beafb75_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iff00616fa06b404996d8b5bb02df09ce_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id89baad6125140598d815d83ca0cfa3f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie3aafe404f0443248657956fd2be506f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7e403872b0564650b45c1c4ce25c58da_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i43b99692a035464f8b8f7f2449d7eccc_I20170711">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-07-11</instant>
        </period>
    </context>
    <context id="i5181311b4b2e46549f7db94eeae94161_I20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-23</instant>
        </period>
    </context>
    <context id="i576cde29c1fd40f8b8fece1e7aeedef2_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="i3ae9de4d3934431b85c33730e67cac1d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if3b6867cf47247f4968d279e124711d2_D20220623-20220623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-23</startDate>
            <endDate>2022-06-23</endDate>
        </period>
    </context>
    <context id="i4bf0ac744d7941f3852747082611c11b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ieee06864f03e4d04abae69411c2a8c28_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BankofAmericaCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5bad9899385e49ba89421036e841df7e_I20200421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-21</instant>
        </period>
    </context>
    <context id="ic3b0bb7e541c48fbad2bb35bbc0811d0_I20201119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-19</instant>
        </period>
    </context>
    <context id="id70a83bdb8dd4e80ac710803192a2c56_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">natr:IndicativeIndexMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-19</startDate>
            <endDate>2020-11-19</endDate>
        </period>
    </context>
    <context id="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">natr:BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iad7a3e92766a4588bcf410162f828313_I20210310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2021-03-10</instant>
        </period>
    </context>
    <context id="iec9e1feefec641229f8793d60e0ba7a2_I20220308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="ic119a54e942d4fb496dbaf51f43c3a16_I20121231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-12-31</instant>
        </period>
    </context>
    <context id="i17132172a34944c19d1a0af61112f1ff_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="ice5ff017c4644e0ba536b10add46fcac_D20210505-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="i60b15fb6f7a54f76a4f03d8f40724290_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:TimeBasedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i148e2e4f78504b7f860c8bb7235cd422_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icd667127b304410783b1f535dacef921_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9dd6e9c7d1174a5196db741bd9bd6e22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f71d03224964432937c9462c7320fd7_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ied1fdb1621154a2c992f780e1bfa1706_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7da32705f94942c49d3c710e71c1c4bc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iec6bb5c1e51f4f79902860d3143fa47f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib20931e909f04ba3884bbaf616843da2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i127289bd16c74b78bcba51e1e0e6b297_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i70143db360d648a09df5ae0c19ad6a0c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iceb089485d284690b3a27c0501d8a380_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">natr:A2012IncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia02c469dbbc24747a8b591560a3ee008_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ib801a3e8a35c48218f48568d2ed7dda1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia01162aa2d194e3182890cbff779a0bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib996c0038abc4f538cb2d29806f221fb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie19d15fa8feb4d7fb9e9852fb4440016_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i170c7005fd4e4233977c6c670cb2c2d6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedRestrictedStockUnitsRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9e76d69fab4344eaaeea5f3f8ddae394_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1894c4004ad148cea83c9610751c7839_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">natr:PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic89e788790814555baa4f501d838cb1d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ide3b537021f84209a36b182180e7beb0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i529b6a830669494b8e359e0f300f1930_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i56d1e2e3fada4727b55573a407169196_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ecf051891dc4540bc1a158727bface1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i72b2b7d2469d443699c8c1599a668568_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i549144157ff34d2fb598832930efc245_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8e4c046cce2249f2aad2d456f289e8b5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3de2700723f44230bd14ea658ce0674b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7865ea6a10c944dd9cf7b4d199be8b36_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:TW</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i704b9d7df3314907a965decd5192d199_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0f4f53a1500e4c3d8c20fceb1d303105_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:KR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6926d9bdf25244c48c11ee85cac897fc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ief991aa102dc4df286a636f2768bf677_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1def7196a1394561a30f23c2f5945836_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7ab4170a48ba44688bfbcdb858a32779_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iafc86721ece64baf808c893cc035d52a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic11c371bce764450ac20c60711a22727_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2403b429d1e4d5dbc736ea9f50b2db0_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3dadec0fe1ce41e581194b370338f5aa_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i286bd26b9ba84374854d6dbd57593217_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i94c5f48d31de4e58896fadefe80c0fb7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie84001b2ee67469ab6af26eafcb4c8d6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icdb780bc72204ed995bb3d5d750aaaa7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie66081dc8a1849988db515744c4a5191_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia242724c2a8d41a2a6629e376281c37d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i27b0de65c7f04151b172ae37f38db95c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i70570a69247e4e4b9228e76f91348f73_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id935bb5a397e4fd5b3068cd551324f0d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0706faf1f08f497a95123914f1ad454c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2e2a755bd504b2d8ab7f427c3ce421e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i82ea8fd02a454b32af363f8584558ce2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19eee5983a13470a8e2f0b19460061cc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4d2601cc29e44ce8a1a4d2e106164fbf_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7646bffa476a454e9fff94e8ff089fe7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iab2c51f1dcbf45489ce126a589c4fed4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i42e775b15edf42e0976566b58638008e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1fd494153a584910be8e82dd4ae90fb8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7f3e9061310940c78e07309d597a0c3f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icd8baa0e541a4e3db131ac25deeece46_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i004051f877df4e358f3020fdd40e15bf_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide005a7559004658904c94d8e1c9d7a3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i09c2138d4f6448da9af09aa9cad5d832_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i31c73008cac84edd9bf7a7c951a8ace6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if89604f393d1406a9dc613f638bb9282_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5c76018a8ad24a3eb01b65729f05e002_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4ee552623371416a91f53435d09209ff_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idea6fbc78a7e42978d9632750e427515_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife96081680724014b04db995e830f541_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2cdde04916fb4085909452d7bf0e104b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i976cb70b3a6d4224ba518c55b10e68f7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0211468578bd4079b559e74b92be8660_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:GeneralHealthProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6a725eb7fa624679b58b3693ddec3496_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i83bf3f9f69a6453284bd5815b5c518b4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:ImmunityProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7ef4c27b992044b28c84833e4d7a9482_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia27f2c9f8dee4c3ebabd4dd807c88816_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:CardiovascularProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3493146182f54b58b709fb841b93942e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibcdd69c0a6834a8f9f59f07e9398c5c4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:DigestiveProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5e831496e7a6437689b1d9ad266655aa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icce691f6ab25492fa9195960972e876b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:PersonalCareProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i26c43ae344d345a98b2a06cdcfe5a28d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic0e66a63f3a348c481089b2cedcad2da_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">natr:WeightManagementProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib66f65baeb8548a496f5f643074ca0b6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i2774331cf67440fb8010640bd77a71d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b4e7456b9664b3bbd2032692ed8e46e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i459e294ae30142cbaa00703fe6880103_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">natr:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63f7ccb539794924835d07e06230787c_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ifb1c7c7993f443cb9775f4cbebcc4b05_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:AsiaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if62877c0017f46508b1b76d1b8b631bf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i84625c382b684cbd80fa57354e915031_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:EuropeSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1edeeda0c4c64b50ada9a9fb45333935_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i35b69da3bc5f431d8d17902ad62e8a25_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:NorthAmericaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b94b216b4504cbeb1073d1ba015dc60_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9d06d946a93b476bb5c22cdc41e56321_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">natr:LatinAmericaAndOtherSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i278d8bc5355b477b92355f58a24f1d03_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ice670056e3d74a568288807e81b6068f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i99ca42816690450e90028e1c208eecb6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia864dc347810434d8b15fe90be07c05b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:NonIncomeTaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc305e5943754b04a7642c1ac05895ad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if40f94801a594eb68bcddde4144029a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e88ec88e467480993fa728e6e906f56_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8ef804aa7364469e9a21ea865050d6ce_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ice92b1b1c68e485b9d90bc7240e9693a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:ValueAddedTaxAssessmentsAndOtherCivilLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80f04b1608e946ceac0e09928db01466_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5c631233fcb545f395609cfbcdaed083_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="id34db597e9e84e55975f561965ebf581_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ida56900bef5d44d6a5e8107f70534e32_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id080f7965727443cb14cd7096debc888_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:FraudExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-17</endDate>
        </period>
    </context>
    <context id="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000275053</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">natr:FraudExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="borrowing">
        <measure>natr:borrowing</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="payment">
        <measure>natr:payment</measure>
    </unit>
    <unit id="segment">
        <measure>natr:segment</measure>
    </unit>
    <unit id="claim">
        <measure>natr:claim</measure>
    </unit>
    <unit id="product_category">
        <measure>natr:product_category</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xLTEtMS0xLTU2NDYy_3002c32a-5f18-4909-add4-831ea1941fb0">0000275053</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y180LTEtMS0xLTU2NDYy_fd30b4ae-a14f-48fc-8f65-de24a42476f9">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xMi0xLTEtMS01NjQ2Mg_0f565c01-3c51-4732-8225-26c54ede91d3">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGFibGU6ZTk2MDFkM2I1ZGRjNGYwMGJmYTUxMDkzZDRmMGRmOGMvdGFibGVyYW5nZTplOTYwMWQzYjVkZGM0ZjAwYmZhNTEwOTNkNGYwZGY4Y18xMy0xLTEtMS01NjQ2Mg_91dd4da1-d32b-4a62-8486-fbaf4dceec36">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80L2ZyYWc6ZDQ0NGMzOWI2YjhkNDc4M2I1MTk4MjA5MWJiZTA3ZGIvdGV4dHJlZ2lvbjpkNDQ0YzM5YjZiOGQ0NzgzYjUxOTgyMDkxYmJlMDdkYl8xOQ_2619f8aa-96c6-484c-9328-2379707d01b5">--12-31</dei:CurrentFiscalYearEndDate>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="i9e76d69fab4344eaaeea5f3f8ddae394_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81NS9mcmFnOjI5M2JiN2MxNTliMjQyMzA5MzU4NjZhNmJkNDYyNDkwL3RhYmxlOjM3ZTJiMGMyMDQ1ZDQ5NDQ4NzEzNmQ0MjRjM2U3Njg3L3RhYmxlcmFuZ2U6MzdlMmIwYzIwNDVkNDk0NDg3MTM2ZDQyNGMzZTc2ODdfMS0xLTEtMS01NjQ2Mg_9d3e6694-8483-4c00-bfd4-e45b3ece9c21">P1Y</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod
      contextRef="i1894c4004ad148cea83c9610751c7839_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81NS9mcmFnOjI5M2JiN2MxNTliMjQyMzA5MzU4NjZhNmJkNDYyNDkwL3RhYmxlOjM3ZTJiMGMyMDQ1ZDQ5NDQ4NzEzNmQ0MjRjM2U3Njg3L3RhYmxlcmFuZ2U6MzdlMmIwYzIwNDVkNDk0NDg3MTM2ZDQyNGMzZTc2ODdfMS0yLTEtMS01NjQ2Mg_b0703ee9-1b27-4006-9eb3-73be1b4a686c">P1Y3M</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <dei:DocumentType
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNTM_0c7930ff-7176-482d-81fe-e22667000ba1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNzA_51f548f2-b301-44ff-8697-21dcaebf4fb4">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yOTc_9eedf71c-beb9-4fa3-adef-37ef119920c8">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8zMDg_24891ba2-baa5-4fec-996c-370d8c434b9b">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV80OTI_a6840f27-397e-4813-a72b-a63d8db8732f">001-34483</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV80OTg_1aafa213-625c-498b-b449-bdb688f848c8">NATURE&#x2019;S SUNSHINE PRODUCTS,&#160;INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6OWRkYWJhZDZhZmE3NGNhMDkzYmI4MzU2ODYwYjg4MGMvdGFibGVyYW5nZTo5ZGRhYmFkNmFmYTc0Y2EwOTNiYjgzNTY4NjBiODgwY18wLTAtMS0xLTU2NDYy_ced88f22-1ab1-4020-bf3f-8090b69a6270">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6OWRkYWJhZDZhZmE3NGNhMDkzYmI4MzU2ODYwYjg4MGMvdGFibGVyYW5nZTo5ZGRhYmFkNmFmYTc0Y2EwOTNiYjgzNTY4NjBiODgwY18wLTItMS0xLTU2NDYy_123fd5b3-89f7-477b-b53b-b9cb573a6b7e">87-0327982</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NjA_14668ad2-91af-4378-97b2-c8d79f5f74d7">2901 Bluegrass Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NjQ_e2c2afa4-930d-4ce5-8eba-ab7e2b032064">Suite&#160;100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81Njc_c3f189d2-9ce0-43e9-8b5b-d5ff03270fa2">Lehi</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NzE_478e6975-3e42-47da-8467-ee1d95772c81">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV81NzQ_633c1e87-571a-4cfb-a46f-b44aa14ac2d7">84043</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV82MzQ_f6a52913-8fca-41e9-a5f4-e48721e0f2b3">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV82Mzg_a8aa810b-6e66-41da-b39d-9c7e1d4cbffa">341-7900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTAtMS0xLTU2NDYy_b8ba02aa-de73-4c71-9142-64c07684416f">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTEtMS0xLTU2NDYy_8850eba4-cc60-46e3-acb0-d2c00358ddbf">NATR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6ZjUxZTIxNmMyODJjNGRlOTgwYmE3MzVjYWViZjcwNzUvdGFibGVyYW5nZTpmNTFlMjE2YzI4MmM0ZGU5ODBiYTczNWNhZWJmNzA3NV8xLTItMS0xLTU2NDYyL3RleHRyZWdpb246NGEyMzAyZjFiY2RmNGE1M2FmOTk0YmU2ODE0NTIzMDhfNA_4652b7d6-ec61-41e7-bac1-973b75181f66">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xMTMy_becd98dd-5fa9-4ec1-ae14-0fdc3082ab69">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8xNDU4_f3e71189-9eb9-45e4-b6a3-abd575d6dcac">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N18wLTItMS0xLTU2NDYyL3RleHRyZWdpb246ODE0YmI5MzJiNWFkNDg4ZWIwNDYyMDQ4NzIwYjFhYTVfNQ_5db1047b-9faa-4fb1-a758-a4d778935492">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N18yLTItMS0xLTU2NDYyL3RleHRyZWdpb246ZWIwMDVjNTI3NjA2NDU0MDg1NDlkNzVhOWRjMzI2OGJfMzE_cb228fd2-a066-4d81-b22d-e0b9a5de6a11">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGFibGU6MjY4ZDljNjk0MGNiNDQ5ODhkZWFhMmIyZGVhNjFlODcvdGFibGVyYW5nZToyNjhkOWM2OTQwY2I0NDk4OGRlYWEyYjJkZWE2MWU4N180LTItMS0xLTU2NDYyL3RleHRyZWdpb246MTc0NmUxOTA3MTEzNGE3NmI4MzE1YzE1ZWFjZDY2MTFfMzA_a2bf061a-f99e-4563-8788-05d8c40f5a0d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yMzAy_598eafc7-d69c-46a5-8a7b-572d43f7af5d">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i323367af1eab405e83322a0281dd711b_I20230421"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xL2ZyYWc6OGMzMjQ2Y2JjM2I4NDJjZTgwYmQ4YTY4ZWFiYzJmNWUvdGV4dHJlZ2lvbjo4YzMyNDZjYmMzYjg0MmNlODBiZDhhNjhlYWJjMmY1ZV8yMjkx_e1eccce4-16ad-4311-9ed0-2c56fb1f223d"
      unitRef="shares">19045405</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMy0xLTEtMS01NjQ2Mg_eedc9b71-77ae-41bc-ae89-0c18d5174986"
      unitRef="usd">65720000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMy0zLTEtMS01NjQ2Mg_f09bfd88-98d2-4a8b-b81f-68b7ecb5747e"
      unitRef="usd">60032000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0wLTEtMS01NjQ2Mi90ZXh0cmVnaW9uOjllYWMxMTViMmQ4ZjRhZDY5YWIxOTM1MWE3NDE1MmI1XzY3_766675c6-c073-44c6-8221-a63886183796"
      unitRef="usd">122000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0wLTEtMS01NjQ2Mi90ZXh0cmVnaW9uOjllYWMxMTViMmQ4ZjRhZDY5YWIxOTM1MWE3NDE1MmI1Xzc0_0692be04-779a-41dc-80bf-e779063b9ee8"
      unitRef="usd">120000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0xLTEtMS01NjQ2Mg_80a4c9f7-5312-467f-841a-0b346f9731fd"
      unitRef="usd">10474000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNC0zLTEtMS01NjQ2Mg_07d7560b-c7c4-4309-bf20-40aa53012f61"
      unitRef="usd">14106000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNy0xLTEtMS01NjQ2Mg_b49de540-76d2-46a2-b56f-dfee9ca21d19"
      unitRef="usd">67524000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNy0zLTEtMS01NjQ2Mg_95b66977-bdad-47fd-895f-05241a63124e"
      unitRef="usd">67949000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOC0xLTEtMS01NjQ2Mg_d2ae8be1-2879-4b4d-ad67-eef2a169e209"
      unitRef="usd">10702000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOC0zLTEtMS01NjQ2Mg_d6d047dc-1812-416c-8ea2-4aa1593152d4"
      unitRef="usd">7420000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOS0xLTEtMS01NjQ2Mg_091b80cc-1e27-4af9-a0f9-87918dca954f"
      unitRef="usd">154420000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfOS0zLTEtMS01NjQ2Mg_feba9238-093a-4003-adf3-77f58cc772f2"
      unitRef="usd">149507000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTEtMS0xLTEtNTY0NjI_c3eaea10-1ed3-49ff-bfa0-a4f6de20257d"
      unitRef="usd">46080000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTEtMy0xLTEtNTY0NjI_6c996d58-2a70-466e-92ac-0c44a2264482"
      unitRef="usd">46162000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTItMS0xLTEtNTY0NjI_a5bc687d-c480-4431-a4c8-7643296a327f"
      unitRef="usd">16152000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTItMy0xLTEtNTY0NjI_14f66ee0-3c4e-43fc-b3cf-56afb13aef67"
      unitRef="usd">16145000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTMtMS0xLTEtNTY0NjI_9c4e80a1-132e-4643-b675-98dc439f7328"
      unitRef="usd">718000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTMtMy0xLTEtNTY0NjI_3659192d-b9fb-4e56-8b49-997944b187ec"
      unitRef="usd">702000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTUtMS0xLTEtNTY0NjI_7d6c04df-0559-4f89-ac1d-812fe2934146"
      unitRef="usd">6965000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTUtMy0xLTEtNTY0NjI_7ff48cae-8344-4d6c-90a6-1fc81811dd04"
      unitRef="usd">6859000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTYtMS0xLTEtNTY0NjI_cda6d13f-2b9d-4343-b94e-ce6511845add"
      unitRef="usd">10249000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTYtMy0xLTEtNTY0NjI_7a1d9fed-2979-43cf-b512-99b3d885b7fc"
      unitRef="usd">10403000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTctMS0xLTEtNTY0NjI_900511f4-c1a7-40b8-aefd-1f43c865b0e8"
      unitRef="usd">234584000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMTctMy0xLTEtNTY0NjI_4c18031a-a659-416d-8bf5-932713303104"
      unitRef="usd">229778000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjEtMS0xLTEtNTY0NjI_8e78b39f-f015-4bbd-b49d-8b4d5198d3ae"
      unitRef="usd">8775000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjEtMy0xLTEtNTY0NjI_8b912fd9-0c36-4771-824b-026231b433d1"
      unitRef="usd">6349000</us-gaap:AccountsPayableCurrent>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjItMS0xLTEtNTY0NjI_de5c2bb7-f526-4e67-8732-a45273c65e2b"
      unitRef="usd">22611000</natr:AccruedVolumeIncentiveandServiceFees>
    <natr:AccruedVolumeIncentiveandServiceFees
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjItMy0xLTEtNTY0NjI_5a787bc7-4a83-499b-a69a-af6da4683ef2"
      unitRef="usd">21830000</natr:AccruedVolumeIncentiveandServiceFees>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjMtMS0xLTEtNTY0NjI_a2be5684-6ab3-41eb-b7d2-0d6d8efa5028"
      unitRef="usd">28730000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjMtMy0xLTEtNTY0NjI_a1dd280e-5a79-4135-8c5b-e93053051513"
      unitRef="usd">25591000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjQtMS0xLTEtNTY0NjI_6a25cc4d-5684-4630-ac1f-6a30c45c3f5e"
      unitRef="usd">1128000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjQtMy0xLTEtNTY0NjI_8eefcd5f-f9dc-486b-a971-7711b64dd479"
      unitRef="usd">2255000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjctMS0xLTEtNTY0NjI_d724de76-745d-4643-851b-35f4550f0e5b"
      unitRef="usd">4654000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjctMy0xLTEtNTY0NjI_80469870-3482-4e9c-b909-b166ddcec544"
      unitRef="usd">4117000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjgtMS0xLTEtNTY0NjI_1840fdec-4ab5-4c3d-b678-75624ed4ef53"
      unitRef="usd">4671000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjgtMy0xLTEtNTY0NjI_4f1b5528-d448-4e8b-a8ec-6478cd319d3d"
      unitRef="usd">4266000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjktMS0xLTEtNTY0NjI_5a282618-dc88-4b8f-b63e-9d4af1c6442f"
      unitRef="usd">1007000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMjktMy0xLTEtNTY0NjI_30b5e068-02ce-4ed1-a6c6-529d149b68a9"
      unitRef="usd">1174000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzAtMS0xLTEtNTY0NjI_cadb4f17-2141-47d4-b2ff-cd4744879d2b"
      unitRef="usd">71576000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzAtMy0xLTEtNTY0NjI_3c938bf3-0fc4-4e9a-8fe6-35e379c6195e"
      unitRef="usd">65582000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzItMS0xLTEtNTY0NjI_99469cb5-8c16-4d33-9790-5e23b5792a60"
      unitRef="usd">215000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzItMy0xLTEtNTY0NjI_2ef3ec32-920c-4905-82ab-930d1b1e8fd0"
      unitRef="usd">209000</us-gaap:LiabilityForUncertainTaxPositionsNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzMtMS0xLTEtNTY0NjI_2bb9b197-be70-4268-88b1-b3217eee28f6"
      unitRef="usd">13382000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzMtMy0xLTEtNTY0NjI_8de7b064-ae13-4a6f-8357-d1d6b02ba01d"
      unitRef="usd">13745000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzYtMS0xLTEtNTY0NjI_24234426-13c4-4d77-9596-e017af3ecb8e"
      unitRef="usd">718000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzYtMy0xLTEtNTY0NjI_4c34dce0-488d-4e83-b4ec-8360c4bb40e1"
      unitRef="usd">702000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzctMS0xLTEtNTY0NjI_dacc6185-acdb-4e32-8385-8887881bea7a"
      unitRef="usd">936000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzctMy0xLTEtNTY0NjI_97529b13-71f8-4575-b201-2c3ab320187a"
      unitRef="usd">1439000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzgtMS0xLTEtNTY0NjI_0382fba6-0fc5-4b38-b99e-e5a3ffd7d927"
      unitRef="usd">1040000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzgtMy0xLTEtNTY0NjI_91121bcc-694b-4539-bfac-2d14ffa6dc1d"
      unitRef="usd">1054000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzktMS0xLTEtNTY0NjI_fb5f411e-db09-48c5-add5-aa55827e75f6"
      unitRef="usd">87867000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfMzktMy0xLTEtNTY0NjI_59d86024-4e34-4fac-b058-420608552cc7"
      unitRef="usd">82731000</us-gaap:Liabilities>
    <us-gaap:CommonStockNoParValue
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8xOA_7e121baf-e531-41c6-a7a7-21f5b3d2a95a"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8xOA_976b87a8-a63f-4635-b2fb-0960a3cd1ae9"
      unitRef="usdPerShare">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8zMg_8dcd7a4a-8707-4454-a1e4-e47b11d1b6c2"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl8zMg_e640dac5-b793-47dc-a130-97c12696f736"
      unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl81NA_48cbfba7-258b-4673-bc97-308034a1118a"
      unitRef="shares">19045000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl81NA_922dfc02-7ebf-49ae-b3c8-671726f6b9ad"
      unitRef="shares">19045000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl82MQ_1b43bdd3-65ba-4886-aee7-f0d0118e5ce4"
      unitRef="shares">19093000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMC0xLTEtNTY0NjIvdGV4dHJlZ2lvbjo4NTVjY2ZiZjYwNjU0NjU3YjBmNzE0Yzg0MzcyOWI3Yl82MQ_5994ad79-7cba-402c-9cdd-a9bacb25d396"
      unitRef="shares">19093000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMS0xLTEtNTY0NjI_6a1519ec-0f12-47fa-af48-6a2878e06dfc"
      unitRef="usd">121653000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDQtMy0xLTEtNTY0NjI_b8f06870-f604-411f-9777-529d85f42a58"
      unitRef="usd">121583000</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDUtMS0xLTEtNTY0NjI_dd9403fc-2f1c-44a6-8d28-a253751757c0"
      unitRef="usd">35495000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDUtMy0xLTEtNTY0NjI_5f09f9a3-7987-4cb0-8418-01b0915689e1"
      unitRef="usd">34635000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:MinorityInterest
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDYtMS0xLTEtNTY0NjI_a648c3ac-e67a-4d92-a41f-df335f2c42b2"
      unitRef="usd">4535000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDYtMy0xLTEtNTY0NjI_eb07483c-5a83-46d0-931b-58ed8ee43115"
      unitRef="usd">4142000</us-gaap:MinorityInterest>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDctMS0xLTEtNTY0NjI_28a9a2f1-a10b-419c-b84d-ec8ea62e3dad"
      unitRef="usd">-14966000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDctMy0xLTEtNTY0NjI_eea20b2a-6f9b-42a0-9d74-2ca10de63629"
      unitRef="usd">-13313000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDgtMS0xLTEtNTY0NjI_e71159aa-bd3f-48ef-92b5-c115e1cc0243"
      unitRef="usd">146717000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDgtMy0xLTEtNTY0NjI_04a58a29-0158-494d-827e-790b15b168c1"
      unitRef="usd">147047000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDktMS0xLTEtNTY0NjI_e8c111ce-c198-488f-a4ed-0d936c726109"
      unitRef="usd">234584000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xOS9mcmFnOjE0OGNlODJiNzQxZTQ2NzhiNzdmOTU5NzMzYTVjYjViL3RhYmxlOmQ0Nzg5MGY2ZmJkZjQ1N2ZiZjE5NDI4OGI5OTczNjA1L3RhYmxlcmFuZ2U6ZDQ3ODkwZjZmYmRmNDU3ZmJmMTk0Mjg4Yjk5NzM2MDVfNDktMy0xLTEtNTY0NjI_82439728-b774-4eb0-9926-ae3455950d1b"
      unitRef="usd">229778000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMi0xLTEtMS01NjQ2Mg_0e87883c-5655-4b57-b087-881f57584c91"
      unitRef="usd">108634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMi0zLTEtMS01NjQ2Mg_eff496f1-dacc-49bc-ae28-9b11a7f4b896"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMy0xLTEtMS01NjQ2Mg_42383e41-0d1a-44a1-9290-36b9feae3092"
      unitRef="usd">31692000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMy0zLTEtMS01NjQ2Mg_24ab851f-fc00-417f-bb60-99a1d04b2af9"
      unitRef="usd">34460000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNC0xLTEtMS01NjQ2Mg_e65415bb-15ec-46ef-9632-280dc46e68cf"
      unitRef="usd">76942000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNC0zLTEtMS01NjQ2Mg_e0e5180e-eed1-44c5-b45f-6ba20331a8ab"
      unitRef="usd">76034000</us-gaap:GrossProfit>
    <natr:VolumeIncentives
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNy0xLTEtMS01NjQ2Mg_37611539-a72f-433a-8473-dd8d2a8db129"
      unitRef="usd">33128000</natr:VolumeIncentives>
    <natr:VolumeIncentives
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfNy0zLTEtMS01NjQ2Mg_9ca06a18-e909-4c15-9a80-f30783089a4e"
      unitRef="usd">34102000</natr:VolumeIncentives>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOC0xLTEtMS01NjQ2Mg_ffbf4f23-8aa7-4708-8d8c-1e73cdb19178"
      unitRef="usd">43642000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOC0zLTEtMS01NjQ2Mg_014dd347-b1c6-4762-a68e-7781f8a11032"
      unitRef="usd">40623000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOS0xLTEtMS01NjQ2Mg_dee28a52-ddae-4c36-9d60-03788ea6b40d"
      unitRef="usd">172000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfOS0zLTEtMS01NjQ2Mg_aa476035-b804-41c4-92a1-f4de6cfa1a9c"
      unitRef="usd">1309000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTAtMS0xLTEtNTY0NjI_337bc55e-016e-448f-bb44-900e202181a6"
      unitRef="usd">1514000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTAtMy0xLTEtNTY0NjI_0eb11d2d-4083-4245-b247-1e4baac054e7"
      unitRef="usd">-314000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTEtMS0xLTEtNTY0NjI_c41c5470-7b83-4e1a-aec5-20c777a2a7ec"
      unitRef="usd">1686000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTEtMy0xLTEtNTY0NjI_764bf453-0d2a-4377-9f94-bd7a20bb97ee"
      unitRef="usd">995000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTItMS0xLTEtNTY0NjI_1c53c0f5-52de-4dc3-935b-c44ea82ba2fd"
      unitRef="usd">433000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTItMy0xLTEtNTY0NjI_a762dd7a-d160-4cc0-bf26-c5ce9042b84d"
      unitRef="usd">3681000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTMtMS0xLTEtNTY0NjI_44ddf386-03a4-40a1-9c0f-2e5b33ad1086"
      unitRef="usd">1253000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTMtMy0xLTEtNTY0NjI_99fa68ad-a87e-4645-8cc7-156bdb288ad7"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTQtMS0xLTEtNTY0NjI_eaa7cf8d-38db-429d-96e1-099280399202"
      unitRef="usd">393000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTQtMy0xLTEtNTY0NjI_863b28e4-a24a-470a-95dd-272cd278b58a"
      unitRef="usd">264000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTUtMS0xLTEtNTY0NjI_4759f11b-942f-40c0-b579-eeecc7d0e0ea"
      unitRef="usd">860000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMTUtMy0xLTEtNTY0NjI_e286afa7-aac7-4479-9b73-8aca492e87c6"
      unitRef="usd">-2950000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjItMS0xLTEtNTY0NjI_2e7ee067-7136-4d87-83ae-de5553786a75"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjItMy0xLTEtNTY0NjI_7dfb5fe3-2335-44bb-8561-89d69418b128"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjctMS0xLTEtNTY0NjI_a3f0069b-9ef1-44f5-b0bd-f6a41aa145a8"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjctMy0xLTEtNTY0NjI_7c7ea667-c6ec-4b00-a7c8-d3d754b4313f"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjktMS0xLTEtNTY0NjI_5b5e2b21-c079-4292-b39c-b3f458780145"
      unitRef="shares">19061000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMjktMy0xLTEtNTY0NjI_8510c6cb-0b94-4913-ae7d-3ebf17a68320"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMzAtMS0xLTEtNTY0NjI_48c91efb-087d-4516-b871-3a5059d3042b"
      unitRef="shares">19433000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yMi9mcmFnOjE0Yzk4MDFiNzU4MzRiMWE5MDI3YjAyMTc4OTM2Zjk3L3RhYmxlOjYyYmU4YTRiNzZjOTQwMjZiZTgwYmRkZTMzMDg0MzQ0L3RhYmxlcmFuZ2U6NjJiZThhNGI3NmM5NDAyNmJlODBiZGRlMzMwODQzNDRfMzAtMy0xLTEtNTY0NjI_baa6a09d-4d36-4d32-a9ed-a0534ee3a32d"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMi0xLTEtMS01NjQ2Mg_8c7381f1-8294-4824-bf61-70ae709579ee"
      unitRef="usd">1253000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMi0zLTEtMS01NjQ2Mg_f9976858-0185-48f3-944b-a8dc387ab571"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMy0xLTEtMS01NjQ2Mg_afd43b07-8cce-43d1-925a-05fd4aa78b0c"
      unitRef="usd">-1653000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfMy0zLTEtMS01NjQ2Mg_6f2e4ed3-af08-442c-b29b-b07f0d7277ce"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfNy0xLTEtMS01NjQ2Mg_09795fad-7393-4308-9c96-59e0928b94e2"
      unitRef="usd">-400000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yNS9mcmFnOmNhZmQzYTg0ZDVjZDQ5N2Q4YTY5YmQ0YWVjY2E3ZWExL3RhYmxlOjUzMzZmMDJmMjhiMDQyMDFiMWZjYTE2OGI3NjBlYzBkL3RhYmxlcmFuZ2U6NTMzNmYwMmYyOGIwNDIwMWIxZmNhMTY4Yjc2MGVjMGRfNy0zLTEtMS01NjQ2Mg_2cca30b2-8659-4bba-9b7e-ce221ff08c9d"
      unitRef="usd">-3661000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i3756408ac1534f02be1f929758b190ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0xLTEtMS01NjQ2Mg_4bfed6cc-bc60-4c47-b6cb-1ce750b79152"
      unitRef="shares">19093000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3756408ac1534f02be1f929758b190ec_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0zLTEtMS01NjQ2Mg_11418bc6-3dfb-48c1-aa96-f59b541762f3"
      unitRef="usd">121583000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1c5ec96e95bb479aa9317328c85875ff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi01LTEtMS01NjQ2Mg_99dcc224-1741-4989-9d86-4f8e36d621ce"
      unitRef="usd">34635000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8e99e23cdc04ca3967d8e0cc86c9bc9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi03LTEtMS01NjQ2Mg_927802b2-a3c2-4415-bbdd-fd0db58f4f17"
      unitRef="usd">4142000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic159bd1e6c754fc598df19fee673181b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi05LTEtMS01NjQ2Mg_cf272285-8f67-4f28-8f8f-fd19fa24d30e"
      unitRef="usd">-13313000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMi0xMS0xLTEtNTY0NjI_75d28ebd-1b3e-44a6-9266-dd65a0b66be6"
      unitRef="usd">147047000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMy0zLTEtMS01NjQ2Mg_8c6920b6-ef63-4682-a58f-ed699caeffae"
      unitRef="usd">1058000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfMy0xMS0xLTEtNTY0NjI_9d3164c7-a9af-4a8d-a6cb-234b6be2b859"
      unitRef="usd">1058000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0xLTEtMS01NjQ2Mg_003a92cc-da52-4ed3-98ab-7b04df31487d"
      unitRef="shares">42000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0zLTEtMS01NjQ2Mg_6072adb2-04a2-49f5-8890-d0c5a8e144f6"
      unitRef="usd">-165000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNC0xMS0xLTEtNTY0NjI_29ce9af1-7ca1-4e6d-8657-b8b2be5f8fa5"
      unitRef="usd">-165000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0xLTEtMS01NjQ2Mg_45e6df45-5dec-43ea-9a49-6e79e6787563"
      unitRef="shares">90000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib959c8c097604e8f8294538dac6a6efd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0zLTEtMS01NjQ2Mg_7b53f89e-8603-4434-9097-7534b58c8448"
      unitRef="usd">823000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNS0xMS0xLTEtNTY0NjI_6342bf40-c00c-4ed3-acc4-426a458aa3ba"
      unitRef="usd">823000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i2f1b157582d54aa5b6c76556a72d0fa1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi01LTEtMS01NjQ2Mg_8619baf8-99c4-4254-8864-784be1f3434f"
      unitRef="usd">860000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i078db4ca9b324f02b4b009b8e5063922_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi03LTEtMS01NjQ2Mg_657582c8-7002-4615-82b1-d7076eb42462"
      unitRef="usd">393000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNi0xMS0xLTEtNTY0NjI_f93e91e4-9f7a-4a99-945c-b3c9d66d4d36"
      unitRef="usd">1253000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia77345b7632f4c3687707a676a2ecdba_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNy05LTEtMS01NjQ2Mg_bd75e1e1-f7be-408f-8c90-5c2640807ebf"
      unitRef="usd">-1653000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfNy0xMS0xLTEtNTY0NjI_c80a2f8b-c735-423e-b81c-7693aedb0e83"
      unitRef="usd">-1653000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i397792870c944251a9e358f23c5e3f82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0xLTEtMS01NjQ2Mg_bf0d7400-f113-4283-9570-d678a28852ea"
      unitRef="shares">19045000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i397792870c944251a9e358f23c5e3f82_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0zLTEtMS01NjQ2Mg_e5db05d9-1377-43f9-ba1b-3788ae014948"
      unitRef="usd">121653000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifecfce154349479aaa1ff1d6bfd331aa_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC01LTEtMS01NjQ2Mg_dbf16e0e-3747-4f0a-b5c7-d7d73cb3f3c5"
      unitRef="usd">35495000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id071f960be3f4eddb4fddc539cef8fb2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC03LTEtMS01NjQ2Mg_71fbf1dc-2972-4234-9b9d-9bdfac4cc152"
      unitRef="usd">4535000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i118dbcf5a4fc44b8985c21224e382a89_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC05LTEtMS01NjQ2Mg_a5286204-5115-4849-8b9e-085908118bbe"
      unitRef="usd">-14966000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjg5YjA5ZDA4MDIzZDRjZDJhNDA4MDBmMTkyZjNkNTViL3RhYmxlcmFuZ2U6ODliMDlkMDgwMjNkNGNkMmE0MDgwMGYxOTJmM2Q1NWJfOC0xMS0xLTEtNTY0NjI_984c4aae-a037-4408-b345-2d15d17bb08c"
      unitRef="usd">146717000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="i0691a9d3b51c404f83e92ca13c32ff39_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0xLTEtMS01NjQ2Mg_7ef749b4-a051-4e04-99bb-fe8f8a9149fc"
      unitRef="shares">19724000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0691a9d3b51c404f83e92ca13c32ff39_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0zLTEtMS01NjQ2Mg_2374c0e1-1332-42dd-a1e9-70a863fbf7a5"
      unitRef="usd">133382000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a92d6d58b6c43fc949181a4738e553c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi01LTEtMS01NjQ2Mg_b9b12ba2-0252-4b4a-95b4-bb7a0f3b3fc1"
      unitRef="usd">35025000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib53dcd0f7b104910a52899f37012afd3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi03LTEtMS01NjQ2Mg_772bcb17-6b92-4a2d-be1e-d206b647fb75"
      unitRef="usd">3202000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f72f97c01a743d790b5acf8b55c9d24_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi05LTEtMS01NjQ2Mg_23070b24-abc0-4472-b0e7-f8a1320e9137"
      unitRef="usd">-10205000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib40450c215064f9a9f895bc248da7a1e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMi0xMS0xLTEtNTY0NjI_c43d9ba3-e0f4-4e2f-9e61-947eb6c52aed"
      unitRef="usd">161404000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMy0zLTEtMS01NjQ2Mg_326195ce-602e-4639-bca0-0595861ebbbb"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfMy0xMS0xLTEtNTY0NjI_d478fedf-7712-4fdc-b4a9-d959c6037377"
      unitRef="usd">801000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationGross>
    <natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised
      contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0xLTEtMS01NjQ2Mg_7cb7f022-3bf9-4fac-87cd-67cea78b2cec"
      unitRef="shares">188000</natr:StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0zLTEtMS01NjQ2Mg_53eafc39-98ab-4092-943b-18fc77068caa"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNC0xMS0xLTEtNTY0NjI_6171ffae-d837-49e4-8bf1-0c4866791e2d"
      unitRef="usd">-795000</natr:StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0xLTEtMS01NjQ2Mg_050401d3-366f-4bf1-9573-9af4d775cf05"
      unitRef="shares">451000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ib304ce0c6d6c450ea872b8da3c3952d9_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0zLTEtMS01NjQ2Mg_ce062d12-6ca1-4e7f-9448-5bf462f7c37e"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNS0xMS0xLTEtNTY0NjI_5131a996-b861-4c50-bf78-fd3ac07bc459"
      unitRef="usd">7971000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:ProfitLoss
      contextRef="i3ce5e44a4ef64052aea959ec0f39d8d8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi01LTEtMS01NjQ2Mg_d3c542c2-9e53-4098-93f6-a0cad98913d1"
      unitRef="usd">-2950000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i25cd1edc1c964494bbd0f0f6d41bfd3c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi03LTEtMS01NjQ2Mg_b656f0ed-e974-49d8-819e-53d9f425e179"
      unitRef="usd">264000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNi0xMS0xLTEtNTY0NjI_2fbe6e2f-0069-4d27-a762-73f48f3a16be"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i66a7e3f9c206413f8e34219e584092b1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNy05LTEtMS01NjQ2Mg_70b7ccd7-dac5-43bb-8653-9c184aec6c06"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfNy0xMS0xLTEtNTY0NjI_6b0567f8-0d7d-4ea6-8f01-c3bfa59b05cf"
      unitRef="usd">-975000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i8deaf3592d424474a99cc4c83beafb75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0xLTEtMS01NjQ2Mg_bdfa8e52-974d-41fb-8cd5-fb6d446eab6e"
      unitRef="shares">19461000</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8deaf3592d424474a99cc4c83beafb75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0zLTEtMS01NjQ2Mg_187f9564-a7a5-455b-97e6-b0f3d8bab719"
      unitRef="usd">125417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff00616fa06b404996d8b5bb02df09ce_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC01LTEtMS01NjQ2Mg_6cc11576-a07e-453d-a71f-8870b096aca3"
      unitRef="usd">32075000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id89baad6125140598d815d83ca0cfa3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC03LTEtMS01NjQ2Mg_395092e7-cf8d-4421-8fe6-743258b4e980"
      unitRef="usd">3466000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3aafe404f0443248657956fd2be506f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC05LTEtMS01NjQ2Mg_8503dd1c-1845-4fee-a2cd-434b8bbc027e"
      unitRef="usd">-11180000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e403872b0564650b45c1c4ce25c58da_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8yOC9mcmFnOmZkODM4YmFmMmZjMDRjN2Q5MWQ3MTMyMzIxZWRhYzQwL3RhYmxlOjgyMjAwY2NiMmRkMDQyZGE5NmE4MDE5ZjBmY2Q1YjU2L3RhYmxlcmFuZ2U6ODIyMDBjY2IyZGQwNDJkYTk2YTgwMTlmMGZjZDViNTZfOC0xMS0xLTEtNTY0NjI_bd14b710-1efb-4740-a9cc-0fdac085f424"
      unitRef="usd">149778000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMy0xLTEtMS01NjQ2Mg_e1162785-85c1-439d-a7b6-57309734d648"
      unitRef="usd">1253000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMy0zLTEtMS01NjQ2Mg_ffb44849-88b2-4c97-a053-21e23636873b"
      unitRef="usd">-2686000</us-gaap:ProfitLoss>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNS0xLTEtMS01NjQ2Mg_85eff410-6cc9-4b74-82cd-970587b4cea2"
      unitRef="usd">4000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNS0zLTEtMS01NjQ2Mg_079e1473-5d32-4ecc-8bd2-f28be19f3a79"
      unitRef="usd">6000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNi0xLTEtMS01NjQ2Mg_b89ae2f5-8bb8-4931-9e21-9269f29f6953"
      unitRef="usd">2805000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNi0zLTEtMS01NjQ2Mg_da3433a7-4453-4514-b250-8071d5488641"
      unitRef="usd">2766000</us-gaap:DepreciationDepletionAndAmortization>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNy0xLTEtMS01NjQ2Mg_1a12d05e-82d1-41c9-94c0-ec91f698d155"
      unitRef="usd">932000</natr:OperatingLeaseNonCashLeaseExpense>
    <natr:OperatingLeaseNonCashLeaseExpense
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNy0zLTEtMS01NjQ2Mg_dd95e683-c3a3-4295-9801-a61e828c9fcb"
      unitRef="usd">1173000</natr:OperatingLeaseNonCashLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOC0xLTEtMS01NjQ2Mg_929bd652-feef-4a30-92d5-2666ca615ff6"
      unitRef="usd">1058000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOC0zLTEtMS01NjQ2Mg_11445214-44b3-41a8-9a7a-f9944e857124"
      unitRef="usd">801000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOS0xLTEtMS01NjQ2Mg_4201c311-ee30-4834-80c3-e60784583b03"
      unitRef="usd">-71000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfOS0zLTEtMS01NjQ2Mg_77e2c8de-07ec-4173-8dd3-510511662fdc"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTAtMS0xLTEtNTY0NjI_775996c3-6f32-43a4-8234-c9ab3ed208e4"
      unitRef="usd">-631000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTAtMy0xLTEtNTY0NjI_ce8a7dc2-2e28-457b-af7f-2b599c85dbea"
      unitRef="usd">3844000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTEtMS0xLTEtNTY0NjI_d536e9eb-1292-4397-a826-3fd2011799b5"
      unitRef="usd">0</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTEtMy0xLTEtNTY0NjI_f42d7809-65ff-451d-ae07-e17bb3b11732"
      unitRef="usd">12000</us-gaap:PaymentsForPurchaseOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTItMS0xLTEtNTY0NjI_5ccbbc4d-0419-4005-baa2-ca7ade5a9653"
      unitRef="usd">31000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTItMy0xLTEtNTY0NjI_286eb30f-e971-40d7-97ed-fb969c523e2e"
      unitRef="usd">35000</us-gaap:ProceedsFromSaleOfSecuritiesOperatingActivities>
    <us-gaap:GainLossOnInvestments
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTMtMS0xLTEtNTY0NjI_3bc2211b-0956-4861-8561-cb351a259545"
      unitRef="usd">47000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTMtMy0xLTEtNTY0NjI_59adb3aa-1d52-4d8d-b3b9-41a8ecc66990"
      unitRef="usd">-58000</us-gaap:GainLossOnInvestments>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTQtMS0xLTEtNTY0NjI_3e6a311b-d9a2-44dd-a768-1673dd0e5d5a"
      unitRef="usd">1477000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTQtMy0xLTEtNTY0NjI_708329c2-3c43-4ffe-9c79-ce8809e9b834"
      unitRef="usd">-402000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTYtMS0xLTEtNTY0NjI_b3d17698-5af2-4264-82ef-f5165822645b"
      unitRef="usd">-3649000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTYtMy0xLTEtNTY0NjI_12c8aa05-00d3-4c17-a9fb-993c47b376d9"
      unitRef="usd">-1447000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTctMS0xLTEtNTY0NjI_158131bf-3678-4a89-8179-6c288f0c0aa3"
      unitRef="usd">-457000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTctMy0xLTEtNTY0NjI_3fde476c-8d9d-4c38-881d-04fea75ccabc"
      unitRef="usd">3489000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTgtMS0xLTEtNTY0NjI_7d191cb9-0551-4ac1-83cf-383570e2fb7b"
      unitRef="usd">3266000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTgtMy0xLTEtNTY0NjI_6f624b37-8db0-4a62-8e71-9ef5f60dde97"
      unitRef="usd">2518000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTktMS0xLTEtNTY0NjI_734fe12b-8226-44d3-b46a-900b790ffea3"
      unitRef="usd">11000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMTktMy0xLTEtNTY0NjI_005dbf63-2f68-49a4-92c5-28e5c8c1490f"
      unitRef="usd">20000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjAtMS0xLTEtNTY0NjI_d9f2fa02-3fc2-452d-93bd-a342496b914d"
      unitRef="usd">2391000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjAtMy0xLTEtNTY0NjI_e5225cf5-14eb-4081-971b-d214729b8b02"
      unitRef="usd">-946000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjEtMS0xLTEtNTY0NjI_6d04061f-424b-49d7-86a7-781ec35493ca"
      unitRef="usd">781000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjEtMy0xLTEtNTY0NjI_28edff1c-ff5f-445c-8747-f4c8974389bc"
      unitRef="usd">-464000</natr:IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjItMS0xLTEtNTY0NjI_90d90bd3-b1b4-49db-b8d6-060fcd358cdd"
      unitRef="usd">2759000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjItMy0xLTEtNTY0NjI_3adbe3dc-b100-4876-9720-c5611d0f31ba"
      unitRef="usd">-5386000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjMtMS0xLTEtNTY0NjI_a1c901b0-d1b2-4b40-bff5-8815dd17d0c2"
      unitRef="usd">-1142000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjMtMy0xLTEtNTY0NjI_24bba76f-2d29-4541-8a29-bb76e7d425bf"
      unitRef="usd">-1632000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjQtMS0xLTEtNTY0NjI_2e8999fb-e232-46da-b3a6-c4f511e88cd5"
      unitRef="usd">-900000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <natr:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjQtMy0xLTEtNTY0NjI_f9d85d16-2592-48ae-8bec-2ee6b27fa540"
      unitRef="usd">-1031000</natr:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjUtMS0xLTEtNTY0NjI_74a0c07e-8da3-40f4-9f76-04f9e8a6c72c"
      unitRef="usd">586000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjUtMy0xLTEtNTY0NjI_d312a782-4682-4754-8713-bf95eacf638d"
      unitRef="usd">-191000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjYtMS0xLTEtNTY0NjI_f637c542-0734-4aab-96fe-8d732ff15754"
      unitRef="usd">6000</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjYtMy0xLTEtNTY0NjI_bfe1de6e-ba54-4fab-8e8e-b048dbc54c42"
      unitRef="usd">0</natr:IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjctMS0xLTEtNTY0NjI_3cb491a7-595e-4289-bad6-8a645ccd63af"
      unitRef="usd">16000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjctMy0xLTEtNTY0NjI_014a0c28-1152-4f6e-9168-f1b3f7081796"
      unitRef="usd">-81000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjgtMS0xLTEtNTY0NjI_e7053351-7e89-446a-a639-1dec960ec97b"
      unitRef="usd">9325000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMjgtMy0xLTEtNTY0NjI_b9fd040d-4b47-47d8-9beb-3c7b95777ee4"
      unitRef="usd">-7924000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzAtMS0xLTEtNTY0NjI_577d4a70-9a8d-4573-a851-cf8b6940ec33"
      unitRef="usd">2325000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzAtMy0xLTEtNTY0NjI_3abac890-0561-4f47-9415-1f88894274ad"
      unitRef="usd">1518000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzQtMS0xLTEtNTY0NjI_8c2b383c-82cc-47ab-b79e-b4d56065b32d"
      unitRef="usd">-2325000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzQtMy0xLTEtNTY0NjI_4537dc46-60e4-4e8c-9321-c462dbef1f1d"
      unitRef="usd">-1518000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzctMS0xLTEtNTY0NjI_de4fc6b2-3d59-462c-b536-a4b4e82a5721"
      unitRef="usd">318000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzctMy0xLTEtNTY0NjI_de83acae-4ad0-4d93-80e0-7bb03c6a0baf"
      unitRef="usd">308000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzgtMS0xLTEtNTY0NjI_f9c7f019-c1f2-4c31-9914-0e264f66910f"
      unitRef="usd">433000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzgtMy0xLTEtNTY0NjI_4b57f57d-27b3-41f5-ae8d-6a3e452dbf18"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzktMS0xLTEtNTY0NjI_41ebff81-4574-4eb5-96e9-ada08841e74f"
      unitRef="usd">283000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfMzktMy0xLTEtNTY0NjI_6bbc56bf-9d23-4c71-8800-571ba5702beb"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDEtMS0xLTEtNTY0NjI_023da8fb-e3a9-43c3-b14c-ca293d76c962"
      unitRef="usd">0</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDEtMy0xLTEtNTY0NjI_eec4d9f1-56f0-445f-ae3a-b7a965f19622"
      unitRef="usd">300000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDMtMS0xLTEtNTY0NjI_e11b2460-2d61-4e91-ae92-3043d14ed54d"
      unitRef="usd">165000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDMtMy0xLTEtNTY0NjI_d75ac47c-8521-4582-b169-24471a36e8ca"
      unitRef="usd">795000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDUtMS0xLTEtNTY0NjI_897f6e63-e382-4ff0-89a2-509e3571717b"
      unitRef="usd">823000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDUtMy0xLTEtNTY0NjI_fd4615cf-8ff1-46c3-be94-756d450b918d"
      unitRef="usd">7971000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDYtMS0xLTEtNTY0NjI_addb4e51-bf7a-4b4b-b43f-fb6a4a298c6b"
      unitRef="usd">-1156000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDYtMy0xLTEtNTY0NjI_f5080a1f-2e14-4c1a-8281-7760e5c9af8f"
      unitRef="usd">-9374000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDctMS0xLTEtNTY0NjI_81718f6b-0bf7-4cc2-b059-ebd32bec01b5"
      unitRef="usd">-156000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDctMy0xLTEtNTY0NjI_64966fe9-a309-49c2-8ee8-5158cc848017"
      unitRef="usd">-827000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDgtMS0xLTEtNTY0NjI_d1ed3d83-bf4c-4fbb-a008-19a6b2c0a46f"
      unitRef="usd">5688000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDgtMy0xLTEtNTY0NjI_4201f8da-85a3-41cf-9b1a-1a3eea5ee56c"
      unitRef="usd">-19643000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDktMS0xLTEtNTY0NjI_c2537fdc-4642-4d9b-849f-5d0447bfc139"
      unitRef="usd">60032000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib40450c215064f9a9f895bc248da7a1e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNDktMy0xLTEtNTY0NjI_125756d2-a036-4147-98ac-cf7ab7c4b3d8"
      unitRef="usd">86184000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTAtMS0xLTEtNTY0NjI_378408fe-dcff-4391-9f94-21b84eb9b75a"
      unitRef="usd">65720000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7e403872b0564650b45c1c4ce25c58da_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTAtMy0xLTEtNTY0NjI_3a567a76-e824-406d-8ef1-b784a88a0414"
      unitRef="usd">66541000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTItMS0xLTEtNTY0NjI_b6ab73ac-2c6a-4c1a-b3ae-af8b04604f8e"
      unitRef="usd">1991000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTItMy0xLTEtNTY0NjI_7b6d64e7-8490-4851-be33-e91afca41a09"
      unitRef="usd">1809000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTMtMS0xLTEtNTY0NjI_bb3dd75a-972d-47b9-b28a-a068db05c7eb"
      unitRef="usd">25000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zMS9mcmFnOmIxOGQxY2RlNjE2MzQ0ZGZiZjNhYjIzNjUyNzQwNjQ1L3RhYmxlOjdlYjkzMmM1YTAwNjRmZmFhMzc5Njc1NTJmMGU3M2M5L3RhYmxlcmFuZ2U6N2ViOTMyYzVhMDA2NGZmYWEzNzk2NzU1MmYwZTczYzlfNTMtMy0xLTEtNTY0NjI_92387514-74b1-4a0d-beaa-e83e3a32f796"
      unitRef="usd">45000</us-gaap:InterestPaidNet>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU1OQ_e24b1d86-d58d-443c-be70-4671ad43e323">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU2NA_fcfb68b4-2b32-4ba3-a873-5221b20e9597">Basis of Presentation&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a natural health and wellness company primarily engaged in the manufacture and sale of nutritional and personal care products. We are a Utah corporation with our principal place of business in Lehi, Utah, and sell our products directly to customers and to a sales force of independent consultants who use the products themselves or resell them to consumers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2023, and for the three-month periods ended March&#160;31, 2023 and 2022. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests changed as a result of the net income attributable to noncontrolling interests of $0.4 million and $0.3 million for the three months ended March&#160;31, 2023 and 2022, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, noncontrolling interests were $4.5 million and $4.1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncement issued or effective during the three months ended March&#160;31, 2023, had, or is expected to have, a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU4MA_786a713e-67f5-423d-b00b-e8e2acba9f04">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") for interim financial information and with the instructions to Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. The unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of normal recurring accruals), considered necessary for a fair presentation of our financial information as of March&#160;31, 2023, and for the three-month periods ended March&#160;31, 2023 and 2022. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the year ending December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU3Mw_222b1e25-497a-46e3-833a-b3f5ac40633c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities, in these financial statements and accompanying notes. Actual results could differ from these estimates and those differences could have a material effect on our financial position and results of operations.&lt;/span&gt;&lt;/div&gt;The significant accounting estimates inherent in the preparation of our financial statements include estimates associated with our determination of liabilities related to independent consultant incentives, the determination of income tax assets and liabilities, certain other non-income tax and value-added tax contingencies, and legal contingencies. In addition, significant estimates form the basis for allowances with respect to inventory valuations. Various assumptions and other factors enter into the determination of these significant estimates. The process of determining significant estimates takes into account historical experience and current and expected economic conditions.</us-gaap:UseOfEstimates>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzAxMg_c178c62f-291e-4363-88a8-983da6e310ea"
      unitRef="usd">400000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterestPeriodIncreaseDecrease
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMTY0OTI2NzQ0NjMwMQ_1c1cf980-d67f-4ffd-a7c2-260d5f814622"
      unitRef="usd">300000</us-gaap:MinorityInterestPeriodIncreaseDecrease>
    <us-gaap:MinorityInterest
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzI0Mw_794a1ee6-c2db-4082-ab78-78b51a0c7372"
      unitRef="usd">4500000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfMzI1MA_afc9d594-c380-4d69-9ccc-3a2b90633b3a"
      unitRef="usd">4100000</us-gaap:MinorityInterest>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8zNy9mcmFnOjcxYmY0ZDE0OGM5ODRhMWU5OThmZjAzMzg2YTc1MDBiL3RleHRyZWdpb246NzFiZjRkMTQ4Yzk4NGExZTk5OGZmMDMzODZhNzUwMGJfNDU1Mg_b67e8129-d468-4697-b31c-4d7101866362">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncement issued or effective during the three months ended March&#160;31, 2023, had, or is expected to have, a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RleHRyZWdpb246MGFhMmRkODc0NDFjNGRjMGI1ZmYxNjY4NDdhNGM2Y2NfMTEw_ddcfb547-2ecf-452a-a6c5-8d9c112169e0">Inventories&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RleHRyZWdpb246MGFhMmRkODc0NDFjNGRjMGI1ZmYxNjY4NDdhNGM2Y2NfMTA2_2fd542f0-8e50-4a20-b0f0-9be3b2ce920d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The composition of inventories is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMS0xLTEtMS01NjQ2Mg_a2f5282d-d654-4711-b04d-712924a6b255"
      unitRef="usd">22183000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMS0zLTEtMS01NjQ2Mg_34cfd828-fb16-419d-a888-82c2570feaca"
      unitRef="usd">23133000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMi0xLTEtMS01NjQ2Mg_1b4eb6c2-2f91-45c5-b666-25982cd6d0a8"
      unitRef="usd">1614000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMi0zLTEtMS01NjQ2Mg_c87648cc-17c3-47e9-b9c7-d84aeb9e661c"
      unitRef="usd">1713000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMy0xLTEtMS01NjQ2Mg_f8fe1982-fc0a-4c5b-ab3f-4cd5cf9d3212"
      unitRef="usd">43727000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfMy0zLTEtMS01NjQ2Mg_5d15b9d4-dd68-4400-86a6-9db1682a4113"
      unitRef="usd">43103000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfNC0xLTEtMS01NjQ2Mg_f85e1948-de1c-43cc-8fec-ea6b2f7b4d74"
      unitRef="usd">67524000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80MC9mcmFnOjBhYTJkZDg3NDQxYzRkYzBiNWZmMTY2ODQ3YTRjNmNjL3RhYmxlOjU4ZTZhYzhjZDNmNDRkOTRhMTA0Y2ZlOWFhYWFlMzY3L3RhYmxlcmFuZ2U6NThlNmFjOGNkM2Y0NGQ5NGExMDRjZmU5YWFhYWUzNjdfNC0zLTEtMS01NjQ2Mg_7991a0ea-1105-49e4-97b6-7867c11e913d"
      unitRef="usd">67949000</us-gaap:InventoryNet>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMjc3_ea29424c-8da7-4605-9b49-eb4c4b355e97">Investment Securities - Trading&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our trading securities portfolio totaled $0.7 million at March&#160;31, 2023, and $0.7 million at December&#160;31, 2022, and generated gains of $47,000 and losses of $58,000 for the three months ended March&#160;31, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfODQ_e940aa49-0c00-466b-a6ec-c83ee55a90fe"
      unitRef="usd">700000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRestricted
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfOTg_dd747dda-4e60-49b6-a5bb-8f4e39e3f749"
      unitRef="usd">700000</us-gaap:DebtSecuritiesTradingRestricted>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMTMy_babf91a7-0df6-4b5a-9f33-eb475d8eb54b"
      unitRef="usd">47000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:DebtSecuritiesTradingRealizedGainLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80My9mcmFnOjYzYzIwMTcwZDllZTQ2ZTE4Y2VmOTQyZGYyOTdjYTgyL3RleHRyZWdpb246NjNjMjAxNzBkOWVlNDZlMThjZWY5NDJkZjI5N2NhODJfMTM5_61430a8f-fa9e-49de-aa2e-813154992bce"
      unitRef="usd">-58000</us-gaap:DebtSecuritiesTradingRealizedGainLoss>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMjEwMA_7082023e-b0e3-4910-a2c1-96eac637043e">Revolving Credit Facility and Other Obligations&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 11, 2017, we entered into a revolving credit agreement with Bank of America, N.A., with a borrowing limit of&#160;$25.0 million (the &#x201c;Credit Agreement&#x201d;).&#160;On June 23, 2022 the credit agreement was amended to extend the term to mature on July 1, 2027 and allows for additional borrowings of $25.0&#160;million or up to three separate increases of no less than $5.0&#160;million each, subject to the lender's due diligence. The amendment to the Credit Agreement also modified the calculation of interest. Interest under the amended Credit Agreement is the greater of BSBY Daily Floating Rate or the Index Floor, plus&#160;1.50 percent&#160;(6.39 percent as of March&#160;31, 2023), and an annual commitment fee of&#160;0.25 percent&#160;on the unused portion of the commitment. As of March&#160;31, 2023 and December&#160;31, 2022 we had outstanding balances under the Credit Agreement $0.2 million and $0, respectively, included in current portion of note payable within our Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement contains customary financial covenants, including financial covenants relating to our solvency and leverage. In addition, the Credit Agreement restricts certain capital expenditures, lease expenditures, other indebtedness, liens on assets, guarantees, loans and advances, dividends, mergers, consolidations and transfers of assets except as permitted in the Credit Agreement. The Credit Agreement is collateralized by our manufacturing facility, accounts receivable, inventories and other assets. As of March&#160;31, 2023, we were in compliance with the debt covenants set forth in the Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 21, 2020, we entered into a credit agreement with Banc of America Leasing and Capital, LLC, with a borrowing limit of $6.0&#160;million (the "Capital Credit Agreement"). On November 19, 2020, we executed on the Capital Credit Agreement and borrowed $3.7&#160;million. We pay interest on any borrowings under the Capital Credit Agreement at a fixed rate of 3.00 percent and are required to settle our borrowings under the Capital Credit Agreement in 36 monthly payments of $0.1&#160;million. The Capital Credit Agreement is collateralized by any new equipment purchased under the agreement. As of March&#160;31, 2023, there was $0.9&#160;million outstanding balance under the Capital Credit Agreement, of which $0.9&#160;million was classified as current.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i43b99692a035464f8b8f7f2449d7eccc_I20170711"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTc1_889ebc6b-0d81-4511-ba79-b9dd6d8b508a"
      unitRef="usd">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings
      contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzM5_e4165706-6abb-4bbb-8629-8971448569d4"
      unitRef="usd">25000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings>
    <natr:LineOfCreditFacilityNumberOfSeparateIncreases
      contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzUx_ab0af69b-9953-48df-b9b4-f3c697658d7d"
      unitRef="borrowing">3</natr:LineOfCreditFacilityNumberOfSeparateIncreases>
    <natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence
      contextRef="i5181311b4b2e46549f7db94eeae94161_I20220623"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMzg5_555046d8-ed8b-4ea1-b97c-6f3a61071942"
      unitRef="usd">5000000</natr:LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i576cde29c1fd40f8b8fece1e7aeedef2_D20220623-20220623"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjMw_73c8c47e-6845-4fca-aa26-fb442a3d2581"
      unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i3ae9de4d3934431b85c33730e67cac1d_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjM0_87bf62b8-3fc5-461c-9fd6-8fbfad8962b1"
      unitRef="number">0.0639</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="if3b6867cf47247f4968d279e124711d2_D20220623-20220623"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfNjgw_7761cf73-63fe-4dda-aef4-fbb158d6154d"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCredit
      contextRef="i4bf0ac744d7941f3852747082611c11b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY0OTI2NzQ0Mzk3Mg_3893715b-4927-4e9b-9039-80a01b435ed9"
      unitRef="usd">200000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ieee06864f03e4d04abae69411c2a8c28_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY0OTI2NzQ0Mzk4NA_d7635397-b1a1-45f3-a5a1-3a2af94fb661"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5bad9899385e49ba89421036e841df7e_I20200421"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTU1Mw_22509866-3217-4d2f-8366-0b95485359d7"
      unitRef="usd">6000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="ic3b0bb7e541c48fbad2bb35bbc0811d0_I20201119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTY2OQ_e59aecbb-c650-44e8-a88e-7b5cd9d51e0d"
      unitRef="usd">3700000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id70a83bdb8dd4e80ac710803192a2c56_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTc2MQ_315156a6-74f3-4747-8a24-2c0680708b63"
      unitRef="number">0.0300</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <natr:DebtInstrumentNumberOfMonthlyPayments
      contextRef="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTg1Mg_06cf80c8-4a25-46b6-86c8-39c030eea6f3"
      unitRef="payment">36</natr:DebtInstrumentNumberOfMonthlyPayments>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i1d75242697824ad2af3cd40128e940b3_D20201119-20201119"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTg3NQ_6d17019b-5586-489a-8414-3262b40aa17e"
      unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCredit
      contextRef="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMTk5OA_663025b4-fc39-4880-8a59-415b9ac70abc"
      unitRef="usd">900000</us-gaap:LineOfCredit>
    <us-gaap:LinesOfCreditCurrent
      contextRef="ica22b5b31a8048ef87c8f2bc7024e7d5_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80Ni9mcmFnOjRmMDE1YzZmNDJlZDQwMGViMjA0NjM5NTBlODJiYzJkL3RleHRyZWdpb246NGYwMTVjNmY0MmVkNDAwZWIyMDQ2Mzk1MGU4MmJjMmRfMjA2Ng_171295c7-cf21-41e0-a5b8-22c8badc1ede"
      unitRef="usd">900000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTc2Ng_2884168b-1020-4cd8-bf7a-b220d637b3ff">Net Income (loss) Per Share&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per common share (&#x201c;Basic EPS&#x201d;), is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted net income per common share (&#x201c;Diluted EPS&#x201d;) reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an anti-dilutive effect on net income per common share.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive shares excluded from diluted-per-share amounts include performance-based options to purchase shares of common stock for which certain earnings metrics have not been achieved. Potentially anti-dilutive shares excluded from diluted-per-share amounts include both non-qualified stock options and unearned performance-based options to purchase shares of common stock with exercise prices greater than the weighted- average share price during the period and shares that would be anti-dilutive to the computation of diluted net income per share for each of the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTc2OA_f591d5a0-6e93-43d7-a833-f97207644f03">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS for the three months ended March&#160;31, 2023 and 2022 (dollar and share amounts in thousands, except for per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:2.264%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income (loss) attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted-average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share attributable to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Anti-dilutive shares excluded from diluted-per-share amounts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &#160;&#160;&#160;&#160;As a result of the net loss for the three months ended March 31, 2022, no potentially dilutive securities are included in the calculation of diluted loss per share because such effect would be anti-dilutive. Potentially dilutive securities for the three months ended March 31, 2022 include 282 restricted stock units.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNS0xLTEtMS01NjQ2Mg_b8351f4c-0a35-4445-aafe-8b62b5457bda"
      unitRef="usd">860000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNS0zLTEtMS01NjQ2Mg_bac058bf-c32f-4a31-8517-633d4f4d22ae"
      unitRef="usd">-2950000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNy0xLTEtMS01NjQ2Mg_60ad4b2c-d9f0-41f2-97d1-84cca67215b0"
      unitRef="shares">19061000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfNy0zLTEtMS01NjQ2Mg_8b6cb30a-397c-49a2-90a7-421365cd4167"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTItMS0xLTEtNTY0NjI_b1a789f8-b252-455c-891d-f13a2b6246a1"
      unitRef="usdPerShare">0.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTItMy0xLTEtNTY0NjI_6b504b6b-ea99-40ae-b1b0-de15b0828af9"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTUtMS0xLTEtNTY0NjI_f0b47c37-3cef-4340-bed3-26090d61365c"
      unitRef="shares">19061000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTUtMy0xLTEtNTY0NjI_48703483-7fe5-4186-bcd6-84a527f0e3ac"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTYtMS0xLTEtNTY0NjI_7b429351-09b4-4086-83d1-756f577c42e5"
      unitRef="shares">372000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTYtMy0xLTEtNTY0NjI_ed64da79-d6a1-46f8-9586-c4f52f0135e0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTctMS0xLTEtNTY0NjI_eda8933c-0f72-44f8-9103-3b2966201f74"
      unitRef="shares">19433000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMTctMy0xLTEtNTY0NjI_2901683b-eb83-456b-a752-ce643029b022"
      unitRef="shares">19573000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjItMS0xLTEtNTY0NjI_32773862-8ff9-436d-9158-e909e7a957d5"
      unitRef="usdPerShare">0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjItMy0xLTEtNTY0NjI_31ff7b76-65a4-45e0-ad54-236d6b4a29d8"
      unitRef="usdPerShare">-0.15</us-gaap:EarningsPerShareDiluted>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjUtMS0xLTEtNTY0NjI_41bd7677-5d33-467e-a5fc-920f1f1c751e"
      unitRef="shares">520000</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <natr:DilutiveSecuritiesExcludedfromComputationofEarnings
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjUtMy0xLTEtNTY0NjI_3ede83e2-c90e-47ce-849b-fa759f5717fc"
      unitRef="shares">0</natr:DilutiveSecuritiesExcludedfromComputationofEarnings>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjgtMS0xLTEtNTY0NjI_45310afe-34e7-4f7b-a66b-f2d622c06375"
      unitRef="shares">102000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RhYmxlOjFkZmYzNWFhYzRmMzQ2NmU4YzRiMGU2N2MzNGEwNzVjL3RhYmxlcmFuZ2U6MWRmZjM1YWFjNGYzNDY2ZThjNGIwZTY3YzM0YTA3NWNfMjgtMy0xLTEtNTY0NjI_97a7f87d-74fc-44a8-8e82-f7e62cd2ff6e"
      unitRef="shares">282000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfOTE0_aab16e74-9251-4c59-bdb2-1ff8f1418caf"
      unitRef="shares">0</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV80OS9mcmFnOmRmNjM3YzM0ZGJhZTRhNTY4YjQzNjljMWY0NDI5OGVkL3RleHRyZWdpb246ZGY2MzdjMzRkYmFlNGE1NjhiNDM2OWMxZjQ0Mjk4ZWRfMTEzNg_59f1b6ee-d932-4369-b508-25ded64ec6f2"
      unitRef="shares">282000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg0NA_af558679-b0e4-42bb-a1c0-88b6540b7a98">Capital Transactions&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The declaration of future dividends is subject to the discretion of our Board of Directors and will depend upon various factors, including our earnings, financial condition, restrictions imposed by any indebtedness that may be outstanding, cash requirements, future prospects and other factors deemed relevant by our Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 10, 2021, we announced a $15.0&#160;million common share repurchase program. On March 8, 2022 we announced an amendment to the share repurchase program allowing the repurchase of an additional $30.0&#160;million in common shares. The repurchases may be made from time to time as market conditions warrant and are subject to regulatory considerations. For the three months ended March&#160;31, 2023, we repurchased 90,000 shares of our common stock for $0.8&#160;million. For the three months ended March 31, 2022, we repurchased 451,000 shares of our common stock for $8.0&#160;million. At March&#160;31, 2023, the remaining balance available for repurchases under the program was $23.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2012, our shareholders adopted and approved the Nature&#x2019;s Sunshine Products,&#160;Inc. 2012 Stock Incentive Plan.&#160;The 2012 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance awards, stock awards and other stock-based awards.&#160;The Compensation Committee of the Board of Directors has authority and discretion to determine the type of award, as well as the amount, terms and conditions of each award under the 2012 Incentive Plan, subject to the limitations of the 2012 Incentive Plan. A total of 1,500,000 shares of our common stock were originally authorized for the granting of awards under the 2012 Incentive Plan. In 2015, our shareholders approved an amendment to the 2012 Incentive Plan, to increase the number of shares of common stock reserved for issuance by 1,500,000 shares. On May 5, 2021, our shareholders approved the Amended and Restated 2012 Stock Incentive Plan, which among other amendments, increased the number of shares of common stock reserved for issuance by 2,000,000 shares. The number of shares available for awards, as well as the terms of outstanding awards, are subject to adjustment as provided in the Amended and Restated 2012 Incentive Plan for stock splits, stock dividends, recapitalizations and other similar events.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding stock options include time-based stock options, which vest over differing periods of time ranging from the date of issuance to up to 48 months from the option grant date, and performance-based stock options, which have already vested upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no share-based compensation expense from stock options for the three- month periods ended March&#160;31, 2023 and 2022. As of March&#160;31, 2023 and December&#160;31, 2022, there was no unrecognized share-based compensation expense related to the grants described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2023, the aggregate intrinsic value of outstanding and exercisable stock options to purchase 127,000 shares of common stock was $0. At December&#160;31, 2022, the aggregate intrinsic value of outstanding and exercisable options to purchase 143,000 shares of common stock was $0.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three-month period ended March&#160;31, 2023, no shares of common stock were issued upon the exercise of stock options. For the three months ended March&#160;31, 2022, we issued 29,000 shares of common stock upon the exercise of stock options at an average exercise price of $9.17 per share. The aggregate intrinsic value of options exercised during the three-month periods ended March&#160;31, 2023 and 2022, was $0 and $0.3 million, respectively. For the three-month periods ended March&#160;31, 2023 and 2022, the Company recognized $0 and $0.1 million of tax benefits from the exercise of stock options, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, we did not have any unvested stock options outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our outstanding restricted stock units (&#x201c;RSUs&#x201d;), include time-based RSUs, which vest over differing periods of time ranging from 12 months to up to 36 months from the RSU grant date, as well as performance-based RSUs, which vest upon achieving targets relating to adjusted EBITDA growth, and/or stock price levels. RSUs granted to members of the Board of Directors contain a restriction period in which the shares are not issued until two years after vesting. At March&#160;31, 2023 and December&#160;31, 2022, there were 106,000 and 94,000 vested RSUs, respectively, granted to the Board of Directors with an accompanying restriction period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three-month period ended March&#160;31, 2023, no RSUs were granted under the 2012 Incentive Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to time-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was approximately $0.8 million and $0.5 million, respectively. As of March&#160;31, 2023 and December&#160;31, 2022, the unrecognized share-based compensation expense related to the grants described above, excluding incentive awards discussed below, was $2.2 million and $3.0 million, respectively. The remaining compensation expense is expected to be recognized over the weighted average period of approximately 1.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to performance-based RSUs for the three-month periods ended March&#160;31, 2023 and 2022, was $0.3 million and $0.3 million, respectively. Should we attain all of the metrics related to performance-based RSU grants, we would recognize up to $4.5 million of potential share-based compensation expense. We currently expect to recognize an additional $2.2 million of that potential share based compensation expense. &lt;/span&gt;&lt;/div&gt;The number of shares issued upon vesting of RSUs granted pursuant to our share-based compensation plans is net of the minimum statutory withholding requirements that we pay on behalf of our employees, which was 15,000 and 60,000 shares for the three-month periods ended March&#160;31, 2023 and 2022, respectively. Although shares withheld are not issued, they are treated as common share repurchases for accounting purposes, as they reduce the number of shares that would have been issued upon vesting. These shares do not count against the authorized capacity under the repurchase program described above.</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iad7a3e92766a4588bcf410162f828313_I20210310"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTEzNA_305708c9-01aa-4887-a60f-309cfa1a51ad"
      unitRef="usd">15000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iec9e1feefec641229f8793d60e0ba7a2_I20220308"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTI4Ng_568afba9-0735-4508-9396-4f09427e1598"
      unitRef="usd">30000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTQ3OA_a2e309a5-6bdd-47ea-8ad9-79743152c0a8"
      unitRef="shares">90000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTUxOQ_c1a638bf-437c-47d3-ae87-98e8066d97b7"
      unitRef="usd">800000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ2Mjk2Mw_50eeabcf-26bd-4b70-bde1-e6c945d8c4ed"
      unitRef="shares">451000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ2Mjk3Mg_9a0d3f1a-9c10-416c-a072-cea6e1944144"
      unitRef="usd">8000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTYyMQ_57276082-7427-4011-bd5a-71b44a7811f2"
      unitRef="usd">23200000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ic119a54e942d4fb496dbaf51f43c3a16_I20121231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjMyOQ_c723d4f6-f9f7-4db8-ab5d-87cd6dd800c5"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i17132172a34944c19d1a0af61112f1ff_D20150101-20151231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjU5NA_9e6db81d-274f-42ac-8ae8-62b083e26fad"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="ice5ff017c4644e0ba536b10add46fcac_D20210505-20210505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjgwMQ_9f2f1b73-070d-4e00-a040-28c5b2caceb4"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i60b15fb6f7a54f76a4f03d8f40724290_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzIzMQ_46c94eca-349c-4e0b-a418-f1812a72eb74">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne
      contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM2OA_e8571d74-b644-4bd4-8f9e-ee7d51fb4192"
      unitRef="number">0.06</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo
      contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM3Mg_77d4cfeb-f3c2-43d5-89d7-f64f2388a609"
      unitRef="number">0.08</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree
      contextRef="ifbbbb2397e8541348882e58fab6bab51_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzM3OQ_d996d8d5-aa7b-48ee-b1f2-0cf54570a717"
      unitRef="number">0.10</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg1MQ_10990a9b-6d86-4480-8081-a030a10a94fd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&#160;Per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited or canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS0xLTEtMS01NjQ2Mg_afa8facc-4ed1-44e2-b563-673a49488026"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS0zLTEtMS01NjQ2Mg_abc475f9-092d-426d-9b47-2a125ac9e158"
      unitRef="usdPerShare">12.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMS01LTEtMS01NjQ2Mg_9ee6f5a6-b2bd-4d96-b341-be55541c6774"
      unitRef="usdPerShare">5.28</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi0xLTEtMS01NjQ2Mg_6cd13ada-7e5b-4baf-bcc5-61dd26e333da"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi0zLTEtMS01NjQ2Mg_48df4eb1-cf5c-429a-8120-661da7b209d2"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMi01LTEtMS01NjQ2Mg_7a416aae-23aa-43b3-81a1-3c286e86af19"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy0xLTEtMS01NjQ2Mg_35637067-e789-4a0e-93de-aed0545aa70d"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy0zLTEtMS01NjQ2Mg_6f1668fe-dfbd-447a-9c9a-22972064156c"
      unitRef="usdPerShare">11.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfMy01LTEtMS01NjQ2Mg_4f5efca6-310d-4c4e-a3c9-76d53f73b6a5"
      unitRef="usdPerShare">0</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC0xLTEtMS01NjQ2Mg_fdbedb0b-f8fb-4240-a0ad-b259b3669fe4"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC0zLTEtMS01NjQ2Mg_43bfff9c-1b9a-49d9-a2ce-af630dc4a8d1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNC01LTEtMS01NjQ2Mg_1e87dda5-b059-4299-b970-59e6205a9735"
      unitRef="usdPerShare">0</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS0xLTEtMS01NjQ2Mg_91a6b44f-bd06-490e-b3b6-d91a79ccd44c"
      unitRef="shares">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS0zLTEtMS01NjQ2Mg_0d18c108-41d5-4ba1-a919-c529d82d0df1"
      unitRef="usdPerShare">12.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOmFlMmM3NTRjM2RmZTQ4ZGZhNzhiNDE3MzRiOWE2ODdkL3RhYmxlcmFuZ2U6YWUyYzc1NGMzZGZlNDhkZmE3OGI0MTczNGI5YTY4N2RfNS01LTEtMS01NjQ2Mg_f56ccc99-eec7-4465-8c77-c2629ac1acea"
      unitRef="usdPerShare">5.16</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_529d1146-5f86-4190-90f5-177618c94ff8"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_869d712e-95b7-4855-aabd-2bced28f2aac"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_9c5b02f5-b4db-4cba-8dd2-967528570517"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzYwNw_a6897db6-fd2c-47de-9522-86fdf06d264c"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzcyMw_1cf8b7ef-a5c1-4043-8957-2d03f1d41c09"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzcyMw_31445fc5-bb67-490e-9180-982fee2c83d3"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzkwNg_be367e44-ae9a-4e88-ad97-84b916ef3e9f"
      unitRef="shares">127000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="icd667127b304410783b1f535dacef921_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMzkzNg_11383a46-8c0c-4c6c-976a-474a9efac935"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDAyOA_d9a98b07-bb98-4003-8bc6-9b60808f2d23"
      unitRef="shares">143000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i148e2e4f78504b7f860c8bb7235cd422_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDA1OA_d0641b1a-d819-441d-96b9-3f2e1b32e1ff"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMTY0OTI2NzQ1NjY3NQ_a9f390ed-a864-4f21-91f1-c62e54124902"
      unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDEyMg_311bfe0d-9e24-46d8-87bf-d763f2cc3417"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDIyMg_0cae716f-9eb8-4bdf-b582-c38f8b88fd46"
      unitRef="usdPerShare">9.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjc0ODc3OTA4NjkwNQ_f327e63e-af1a-4713-a96a-667e3c684448"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDM1Nw_df2e1b67-ef40-47e2-9a7f-9fef00deaf49"
      unitRef="usd">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDQ0MA_23de8bdf-9217-4645-a49d-3325deda03de"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="ibb15334867c24f4883d4b2f9d96c952c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDQ0Nw_be4ef960-558f-4db6-9a10-4d08ee4d54e9"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i9dd6e9c7d1174a5196db741bd9bd6e22_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDU0MQ_e800bec7-282e-4c7d-949a-227a07908d30"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i9f71d03224964432937c9462c7320fd7_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDU0MQ_ea064cb1-2b32-447a-ad5d-a07a436160e1"
      unitRef="shares">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ied1fdb1621154a2c992f780e1bfa1706_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDc0Ng_ec276eeb-2d33-436e-9861-61e5e19f2df8">P12M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7da32705f94942c49d3c710e71c1c4bc_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNDc1OA_62db5665-461f-489c-87d4-b4fe601db25f">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <natr:RestrictionPeriodForIssuanceOfShares
      contextRef="iec6bb5c1e51f4f79902860d3143fa47f_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTAzNQ_92ab85bd-ad56-4955-a8a7-beaa9be258f4">P2Y</natr:RestrictionPeriodForIssuanceOfShares>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="ib20931e909f04ba3884bbaf616843da2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTA3OA_0ed198dd-8ea1-4713-9e50-06700bdbabb8"
      unitRef="shares">106000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber
      contextRef="i127289bd16c74b78bcba51e1e0e6b297_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTA4NQ_553115b2-5cc0-4512-a0d3-54b0ac75d3d1"
      unitRef="shares">94000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODg2MQ_92bb777d-3a31-42dd-87df-b44c7adee3c4">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock unit activity for the three-month period ended March&#160;31, 2023, is as follows (amounts in thousands, except per share information):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number&#160;of&lt;br/&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&#160;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted Stock Units outstanding at March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i70143db360d648a09df5ae0c19ad6a0c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMS0xLTEtMS01NjQ2Mg_568f9ff4-01cd-4180-99a1-1d76d5dc14ae"
      unitRef="shares">1091000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i70143db360d648a09df5ae0c19ad6a0c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMS0zLTEtMS01NjQ2Mg_a0e5e311-6dcc-4f24-b8f7-81e572d8003c"
      unitRef="usdPerShare">10.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMi0xLTEtMS01NjQ2Mg_7bf06202-73c2-4d8d-90df-dfc7f9e018fa"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMi0zLTEtMS01NjQ2Mg_d73008b4-7c90-4db0-8ad4-2b0786856ddf"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMy0xLTEtMS01NjQ2Mg_1de27cdb-6dbf-4612-ab09-fa71b5f4da14"
      unitRef="shares">45000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfMy0zLTEtMS01NjQ2Mg_6058f460-16e3-4e7e-8ede-3c815da547d8"
      unitRef="usdPerShare">2.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNC0xLTEtMS01NjQ2Mg_6d5cd9ff-6ce5-4793-9afd-ef8d14444415"
      unitRef="shares">57000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNC0zLTEtMS01NjQ2Mg_dfa3da7b-e320-4f54-95e5-e9ee28721a22"
      unitRef="usdPerShare">12.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iceb089485d284690b3a27c0501d8a380_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNS0xLTEtMS01NjQ2Mg_7a6e5239-cf96-4580-b328-3d3386eceadb"
      unitRef="shares">989000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iceb089485d284690b3a27c0501d8a380_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RhYmxlOjRjNDA5NzEwMTM4ZTQ5NTk4ZGRmMzJkNTBjYjZiYzFjL3RhYmxlcmFuZ2U6NGM0MDk3MTAxMzhlNDk1OThkZGYzMmQ1MGNiNmJjMWNfNS0zLTEtMS01NjQ2Mg_1d525e8e-6fe4-4107-9bbf-064e2c5fdea2"
      unitRef="usdPerShare">11.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2291328f3b5a4d449d0215a204417f0e_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNTM3NQ_91ab5318-bf56-47aa-9c97-c6a9da4d860b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzM2MQ_ec822452-402b-462f-a8a3-210520b2de38"
      unitRef="usd">800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzM2OA_1436745f-430d-4a41-ad5b-80d1811368ba"
      unitRef="usd">500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ia02c469dbbc24747a8b591560a3ee008_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzY4NQ_77718954-306e-4a0c-bd49-4e7ec42827e9"
      unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ib801a3e8a35c48218f48568d2ed7dda1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzY5Mg_96e3972e-d3e6-47f0-8389-46b9e3f3a792"
      unitRef="usd">3000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzgyNA_6aa02a83-1923-456a-96cf-9e0a0c062e47">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia01162aa2d194e3182890cbff779a0bf_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzk0Ng_df046b1e-7f19-4193-a57b-3d7a7c02a516"
      unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib996c0038abc4f538cb2d29806f221fb_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfNzk1Mw_52ec7f1b-569e-4cf7-9454-cca65eb9eff8"
      unitRef="usd">300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="ie19d15fa8feb4d7fb9e9852fb4440016_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODIxMQ_5fe43aa6-6bed-4bf3-aa00-8d1ca42722ce"
      unitRef="usd">4500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i170c7005fd4e4233977c6c670cb2c2d6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfMjc0ODc3OTA4NjI3MA_e184ef8d-6d69-4a22-a511-7f962856ad31"
      unitRef="usd">2200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="i72ee30156b4c4f8c8947c7adf5978b50_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODQ3NA_c3e8b8f1-77c8-4c23-bf30-69a3da4fe71d"
      unitRef="shares">15000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements
      contextRef="i1bfd49e5f95b4116a60e3d1e7a8af97d_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81Mi9mcmFnOmIyMWUwYjcwMTQ1YjRlZTVhYTk4NTY3YWYyMzY3MGZlL3RleHRyZWdpb246YjIxZTBiNzAxNDViNGVlNWFhOTg1NjdhZjIzNjcwZmVfODQ4MQ_0f448963-c16f-4e9d-83f9-b21e4b3fe174"
      unitRef="shares">60000</natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4MQ_2bf3334d-c230-413f-bb17-cd7aa87db56c">Segment Information&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have four business segments (Asia, Europe, North America, and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. The geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy WorldWide&#xae; brands. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities independent of the Company that we have granted distribution rights for the relevant market.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales for each segment have been reduced by intercompany sales as they are not included in the measure of segment profit or loss reviewed by the chief executive officer. We evaluate performance based on contribution margin by segment before consideration of certain inter-segment transfers and expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $3.7 million and $4.9 million for the three-month periods ended March&#160;31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March&#160;31, 2023 and 2022, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMzk_a2ed756c-bce7-407d-beac-f889fd06ffe9"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4Mg_5e96bd07-8cf9-4ebb-93a1-62c1124f121c">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reportable business segment information is as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contribution margin (1):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expenses (2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other loss, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(314)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_________________________________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:27pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Contribution margin consists of net sales less cost of sales and volume incentives expense.&lt;/span&gt;&lt;/div&gt;(2)&#160;&#160;&#160;&#160;Service fees in China totaled $3.7 million and $4.9 million for the three-month periods ended March&#160;31, 2023 and 2022, respectively. These service fees are included in selling, general and administrative expenses.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMy0xLTEtMS01NjQ2Mg_c94b3124-49e4-4d8d-b817-0f3f310af78f"
      unitRef="usd">46345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMy0zLTEtMS01NjQ2Mg_919c3dc6-d881-4402-9c3b-3e12f2e94477"
      unitRef="usd">46110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNC0xLTEtMS01NjQ2Mg_d5f8ab97-c409-40ad-a33b-e7ebd8e587ea"
      unitRef="usd">21405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNC0zLTEtMS01NjQ2Mg_b53f98dc-f1be-4b59-aa93-6f26c373e836"
      unitRef="usd">21777000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNS0xLTEtMS01NjQ2Mg_29766de6-2e5e-4724-9f22-d1bd9a124591"
      unitRef="usd">34648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNS0zLTEtMS01NjQ2Mg_47e30e3a-3f4c-460b-b175-9cbd46cd9923"
      unitRef="usd">35981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNi0xLTEtMS01NjQ2Mg_de5370ab-a17d-4c46-854c-48c13d30b460"
      unitRef="usd">6236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNi0zLTEtMS01NjQ2Mg_6ba61c6d-1c4c-4d9f-8a8e-18a7b297de30"
      unitRef="usd">6626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNy0xLTEtMS01NjQ2Mg_f9281f3c-b44e-46e8-85e7-4ff27bf5b9bb"
      unitRef="usd">108634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfNy0zLTEtMS01NjQ2Mg_8e757514-6157-481e-83ec-d16ef9b367ba"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <natr:ContributionMargin
      contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTAtMS0xLTEtNTY0NjI_3e78cb36-3878-452d-b138-363c03f0c3ef"
      unitRef="usd">21951000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTAtMy0xLTEtNTY0NjI_0b23e619-cb03-4681-a7aa-43c52f82964c"
      unitRef="usd">21939000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTEtMS0xLTEtNTY0NjI_f11c1b8c-ca9d-450e-a0d5-8defb7f8d788"
      unitRef="usd">6536000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTEtMy0xLTEtNTY0NjI_411eb8f7-04a8-4f22-8c03-af0b5f9fe034"
      unitRef="usd">4373000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTItMS0xLTEtNTY0NjI_e7a0b92b-88f2-4b2c-a9f8-08b9855513c9"
      unitRef="usd">12861000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTItMy0xLTEtNTY0NjI_211101a2-bf5c-4b7b-934c-56270944a2c7"
      unitRef="usd">12719000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTMtMS0xLTEtNTY0NjI_88f74a66-1b0b-4731-a4e9-6ba004a20163"
      unitRef="usd">2466000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTMtMy0xLTEtNTY0NjI_3b2bd557-dc29-4162-b87b-f1c4c825d5c1"
      unitRef="usd">2901000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTQtMS0xLTEtNTY0NjI_b1a662c7-cd99-420c-b277-4b7fe03f66a0"
      unitRef="usd">43814000</natr:ContributionMargin>
    <natr:ContributionMargin
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTQtMy0xLTEtNTY0NjI_6a81a7d0-a566-4aac-b665-e8dd94f14f4a"
      unitRef="usd">41932000</natr:ContributionMargin>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTYtMS0xLTEtNTY0NjI_3f2faa26-9110-453c-83fd-46c27ea68bb2"
      unitRef="usd">43642000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTYtMy0xLTEtNTY0NjI_e4397737-7dab-4f9c-9694-1326a159fb8f"
      unitRef="usd">40623000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTctMS0xLTEtNTY0NjI_42d04bdc-6323-49dd-bc66-b6d8032a2032"
      unitRef="usd">172000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTctMy0xLTEtNTY0NjI_181cb37c-e69a-458a-b0d6-207d36070bb1"
      unitRef="usd">1309000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTktMS0xLTEtNTY0NjI_8e956c18-fefc-4b58-bde6-de68465e9389"
      unitRef="usd">1514000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMTktMy0xLTEtNTY0NjI_c1716939-275b-4ea1-8a3b-621ade47bc43"
      unitRef="usd">-314000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMjAtMS0xLTEtNTY0NjI_8f34c5f2-b56b-46b7-bc53-0788936d5fd7"
      unitRef="usd">1686000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmQ1OWY4NTEyNWQ1MTQyNThhNTA2OWVhMzA3YWY5NzRkL3RhYmxlcmFuZ2U6ZDU5Zjg1MTI1ZDUxNDI1OGE1MDY5ZWEzMDdhZjk3NGRfMjAtMy0xLTEtNTY0NjI_51c239ea-f9ff-41ea-9988-acd781b9c9f6"
      unitRef="usd">995000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1ecf051891dc4540bc1a158727bface1_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTE2Nw_add5415e-331e-495d-9a22-a57624e7ca53"
      unitRef="usd">3700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i72b2b7d2469d443699c8c1599a668568_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTY0OTI2NzQ0MzY2Ng_b767e885-8dfd-4b2e-b108-dc7866c1f273"
      unitRef="usd">4900000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk3Ng_23495025-4e9f-4534-a4b7-79802004b59a">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country/region perspective, the United States, South Korea and Taiwan comprise 10 percent or more of consolidated net sales for the three-month periods ended March&#160;31, 2023 and 2022, as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net sales:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Taiwan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;South Korea&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i549144157ff34d2fb598832930efc245_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfMy0xLTEtMS01NjQ2Mg_4357ace6-e2d4-4e5e-bbfa-31747602a838"
      unitRef="usd">31986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e4c046cce2249f2aad2d456f289e8b5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfMy0zLTEtMS01NjQ2Mg_176de013-08c5-4462-a59f-17e13528c8ae"
      unitRef="usd">33229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3de2700723f44230bd14ea658ce0674b_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNS0xLTEtMS01NjQ2Mg_81197a9f-8cb3-4a57-b6b7-3d61c242aaa9"
      unitRef="usd">14175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7865ea6a10c944dd9cf7b4d199be8b36_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNS0zLTEtMS01NjQ2Mg_b5457669-4a1c-4dfc-a83c-faa498e98cc8"
      unitRef="usd">9750000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i704b9d7df3314907a965decd5192d199_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0xLTEtMS02MDEyMg_a70d3fb5-76e8-4e20-909c-ca953cc87883"
      unitRef="usd">11240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f4f53a1500e4c3d8c20fceb1d303105_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0zLTEtMS02MDEyMg_b277e3a1-594a-4202-9ddb-3e6dc966d451"
      unitRef="usd">13653000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6926d9bdf25244c48c11ee85cac897fc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0xLTEtMS01NjQ2Mg_b777a9d3-0782-4015-99af-7d79396e723c"
      unitRef="usd">51233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief991aa102dc4df286a636f2768bf677_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNi0zLTEtMS01NjQ2Mg_1eec1aaf-07f0-4cc7-8e8f-42e0cdb1fb19"
      unitRef="usd">53862000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNy0xLTEtMS01NjQ2Mg_35cc49a6-751c-472b-bcc9-aac2da845ac3"
      unitRef="usd">108634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmUzNTRkOGM5Y2FkMTQyMDA4MmRhODNjMzY5MTZkMjc5L3RhYmxlcmFuZ2U6ZTM1NGQ4YzljYWQxNDIwMDgyZGE4M2MzNjkxNmQyNzlfNy0zLTEtMS01NjQ2Mg_64e6eafb-6c32-42e8-9dd3-1d31f8fbf45d"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk2OQ_b28fde80-5ee7-4f47-aa54-a55e445e1283">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Immune&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cardiovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Digestive&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Personal care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weight management&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1def7196a1394561a30f23c2f5945836_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMy0xLTEtMS01NjQ2Mg_204b8b15-fb47-4f1e-8ccf-cc22252fa4f8"
      unitRef="usd">13764000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ab4170a48ba44688bfbcdb858a32779_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMy0zLTEtMS01NjQ2Mg_03b46df0-1901-4f44-ad1b-dc10ac669270"
      unitRef="usd">12986000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafc86721ece64baf808c893cc035d52a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNC0xLTEtMS01NjQ2Mg_cf4269d0-72a5-4f45-a43e-d4d86b70e8eb"
      unitRef="usd">462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic11c371bce764450ac20c60711a22727_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNC0zLTEtMS01NjQ2Mg_41bd24e1-bd32-47ca-8a5c-959d3823e835"
      unitRef="usd">1344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2403b429d1e4d5dbc736ea9f50b2db0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNS0xLTEtMS01NjQ2Mg_e6d06572-69f7-40b5-aee4-0e66cac551c0"
      unitRef="usd">14895000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3dadec0fe1ce41e581194b370338f5aa_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNS0zLTEtMS01NjQ2Mg_135a9a97-8bd8-4645-be48-59c066f7955d"
      unitRef="usd">13630000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i286bd26b9ba84374854d6dbd57593217_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNi0xLTEtMS01NjQ2Mg_99f84843-4394-4cf1-afe0-c4775313a93e"
      unitRef="usd">9422000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94c5f48d31de4e58896fadefe80c0fb7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNi0zLTEtMS01NjQ2Mg_5e843f85-8c55-40c3-a8f5-47bc5fa8e42c"
      unitRef="usd">9036000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie84001b2ee67469ab6af26eafcb4c8d6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNy0xLTEtMS01NjQ2Mg_4129c539-cbc3-40c8-8388-2f78ac6d1166"
      unitRef="usd">1341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdb780bc72204ed995bb3d5d750aaaa7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfNy0zLTEtMS01NjQ2Mg_c9a012e0-1347-47d8-9072-7b6f54ddbb5d"
      unitRef="usd">2543000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie66081dc8a1849988db515744c4a5191_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOC0xLTEtMS01NjQ2Mg_2c4c7126-9b63-495a-bca0-85413a361348"
      unitRef="usd">6461000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia242724c2a8d41a2a6629e376281c37d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOC0zLTEtMS01NjQ2Mg_3c82e0f1-fd1b-4c17-afad-89d5b7258963"
      unitRef="usd">6571000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i876de795cf24475e82b8e60d38aaf7e6_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOS0xLTEtMS01NjQ2Mg_b15755e8-23fa-43b9-96d4-0fc368e58e15"
      unitRef="usd">46345000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i173e420a774945fe8a9cab51cc4605ff_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfOS0zLTEtMS01NjQ2Mg_bb902cbd-3796-4285-b991-49e7d434ac94"
      unitRef="usd">46110000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27b0de65c7f04151b172ae37f38db95c_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTEtMS0xLTEtNTY0NjI_4f265ab5-2237-4b53-857e-7bcf5472bf0f"
      unitRef="usd">9174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70570a69247e4e4b9228e76f91348f73_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTEtMy0xLTEtNTY0NjI_50bc46d3-67e4-4381-9a84-2b813ff78949"
      unitRef="usd">9196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id935bb5a397e4fd5b3068cd551324f0d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTItMS0xLTEtNTY0NjI_54836eeb-6843-4ff0-9769-00bc229ce374"
      unitRef="usd">2284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0706faf1f08f497a95123914f1ad454c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTItMy0xLTEtNTY0NjI_7f4656f0-9598-4258-a664-97089878ed4f"
      unitRef="usd">2631000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2e2a755bd504b2d8ab7f427c3ce421e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTMtMS0xLTEtNTY0NjI_2b416507-c6ad-4a7e-a826-c6a1d47173f0"
      unitRef="usd">2519000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82ea8fd02a454b32af363f8584558ce2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTMtMy0xLTEtNTY0NjI_083ac4f6-cf29-4752-874e-52d369e61770"
      unitRef="usd">2633000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19eee5983a13470a8e2f0b19460061cc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTQtMS0xLTEtNTY0NjI_58f5bad7-857a-466d-ab98-8279320cc928"
      unitRef="usd">5738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d2601cc29e44ce8a1a4d2e106164fbf_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTQtMy0xLTEtNTY0NjI_5be49316-f4c8-4d1d-a9f3-7db20c51aa2e"
      unitRef="usd">5591000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7646bffa476a454e9fff94e8ff089fe7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTUtMS0xLTEtNTY0NjI_e28a3e00-ab51-47ac-bba3-6f12bd178f5f"
      unitRef="usd">1177000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab2c51f1dcbf45489ce126a589c4fed4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTUtMy0xLTEtNTY0NjI_3993538d-8e96-4941-bae0-0aadeb7193ea"
      unitRef="usd">1233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42e775b15edf42e0976566b58638008e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTYtMS0xLTEtNTY0NjI_93999a0d-a4e0-4193-9685-6eedd90de2a5"
      unitRef="usd">513000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fd494153a584910be8e82dd4ae90fb8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTYtMy0xLTEtNTY0NjI_782eba0c-b861-4f8f-87b0-387322e453ef"
      unitRef="usd">493000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic89e788790814555baa4f501d838cb1d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTctMS0xLTEtNTY0NjI_9118522f-4c44-4999-9e3f-3b20569d8b51"
      unitRef="usd">21405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2690c54cb5546f4b5b652dcdb8e3c09_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTctMy0xLTEtNTY0NjI_f971a88e-77cb-42e3-b7bb-d356db634a74"
      unitRef="usd">21777000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f3e9061310940c78e07309d597a0c3f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTktMS0xLTEtNTY0NjI_ba4d5fd4-9f86-4301-ad74-7ab07e202aaa"
      unitRef="usd">15534000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd8baa0e541a4e3db131ac25deeece46_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMTktMy0xLTEtNTY0NjI_9dfb932f-fab6-4435-a6c0-0953fb3d7cc7"
      unitRef="usd">15314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i004051f877df4e358f3020fdd40e15bf_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjAtMS0xLTEtNTY0NjI_51a195e6-c722-4928-a5cb-5e1a5c1f8f5d"
      unitRef="usd">4320000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide005a7559004658904c94d8e1c9d7a3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjAtMy0xLTEtNTY0NjI_39b3e382-822e-43a4-80a8-86682c272a80"
      unitRef="usd">4872000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09c2138d4f6448da9af09aa9cad5d832_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjEtMS0xLTEtNTY0NjI_51eb0595-74d4-4777-915d-b2ae1dece84d"
      unitRef="usd">3588000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31c73008cac84edd9bf7a7c951a8ace6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjEtMy0xLTEtNTY0NjI_6d817307-2103-4e51-b07b-be2edcd16985"
      unitRef="usd">3842000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89604f393d1406a9dc613f638bb9282_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjItMS0xLTEtNTY0NjI_bfc535a1-004a-4c02-a1a9-d18609960163"
      unitRef="usd">8731000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c76018a8ad24a3eb01b65729f05e002_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjItMy0xLTEtNTY0NjI_1e34d9b5-0ee0-45e4-9d1f-2f012b3546bb"
      unitRef="usd">8594000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ee552623371416a91f53435d09209ff_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjMtMS0xLTEtNTY0NjI_d2c282dd-058b-436b-ba6c-064f0258e0be"
      unitRef="usd">1464000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idea6fbc78a7e42978d9632750e427515_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjMtMy0xLTEtNTY0NjI_241f233d-efc6-4ad8-9805-3c629dc378c5"
      unitRef="usd">2175000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife96081680724014b04db995e830f541_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjQtMS0xLTEtNTY0NjI_6a65f1b0-2b39-4885-9a65-ac9ce1e9e740"
      unitRef="usd">1011000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cdde04916fb4085909452d7bf0e104b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjQtMy0xLTEtNTY0NjI_5403e69d-96c9-4435-babe-82c8931f833d"
      unitRef="usd">1184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide3b537021f84209a36b182180e7beb0_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjUtMS0xLTEtNTY0NjI_7f9ff2ab-797f-41d9-849d-c06e8a7e5f00"
      unitRef="usd">34648000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i529b6a830669494b8e359e0f300f1930_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjUtMy0xLTEtNTY0NjI_77fdb295-ce21-472c-947a-f2360f71ee00"
      unitRef="usd">35981000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i976cb70b3a6d4224ba518c55b10e68f7_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjctMS0xLTEtNTY0NjI_c0419b5e-d9ee-47ac-b281-e63bc52a2596"
      unitRef="usd">1637000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0211468578bd4079b559e74b92be8660_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjctMy0xLTEtNTY0NjI_be20a214-d9ac-4116-b3fb-968e27a06ba1"
      unitRef="usd">1818000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a725eb7fa624679b58b3693ddec3496_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjgtMS0xLTEtNTY0NjI_e27e73dd-e1f1-4912-a53a-f0350392f734"
      unitRef="usd">744000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83bf3f9f69a6453284bd5815b5c518b4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjgtMy0xLTEtNTY0NjI_f9ca4b7b-ad29-4ca3-a1c6-2da647a0a94f"
      unitRef="usd">761000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ef4c27b992044b28c84833e4d7a9482_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjktMS0xLTEtNTY0NjI_f8f56380-e1c2-4584-9d15-e56f9f5af11a"
      unitRef="usd">466000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia27f2c9f8dee4c3ebabd4dd807c88816_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMjktMy0xLTEtNTY0NjI_6e45c99f-a7ec-42c8-8c96-4d810b7de13d"
      unitRef="usd">357000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3493146182f54b58b709fb841b93942e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzAtMS0xLTEtNTY0NjI_cc6a6006-8dbc-4741-b4b6-af07571f8029"
      unitRef="usd">2885000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcdd69c0a6834a8f9f59f07e9398c5c4_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzAtMy0xLTEtNTY0NjI_1c4ef774-13f5-4125-882a-50bebf03ed5a"
      unitRef="usd">2841000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e831496e7a6437689b1d9ad266655aa_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzEtMS0xLTEtNTY0NjI_c61c883c-ff22-4552-a15c-aa72c4b9476a"
      unitRef="usd">351000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icce691f6ab25492fa9195960972e876b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzEtMy0xLTEtNTY0NjI_2a155584-2fb4-46ec-96ea-cdff1b4812da"
      unitRef="usd">641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26c43ae344d345a98b2a06cdcfe5a28d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzItMS0xLTEtNTY0NjI_d6f0519c-dc18-476c-81c8-6043704978c6"
      unitRef="usd">153000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0e66a63f3a348c481089b2cedcad2da_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzItMy0xLTEtNTY0NjI_481e0d08-ddf7-4d58-ad7c-0398315f46f7"
      unitRef="usd">208000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56d1e2e3fada4727b55573a407169196_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzMtMS0xLTEtNTY0NjI_9b148bf5-f141-4500-8df5-fb052ed23741"
      unitRef="usd">6236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f2303074f7c4005b174b2f498323c90_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzMtMy0xLTEtNTY0NjI_f1c6b6cc-af22-4170-9022-91857f3b5626"
      unitRef="usd">6626000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzQtMS0xLTEtNTY0NjI_40da9d53-b1ef-4810-b529-47c2f5de4e7d"
      unitRef="usd">108634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjk5MDQ2NWUwMDA1NzQyMjc5Njc4ODRkZDBjOWZjODBjL3RhYmxlcmFuZ2U6OTkwNDY1ZTAwMDU3NDIyNzk2Nzg4NGRkMGM5ZmM4MGNfMzQtMy0xLTEtNTY0NjI_7501ca2b-efa2-44eb-9a25-7d4d8643ea7c"
      unitRef="usd">110494000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk3MA_908916c9-3a2c-43a7-ab8d-0ffc2fdb92b6">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib66f65baeb8548a496f5f643074ca0b6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMi0xLTEtMS01NjQ2Mg_f4d4b067-3a5c-4e3a-a4f3-7340aa1e8747"
      unitRef="usd">42424000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2774331cf67440fb8010640bd77a71d6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMi0zLTEtMS01NjQ2Mg_405712c1-84e0-4d84-8556-0e3e1b232868"
      unitRef="usd">42389000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2b4e7456b9664b3bbd2032692ed8e46e_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMy0xLTEtMS01NjQ2Mg_ccf1b2c6-d9e4-4507-bce8-b92bd996141c"
      unitRef="usd">3656000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i459e294ae30142cbaa00703fe6880103_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfMy0zLTEtMS01NjQ2Mg_a8d6d6db-90e0-4f8e-b4db-872825cd642a"
      unitRef="usd">3773000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfNC0xLTEtMS01NjQ2Mg_20e94fba-5e31-42c7-8e8f-dcf398b87396"
      unitRef="usd">46080000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOmNmMzY5NDYwM2RmNjQwYjM4NjQyYTRjODI0Yzg4OTA5L3RhYmxlcmFuZ2U6Y2YzNjk0NjAzZGY2NDBiMzg2NDJhNGM4MjRjODg5MDlfNC0zLTEtMS01NjQ2Mg_72cd8f02-47cd-4c11-a1af-ca838bbaa3c1"
      unitRef="usd">46162000</us-gaap:PropertyPlantAndEquipmentNet>
    <natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RleHRyZWdpb246NzZkYzJkZGVjYzRiNDUzZWFkYzU0NmY5MWVkNjVjYWZfMTk4MA_500aa869-2b71-4326-a40a-ba7b77ef4b6a">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets per segment is set forth below (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.363%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.364%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</natr:ScheduleOfSegmentReportingInformationBySegment1TableTextBlock>
    <us-gaap:Assets
      contextRef="i63f7ccb539794924835d07e06230787c_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMi0xLTEtMS01NjQ2Mg_3cd708c7-0206-4f0e-a3d8-12cb05e4f038"
      unitRef="usd">100592000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifb1c7c7993f443cb9775f4cbebcc4b05_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMi0zLTEtMS01NjQ2Mg_35d09580-2dfd-49e3-a8e7-022343d19ddf"
      unitRef="usd">95362000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if62877c0017f46508b1b76d1b8b631bf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMy0xLTEtMS01NjQ2Mg_88746fc8-b8e6-4c2b-ad4c-2f7e4ebb81a6"
      unitRef="usd">18610000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i84625c382b684cbd80fa57354e915031_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfMy0zLTEtMS01NjQ2Mg_5ceb5c5d-6b0d-4330-bcae-f05ea6e92af1"
      unitRef="usd">15773000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1edeeda0c4c64b50ada9a9fb45333935_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNC0xLTEtMS01NjQ2Mg_a6fc884f-d25c-4632-85b1-0f066da018f6"
      unitRef="usd">107507000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i35b69da3bc5f431d8d17902ad62e8a25_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNC0zLTEtMS01NjQ2Mg_59bc537c-7d3c-4a81-8738-1d506015da90"
      unitRef="usd">112319000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1b94b216b4504cbeb1073d1ba015dc60_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNS0xLTEtMS01NjQ2Mg_1ef648b5-0d97-42ba-98dc-20891395465d"
      unitRef="usd">7875000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9d06d946a93b476bb5c22cdc41e56321_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNS0zLTEtMS01NjQ2Mg_6479e2a0-9b2c-4271-ad60-2e8e8baba99a"
      unitRef="usd">6324000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNi0xLTEtMS01NjQ2Mg_7ff9e5e1-78ee-4490-9124-798c820cc962"
      unitRef="usd">234584000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV81OC9mcmFnOjc2ZGMyZGRlY2M0YjQ1M2VhZGM1NDZmOTFlZDY1Y2FmL3RhYmxlOjMxM2IwYmFkNDUyYjRjMmM5ZWVmMDdlZGU4NmVlZjU1L3RhYmxlcmFuZ2U6MzEzYjBiYWQ0NTJiNGMyYzllZWYwN2VkZTg2ZWVmNTVfNi0zLTEtMS01NjQ2Mg_7f9f2924-4cb9-40a8-ac9f-ad57259660d0"
      unitRef="usd">229778000</us-gaap:Assets>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMjE5Ng_035c692f-33a4-4cc4-9fa1-0d55348006b7">Income Taxes&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022, our provision for income taxes, as a percentage of income before income taxes was 25.7 percent and 369.9 percent, respectively, compared with a U.S. federal statutory rate of 21.0 percent. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2023, was primarily attributed to an increase in tax liability related to foreign operations which are treated as a branch for US tax purposes and current year foreign losses that presently do not provide future tax benefit, partially offset by favorable adjustments to deferred tax assets and foreign tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate and the U.S. federal statutory tax rate for the three months ended March&#160;31, 2022, was primarily attributed to recording a valuation allowance against deferred tax assets for which we do not expect to receive a benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The difference between the effective tax rate for the three months ended March&#160;31, 2023 compared to March&#160;31, 2022 is primarily caused by recording a valuation allowance in the prior period against deferred tax assets for which we do not expect to receive a benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. federal income tax returns for 2019 through 2021 are open to examination for federal tax purposes. We have several foreign tax jurisdictions with open tax years from 2017 through 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, we have accrued $0.2&#160;million and $0.2 million, respectively, related to unrecognized tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interim income taxes are based on an estimated annualized effective tax rate applied to the respective quarterly periods, adjusted for discrete tax items in the period in which they occur. Although we believe our tax estimates are reasonable, we can make no assurance that the final tax outcome of these matters will not be different from that which we have reflected in our historical income tax provisions and accruals. Such differences could have a material impact on our income tax provision and operating results in the period in which we make such determination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTQ0_f19dc501-f436-4802-b97e-caeb621304c8"
      unitRef="number">0.257</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie98b286b49214fd4aba6420a7ae2e127_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTUx_a4f17406-4bcc-44a6-b716-1bf2df9b69f2"
      unitRef="number">3.699</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5013a2410f1f48fe86da71c75ac9b931_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTU1Nw_6aaa5797-913b-48c7-aa28-ecefb8d50445"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i0eb8c277981f4b25971776c77e8450b0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82MS9mcmFnOjE2ZGZlNGY5ZmRlYjRiNmNhOGJhYTcyYzI4NzM3OTBiL3RleHRyZWdpb246MTZkZmU0ZjlmZGViNGI2Y2E4YmFhNzJjMjg3Mzc5MGJfMTU2NA_dc1c5b5d-da7e-4b67-99d9-321b6c5a7399"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY4OQ_e4d96c32-f409-440c-8d86-9baf2eb6b149">Commitments and Contingencies&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are party to various legal proceedings and disputes. Management cannot predict the ultimate outcome of these matters, individually or in the aggregate, or their resulting effect on our business, financial position, results of operations or cash flows as litigation and related matters are subject to inherent uncertainties, and unfavorable rulings could occur. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on our business, financial position, results of operations, or cash flows for the period in which the ruling occurs and/or future periods. We maintain product liability, general liability and excess liability insurance coverage. However, insurance may not continue to be available at an acceptable cost to us, such coverage may not be sufficient to cover&#160;one or more large claims, or the insurers may successfully disclaim coverage as to a pending or future claim.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-Income Tax Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reserved for certain state sales and use tax and foreign non-income tax contingencies based on the likelihood of an obligation in accordance with accounting guidance for probable loss contingencies. Loss contingency provisions are &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recorded for probable losses at management&#x2019;s best estimate of a loss, or when a best estimate cannot be made, a minimum loss contingency amount is recorded. We provide provisions for potential payments of tax to various tax authorities for contingencies related to non-income tax matters, including value-added taxes and sales tax. We provide provisions for U.S. state sales taxes in each of the states where we have nexus. As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $0.3 million and $0.3 million, respectively, related to non-income tax contingencies. While we believe that the assumptions and estimates used to determine contingent liabilities are reasonable, the ultimate outcome of these matters cannot presently be determined. We believe future payments related to these matters could range from $0 to approximately $2.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;We are a party to various other legal proceedings and disputes in the United States and foreign jurisdictions.&#160;As of March&#160;31, 2023 and December&#160;31, 2022, accrued liabilities were $0.5 million and $0.6 million, respectively, related to the estimated outcome of these proceedings. In addition, we are a party to other litigation where there is a reasonable possibility that a loss may be incurred, but either the losses are not considered to be probable or we cannot at this time estimate the loss, if any; therefore, no provision for losses has been provided.&#160;We believe future payments related to these matters could range from $0 to approximately $0.4 million.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover
      contextRef="i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfODc2_01d73d05-288b-4c90-b164-208b7ffde994"
      unitRef="claim">1</natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i278d8bc5355b477b92355f58a24f1d03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMTcyMw_76ec9ae8-7eb8-4891-b7b3-99cf3ca427ba"
      unitRef="usd">300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ice670056e3d74a568288807e81b6068f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMTczMA_ea21c01f-12f0-4e27-9687-91fc97077314"
      unitRef="usd">300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i99ca42816690450e90028e1c208eecb6_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjAzNw_729ec385-4c77-4b12-92f7-c3782e78eb1f"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ia864dc347810434d8b15fe90be07c05b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjA1Nw_43276dd8-fac6-4d7c-b5de-b701d7b48f3b"
      unitRef="usd">2900000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="idc305e5943754b04a7642c1ac05895ad_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjIzNQ_f4807465-da47-446d-b942-f59abd0a401e"
      unitRef="usd">500000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="if40f94801a594eb68bcddde4144029a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjI0Mg_fe479fb1-3797-40cf-8f65-8bdb9d55644f"
      unitRef="usd">600000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i7e88ec88e467480993fa728e6e906f56_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjU1Mg_2ea36a2a-d35a-434f-834c-ef84003d15f3"
      unitRef="usd">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i8ef804aa7364469e9a21ea865050d6ce_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY2NA_b21ae80e-5d0c-476c-b707-95853c896571"
      unitRef="usd">0</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ice92b1b1c68e485b9d90bc7240e9693a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV82NC9mcmFnOjNjMTRlMmYwMDQ0MDRhZWQ5MTc3YjU3MTVlNzY2NDExL3RleHRyZWdpb246M2MxNGUyZjAwNDQwNGFlZDkxNzdiNTcxNWU3NjY0MTFfMjY4NA_a16bd101-33f1-46f9-b2a0-e0e1cfe2221e"
      unitRef="usd">400000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RleHRyZWdpb246NzNlNjMyMjBkN2NhNDc2ODg4MDMyNzIzZGU4ZTJjZmJfMjE2Nw_5fc72024-02e4-438b-bf9d-607d3432804c">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of a financial instrument is the amount that could be received upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets are marked to bid prices and financial liabilities are marked to offer prices. Fair value measurements do not include transaction costs. A fair value hierarchy is used to prioritize the quality and reliability of the information used to determine fair values of each financial instrument. Categorization within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The fair value hierarchy is defined into the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1: Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3: Unobservable inputs that are not corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2023 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment securities - trading&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Our trading portfolio consists of various marketable securities that are valued using quoted prices in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and for the year ended December&#160;31, 2022, there were no fair value measurements using significant other observable inputs (Level 2) or significant unobservable inputs (Level 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;The carrying amounts reflected on the condensed consolidated balance sheets for cash and cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The carrying value of our debt approximates fair value due to its recent acquisition and short maturity. During the three months ended March&#160;31, 2023 and 2022, we did not have any re-measurements of non-financial assets at fair value on a nonrecurring basis subsequent to their initial recognition.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RleHRyZWdpb246NzNlNjMyMjBkN2NhNDc2ODg4MDMyNzIzZGU4ZTJjZmJfMjE2OA_d1e07351-d51c-40c0-9c0d-b8fb3c55c8dc">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of March&#160;31, 2023 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our hierarchy for our assets, measured at fair value on a recurring basis, as of December&#160;31, 2022 (dollar amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in&#160;Active&lt;br/&gt;Markets&#160;for&lt;br/&gt;Identical&#160;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities - trading&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:TradingSecurities
      contextRef="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi0xLTEtMS01NjQ2Mg_87af8fea-aa44-4182-a9db-011052b709a3"
      unitRef="usd">718000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i80f04b1608e946ceac0e09928db01466_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi0zLTEtMS01NjQ2Mg_f2bd0d13-70c2-45fd-bccb-c45ba68099b8"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i5c631233fcb545f395609cfbcdaed083_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi01LTEtMS01NjQ2Mg_59c1253f-ab77-44d8-81fd-e539eddbb61f"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id34db597e9e84e55975f561965ebf581_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMi03LTEtMS01NjQ2Mg_5d4a28c1-cb38-40df-9d08-946df8963489"
      unitRef="usd">718000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id6e3a3b66f9b41d3aba5759632fdfb8f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy0xLTEtMS01NjQ2Mg_ddd15714-1b5d-482d-857c-6405d1f72c1b"
      unitRef="usd">718000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i80f04b1608e946ceac0e09928db01466_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy0zLTEtMS01NjQ2Mg_dd3a6582-5e0c-47ba-b28d-f284490050f9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c631233fcb545f395609cfbcdaed083_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy01LTEtMS01NjQ2Mg_50592f13-291e-439e-a6d6-0447a85f0c5b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id34db597e9e84e55975f561965ebf581_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjQ2MDlmZTNjZDYxNjQ5YmE4MTIzMGQxOGFjNGYxOWRlL3RhYmxlcmFuZ2U6NDYwOWZlM2NkNjE2NDliYTgxMjMwZDE4YWM0ZjE5ZGVfMy03LTEtMS01NjQ2Mg_b5e0a738-a890-4219-b345-56fdc2c49717"
      unitRef="usd">718000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:TradingSecurities
      contextRef="ida56900bef5d44d6a5e8107f70534e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC0xLTEtMS01NjQ2Mg_27978eda-dee0-43be-b3df-39387f1821a6"
      unitRef="usd">702000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC0zLTEtMS01NjQ2Mg_f9ad07e4-a901-4710-b759-4c0acb21e4b1"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="id080f7965727443cb14cd7096debc888_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC01LTEtMS01NjQ2Mg_1358d489-9d9e-46ed-bec7-eca057b810c9"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNC03LTEtMS01NjQ2Mg_f4d1947f-ca4b-4f7b-a71d-472f00d3dad1"
      unitRef="usd">702000</us-gaap:TradingSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ida56900bef5d44d6a5e8107f70534e32_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS0xLTEtMS01NjQ2Mg_ba36ac20-b8dc-4801-9159-e575988cf56a"
      unitRef="usd">702000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic13edbcc91f04a2aa2e5443ae0d03346_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS0zLTEtMS01NjQ2Mg_5a37beb8-469e-4058-a8fd-6e33e5348171"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id080f7965727443cb14cd7096debc888_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS01LTEtMS01NjQ2Mg_6782b2b6-0664-4511-b07c-cadd3761619d"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i66fd75e0d1a145098d7cc511e20b4d8f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83MC9mcmFnOjczZTYzMjIwZDdjYTQ3Njg4ODAzMjcyM2RlOGUyY2ZiL3RhYmxlOjg2MmVmNWNlNWE0ZDRkNzQ4ZWI4ZWI5YWU3MTg1NjgyL3RhYmxlcmFuZ2U6ODYyZWY1Y2U1YTRkNGQ3NDhlYjhlYjlhZTcxODU2ODJfNS03LTEtMS01NjQ2Mg_04027465-6e4e-4a62-b71f-9be4583153b8"
      unitRef="usd">702000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMzUyNw_81472f80-3933-4e3c-a5a8-d5d7875ffd35">Revenue Recognition&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net sales include sales of products and shipping and handling charges, net of estimates for product returns and any related sales incentives or rebates based upon historical information and current trends. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring products. All revenue is recognized when we satisfy our performance obligations under the contract. We recognize revenue by transferring the promised products to the customer, with revenue recognized at shipping point, the point in time the customer obtains control of the products. The majority of our contracts have a single performance obligation and are short term in nature. Contracts with multiple performance obligations are insignificant. Sales taxes and value-added taxes in the United States and foreign jurisdictions that are collected from customers and remitted to governmental authorities are accounted for on a net basis and therefore are excluded from net sales. Amounts received for unshipped merchandise are recorded as deferred revenue. Amounts for membership fees are deferred and amortized as revenue over the life of the membership, primarily one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reserve for product returns is recorded based upon historical experience and current trends. We allow independent consultants to return the unused portion of products within ninety days of purchase if they are not satisfied with the product. In some of our markets, the requirements to return product are more restrictive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Amounts billed to customers for shipping and handling are reported as a component of net sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Volume incentives and other sales incentives or rebates are a significant part of our direct sales marketing program and represent commission payments made to independent consultants. These payments are designed to provide incentives for reaching higher sales levels. The amount of volume incentive expense recognized is determined based upon the amount of qualifying purchases in a given month and recorded as volume incentive expense. Payments to independent consultants for sales incentives or rebates related to their own purchases are recorded as a reduction of revenue. Some payments for sales incentives are processed daily; while others, including rebates, are calculated monthly based upon qualifying sales. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products are grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. We have four business segments that are based primarily upon the geographic region where each segment operates. Each of the geographic segments operate under the Nature&#x2019;s Sunshine Products and Synergy WorldWide&#xae; brands. See Note&#160;7, Segment Information, for further information on our reportable segments and presentation of disaggregated revenue by reportable segment and product category.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Practical Expedients and Exemptions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have made the accounting policy election to treat shipping and handling as a fulfillment activity rather than a promised service under Topic 606.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <natr:RevenuefromContractwithCustomerRefundPeriod
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMTQxMg_c71bc13c-478f-4344-96df-3fc24777e6cc">P90D</natr:RevenuefromContractwithCustomerRefundPeriod>
    <natr:NumberofPrincipalCategoriesofProducts
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMjU3OQ_07a25f54-e657-4913-a7cc-cc88f01f0f28"
      unitRef="product_category">6</natr:NumberofPrincipalCategoriesofProducts>
    <us-gaap:NumberOfReportableSegments
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV83My9mcmFnOjdiYjQzMGVkN2JmMjQ4NWQ5ZWY2ZTlkN2VmNWJkYTg0L3RleHRyZWdpb246N2JiNDMwZWQ3YmYyNDg1ZDllZjZlOWQ3ZWY1YmRhODRfMjcwMA_1917b44f-275a-4690-8c0a-7c619c6cb9b4"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:LossContingencyDisclosures
      contextRef="i037da2db44724416a7e87967f0045ef9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV81NDk3NTU4MTc1NjE_8b6f1882-9d1b-4cc6-8763-d6e01bc5370a">Synergy Japan LossOn February 17, 2023, we became aware that Synergy Worldwide Japan G.K., a Japan entity and wholly owned subsidiary of the Company (&#x201c;Synergy Japan&#x201d;), was the victim of a criminal scheme involving employee impersonation and fraudulent requests targeting Synergy Japan. The criminal scheme resulted in a series of fraudulently induced wire transfers between February 1, 2023, and February 17, 2023 totaling $4.8 million. We promptly launched an investigation, led by an independent third party, to determine the full extent of the fraud scheme and related potential exposure. We self-discovered this fraudulent activity and promptly initiated contact with our bank as well as appropriate law enforcement authorities in an effort to, among other things, recover the transferred funds. To date, we have not found any evidence of additional fraudulent activity and do not believe the incident resulted in any unauthorized access to confidential consumer information or other data maintained by the Company.  As a result of this matter, we incurred investigation and other professional fees of $1.0 million, which along with the initial $4.8 million loss, were recorded in Selling, General and Administrative expense for the three months ended March&#160;31, 2023. We do not expect this incident to otherwise have a material impact on our business.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDU4_a8547c46-d52f-4988-b137-030954171614"
      unitRef="usd">4800000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:ProfessionalFees
      contextRef="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDUy_61723ac0-8472-4652-aa91-6af8b0eab80a"
      unitRef="usd">1000000</us-gaap:ProfessionalFees>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="if71398dbc89d4a618f3225c340b48e5c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmFmZjgwZDZmZWJhODQ1MzFhYTc2ZTZhZGFmZWNhZjNhL3NlYzphZmY4MGQ2ZmViYTg0NTMxYWE3NmU2YWRhZmVjYWYzYV8xMDYzL2ZyYWc6OTk5ZDI5N2IwNWJhNDU0ODk0NTcxOWU5NzcxMTY1MjEvdGV4dHJlZ2lvbjo5OTlkMjk3YjA1YmE0NTQ4OTQ1NzE5ZTk3NzExNjUyMV8xNjQ5MjY3NDQ0MDc1_a40768e4-9277-4c2c-b0ab-9d8d2e528fce"
      unitRef="usd">4800000</us-gaap:LossContingencyLossInPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !MB:E6>:U5%?$%  #$'P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69[V_:.!C'_Q6+2=.=5)K8@4(WBD33=D.W,0;T3KO3O3")@6A)S#D.M/_]
MV0DD;>4\1-'HBY*$/%_\\>,?7]N#/1<_DPUC$CU%89S<M#92;C]85N)M6$23
M2[YEL?IFQ45$I;H5:RO9"D;]+"@*+6+;5U9$@[@U'&3/IF(XX*D,@YA-!4K2
M**+B^9:%?'_3PJWC@UFPWDC]P!H.MG3-YDP^;J="W5F%BA]$+$X"'B/!5C>M
M$?[@.HX.R-[X,V#[Y,4UTBA+SG_JF[%_T[)UB5C(/*DEJ/K8,9>%H592Y?CO
M(-HJ?E,'OKP^JC]D\ IF21/F\O"OP)>;FU:_A7RVHFDH9WS_F1V NEK/XV&2
M_4?[_-U.IX6\-)$\.@2K$D1!G'_2IT-%O A0H.8 <@@@;P)PU2\XAX"LYJR\
M9!G6'95T.!!\CX1^6ZGIBZQNLFA%$\0ZC7,IU+>!BI-#E^^80%.5,=1&R88*
ME@PLJ83UUY9W$+G-14B%B(.^\EAN$G0?^\Q_'6^I A6E(L=2W1)0\"L5E\C!
M%XC8Q#&4QX7#1UL53HSAKXKC%)7D9'H.6$G_C):)%*K=_6NJH5RA8U;0G?%#
MLJ4>NVFIWI8PL6.MX?MW^,K^:,+[16*O8#L%; =2']YQ+U7]5*+%\Y:92.%P
M;+>_FY# J(9(W0*I6P_I>TJ%9")\1C.VY4*:\& I*5)3I;A@5$.\JP+OJA[>
ME(F ^[H7(C48&),'*Q7]KK+C@?$-.7L%9Z]FRQ14S2/9-%"=1UAK1</$F$@P
MK"%@OP#L@X6ZCV4@G]%#$#(T2:,E$R8P6,.V<=OI=/K&[(&A#>&N"[CK.G S
MM@[T,*K2.*&1L8W".I/1XG%V__Y=G^#>QSF:/T[FG\>3>S2=?;M[=!?SB[S$
MXXE[::H"4+QA%6"[G&WM.I4PCCTN5,.EN@U?H+E4O15Q@5R>QE(\JT_?6#,G
MU!\7)F(XJ"GR"X.!ZR OZ!,:^ZKW!JO R[B!)GY"LM]KVP[I7?>)D1<,;LI+
M2EY2AW?D^TH]N3A>H"_J/?0M-N<5EB37-D:W8<K6@BJE6YZ&;$>%;Z0'I9K2
METX)@]X$IE_LN9$>EIRG@61Y$;%M&YG/X9=P:9@P;'G>,KOZ3O7F!=_'1EY8
M[@O;!$;*<U@H7'HH##N?MY3%H#45?!?$GKEAPYH5 ]8YS!0NW12&3=!;T"E/
M) W1W\&V>ER&%?L=NV.<C^&XIJ2EG\*P"<H:ZDBM_JO!8(&^C8U8YS!1N'11
M&+9 7[BG\C7=\!BR42=$G YN]ZXKQIMS^"A<&BD,.Z!%()5!Y"N$R6_+W]&<
M>:E0F31"PDHNCR(U$<\E]WY>H)BC+15H1T/S&@<6:XA-2N]$8'>C7+\?Q&LT
M?XZ6/#31GA!0SG%FW$PXAT$BI4$BL)LYY@_=/WD;&J]9I3$^(309S>]&QL4W
M'-B4L+1$I)8E<E,A]/(M7[-EJ51S2&K<<#JA^,.X3>7"44TY2_-#:IF?<2R9
MR/<G]3J<'L&-G+!B%><Y# \I#0^I97CT.E6M690-6'-A''Y.Z(P\CRD))>#G
M8D;6<]@>4MH>4LOVS",:AN@V3=37B;G%-MLX@L.:XI5FA]0R._<1$VO=(S\I
M!;E1?B#:TMB<4UBP<F,%CFL*6GH= EN58QXW3.41PFNX;P3'-<4K/0^IM77T
M>D*?9_OYZ%LJE8.-]>1I)/Y%;N90#[E:-U/3ATB[(;ZV.]V.W1U8.Q-CZ7M(
MK1TD5PVE0AF\<>RS)_0',Z<1EK+5'^EU[:[Y=.$<1L<IC8X#^Y11Q&(_V^A\
M"*DQ92<$*ALI'-<4K'0Z#FQ0B@W<AR#1%OT'4W;S03TT#J@GQ*IVJ.&PIHRE
MUW%@9_*6\; G7TT)RWTW+K#@H*:,+X[#8%=R-'(OTP@=.IR0:[<Q:3MFT%]J
M=*P7YZ1ZPLN.CQ/DZ5W7_,BT>%H<48^R@UFK?#T_W_Y*]7R9H)"M5*A]V5,#
MGLB/C/,;R;?9J>N22\FC['+#J,^$?D%]O^)<'F_T#Q0']\/_ 5!+ P04
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MWKY;VMY8M6Y>S]PI:]6JN5Q* >*= 7R_4- P[V[<&Y_V#=_T/U!+ P04
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M/$ #55Y49<?(K#CK%]+@S5$T$[S;0=D ?+Z4TCQU[/51_UL(_@)02P,$%
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ML8QCN[<&>084IH/=*\Z>C:^,;"@C.L%"36 =1IP#(\[SC+ C0UGN&2?W!<D
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M)D>O5O)7;=E3;Q)V7DWQ/7,TWK@,IZC?7JUO*-E5;UM^(922K+K<XFB-"V[
MOK\GA/ZXX2]P'MXAGO\'4$L#!!0    ( &V)J59IFE/IDP@  + E   8
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M\>@D -V9ODLL-=YH"[)L6Q^6_$ZB=@6\OB2RV\1MT+^\LW]02P,$%     @
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MU@A'\[/!=/SBXI#EH\#OBM9^ZRS8DYFU7_CA=74VR)D0:2H#(TC\6=$E:<U
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MZ,!(2GSD)>)3K=QC56*(8\7[;B=A?XNY,M!3,;@KPCGX#37V=<<UW- IV:A
M9@02N"K3?-&T(H</ 2ZNOH>&NX/$I8=Q <B2'!-#I38JP!C=X'L%PNA3T-'<
M2-^]LW&.*<1B!O<-N@MR"H'A*I#>$_NQ:-&,J/$(8B4N8SU5JYB_(7IKI1#,
M"D<,K@4Y',H^JG$ZL@(6B?%SW')>$C;8E-3$LD7UH;!"2N0N/_<D PV%O:^Y
MFZ16_T!_=AOC64O3SK&Z6A<ST$UO]$)9VC8EH"2UXL+@5"'VP3I%B6N*2R*Y
MN]#C?%^C[V/AV;K1*E9.'-;,GT.ZE6X@\4#$Y5[_,)FGC5-:%,E&OFN'[-T<
MY=;F$&^0:W:;?;E,U3 4;]Y</KA,CK_?)8-.]1[70=HC[^!=[//Q\VW"-U2V
MG,AND.P#B>02#P@?3+*3C?5,?(Y-V\_86(WF=GN%;$V-O?CXA]:[ 7I<)O!Q
MDN5WHS-6,1+HZ&NK7%IT2%/ I. "^G_&D-7),18&ON\PR4&>WZ9-EV?C.\\^
M/0BRJYC9<8-/>F;91+&F125*'EY;&^>NCG:7*U<TQ;T.0L_O-N_]D?P?W!VR
MA?52P<(W: Q?:O1-6IO\E&9RMNN;;[3UK1XG!_\BX1"@/]-G>_^V_]$S3=_Z
M=^+I%Q.\7?!(UC2':IZ=' V$2[]"TD.P3?SRG]F F1V/2_QP(\<"N)];;(KN
M@0WT/P7/_P502P,$%     @ ;8FI5IQ(5RH8!0  00X  !D   !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&ULK5?;;MLX$/T50ET4"9#8LARG:2X&DE[0/K0(
MFKT\+!8+6AI;1"72):DX_?L]0\J2G2:INZT?K-O,F3-7DN<K8S^[DLB+N[K2
M[B(IO5^>#H<N+ZF6;F"6I/%E;FPM/1[M8NB6EF01E.IJF*7I\;"62B?3\_#N
MVD[/3>,KI>G:"M?4M;1?KZ@RJXMDE*Q??%*+TO.+X?1\*1=T0_Z/Y;7%T[!#
M*51-VBFCA:7Y17(Y.KTZ8OD@\*>BE=NX%^S)S)C/_/"^N$A2)D05Y9X1)"ZW
M](JJBH% XTN+F70F67'S?HW^-O@.7V;2T2M3_:4*7UXD)XDH:"Z;RG\RJW?4
M^C-AO-Q4+OR+590=IXG(&^=-W2J#0:UTO,J[-@X;"B>/*62M0A9X1T.!Y6OI
MY?3<FI6P+ TTO@FN!FV04YJ3<N,MOBKH^>E'Y/V]SDU-8J\RSNV+:[+BII26
MSH<>!EALF+=@5Q$L>P1L+#X8[4LGWNB"BFW](8AU[+(UNZOL2< /T@[$>'0@
MLC0;/X$W[KP=![SQ(WAOI-5*+USOI/C[<N:\17'\\Y"_$>[H83ANF%.WE#E=
M).@(1_:6DNGS9Z/C].P)LD<=V:.GT'\T-?\;3%Q)IW*A(:&BQ!*?<%.C:UR0
MV'O^["3+TK,H^>;Z)CR/SO8/A'(LNFP\%6+V513J5A4(\28<7ON2Q"IT",3D
M+5DTO-!-/8,E,]\RY@1FA_-2!YBBL7QA?;!2IAB(UZH*UG8AO);=H,RCA&>"
MBZ#&D_9*5F .41X4OI0>:$U5")/GC15J+M"'^6=AEBP @B -9;:I0^T RR 2
MKJ&.1E!8$;C0'=E<.; P00/>,R6EH;,I/1"_E]0&4P8FB,R& Z(P"(XV7DA8
MJGO@'M>U6H[ 6WE%+GJS"MZ4"+R0F(1P^#"ZBQ<TGR,: HI/!'0@WIH* YQS
M@8Q+!!$6<U6ICBE'$QE%:CWX('T8CMI@9(5G"'3%P\'ZKO2FXUA[@H(O+9&H
MXXPAGC$"$R(ONQ$1@'"3B;T"?&5$CB4A:]-H9$IQADWC\,4=((8Y+7VPP#Y'
M4:7C:@?/]D^1%;:Z.=FBK6#G8Q^SMJ^D]U;-D,)916(CQ8Q<FJI EL1OXN0X
MQ?]>=O!RDNZWH?FF01[HA]'+@_1XQ)?)BW&K1^NIUC+H'=F-2SI()TPF'8PF
M^UW@OS5^>H_GX<X\;[B^#WGUA',K:0LGQB\RP2TYRLXZDSL"'XW':^"UYB\(
MP=&]$'!OM/91)%7#>9];4\=! 9*P<;A56J=QGF[[.<G2SL_+K<;[!>"C-!/9
M":I]M"_^W?47I"]C$SML7KKF12ES]'9NM^P TZB?H-57T?O6#Z#84*V/H?DP
MY&25-U4W.EJGH_4^=3/*98/QYAK8;,=4G&0SVAYB W']'18[^[3F&N** *%Z
M\M .8: W6F$/_(BU'\IG9P=?PK31^3JYZV4&U;ILP$VZOA/FVPL,N[4J%?CG
M6%6P!^\[H2:F[N+4YU5C1L2[X%+1+17;/LB?*,S.D1G61!C2AU\:6:FYZH*V
M]H=G<:.9(#[]E-LK!5/=\K>$GQ!:X%#BB=,L]=:&XW![H$;Y;W<6_5JQM6K>
MK[7UZG5OH2X>WI5$BYPF0NC7K18-HM9YUZBA-GAHOSC<V-9CI5R$PPMOMQ#V
MN,/OWG;GH\MX+.C%X^$*-;Y0B&U%<ZBF@Q>31-AX8(D/WBS#(0%)Q)$CW)8X
MXY%E 7R?&Y1+^\ &NE/C]#]02P,$%     @ ;8FI5@W+]E'P"0  [QX  !D
M  !X;"]W;W)K<VAE971S+W-H965T,3,N>&ULS5G9;ALY%OT50FTT$D"12HNW
MQ#9@Q^F9/*03Q,[T0V,>J"I*JDYM(5F6U5\_YUZR-FVVN]' /-BJA;R\Z[F'
MK(M5KK^;I5)6/*9)9BY[2VN+M\.A"9<JE6:0%RK#FWFN4VEQJQ=#4V@E(YZ4
M)L-Q$)P,4QEGO:L+?O9%7UWDI4WB3'W1PI1I*O7Z1B7YZK(WZE4/OL:+I:4'
MPZN+0B[4G;+?BB\:=\-:2A2G*C-QG@FMYI>]Z]';FRF-YP'_B=7*M*X%63++
M\^]T\S&Z[ 6DD$I4:$F"Q,^#>J^2A 1!C1]>9J]>DB:VKROIO[#ML&4FC7J?
M)[_%D5U>]LYZ(E)S62;V:[[ZM_+V').\,$\,_Q<K-W:,%</2V#SUDW&?QIG[
ME8_>#ZT)9\&>"6,_8<QZNX58RUMIY=6%SE="TVA(HPLVE6=#N3BCH-Q9C;<Q
MYMFK][*(K4S$O9:9D>PI<S&TD$SOAZ&7<N.DC/=(F8A/>6:71GS((A5UYP^A
M4:W6N%+K9GQ0X">I!V(RZHMQ,)X<D#>IS9RPO,D>>1]^E+%=B]^O9\9JF/G?
M738Z$=/=(J@ZWII"ANJRA_0W2C^HWM7//XU.@G<'%)S6"DX/27]V' Y*V:WC
M+M'B-GZ((Y5%1MPO%=(X3*267"?Y7,Q+6VH\K<?$!E4[^P.5)&PN+,V(3:A5
M-2$OM;C)I8[HYC;6&)AK(V06(9V3!/(!(I$H"PQ_D#K.2R/FD@?U19R%21G%
MV8+%**DS7./Y/,YD%L;0/,RS**:U^L !!##V1L1ID1L5B=D:2ZTA*%(SJZ),
M&0,EI46AK,5,0:XU%LI ;E^$TBPA!@FA%=#%TDK.WD+GIH#J3O$<9NI*2UB
MP1'F)>I!9I:6W&WT0-PM)81]546IPR4 0WS1^4++5'S.!/(Z7(I1P(F-]%XI
MK)7E919"N!1'H^-!@#)/$G)LF*<I?@S+TXV\PLD;- +/6-YX0QPP#P9&9&05
MMGVRA$P SQ0#&M5Z#]-(3N3\CU@<38*6BG%72UA_WYEOJA"D,E)BKO-46& Z
MJT._D@;H[V@^=8R-6$FMR<<4!5*WE7I:+<I$PL]KFF"0GBYKL3! FI6W2ZVP
MGL,C17CDG53!"7N]43$2YT$_" )O097.E5DV#[\+-#]Q% S.*KN?O]IX:[7I
M\>A9RYTU;AZ(:[MEA L4]5T*VTPF*!8X]$'&B9PEBH6T U%".:=S%?,5O'\T
MG@S&S3J<NV]N6-'W>8JJ-0X5;DM=9<<:)>I-O56A2F<0Z]0:P5HRADU;Y@D6
M1"U%>6$Y'?%78.T'W)"<7R55W<\_G8U'I^^,N"LSLP2>4;E$94AU^3$+!RQ6
MW+%?<(]<1A<77V"MRS5^W7U!!A)R&?8!+;7@?(*KXWJ@\S14H^SIBRS/W@ C
M;,FYM?'2W9+R"GC$_M#4[4V#1[")1VT_@>-C&EFAJ2#H>9 )564EI5":^15'
M$.D?-8OR70N0^/&;&4?(O71^Z$0+-VELK>+Z)0?L &=DA9"E7>::.B,MT,)T
ME%JDK-(I!83S?%TX,* E^U2W*S I^J6W,@7F6.0D9CAE6^6,64HB=7EJ*PUW
M1*Z_V6:2&';(6LZ>::@/3* >AS&C_G'P9$&O%' %EB_08Y)D73GB3SBUDS/<
ME>95% [J/L ]/3_>50-5WN_"Y)U^P#OD*FBV<?[/2JXSZ-)8U;'(MWNG?VQ,
MR<F$-K7I#]\VUN*X:D+[U:65KU-7ZQ35KXIJ!#=[BQ)PMXPIV-!LX5.VMM@U
M>S8J^IM6C<FBCE7WN^1UX; JK8WL=5G+:5+SA&9LMP')Z ^0<@X?9GN@B:@/
M'O;5!D*1-LY"4R0,#^ZNIER$(Z$C;O&?O@!:(("R2 B%'\BK Q^)SPZOQ&?$
MLVU*!\T\W5+<?SV.;,"=B^ #]!?( @VEYG/%\ ^<BO/(E2*U;Y3(@IZ[QDZT
M$!8SSE:A@LO*@OY/SZHN60]V"WIPIIE]-K$%AH?T6THX4R:T$UVSLLH33&!-
MK!ZX<@NF![B"T7E*+$1#7];?Q(]]P7LV7M2JC!8.?6#1.'-M76#G5!_$BBEZ
MQ#I46'(D?Y028U O[*4JDRJ<\NI6P?'&\BZ4 '?>)A!OV#7>O7M("SBXI(Y&
M1,V(5PYRC<L\\&G)2:,>0U58$N2I7IRYC3O6?OU6_%K7QV]L.I:YAN[8?6\_
MJ+*I4Q1VL^6#=(ZF$W$D1N/!Z1B_QX/QF?@7A12RN+F/WVW]@CW-54PCX(60
M(IW@^M7HY+48C0;G9_7 #X^(26P.B-JC9M=[T.[4Z7@V8AU')X07\ ]QH"QW
MSO+9%K8[J7JD:T]=NX74C:!HAW W\>1$(Y>A7W$.[GB]Y5XF>HVB909<R!<9
MMZHGM<9VA2'(=QJN--K+H,_',\*I&5)W+[N4BP7X-E5TG('2@&Z'V+TEI=K"
M2F(U+E*,M5T_8?%Z.X$X;+3F;ELF1AJP0KL=\==UVJG-=/(<;7YY::E6";5#
M)(62P+$"*Y+KU603.JY[Z3;#"QZ?'[+JZ66I?HBH>""HQQ6@M3SZZ'PP.FU
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MHUK!7N$S(U6*&HN!H1#A.G+LC 4HB#BC*(+ZH2)CC_V'/#OX?@'I2_>5QO9
MZS]E[%?W'X*N^^\?]]O[KTB?W A#T\H"1_UI&D_Z?V'&'ZU>NZ\A<]VVNG:/
M*$/,\K0![Q=:M^,/4K#_/';U!U!+ P04    " !MB:E6+3P7010%  #9#
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M6O@@PQ"LVPLG0[1=K/+E!)6+#W"V5DU#CDS%C,*.R,08$$ZC$6:6U)D+?WK
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M U;A^-CB?P]R+(#OC;5A>F$#\W\SF[\!4$L#!!0    ( &V)J5:Z=[% D04
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M?K^08P-\KRWZJG_A +M?1(N_ 5!+ P04    " !MB:E6<!<2 ;,$   5#0
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6S-5VUOVS80_BL'=2A:(/6+
MG+:!:QO(RX(56-"L2;L/PSY0TMDB(I$*2=EU?_WN2$E14MM!,6#8%ULD[YY[
M[E74;*/-G<T1'7PK"V7G4>Y<-1T.;9IC*>Q 5ZCH9*E-*1PMS6IH*X,B\TIE
M,8Q'HW?#4D@5+69^[]HL9KIVA51X;<#692G,]@P+O9E'XZC=^"Q7N>.-X6)6
MB17>H/M271M:#3N43):HK-0*#"[GT>EX>G;,\E[@J\2-[3T#>Y)H?<>+C]D\
M&C$A+#!UC"#H;XWG6!0,1#3N&\RH,\F*_><6_=+[3KXDPN*Y+OZ4F<OGT4D$
M&2Y%7;C/>O,;-OZ\9;Q4%];_PB;(3HXC2&OK=-DH$X-2JO OOC5QZ"F<C/8H
MQ(U"['D'0Y[EA7!B,3-Z X:E"8T?O*M>F\A)Q4FY<89.)>FYQ:60!KZ*HD:X
M0F%K@Q1Q9V=#1^ L,DP;H+, %.\!FL"55BZW\*O*,'NL/R12';.X9786'P2\
M$F8 D_$1Q*-X<@!OTGDZ\7B3YSV]D#8M-#MKX:_3Q#I#Q?'W+I\#Y/%N2&Z8
MJ:U$BO.(.L*B66.T>/EB_&[TX0#AXX[P\2'TGTG-0:#=-/>@PVV.L.2SM3_3
M2Q"PE$JH5(H"I*)@U2P)TH(C65'JFE8N%PY271<9)$C=FB(U6P9U19W'8E84
M 8P:T5H:-MI )60&3@.%7]DE&K)42)'(0KHM66)9;3(TQ3:(B-#(";H-HJ(N
M,'<$5 GC9"HKP>R%\];*!X\@$PX'<-FYX,V3I,& X"DDQ*0R,J6"$"KK.=P2
MDOA412^9<E B_(>0E?UP9AJ4IF"IM*@S?.1'JBW-4SCMASN7:(1)\RV'M[;!
M$MG0ABA\1^_<?2U\A)BHP8>(473Y6*HPJME$BY"A0T/3HY]:RPHHTGQG>@=P
M3G%;D=WO 6HC72Y#+O?QY>F809-PFO9H'12XQH(M257539F0J)4K)9<R%5PZ
M^BEJ+X*#IP7YR"*-7W(J(_ 61!=D6*H5K0PBI(T3:*?PNZ<RGL(?M7:DU-9/
M2+MLWQ#-OB4L S(C#D2S*QO:ZY7$H &-I_ IX<822=$"O GA\'Y[O5KI!YEF
MV\>#ZRK5QNA$&\',DFU+CHI7M$8F4_AR"(+K["#,[>, >1 _$+A0=6UZL67?
M>2=X?=1F).,&ZT\'"AHW>VT,0Y+'DH2%+ZTK1NH&.+S*R+(PS;SP\7:YKBU5
ML7W=):>-9^MRFZOKD*2;7MGTGV^UHQ1]5&LJ.=_TECF%KGW#39<QO5_@_?B$
M?E^^.(G'\8='3WP24)I$_X3'SP/_IX&_H.%;)C2;FMC'_Y/8C^)](:*3?Q/[
M@\#/$6NE/U'0V[U*&T?YDIKZB:Z?UOFXK@7-X=HV/>63V$/LVM!SI3>?9:3[
M$,)],X;>&Y1O'EQA7)7A"H5\A7K:0/Z]U$AOD;(9I'[(]A%+$(\-^IFP9Z[:
MAF!_$&M6A!\GS*NF,%[S%.LK[)IHC?#D]0!VW8&&O:MJB6;E+^26;P[*A5MK
MM]O=^4_#5?=!/'PP4'Q6],*B5\R25$>#]V\C,.$2'A9.5_[BFVA'UVC_F--W
M"QH6H/.EIN0T"S;0?0DM_@%02P,$%     @ ;8FI5HWFIZX$!P  S1   !D
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M+4P/WBF@L 8'47BC:K*8-5K5D&YC T.[;K"TQ!Y?&K?3@>U#FRY-S>/3#I]
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MB^A*\HA:@8V\ =\KA_3G!2N8_@?C]K]02P,$%     @ ;8FI5AVN_=>M!
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M7Q1G!6FN5&?3!]^_Y5'/4\$KO8WY/_7#VJ?+@LHN)M^,P6#0&#?\JMO1AZ.
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M68#WE<?0CC>2X/#5M_H;4$L#!!0    ( &V)J5:^D&T+# 8  !$0   9
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M6;I$^->2;FVHG0&M;Q5EHQVX -T]</X?4$L#!!0    ( &V)J58G3S'D+ ,
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MW>7L6IR_+6A]6/"/6C^X9_>,+%D8\RL]?*@N9Q$!THU>>I*@<+G7[W33D"#
M^&TK<S:JI(W/[W?2OP^VPY:%<OJ=:7ZI*[^^G!4S5ND[U3?^DWGXJ][:DY*\
MI6E<&-G#=FTT8\O>>=-N-P-!6W?#57W9^N$U&^+MACC@'A0%E.^55U<7UCPP
M2ZLAC6Z"J6$WP-4=!>766[RML<]?W>H57.S9AVX(,'GJ]+-:--J=7<P]--"Z
M^7(K[>T@+?Z*-,D^FLZO'?NNJW2UOW\.9".\> ?O;3PI\*.R;Y@4G,51+"?D
MR=%<&>3)_V+N)[TQUM?=BOWS>N&\17+\ZYBY@[3DN#0JF'.W44M].4-%.&WO
M]>SJCW\06?27":S)B#69DGYUBP*L^D8S<X?T)[P4%K;H'18ZQ]S6EOHI=,=,
MF%;RZ76"6>V8<NS.-*ABQTXKW"C+5&OZSCNL9'YM>J>ZRIV=L\]KJ_5>*H3X
MT1"S'\$T3B&_SMFUJQ4[84G&99(.-T)$[+O>@G18+'@2I73)\YS]")AK=MUJ
M6R\5DPG/DH+)E)>%8'\'QFY\!Q#L)[_6EF4\EAG&+,[89^-5P[J=<B:B@F<R
M85#(DS)A[X#6UHL^6 M^6D'BJ3C;@@2(,A7A(LL=P(RG$)]PF<L7\$3,BTS0
M)1?E5^'%/,DRC&4DMO"61T DDA<B80FICMDM^ MIR]E*=]IB"XE3%9BAIC0F
MBF/Z"RC;P<;3^(RV9TG,D@A>D.RGC:9%R/NZ6YI6,Y''3' 9E5M,C7&.!S<)
MGD+MJ13)&=@A+%YH)(1F&VONZ\#*>-P)\NH+-)Y@6U9DN)9ERO[]VA]Y^F@$
MX! 'PQS5P%/L&LK2I7&>IH<I<L.]:7H@ 2!D+QSA=IYX,U&-Z5B-Z:NKD5"9
MIJZ41V8_P;+Z7G<]W/2(Z)B559LU M[ I\M01.Y8>4YJ/<XPWUO3PF 86M7W
M==6'Q$$=VL>YU2OR'J+L-CHT/([*U.SGKB:LMQZ0$=];M.<U^QN".>3C9U4_
M*/)VN[&U0U9$)(+<R!#AEH+^=;,I"4B'IZK_<TM53[MK4R$ H?C!XLOU2.-!
M(U$!_S]0RIZA2$,H+4,^2LGCN-Q9*A(N\I25/$^C/6\(P>,D8@)5D\IM3:28
MDY*E*,0LIA3?4L?)2!X3^96-^95] ]L/B334.-F#E-(*/L1+<O4[!$IUCW]R
M5(M5O_2,Q!W-KTFMQ_-K=.=Q *:W^VJI.3CLN0L<N*"#WO\4SL"X/VSY;:U5
M ZDG%)(\"TZ/0T@_M&W?:?2,0& )&%S9JC;WRBU[THP0%^ @BJ2,V/MZI5U@
MQY(GT%'R"-Q]@SHQ'=6/0HJ3&' \3Q/)?@G'.=!0AZ-IZ(89V%H0Y^=BU['V
M^]4!XA(YE@S7<L0;\[A(,&92O$0,S>@6]$H^PYOR7!88TU(<X!5HC$-R'N)-
MA61)*2?;Z*&3H6?([)2#^4<G<QE'& MTBQ>@)4\+-&)>H,D\@2X 6F!,41PO
M02<9V4_E=PA:\$@(,@P^>EV//S0!_LO#M1#%SH <^9%G!QZG_BO3_!EP-.XB
MI3%YZ6V)_I]A]@CHE!*WV#MN?"-+Y"-+Y+^O"VTH!:U_Y&S3*& B!^G?^GH3
M$'Y31YI$\*T=:;\5F:YY/.Q'8]^I7M-XIBU]?4=Y:DKO]5*W"^02/=Q,B3_L
M+PD.<7$RW,AB=XJB[H',0L7)[<EN$O5PX KGWZB(M@=A\-I$PA1CPA2O3ACE
MP-*.'+P[XA\+_Z2\X^$?3#P4_SL:PU>B<AUDCU\,(HI +=2+2_ 4/+6E8(&2
M0PJ!O/+#,WF4\S0"7Z)_R(E3>0Z62U'%$F'=,^R$Q:"DM*!HXR@!%<71",V?
M?8U#^BK\Y^"&@A@^S,?9\6^-Z^%K_FGY\)_(QW *I@/O';9&;W*<%NWP/\/P
MX,TF?-LOC/>F#;<@PDI;6H#W=\;XW0,I&/_LN?H/4$L#!!0    ( &V)J5;G
M)FW6X@(  /,'   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;,U5;4_;
M,!#^*Z=L8B QDB;E1:6-1&%H2*O44<8^3/O@)I?&PK$SVVGAW^^<I!E,I0Q-
MFO;%KW?//7>^\PU72M^9'-'"?2&D&7FYM>7 ]TV28\',@2I1TDVF=,$L;?7"
M-Z5&EM9*A?##(#CR"\:E%P_KLZF.AZJR@DN<:C!543#],$:A5B.OYZT/KODB
MM^[ CX<E6^ ,[9=RJFGG=R@I+U :KB1HS$;>66\P[COY6N"6X\H\6H/S9*[4
MG=M<I2,O<(108&(= J-IB><HA ,B&C]:3*\SZ10?K]?HE[7OY,N<&3Q7XBM/
M;3[R3CQ(,6.5L-=J]1%;?PX=7J*$J4=8M;*!!TEEK"I:96)0<-G,[+Z-PY\H
MA*U"6/-N#-4L+YAE\5"K%6@G36AN4;M::Q,Y+MVCS*RF6TYZ-KYD7,,M$Q7"
M!)FI-%+$K8'=&S87:/:&OB4K3M9/6L1Q@Q@^@QC!1$F;&_@@4TR?ZOO$KJ,8
MKBF.PZV $Z8/(.KM0QB$T1:\J',YJO&BEUV^X"81RGEMX-O9W%A-6?)]D\\-
M9'\SI*N<@2E9@B./2L.@7J(7[[SI'06G6PCW.\+];>CQC"HQK02"RL#F"(DJ
M2B8?WAG(.6JFD_P!J#R!&8/T=$7SCBDP"YGS=5G[ZDJ RBBIM.9RX5*9FTV>
M;N6RV=,;(I4I007ND*W+'*AO72:I2O_&TYTT7/=?0W:?E%P()@ZI2PC83<DR
M(\1"5<X>EQ0D51DF4[,W@$^X1 &]=@[;.8+/E;)D=JIY0H\_XPO),YXP:9^L
M;Y1E J[D$HUUA0'&<>*6D\Y[H'1)';VW<-P[H7'GS4G8"T^?K-Q-@_+ZYWD9
M^)\&_@(3+.:HU[$/_Y/8!^%S(:*;OXG]5N!-A>T_^H@+U(NZW1@J6(I.\R=W
MIUU'.VL^\E_B33ND+%]P:4!@1JK!P?&A![II,<W&JK+^UN?*4I.HESEU9=1.
M@.XS14%N-\Y U^?CGU!+ P04    " !MB:E6P[$Z=;H"  #I!P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R-BYX;6RM55%OFS 0_BL6JZ96Z@H!TDT906K"
MJO6A6]2LV\.T!P<NP2K8S':2;K]^9T-8DI*HF_J2V,=]W]U]!W?16L@'E0-H
M\E@67 V=7.MJX+HJS:&DZD)4P/')7,B2:KS*A:LJ"32SH+)P?<^[=$O*N!-'
MUC:1<226NF <)I*H95E2^6L$A5@/G9ZS,=RQ1:Z-P8VCBBY@"OJ^FDB\N2U+
MQDK@B@E.),R'SE5OD/2-OW7XRF"MML[$5#(3XL%<;K*AXYF$H(!4&P:*?RL8
M0U$8(DSC9\/IM"$-</N\8;^VM6,M,ZI@+(IO+-/YT'GGD SF=%GH.['^"$T]
M-L%4%,K^DG7CZSDD72HMR@:,&92,U__TL=%A"X \W0"_ ?C[@/  (&@ P7,!
M80,(K3)U*5:'A&H:1U*LB33>R&8.5DR+QO(9-VV?:HE/&>)T/****2+F9")!
M =?4=N,T 4U9H<[(&W(_3<CIR1DY(8R3+[E8*LHS%;D:HQL.-VTBC>I(_H%(
M ;D57.>*?. 99+MX%[-N4_<WJ8_\HX2W5%Z0H'=.?,\/.O(9/Q_N=\"3X_ $
MTD/PG6J"MA&!Y0L.\'V6"\K9;ZO_.1D+KD3!LKH=*/AN?[!?UXQ3GC):D"D:
M ;]$K<CWJYG2$K^E'UW]J1,(NQ,P\V6@*IK"T*E,++D")W[]JG?IO>\2]R7)
MDA<BVQ$^;(4/C[''-SS%>:F G&90G\[,F\X%3_%]E:) P (M&C"V[M*UYK^T
M_&;,KN+0\R)WM2W74Y]@WR<YFN=_JM!O5>@?5>'3\\OM/RVW'_3WZCT:[5]?
MCXZ(O=!O(]8%NUM#L 2YL,M$D50LN:Z'2FMM]]65'=-[]E%O,*[7SE^:>@GB
MR%@PKD@!<Z3T+MYB8K)>+/5%B\J.VIG0.+CM,<==#-(XX/.Y$'IS,0':[1[_
M 5!+ P04    " !MB:E6S/?\6H,"  #-!@  &0   'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6RM55U/VS 4_2M6AB:0-O+9%%@;"5JA\3"IHC >ICVXR6UC
MX=B9[3;P[W>=A*PM:;>'O23^N.?X'-OW>E1)]:QS $->"B[TV,F-*:]<5Z<Y
M%%2?RQ($SBRE*JC!KEJYNE1 LQI4<#?PO-@M*!-.,JK'9BH9R;7A3,!,$;TN
M"JI>;X#+:NSXSMO /5OEQ@ZXR:BD*YB#>2QG"GMNQY*Q H1F4A %R[%S[5]-
M8AM?!WQG4.FM-K%.%E(^V\Y=-G8\*P@XI,8R4/QM8 *<6R*4\:OE=+HE+7"[
M_<9^6WM'+PNJ82+Y$\M,/G8N')+!DJZYN9?55VC]#"Q?*KFNOZ1J8J.A0]*U
M-K)HP:B@8*+YTY=V'[8 ?G0 $+2 X%\!80L(:Z.-LMK6E!J:C)2LB++1R&8;
M]=[4:'3#A#W%N5$XRQ!GDCNQ 6&D8J#)Z10,95R?D<_D<3XEIR=GY(0P01YR
MN=949'KD&ES3(MVTY;]I^(,#_-^H.B>A_XD$7A#VP"?'X5-(.WBP"W?1:6<W
MZ.P&-5_X%[NO9,ITRJ5>*R _KA?:*+Q0/_O\-811/Z%-LBM=TA3&#F:1!K4!
M)_GXP8^]+WUN_Q/9CO>P\QX>8T_N:84WQX!BE/>>9 ./:[C-_DT2!/X%GMIF
MVT)/5.B'?Z)VM$6=MNBHMB?,=7O32B57Z+Q77L,PV%K8C_UH3UU/T- _(&[0
MB1L<%7?+!,,,R\A*ROX<&+Q;-0J'P7!/6U^4[QT0%W?BXJ/B'J2A'+>N2^,^
M??&[,XN'@V!_[_JB+J/+/7WN5K&QA1XS?,6$)AR6B//.AVA0-<6SZ1A9UO5G
M(0U6L[J9XWL#R@;@_%)*\]:Q):U[P9+?4$L#!!0    ( &V)J5:\;!^ N (
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MADGSF,"\3X06@/<K#NXO%_J ZC\(LW\!4$L#!!0    ( &V)J5:/C$6_- T
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M?"@M@-(HE,:@- ZEB8:V6U$VHQ+;@E)7\8Z?X5A5_'XVBZH..UR2!"=HIUT
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MXZMAV2F===Q^5ENKFH"Z=5 :A=(8E,:A-(&BZ>)4;MWPR+/?-D7'2SG<M?R
M^G=0F@^E!5 :A=(8E,:A-(&BZ?)67M[PXMSE!]05A-)\*"V TBB4QJ T#J4)
M%$T_!)0K.+3/'3R^*H<=T%G"]N:49Q?+T!S4PX/2*)3&H#0.I0D431>L\O"&
M=@_OI239W ;:N22!NGE0F@^E!5 :A=(8E,:A-(&BZ<_[5L[@:'#FDF0$M0ZA
M-!]*"Z T"J4Q*(U#:0)%TP\!94*.[";=\9+$#N@L87MS/)M;"&U) *51*(U!
M:1Q*$RB:+ECE%H[L;F%3DOA1)J=%FG6M2>STSFJ&SC*$T@(HC4)I#$KC4)I
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M-T6ZNNF51^M#6A1I7+]<R' FLVJ#\O>/:7G(-&^J!,]I]K5N]N3_4$L#!!0
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M5-_I5%/Y [U]#Y+06+PK1[!L;_$&N4BL"0<Q=J4*3+MWPR*(^SP(_X4@ O3
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M@#W"G\V >W!!DP!?F7LK@4*V265^JU'VEG=C=^9&Z*3_'M_.\ANNRDU^X?9
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M;Y;T3T'M"NC[2BF[[[@)VK]4^@M02P,$%     @ ;8FI5L(!M2LL P  ZA(
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M@ 8,B:)J']S;C\)FGPHW_VZ-GP!02P,$%     @ ;8FI5I>*NQS     $P(
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MP?XMUN=<YC/#JL/NC<OQ294Q+392#K%NJFXT+_:?0O:?<<Y_ 5!+ P04
M" !MB:E60+O#+8<!  "\%P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QSS=C+;L(P$(7A5T%Y )R9X5H!JV[85KQ !.8B<E/LJO#VC6 !!W71#?)9
M1;:5R;_Z%'GQY<LBGIHZ'$]M&%RJL@[+[!AC^^%<V!Y]581AT_JZ/]DW757$
M?MD=7%MLS\7!.\WSB>N>9V2KQ?/,P>;:^O],;/;[T]9_-MOORM?QC\'NI^G.
MX>A]S :;HCOXN,S<I7QL!W=[R+"?G W6NV76K7>2N=1!"D&:/L@@R-('C2!H
ME#YH#$'C]$$3")JD#YI"T#1]T R"9NF#YA T3Q\D.<J8$R2]8$V@M2#70N"U
M(-A"(+8@V4)@MB#:0J"V(-M"X+8@W$(@MR#=0F"W(-Y"H+>BWDJ@MZ+>2J"W
MOOQL$^BMJ+<2Z*VHMQ+HK:BW$NBMJ+<2Z*VHMQ+HK:BW$NBMJ+<2Z&VHMQ'H
M;:BW$>AMJ+<1Z&TOER4$>AOJ;01Z&^IM!'H;ZFT$>AOJ;01Z&^IM!'H;ZFWO
MU#O$:^G#H^>^QMO(=U(=^W?]X_.WY7T3<1[=<'9P6;_Z!5!+ P04    " !M
MB:E6_WEJDI\!   =&   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-F<UN@S 0
MA%\%<8V"8[M-?Y3DTO;:YM 7<&$)*( MVTF3MZ\A/U*K%"5*I<X%"[P[,WBE
M[P"3]ZTA%VWJJG'3N/#>/#+FTH)JY1)MJ D[N;:U\N'6+IA1Z5(MB(G1:,Q2
MW7AJ_-"W&O%L\DRY6E4^>MF$QZ[4S32V5+DX>MH5ME[36!E3E:GR89^MF^R'
MRW#OD(3.KL85I7&#4!"SDP[MSN\&^[ZW-5E;9A3-E?6OJ@Y5;%,QY[<5N:1?
MXD1&G>=E2IE.5W5H29RQI#)7$/FZ2G:B@WYG'TZ8=E=^M7\GTV<8*N=6&Q<F
M9NERN\-(VNZA"4)D?=G_BD?'('WU^U$[[8RR,[W#\7YJN^SFX5BW7'_&WV=\
MU+\PAP#)(4%RW(#DN 7),0;)<0>2XQXDQP-(#CY""8)"5(Z"5(["5(X"58Y"
M58Z"58["58X"5HY"5H%"5H%"5H%"5H%"5H%"5H%"5H%"5H%"5H%"5H%"5HE"
M5HE"5HE"5HE"5HE"5HE"5HE"5HE"5HE"5OF?9/W0>OG7'ZS;-:E5V1S\6?=7
M8/8%4$L! A0#%     @ ;8FI5@=!36*!    L0   !               ( !
M     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !MB:E6BJCS<>\    K
M @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M    " !MB:E6F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE
M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &V)J59YK545\04  ,0?   8
M          " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !MB:E6&LDT"=(&  #M&P  &               @($U#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ ;8FI5KLA?I;U @  .0@
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M965T-RYX;6Q02P$"% ,4    " !MB:E6RDJ00RP'  !K$@  &
M    @($X,   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M;8FI5L>O*E:" @  A04  !@              ("!FC<  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( &V)J58A!0WG> (  ,0%   9
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M970Q-"YX;6Q02P$"% ,4    " !MB:E6+3P7010%  #9#   &0
M    @(%M6@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M &V)J5:Z=[% D04  !T-   9              " @;A?  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ ;8FI5G 7$@&S!   %0T  !D
M             ("!@&4  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !MB:E6C>:GK@0'  #-$   &0              @(%J:@  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &V)J58=KOW7K00
M  $*   9              " @:5Q  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ ;8FI5KZ0;0L,!@  $1   !D              ("!
MB78  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !MB:E6
MFO8N 9("  "=!0  &0              @(',?   >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( &V)J5;F?2IXR ,  !,*   9
M      " @95_  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ ;8FI5B=/,>0L P  ;P@  !D              ("!E(,  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !MB:E6T5?&KW$&  #X$0
M&0              @('WA@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( &V)J5;G)FW6X@(  /,'   9              " @9^-  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ ;8FI5L.Q.G6Z
M @  Z0<  !D              ("!N)   'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " !MB:E6S/?\6H,"  #-!@  &0
M@(&IDP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( &V)
MJ5:\;!^ N (  -L'   9              " @6.6  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ ;8FI5OPZZJL.!@  SS,  !D
M         ("!4ID  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " !MB:E6]+S3]!X$  !-$   &0              @(&7GP  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &V)J5:/C$6_- T  &JM
M   9              " @>RC  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ ;8FI5O[B(-T)!   510  !D              ("!5[$
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !MB:E6@!9\
M/$P#  !2"P  &0              @(&7M0  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( &V)J58/;8BBEPX  !J5   9
M  " @1JY  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M;8FI5MI,-/## @  [@<  !D              ("!Z,<  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " !MB:E6?%6ZA$X$  "@&   &0
M            @('BR@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( &V)J59XS"&CC ,  .<0   9              " @6?/  !X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ ;8FI5A]5CL-_ @
M_@4  !D              ("!*M,  'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " !MB:E6,%D1]HT"  "Q!@  &0              @('@
MU0  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( &V)J5;"
M ;4K+ ,  .H2   -              "  :38  !X;"]S='EL97,N>&UL4$L!
M A0#%     @ ;8FI5I>*NQS     $P(   L              ( !^]L  %]R
M96QS+RYR96QS4$L! A0#%     @ ;8FI5O"LJ+V- P  2AH   \
M     ( !Y-P  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &V)J59 N\,M
MAP$  +P7   :              "  9[@  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( &V)J5;_>6J2GP$  !T8   3
M  "  5WB  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     O "\ P P  "WD
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>172</ContextCount>
  <ElementCount>227</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>43</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Investment Securities - Trading</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTrading</Role>
      <ShortName>Investment Securities - Trading</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Revolving Credit Facility and Other Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</Role>
      <ShortName>Revolving Credit Facility and Other Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Net Income (loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomelossPerShare</Role>
      <ShortName>Net Income (loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Capital Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactions</Role>
      <ShortName>Capital Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Synergy Japan Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SynergyJapanLoss</Role>
      <ShortName>Synergy Japan Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Basis of Presentation (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationPolicies</Role>
      <ShortName>Basis of Presentation (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/Inventories</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Net Income (loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomelossPerShareTables</Role>
      <ShortName>Net Income (loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomelossPerShare</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Capital Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsTables</Role>
      <ShortName>Capital Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CapitalTransactions</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/BasisofPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/BasisofPresentationPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InventoriesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Investment Securities - Trading (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails</Role>
      <ShortName>Investment Securities - Trading (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/InvestmentSecuritiesTrading</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Revolving Credit Facility and Other Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails</Role>
      <ShortName>Revolving Credit Facility and Other Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Net Income (loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/NetIncomelossPerShareDetails</Role>
      <ShortName>Net Income (loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/NetIncomelossPerShareTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Capital Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails</Role>
      <ShortName>Capital Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Capital Transactions - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails</Role>
      <ShortName>Capital Transactions - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Capital Transactions - RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails</Role>
      <ShortName>Capital Transactions - RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SegmentInformationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/CommitmentsandContingencies</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="natr-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Synergy Japan Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://naturessunshine.com/role/SynergyJapanLossDetails</Role>
      <ShortName>Synergy Japan Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://naturessunshine.com/role/SynergyJapanLoss</ParentRole>
      <Position>39</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. natr-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: natr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod -  natr-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="natr-20230331.htm">natr-20230331.htm</File>
    <File>natr-20230331.xsd</File>
    <File>natr-20230331_cal.xml</File>
    <File>natr-20230331_def.xml</File>
    <File>natr-20230331_lab.xml</File>
    <File>natr-20230331_pre.xml</File>
    <File>natr2023331-ex311.htm</File>
    <File>natr2023331-ex312.htm</File>
    <File>natr2023331-ex313.htm</File>
    <File>natr2023331-ex321.htm</File>
    <File>natr2023331-ex322.htm</File>
    <File>natr2023331-ex323.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>natr-20230331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="494">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "natr-20230331.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 494,
    "http://xbrl.sec.gov/dei/2022": 30
   },
   "contextCount": 172,
   "dts": {
    "calculationLink": {
     "local": [
      "natr-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "natr-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "natr-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "natr-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "natr-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "natr-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 355,
   "entityCount": 1,
   "hidden": {
    "http://naturessunshine.com/20230331": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 27,
   "keyStandard": 200,
   "memberCustom": 21,
   "memberStandard": 22,
   "nsprefix": "natr",
   "nsuri": "http://naturessunshine.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://naturessunshine.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Investment Securities - Trading",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTrading",
     "shortName": "Investment Securities - Trading",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Revolving Credit Facility and Other Obligations",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations",
     "shortName": "Revolving Credit Facility and Other Obligations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Net Income (loss) Per Share",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://naturessunshine.com/role/NetIncomelossPerShare",
     "shortName": "Net Income (loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Capital Transactions",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://naturessunshine.com/role/CapitalTransactions",
     "shortName": "Capital Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://naturessunshine.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://naturessunshine.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://naturessunshine.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://naturessunshine.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://naturessunshine.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Synergy Japan Loss",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://naturessunshine.com/role/SynergyJapanLoss",
     "shortName": "Synergy Japan Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Basis of Presentation (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://naturessunshine.com/role/BasisofPresentationPolicies",
     "shortName": "Basis of Presentation (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Inventories (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://naturessunshine.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Net Income (loss) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://naturessunshine.com/role/NetIncomelossPerShareTables",
     "shortName": "Net Income (loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Capital Transactions (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://naturessunshine.com/role/CapitalTransactionsTables",
     "shortName": "Capital Transactions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://naturessunshine.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Basis of Presentation (Details)",
     "menuCat": "Details",
     "order": "26",
     "role": "http://naturessunshine.com/role/BasisofPresentationDetails",
     "shortName": "Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Inventories (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://naturessunshine.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRestricted",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Investment Securities - Trading (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails",
     "shortName": "Investment Securities - Trading (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesTradingRealizedGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i43b99692a035464f8b8f7f2449d7eccc_I20170711",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Revolving Credit Facility and Other Obligations (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails",
     "shortName": "Revolving Credit Facility and Other Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i43b99692a035464f8b8f7f2449d7eccc_I20170711",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i5013a2410f1f48fe86da71c75ac9b931_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Net Income (loss) Per Share (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://naturessunshine.com/role/NetIncomelossPerShareDetails",
     "shortName": "Net Income (loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "iec9e1feefec641229f8793d60e0ba7a2_I20220308",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Capital Transactions - Narrative (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
     "shortName": "Capital Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "iec9e1feefec641229f8793d60e0ba7a2_I20220308",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i148e2e4f78504b7f860c8bb7235cd422_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Capital Transactions - Stock Option Activity (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails",
     "shortName": "Capital Transactions - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i83530fd6ee8c4fbcbad9b33b6fa4c38c_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i70143db360d648a09df5ae0c19ad6a0c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Capital Transactions - RSU Activity (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
     "shortName": "Capital Transactions - RSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i70143db360d648a09df5ae0c19ad6a0c_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Segment Information (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://naturessunshine.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "natr:ContributionMargin",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://naturessunshine.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Commitments and Contingencies (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i8d0f247c4d5a40e68dd87f64d2012a5e_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "natr:MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claim",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "id34db597e9e84e55975f561965ebf581_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Fair Value Measurements (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://naturessunshine.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "id34db597e9e84e55975f561965ebf581_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Revenue Recognition - Narrative (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "natr:RevenuefromContractwithCustomerRefundPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Synergy Japan Loss (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://naturessunshine.com/role/SynergyJapanLossDetails",
     "shortName": "Synergy Japan Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i736f0ff6f9d045f7b7ef1525e2c92ad4_D20230201-20230217",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i0691a9d3b51c404f83e92ca13c32ff39_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i0691a9d3b51c404f83e92ca13c32ff39_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Basis of Presentation",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://naturessunshine.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Inventories",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://naturessunshine.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "natr-20230331.htm",
      "contextRef": "i037da2db44724416a7e87967f0045ef9_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 43,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_KR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KOREA, REPUBLIC OF",
        "terseLabel": "South Korea"
       }
      }
     },
     "localname": "KR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_TW": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TAIWAN",
        "terseLabel": "Taiwan"
       }
      }
     },
     "localname": "TW",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://naturessunshine.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "natr_A2012IncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to 2012 incentive plan.",
        "label": "2012 Incentive Plan [Member]",
        "terseLabel": "2012 Stock Incentive Plan"
       }
      }
     },
     "localname": "A2012IncentivePlanMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_AccruedVolumeIncentiveandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the liability that is related to incentives that are payable, due to volume sales.",
        "label": "Accrued Volume Incentive and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "AccruedVolumeIncentiveandServiceFees",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Dilutive Earnings Per Share [Abstract]",
        "terseLabel": "Anti-dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfDilutiveEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_AsiaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Segment [Member]",
        "label": "Asia Segment [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaSegmentMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Banc of America Leasing and Capital, LLC, Credit Agreement",
        "label": "Banc of America Leasing and Capital, LLC, Credit Agreement [Member]",
        "terseLabel": "Banc of America Leasing and Capital Credit Agreement"
       }
      }
     },
     "localname": "BancOfAmericaLeasingAndCapitalLLCCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_BankofAmericaCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bank of America Credit Agreement [Member]",
        "label": "Bank of America Credit Agreement [Member]",
        "terseLabel": "Bank of America Credit Agreement"
       }
      }
     },
     "localname": "BankofAmericaCreditAgreementMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_CardiovascularProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to cardiovascular products of the entity.",
        "label": "Cardiovascular Products [Member]",
        "terseLabel": "Cardiovascular"
       }
      }
     },
     "localname": "CardiovascularProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ContributionMargin": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of contribution margin which consists of net sales revenue less cost of sales and volume incentives expense.",
        "label": "Contribution Margin",
        "terseLabel": "Total contribution margin"
       }
      }
     },
     "localname": "ContributionMargin",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_ContributionMarginAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contribution Margin [Abstract]",
        "terseLabel": "Contribution margin:"
       }
      }
     },
     "localname": "ContributionMarginAbstract",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_DebtInstrumentNumberOfMonthlyPayments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Monthly Payments",
        "label": "Debt Instrument, Number of Monthly Payments",
        "terseLabel": "Number of monthly payments"
       }
      }
     },
     "localname": "DebtInstrumentNumberOfMonthlyPayments",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_DigestiveProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to digestive products of the entity.",
        "label": "Digestive Products [Member]",
        "terseLabel": "Digestive"
       }
      }
     },
     "localname": "DigestiveProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities Excluded from Computation of Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive shares excluded from diluted-per-share amounts:"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAbstract",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "natr_DilutiveSecuritiesExcludedfromComputationofEarnings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents potentially dilutive securities excluded from diluted per share amounts. It includes performance-based options to purchase shares of common stock which will not vest until certain earnings metrics have been achieved.",
        "label": "Dilutive Securities Excluded from Computation of Earnings",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "DilutiveSecuritiesExcludedfromComputationofEarnings",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_EuropeSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Europe Segment [Member]",
        "label": "Europe Segment [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeSegmentMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_FraudExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fraud Expense",
        "label": "Fraud Expense [Member]",
        "terseLabel": "Fraud Expense"
       }
      }
     },
     "localname": "FraudExpenseMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_GeneralHealthProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to general health products of the entity.",
        "label": "General Health Products [Member]",
        "terseLabel": "General health"
       }
      }
     },
     "localname": "GeneralHealthProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ImmunityProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to immunity products of the entity.",
        "label": "Immunity Products [Member]",
        "terseLabel": "Immune"
       }
      }
     },
     "localname": "ImmunityProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net changes in liability that are related to gross amount of unrecognized tax benefits (tax reductions recognized in financial reports but excluded from tax returns), which pertain to uncertain tax positions taken in tax returns, as of the ending balance sheet date, which excludes amounts that pertain to examined tax returns.",
        "label": "Increase (Decrease) in Liability Related to Unrecognized Tax Positions",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInLiabilityRelatedToUnrecognizedTaxPositions",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease, Liabilities",
        "label": "Increase (Decrease) In Operating Lease, Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the net increase or decrease in payables that are related to accrued volume incentives, during the reporting period.",
        "label": "Increase (Decrease) in Accrued Volume Incentives and Service Fees",
        "terseLabel": "Accrued volume incentives and service fees"
       }
      }
     },
     "localname": "IncreaseDecreaseinAccruedVolumeIncentivesandServiceFees",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_IndicativeIndexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicative Index",
        "label": "Indicative Index [Member]",
        "terseLabel": "Indicative Index"
       }
      }
     },
     "localname": "IndicativeIndexMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LatinAmericaAndOtherSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Latin America And Other Segment [Member]",
        "label": "Latin America And Other Segment [Member]",
        "terseLabel": "Latin America and Other"
       }
      }
     },
     "localname": "LatinAmericaAndOtherSegmentMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings",
        "terseLabel": "Potential increase in maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowings",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity, Increase From Additional Borrowings, Minimum Per Occurrence",
        "terseLabel": "Potential increase in maximum borrowing capacity, per occurrence"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncreaseFromAdditionalBorrowingsMinimumPerOccurrence",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_LineOfCreditFacilityNumberOfSeparateIncreases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Number Of Separate Increases",
        "label": "Line Of Credit Facility, Number Of Separate Increases",
        "terseLabel": "Number of separate increases"
       }
      }
     },
     "localname": "LineOfCreditFacilityNumberOfSeparateIncreases",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of claims the Company's insurance coverage may not be sufficient to cover.",
        "label": "Minimum Number of Claims Companies Insurance Coverage May Not Cover",
        "terseLabel": "Minimum number of claims that the Company's insurance coverage may not be sufficient to cover"
       }
      }
     },
     "localname": "MinimumNumberOfClaimsCompaniesInsuranceCoverageMayNotCover",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_NonIncomeTaxMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to non-income tax matters, including value-added taxes.",
        "label": "Non Income Tax [Member]",
        "terseLabel": "Non-Income Tax Contingencies"
       }
      }
     },
     "localname": "NonIncomeTaxMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NorthAmericaSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "North America Segment [Member]",
        "label": "North America Segment [Member]",
        "terseLabel": "North America"
       }
      }
     },
     "localname": "NorthAmericaSegmentMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_NumberofPrincipalCategoriesofProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Principal Categories of Products",
        "label": "Number of Principal Categories of Products",
        "terseLabel": "Number of principal categories of products"
       }
      }
     },
     "localname": "NumberofPrincipalCategoriesofProducts",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "natr_OperatingLeaseNonCashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Non-Cash Lease Expense",
        "label": "Operating Lease, Non-Cash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseNonCashLeaseExpense",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information related to all other international countries.",
        "label": "Other Countries [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedRestrictedStockUnitsRSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "label": "Performance-Based Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsRSUsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the performance based stock options, which vest upon achieving operating income margins.",
        "label": "Performance Based Stock Options Vesting Upon Achieving Operating Income Margins [Member]",
        "terseLabel": "Performance based stock options operating income margins"
       }
      }
     },
     "localname": "PerformanceBasedStockOptionsVestingUponAchievingOperatingIncomeMarginsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_PersonalCareProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to personal care products of the entity.",
        "label": "Personal Care Products [Member]",
        "terseLabel": "Personal care"
       }
      }
     },
     "localname": "PersonalCareProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_RestrictionPeriodForIssuanceOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the restriction period before shares will be issued related to a share-based compensation plan.",
        "label": "Restriction Period for Issuance of Shares",
        "terseLabel": "Restriction period for issuance of shares"
       }
      }
     },
     "localname": "RestrictionPeriodForIssuanceOfShares",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_RevenuefromContractwithCustomerRefundPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer, Refund Period",
        "label": "Revenue from Contract with Customer, Refund Period",
        "terseLabel": "Refund period"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerRefundPeriod",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ScheduleOfSegmentReportingInformationBySegment1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Segment Reporting Information, by Segment1",
        "label": "Schedule of Segment Reporting Information, by Segment1 [Table Text Block]",
        "terseLabel": "Schedule of assets per segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegment1TableTextBlock",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Award Performance Period",
        "terseLabel": "Award performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the minimum number of shares paid on behalf of the entity's employees per statutory withholding requirements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Minimum Withholding Requirements",
        "terseLabel": "Minimum withholding requirements (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMinimumWithholdingRequirements",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments subject to restriction period, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested Subject to Restriction Period, Number",
        "terseLabel": "Nonvested subject to restriction period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedSubjectToRestrictionPeriodNumber",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the first operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, One",
        "terseLabel": "Operating income margin, one (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsOne",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the three operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Three",
        "terseLabel": "Operating income margin, three (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsThree",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the second operating margin percentage to be achieved for the vesting of stock options.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award, Operating Margins, Two",
        "terseLabel": "Operating income margin, two (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOperatingMarginsTwo",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Or Canceled Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedOrCanceledWeightedAverageGrantDateFairValue",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "natr_StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised, and issuance of restricted stock units during the current period.",
        "label": "Stock Issued During Period, Shares, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "natr_StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options and issuance of restricted stock units.",
        "label": "Stock Issued During Period, Value, Stock Options and Restricted Stock Exercised",
        "terseLabel": "Shares issued from the exercise of stock options and vesting of restricted stock units, net of shares exchanged for withholding tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockExercised",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_TimeBasedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the time-based stock options, which vest over differing periods.",
        "label": "Time Based Stock Options [Member]",
        "terseLabel": "Time-based stock options"
       }
      }
     },
     "localname": "TimeBasedStockOptionsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_ValueAddedTaxAssessmentsAndOtherCivilLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to value added tax assessments and other civil litigation in which the entity is involved.",
        "label": "Value Added Tax Assessments And Other Civil Litigation [Member]",
        "terseLabel": "Value-added tax assessments and other civil litigation"
       }
      }
     },
     "localname": "ValueAddedTaxAssessmentsAndOtherCivilLitigationMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "natr_VolumeIncentives": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the expenses that are related to incentives on volume sales, during the reporting period by the entity.",
        "label": "Volume Incentives",
        "terseLabel": "Volume incentives"
       }
      }
     },
     "localname": "VolumeIncentives",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "natr_WeightManagementProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to weight management products of the entity.",
        "label": "Weight Management Products [Member]",
        "terseLabel": "Weight management"
       }
      }
     },
     "localname": "WeightManagementProductsMember",
     "nsuri": "http://naturessunshine.com/20230331",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r255",
      "r257",
      "r258",
      "r259",
      "r314",
      "r411",
      "r424",
      "r444",
      "r445",
      "r463",
      "r469",
      "r477",
      "r510",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r255",
      "r257",
      "r258",
      "r259",
      "r314",
      "r411",
      "r424",
      "r444",
      "r445",
      "r463",
      "r469",
      "r477",
      "r510",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r225",
      "r413",
      "r464",
      "r475",
      "r505",
      "r506",
      "r511",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r225",
      "r413",
      "r464",
      "r475",
      "r505",
      "r506",
      "r511",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r255",
      "r257",
      "r258",
      "r259",
      "r307",
      "r314",
      "r340",
      "r341",
      "r342",
      "r409",
      "r411",
      "r424",
      "r444",
      "r445",
      "r463",
      "r469",
      "r477",
      "r501",
      "r510",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r255",
      "r257",
      "r258",
      "r259",
      "r307",
      "r314",
      "r340",
      "r341",
      "r342",
      "r409",
      "r411",
      "r424",
      "r444",
      "r445",
      "r463",
      "r469",
      "r477",
      "r501",
      "r510",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r226",
      "r227",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r465",
      "r476",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r226",
      "r227",
      "r431",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r465",
      "r476",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r499",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r11",
      "r474"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r231",
      "r232"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net of allowance for doubtful accounts of $122 and $120, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r2",
      "r105",
      "r116"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r23",
      "r24",
      "r25",
      "r136",
      "r419",
      "r429",
      "r430"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r22",
      "r25",
      "r89",
      "r405",
      "r425",
      "r426",
      "r487",
      "r488",
      "r489",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r137",
      "r233",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r103",
      "r115",
      "r134",
      "r158",
      "r209",
      "r215",
      "r221",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r372",
      "r376",
      "r390",
      "r474",
      "r508",
      "r509",
      "r544"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r130",
      "r139",
      "r158",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r372",
      "r376",
      "r390",
      "r474",
      "r508",
      "r509",
      "r544"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r47",
      "r132",
      "r447"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r40",
      "r47",
      "r49"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the period",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r40",
      "r97"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r67",
      "r251",
      "r252",
      "r434",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r494",
      "r495",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common\u00a0Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockNoParValue": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount per share of no-par value common stock.",
        "label": "Common Stock, No Par Value",
        "terseLabel": "Common stock, no par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockNoParValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r5",
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r5",
      "r474"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, no par value, 50,000 shares authorized, 19,045 and 19,093 shares issued\u00a0and outstanding, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r92",
      "r142",
      "r144",
      "r149",
      "r415",
      "r421"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r87",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r292",
      "r293",
      "r304"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r32",
      "r413"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r1",
      "r2",
      "r3",
      "r104",
      "r106",
      "r114",
      "r161",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r402",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r16",
      "r99",
      "r290",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r17",
      "r161",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r402",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r17"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r17",
      "r72",
      "r73",
      "r74",
      "r75",
      "r98",
      "r99",
      "r100",
      "r113",
      "r161",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r402",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesTradingRealizedGainLoss": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Realized Gain (Loss)",
        "terseLabel": "Debt securities, trading, realized gains (losses)"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesTradingRestricted": {
     "auth_ref": [
      "r410",
      "r432",
      "r433"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading, Restricted",
        "terseLabel": "Investment securities - trading",
        "verboseLabel": "Trading securities portfolio"
       }
      }
     },
     "localname": "DebtSecuritiesTradingRestricted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InvestmentSecuritiesTradingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r45",
      "r83",
      "r359",
      "r364",
      "r365",
      "r493"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r45",
      "r204"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Basic and diluted net income (loss) per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r150",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r175",
      "r178",
      "r184",
      "r185",
      "r186",
      "r190",
      "r379",
      "r380",
      "r416",
      "r422",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r150",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r178",
      "r184",
      "r185",
      "r186",
      "r190",
      "r379",
      "r380",
      "r416",
      "r422",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings (loss) per share attributable to common shareholders (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r187",
      "r188",
      "r189",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r393"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rates on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Provision (benefit) for income taxes, as a percentage of income before income taxes"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period over which the remaining compensation cost is expected to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share based compensation potential compensation expense to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Tax benefit from the exercise of stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r71",
      "r126",
      "r145",
      "r146",
      "r147",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r174",
      "r192",
      "r235",
      "r291",
      "r347",
      "r348",
      "r349",
      "r360",
      "r361",
      "r378",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r401",
      "r405",
      "r425",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r281",
      "r389",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r381",
      "r382",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r94",
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of the company's hierarchy for assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r281",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r382",
      "r406",
      "r407",
      "r408",
      "r459",
      "r460",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r94",
      "r96",
      "r281",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r381",
      "r382",
      "r383",
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r281",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r281",
      "r308",
      "r313",
      "r382",
      "r406",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 - Quoted Prices in Active Markets for Identical Assets"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r281",
      "r308",
      "r313",
      "r382",
      "r407",
      "r459",
      "r460",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 - Significant Other Observable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r281",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r382",
      "r408",
      "r459",
      "r460",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3 - Significant Unobservable Inputs"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r281",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r406",
      "r407",
      "r408",
      "r459",
      "r460",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r385",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r46",
      "r541",
      "r542"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedLabel": "Foreign exchange losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r34",
      "r62",
      "r484"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "negatedLabel": "Realized and unrealized (gains) losses on investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedLabel": "Loss on sale of property, plant and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r31",
      "r158",
      "r209",
      "r214",
      "r220",
      "r223",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r390",
      "r456",
      "r508"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r27",
      "r101",
      "r110",
      "r122",
      "r209",
      "r214",
      "r220",
      "r223",
      "r417",
      "r456"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before provision for income taxes",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r355",
      "r357",
      "r358",
      "r362",
      "r366",
      "r368",
      "r369",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r160",
      "r173",
      "r174",
      "r207",
      "r353",
      "r363",
      "r367",
      "r423"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r412",
      "r490"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 23.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Deferred compensation payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Shareholders' Equity"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r186",
      "r317"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Stock-based awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r153",
      "r156",
      "r157"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r64",
      "r450"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r138",
      "r448",
      "r474"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r64",
      "r452"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r64",
      "r451"
     ],
     "calculation": {
      "http://naturessunshine.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r63",
      "r102",
      "r112",
      "r125",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investment Securities - Trading"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InvestmentSecuritiesTrading"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r13",
      "r158",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r373",
      "r376",
      "r377",
      "r390",
      "r455",
      "r508",
      "r544",
      "r545"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r7",
      "r108",
      "r119",
      "r474",
      "r492",
      "r500",
      "r540"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Shareholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r15",
      "r131",
      "r158",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r373",
      "r376",
      "r377",
      "r390",
      "r474",
      "r508",
      "r544",
      "r545"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent.",
        "label": "Liability for Uncertainty in Income Taxes, Noncurrent",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "LiabilityForUncertainTaxPositionsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r3",
      "r106",
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-Term Line of Credit",
        "verboseLabel": "Long-term line of credit"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r12"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Annual commitment fee"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r1",
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of credit, outstanding, current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "terseLabel": "Current portion of note payable and revolving credit facility"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Revolving Credit Facility and Other Obligations"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r68",
      "r69",
      "r253",
      "r255",
      "r257",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r68",
      "r69",
      "r253",
      "r255",
      "r257",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r253",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r253",
      "r254",
      "r256",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Synergy Japan Loss"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SynergyJapanLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r255",
      "r257",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Provision for losses"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r68",
      "r69",
      "r253",
      "r255",
      "r257",
      "r503",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails",
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r20",
      "r107",
      "r118",
      "r158",
      "r234",
      "r264",
      "r266",
      "r267",
      "r268",
      "r271",
      "r272",
      "r390"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestPeriodIncreaseDecrease": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.",
        "label": "Noncontrolling Interest, Period Increase (Decrease)",
        "terseLabel": "Increase (decrease) in noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterestPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r40",
      "r43",
      "r46"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r28",
      "r46",
      "r111",
      "r121",
      "r129",
      "r140",
      "r143",
      "r147",
      "r158",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r182",
      "r209",
      "r214",
      "r220",
      "r223",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r380",
      "r390",
      "r456",
      "r508"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r88",
      "r91",
      "r140",
      "r143",
      "r173",
      "r174",
      "r489"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r175",
      "r176",
      "r183",
      "r186",
      "r209",
      "r214",
      "r220",
      "r223",
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net income (loss) attributable to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r84",
      "r291",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of business segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognitionNarrativeDetails",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r209",
      "r214",
      "r220",
      "r223",
      "r456"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r404"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r404"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r403"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r50",
      "r51",
      "r55",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r21",
      "r23",
      "r391",
      "r392",
      "r394"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation loss (net of tax)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r71",
      "r141",
      "r144",
      "r148",
      "r395",
      "r400",
      "r401",
      "r414",
      "r420",
      "r487",
      "r488"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other loss, net",
        "verboseLabel": "Other income (loss), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForPurchaseOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid to purchase debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Payments for Purchase of Securities, Operating Activities",
        "negatedLabel": "Purchase of trading investment securities"
       }
      }
     },
     "localname": "PaymentsForPurchaseOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r152"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Payments related to tax withholding for net-share settled equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r486"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r37",
      "r491"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfSecuritiesOperatingActivities": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from sale of investments in debt and equity securities, classified as operating activities, during the period; includes trading securities and any other investments classified as operating.",
        "label": "Proceeds from Sale of Securities, Operating Activities",
        "terseLabel": "Proceeds from sale of trading investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSecuritiesOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfessionalFees": {
     "auth_ref": [
      "r123",
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.",
        "label": "Professional Fees",
        "terseLabel": "Investigation and other professional fees"
       }
      }
     },
     "localname": "ProfessionalFees",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SynergyJapanLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r129",
      "r140",
      "r143",
      "r154",
      "r158",
      "r165",
      "r173",
      "r174",
      "r209",
      "r214",
      "r220",
      "r223",
      "r234",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r371",
      "r374",
      "r375",
      "r380",
      "r390",
      "r417",
      "r456",
      "r472",
      "r473",
      "r489",
      "r508"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r66",
      "r120",
      "r418",
      "r474"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "verboseLabel": "Total property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r151",
      "r237"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r39",
      "r491"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Principal payments of revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.",
        "label": "Repayments of Other Long-Term Debt",
        "negatedTerseLabel": "Principal payments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.",
        "label": "Repayments of Related Party Debt",
        "negatedTerseLabel": "Principal payments of related party borrowing"
       }
      }
     },
     "localname": "RepaymentsOfRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r6",
      "r76",
      "r117",
      "r428",
      "r430",
      "r474"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r126",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r174",
      "r235",
      "r347",
      "r348",
      "r349",
      "r360",
      "r361",
      "r378",
      "r425",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r200",
      "r201",
      "r213",
      "r218",
      "r219",
      "r225",
      "r226",
      "r229",
      "r302",
      "r303",
      "r413"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total net sales revenue",
        "verboseLabel": "Net sales"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r305",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of reconciliation of the numerator and denominator of Basic EPS to the numerator and denominator of Diluted EPS"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Schedule of consolidated property, plant and equipment by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of revenue generated by each of the Company's product lines"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r0",
      "r8",
      "r9",
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of composition of inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r30",
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Schedule of consolidated net sales revenue by geographical locations"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of reportable business segment information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of restricted stock unit activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r78",
      "r79",
      "r80"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r229",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r250",
      "r457",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r209",
      "r212",
      "r217",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment information"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "terseLabel": "Net sales:"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://naturessunshine.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative",
        "verboseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in shares)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r329",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Restricted Stock Units outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Restricted Stock Units outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant\u00a0Date Fair\u00a0Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Issued (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized under the plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r336"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic values of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedLabel": "Forfeited or canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited or canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding at the end of the period (in shares)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number\u00a0of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r321",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the end of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted\u00a0Average Exercise Price\u00a0Per\u00a0Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsRSUActivityDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Unvested stock options outstanding (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding at the beginning of the period (in dollars per share)",
        "periodStartLabel": "Options outstanding at the beginning of the period (in dollars per share)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted\u00a0Average Grant Date Fair Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r77",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "terseLabel": "Capital Transactions"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r128",
      "r197",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r223",
      "r229",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r457",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r19",
      "r71",
      "r126",
      "r145",
      "r146",
      "r147",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r174",
      "r192",
      "r235",
      "r291",
      "r347",
      "r348",
      "r349",
      "r360",
      "r361",
      "r378",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r401",
      "r405",
      "r425",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r192",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r4",
      "r5",
      "r71",
      "r76",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails",
      "http://naturessunshine.com/role/CapitalTransactionsStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, before Forfeiture",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r4",
      "r5",
      "r71",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r4",
      "r5",
      "r71",
      "r76"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY",
      "http://naturessunshine.com/role/CapitalTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r84",
      "r85",
      "r90",
      "r126",
      "r127",
      "r146",
      "r162",
      "r163",
      "r164",
      "r166",
      "r172",
      "r235",
      "r291",
      "r347",
      "r348",
      "r349",
      "r360",
      "r361",
      "r378",
      "r395",
      "r396",
      "r401",
      "r405",
      "r426",
      "r427",
      "r492",
      "r500",
      "r540"
     ],
     "calculation": {
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCHANGESINSHAREHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r109",
      "r135",
      "r449"
     ],
     "calculation": {
      "http://naturessunshine.com/role/FairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Investment securities - trading"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r350",
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Liability related to unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r193",
      "r194",
      "r195",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/BasisofPresentationPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/RevolvingCreditFacilityandOtherObligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Potentially dilutive shares included in the calculation of diluted earnings per share"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r177",
      "r186"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average diluted common shares outstanding (in shares)",
        "totalLabel": "Diluted weighted-average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Diluted shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r175",
      "r186"
     ],
     "calculation": {
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "netLabel": "Basic weighted-average shares outstanding (in shares)",
        "terseLabel": "Weighted average basic common shares outstanding (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://naturessunshine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://naturessunshine.com/role/NetIncomelossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "220",
   "Subparagraph": "(k)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=127002003&loc=SL6242269-115581",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r478": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r479": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r481": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r482": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r483": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "https://asc.fasb.org/topic&trid=2122394",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000275053-23-000007-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000275053-23-000007-xbrl.zip
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M&))(1!-Q1"HR+8U.QS)KS"(VGG&V2">D_>+L,YN]!T@@1G)N?3I/E'AEK(R
MKAUU@1&\"-MM/\7*PL*:L-F4HI!@5/2(&- XEA(3J:!1<<5X*FH@"Z"#:B::
MM2;".H3 M:(&P#.@:A5(1!9K)A 2V"V!/_:C2PP+RS\S44+,$X& 3X@.C+F@
M##;P4\# /()%NPA[(M7\,\L*(<&$C>EX-Y',6- Q1LV"BH"L=0R+L"X_YTL;
M2Z^"C"6.XXB]LQ%82&D7,!&&PP<6@V>+KX)^)1::B19B)$C)+>;!@QL6D):"
M"V&Y$E0AI!;!'YM7=_Y76B'#Z>04ACD%Y<,T1C:HH(CWS 2-HEV$#3EJ-IJ]
M-I*1 K\(3#'2##FI I(4:<^U-,C113J&XFGV2'LL,_TR=6/.*VL,"IR!6Q:H
MM\!3QA'NP>EW@2W"S@DU)\V%3D*((0#92DI 2(%R%2DB*()M0P'SA3H:9SXY
MZ5=8-?,!(9[6/32PDP '#3&GF5<!.^VE682%^YJ)9JZ)M".8*L^B8$QYHTU$
MVJ2MV#WWBI):$SV2B7ZANC+L %@CE;9&8<%[;:,TTFF.C3(NU/!H(5EI)EHI
M*BT0BU13CQD21GL'#EP45%FKB:JUTF-9Z9>H,^-."H05:!]/F*'!(FP%ET1'
MQ $[+<*2?LU%,]=%+ 3.B2"42LPPZ"(<.664>Z0)TG$1?+4Y7Q#Y10YK\,&(
M:)U41@9&M%1>"YJ(#-\DQXNR"6#-2+/62#'H5( F%)*$(<PL8MYJS8.B*'*V
M;/5GSV_7?J55-N*\#XAI#+J)(<4UTHP3+VU$ 2.V2$<YU\PT:\VDI7!6(DN-
M\(P09@W'RG%N,0I"Q27(/YIY+=$O=EH.(A@SH;A4UC,DM>5<!YFJU&Q00BS"
M:3DU1\V5CA)&$AZLC$80)A)'I5WO-04SZ"BK3]=:U.63V52-4!MIU%%H(QBG
M1#'KN<+<<@>6SRY"MF3-3/.BF62(S!$)KAQ!C%FBG&**TL"\-)HM1-1[[DN0
M?C'X9(B,Q.FH?$@'3P1K $9YKY!T2BF\"&MR-4O-EY8"C$0!DF-%(F<)/$FD
MHU4,6TTU(XN0W3W/-4J_F(*RSGNA'3)"46840"FN(Y(!>$DY[A8!0-7<-#>Z
M*87 ,?AP00(<IU(H;;'7QA,A!)]L;;S0NFG62RR_F'IR+@B-HS"6<*9)-!IK
MK@72D@0EQ2)$QVN&FB<-181CU 3*F*>,&ZTL,4@X[V+@AJAEVREI=@&#7VD-
MSZ$@TG%FD1K*E&,*([!\Q 7OTH&ZR[:C_R_'5#/15%:(*+@UP2K.E %4%7D$
M5(4D<P99\7EK7A743(YD+KI %FA[6[ G5W[&6DC)8()=%)*Q5/,*,BP8LEY*
M([$?T8!@4M/@)@U(CLF4:&!9D(P+JX5@EEKK08$2H4GP*C 1%E8.GN6\R"<1
M"\9U()H!C$*8$9>*,I%$- :ADH30A16+YR;)]*0$P(=TSG*JI09'B:F4("L#
M$B :4DDWOU(R-QO;/XFH1(N==%)K&AFCSFHI>63.!NL<LXC/KZC,(UVF)R]1
M$"6E0PC+R 1'RF(KA<=664&QC<LA+T^\U<V32(QB@G!'%;%"@:!XA:+ADJ;=
MM#!'%"^'Q#P?9:8G,SCX$+Q!CCE 8AR95*ZJHV6<4JHI7PZ9>98D]B>1',JM
MT-Y0FX[WHM@KCZ5&Q'A!@C)D26S-<]-GBO)C-;,$"Q 85$$ C"0%DV,0YMX)
MM!SR\ZP!Y2>1(^V1\)H)HZEE4EC+'2'.NW18IZ!D22S0K.@T/7E2'D7"I&.>
M&Y82W+U7,@KF"<+$\#F.#$SH]*[7[[^&(17=P]!UX&W^==XT@V$9MN/7G\^O
M$.VC:0_#NO?![YFS]7X?2#NBZYB KXN3HOVN&!2'0-U>=WX%+B435E1T;5-T
M+NG3":8/PQ\-MKHTN7]R9?(]/>">F)WR"DP@Y1RD5UI-X%/D8 !9Q'X<G%@N
MKFCVNEM=U^L$8(KY)?GU)9,@)$)<!.HE,UPHHI1",BAL!1(JSK^.G5\J34_#
M:NT,(PH+H1& EJ!A(M/^1@2I$-R\KT'L&*#!B #I:Z/H%IUA9UJ+Z_-+_^E)
MJ5%@31UE4F'$* .]BGD$+K !28>X72SZF[.:_C]&?Z ]XH%K1B5/9<Y&"D8<
M-D![I;GQ\TO_2RI=8J&$B8=C #RY^D_H>B#4(@"FZ]%+AJ)F"F$#M E6J)3&
MZ0/#C"&B#5D ZSE'=)F>O03\HH)3:5U2 GE2U-](L)@B[8 ;^2+5MBV>:S+[
M/" 5H@(E:205C D=0!)Q !L*M$%>N#EV2.<0+LV<GY[([]'$8HN= "6AN-5>
M5T>A,P#70E.S6"PR8T2UG"SBP2DV-*5_:<NPI\8:+GG:JRCZ:-4"+$V^,459
MT>:O\\8H;),>\*8,_QE^I>"MQE>:]G>"&Y8E4'Q:O'6E2Y<?_PV#-*5KG;\+
M)Z%]3Z^VNL?#0;]J@1>$@12*B%DLP$G7#,P.P/4 6(0H;Q%F8HZ]]B5G(+(@
M#,2=H. \T.@L9SQ2S072+H*388)':@%"J$O*0'1!&,A3YBW7,NB@6.#PB8/W
M@[7@P4:N<,U CV.@*^_YR_2+&][S9G]0=,"%V8Z7MUQ^V"CZKMU+-R\**QDN
M-$(V1.X9\\+PH#"240+!6: +$.J8;U::4S0TO9B,PS1XZYS&@(H,,88$SE(-
M&/*@@-@<Y_ O.0,]+1J:'@,!XD%1ZK1SM:QR>#%S7B(M?+!I%X^:@982#4TQ
M-U]$+SGH&VPPXT@K+YWC& >"+/.+L-8]WPPT]VCH4:QTF2ES/"IV_.Q@,(>]
M\OSNI)F;K29/?7#^C*0BHAA%U!Z!\R>M#!%SP@-QFICQ ;3IN*SQ&@;!<E[9
M]H<#BF]*,_2;9\?PH"?@B)L+%.3A"Q3 07(*"Q118@KJ!\R6]LP(K"(E*=F>
M@2)2@;ME7I]Z7MH^\>+3B^+L91GZO6'I0G_TM16,KSKOBY-7?\"?<0I'C IY
M$8,UBG&*C9$B".--#,Y$:CXG"G^]IS\X;P,M.T4W;U7%UB\I7N/'@]]/"S]H
MO<0(_>^5JN6K/_K'ICMI[WKM7OGR?R92Q_A[A&[FT72*]OG+_[L'M.MGS7":
M[?0ZIOM_5_NFV\_[,+!QPWYQ$>#!\([JZ^GHM0RAW]M%-TRZ@0GZW[^GP><^
MN%Y9!?1!B<&04ROHDYF;OF2M,L0_5_[G]^<>-.>>L>V0]6*6N#99RC]>&"!(
MFMP)76Y1IWJU:1>'W9<.;@DE#']0/6?<P/9*Z$P.,]$VQ_WP<O+A=U_TC]OF
M'$Q0-9[JIM\[ICP$>MO>8-#KO$S$/@GE(%5%CE]2O6]T><P'6J\I3A,K#(#E
M!G[RXC&7K%5<\F+@;U_3:DVC^R^C-7QY[47U['+28,*/QX.5ZCX85)JE/U?H
MRHUQCT>"CP=9O]<N?%8Q Q!Q?'W0.WY);ET\-CXE';Q$&:Y>\;4/+ZIY>B A
M[A$+>,'/L**XP8KR#E9<>?6AN;6WN9'M[JWO;>Y>9YXY[.WNYNL/.UM[6YN[
MV7IS(]O\[]?_7F^^W<Q>;S<:6[N[6]O-V0U!/6@$GTR_!:PRZ'57LXVUUVL9
M09SI2:^G.Z</448KK_[/_\0"_3Y#TC^LFY\?^]_<CW#FA'B8#+[9WFF,NPK8
MH=OK-H=5*4@VAA@[R8(5B$IOB+>,2<+2X4LR**F%C A<@Q#U77@QZYJ$!GTH
M7F[TW# AJ+WS8["*XY6!C^=VHW?RCNR<[-/&T!]MGAR\U4?;G3>=@Z/#TX.-
M@\[!I[];VQOO<>/B36M_SY&#O8/6P5NX_JG9.CAJMM[19GO_XKAUT-EGC;?O
MR4'G8[&_=XB:>XVS_4^;M-GY0/8_[<#UCT?[G_8O]C^JLW?DX'S_DQ/;;QL7
MC:/W9)_\?=0@6ZRY\??1P=[AZ7[G/=O?VV<'G]X4^Q=_=YJ?/ISXMQ^9__??
M[0/2/K%'/;9_T3AO;AP<[7<:%_M'AZC1:;:W-_XJ#C9:K>91J[W_"9[9V<<'
M\#[HRV?DI*: 07*)I<B9(CY7.(8\$")2]CNR!L 71OG["L!])<*K.=0D,]&S
MOS5,^27;[H9_/75_IBC=13>Y-R^QJE#$ WOY"<Q)0A_]A_;O[@E[!F%^/P1O
M!I#N^4XX[I6#E2SVRHX9P O.!B]C<19\/BB'OYR\7ZQ_YCARIB+)+<QBSAA(
MOA):Y@1[9X*-+%J66$A+)GZ?C<C?S34CKK[]-WO_87UG;W/GW7ZVL_G/]LY>
M]L^'G=T/Z\V];&\[ QBW!UAMU!33;'LGP_PW_Z_1#]MOLKU_;V97L-XESEM_
MO9?!9:PIFT-%-V=0\TVOS :MD/UG(G;9*":0!5 S/GL&@?^G>M_F*#)Q7=P]
M_))WX)VM=%ONS7E^'DR9A^ZO)?[GVWONLP[!1XE=;H/5.8N&YL:'F-,40,7I
M4 &G5EXUT@K'B/4H7LW2Q-]4!=G\\.0B2\[VSE(X"TL.)_9*Z%^1(FCWXXEH
MVOU?#%!<-#8./Q.F-+8& (4Q'#1*<+G6PH%&05XY1IG5=@PHV$( BCL@QM[.
M>G-W*P&)&F/,&F,,+F5Q C)BV>L\G)CW$GG0F\)#UN9G&A>9V*][G4[13XMI
MV9NB'3+0%S:4+Y\226Y6"V?I;:.7_5JJ'&WO;7TV0C$4B<RIEB%G"@,XE,3F
M1E"OO%62DIB62G%.&5.W(.$/,571.<SZI?MS):U[7A+D\R%>.SH^7,E,&XQK
M<S=O]PY[ -G++X=E"-W1M>M++4H<G_W,ZA!%Z/ALY<4L;<_<!V"?7-QVPF'1
M3QI]T(0KOYS('7[&QD1#0-#2?H(YT\KF,*,ZM]X*I:)B*OECS?6]#SN;_^=_
M*H+E[[O9[H?F[K^WFIO9/SO;&Q]>[^VNCOAIJ_EZ[5%".0-[]-OFF7&#BC'2
M O-7ALA,/^L?!Y=2,'Q6=+-BT,]<JPHP_&M^X-*S+VE+)']F29N)-:WI@Y:T
M?^2Q9(T+/O6G,KF&&?F1]??[%MLGZ^7D^"RMF/]^B^MOS7GO^-DA#WH679OV
M]2B/QYD@U>9KH_VCSU_W_/60&8S I82@03@N>R?I.0L:*WM3V+<?Q/:GG2^@
M=UO0-W@F//]ML]78^'*QW]EBC8L/9'MC_Q1T-?2E,;[G([R+=P_V>OS@[4YK
MO_/F2Q/&!V-!^V3S='NO64#[BR:\KWGT5[&] >_'ZO3=WOJ@L8O.WNU](,V-
M_?//+GC0X2FSTEB<,T10GDZ"S172R*;38(E$*Z\^#$SK7JT]9O\?X^QVB+=T
MR4B-S(:U;Z"=GQK3KR:M>^9L:YR!Z"J)76"OY+G%<.NZ&&)"H^>6YDI'F:?M
M]G++*?S1SG))C; RK+Q2,D>42*W(-X5Q >W-+1A3<?!OE0G(>F762]L09$?#
MLNC[PE61E5Y<5 UT]V 76@/=0[^MG=ULLW/<[IVG+.%E9-'B*F*I.+4\--WB
MHOK^KYI#YYQ\U^U7UNRM_>LVG\XP;769HN-/CD?6O2]#OS_^YQUT "\D%OGI
M< UN'JU_3CN3*.-)KK&).:-2Y5I:DCOEI8X\2N;ERBNB$<[^:@_#86GZ_>RO
MWK =3DSI;P*+U:>/9]\F&_GER/;^<R".F&A8KBGR.7.!YRI8DQM ?L0"[$."
MK;S:'1:#,%[%0VA^ VFSU0"OX>-VN=<[7<R0P&,8R7UV-&*ED_R[@$#^@\Z5
MY3;W/,;D/:!HR,JK=Z%5S$[6*UR_7?Y3]DX 0"UI9.<19+S8_,RD"D)+GM/
M"'B$WN2*"9F'@+WF4A*G\-V!F6>CXC\](%/[H#@>1>=^,1*]_RPH=1BF+^<2
M&U#9T>:&B9A61XS!S#B2+*UBB#UN'7(62QYC$J?UCN,29+0X-NTLG 4W'!0G
M:1D$,#.\S71]=E$< X_Y.W++YVQ0BP&3?WM"\4V&<;T,YM<36-( @8W"<*(Q
MS55T(+ 83*/AD>6!*4EP0)%8"@*;*HZOB^N_GE*GONN!(_Q/J]?]);,Z@#"'
MGXTR1F%D<Q&$ ,* L;-4>X P$LP=<S9&L_**,IQ+/<^P]QYE^G7%>+P^WL\&
MH1V.$\VS;D7T#'1L>YBB)ID! ?U)A?KJ#UN^F/OYV$U[F!2# AY85C,3RN"S
MXV'9'Z9%]4$O@Q95/ :3W^R_D@U*6757;ML\<ZVTA6ZV[@;I\M7TQ.==[08O
M; V-EEM^=+F;DC5"I[_<_92/9<NZWGUW='"O&(SV% C&M3+7-OW^4D4_]TI3
M:9S=\X[MM7_K/S)>/6>C:X[S=2KBA8G& *URVBK@EZ^J9SE7)IX0L8PU\3DF
MMA*1A40LHQ7?@Z,/9P=[6V?-3N-\&]HWW^ZTMZM[-FGC(KWC8W%PY$Z;%Q]N
MK/@>=YI[;]J-HTVR?['%&IT&.GC[@2>4 ^.Z:*;Q?()W7:S39NKCS<0+JZQ!
MQ)C<!TG!>90XUQ@\?<$<DD(EJL11DC%P[.Z@Y[ZL9MU>=FS*["1MN37==(Q?
MAW?'.F^D\FK&?0#C;EYG7*4X"M:PW#F!<B8"S8VS*/?$(42Y\M[&*AUTY^DS
MAD8,.E<(][ET[P0"CY*2;\9/D[E;X-#I<[/X]6R<=W2G'?Z]<W[PR1];PD3S
M[>9YXV+]_. (^DAV.O =-\B;SO;>%[3?25E!FS '6Q>-C59LKG]F@A,KO<B#
M$SA%&61NC0/U+JF5'"L<A4CHI._-?V[%;E^;XV)@VEG:L"$,;NQ?]?,KTHOA
M&#Y9&><T.[G5]2E=(&3V/'.MX+YDG;2YQFDK5#E*R5,M+_W]W[/?\+C(KF7Z
M62S:X.F:=AN:I"+-Y #_9U@D]Q>\7AO&#>#)8P_XLF"O5UXMV'N81YSY8=HI
MM&IZ7 87*K"/2595FO>SW^"AH#BR_A#@<+_52VGKDX*U0<L,;HPE.S77^YLZ
M.[IY/)I_K58!X=_(E2%;T$'0R![!@-)-57NX,W5E_+!J8].J)U5/37^0:91Y
M<]Y?&Y>L/?F*QNMA64(O1J6S"1Y4AZDMI.[\^;TW&GL-P*7!>0U&/.?1Z)P%
M4%PF8):CF XQ5,18H5=>[8?^3=5UM<;P!VL?OE=E_5#M03C]T5=/7WV-_C9[
M,Y^/WIPKTN73]EE2>*#K.L5@ "HRM$'GE;UN JSM\RP >#W/MI)Y-:Y:1=LP
M S,J'KUA!KX^XVI4=&<(+1GBXR*D87N4M+:;[V6_I<F4OV>$DK5QBT&KJ(J1
MCE,QTE.;@E&'+Y5[Z/]K[1K_/WWAR.6LIDD=J_-?3'\W-SZPSY$&B;'2N:YV
M3^&!Y5:D+52LYY)[X9UQM?ZN]7>MO^_0WZ Q3=8V)>!HXQSH[](D)9PT6IFP
M[9V_9B!$^9T7^AU0_/"6<@(K0?-U8 [.5Q.>A\<!]$TK3H?98=D[';0FE]<
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M1LTPN)2D&J!-3<QN>I *&>9TE#FG& ":D#%7#)L<6<I$U)+BZ$%0T"J3[+$
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MCH W*'*,.QIY6'F%5S&I-Z198H&>%KZH!?K9!?KF$@IPJ_,\YE%[ES,E;&Z
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MW1]\Z-DX&;K3:^OO[_K#3FF37BUSG]%] 72?S_56BG)E3<K<0!Q01PA00D'
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MN-$* HQ5 A H(:$:(21_QMH>=U'M#8=G&>!JO9X4QBY8B('P)A(WI3TPQ$K
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M"J\'O3C^G V[=!HQG?+=R8QO67MV<E:6PMWQH6,[.2Z^0F3Z,)\MZQ2%)%B
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MUDPHX+V/]J&#'OH(Q[*R8KJKXAK*2+8>2%8/-]@,IF5/6(6 -\,_?92@#EH
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MR7^7%M"WMLZ,ATW-\R$%R[,8;N #T\T\_M4]2[/YKC\HV< JM79:!0+0FC<
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ME!'IM.6:^^ 6+N5;;DOCT_VKI9S^UMTS7VK3JZ1,VU=TZ<U@92IBKL0^-)^
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MB\\2%Q<Y]D!(.F,#TS182HU4DEF,,*:>2*RENAT8<R? 54'(V=-.S;#D&%+
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M&EOF8X_],&L6PW [5"W7JW+-O?Q#&C=X5S(,+0)#AW-N$\@@A<@10#@/@"8
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MB0RZ/ULNB<*U'G1[Y=%(XL\M/]H/;?T]4^5%J/+Y7,%, 8VPU@G@M&6 $F.
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M,VFH5Q*F[G^4SP>U9%S,N+CZN+C0N0;1.OC(%0.D44&HY$Q$@RLX;#R#_"?
MF+O_K0I"SAYF2@:)<\@")&DTJH/W0&,;L9)0(XVQ$*<2#0@UD*P@!R*C8T;'
M.CWX(JU1(S"25(X&,DXY@X8RBRRU'C/+I-.9-:XL)LZ=$!N'J!$( N2# 510
M"+2R%L#@M(62!8II!$6J&D)45<+[<;K__5ZNJOBOZWS=_#/^F([KRKVL3XML
MHI&;?YK![YN7#W/7CSVB(N.RQ8'WA;8I0%KWSE//@5Y_%.\^ZB<E=JGA7]H8
M>N6LZM3(('1ZNF<[NAM'&E\XB8,?OKCU,2??1?$X3ORT/^PD4;\<^*X>=;[Z
M/[YUW.AX"BI7/C@6P4OXXR/:Q$&<C6[_2%VF5%Z?C:L_TVA+8-$A2.AX\$9'
M^D"0UH)[KEVDD58'HO^-:#C]T/%@^@2G^I,'9N#U%Z!#?,"7NOM-GP\W?K\V
M#R>='IB9]]DINW5B0EC:Q(RU+B)M?U"VD'D95=D/TE5Q3+HV8RF.!VG;^I]?
MBTAL;+83**3JDMMIQXN:\.?O>O,F\==PF;:VVA\.=LL@6?''87'XH77XUUYK
MMWAWL+_S8;M]V!C#\5YK^T6QU=J)%[PZW-O9VSK8VSVL/:QM[[=V=EN'NSM%
M_.UP_^W>SE8[_G'8CO\T=UOMPV+_=;&]=?A7\?KM_C_U?Y[?MD[BUC<:%IU>
M,3KNG\5[N2L%.YYPV.4=7W9&\=OL71[D0T]'SA9WDLO1/\5\7J<:Y=[^8^<I
M^40<25>?#OW+Z2]_N,[PM*O/7W9ZY?W*#_UQH@>?(MY.MJN$M;/A84D4X[<G
M,*S4"P%%0N))<-KDBR<@_:($Z1GV,WY/D!>8WOXV?(%N?>]GMT7H!>'D7K?]
M^7N,W.^NOQPLO=-M?Q$ N&"<WR/96^*67(:;J/'E0ZF[/-08"1[GL>2=GJH=
M]UI?-.-UQ\-B-V[!KB3-E\&,UYYW?:1YQ?^R@&U3;U%'&Y]4]<"W1M@_TXG#
MB^A!56'-RWEF]8+=R;_T@YH5KP_VF\7^N]V#K?9>ZTVQM=W>^WNO'4GHR[NL
MIRJ\!D_DBKOK7-T=3>Y=IV'M)_3Q<^:?=@I^61OPP9E,]7OFNSOS;WK&FJ_I
M!1SVD BGL3.4"DPI2BF74B@N H24^3"N)4^F65IDL=).*^!]OV@>3KWO>]_W
MW[S_?H0/NJW/N[AY\1Y^?/.QD^Y[]'GOHO7YPWGKXOVWUN?WZ(?WW76//G^Y
M:)XTT5%[*[YW</+QY/5Q\\*RUF>+6NW_GC3??"!-W&2SWO<6_KNSWVZ>'UW\
M?=S<V<*M-W'4_^Q>M"Z^X-;%!]0\.?KVL6TOCBZZ93OAF1-)CQ#'0C(@F46
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MK.&J(.+O75\&)/?<UA5Y9!]#94C5F:_^(E7<0 *+^&0DH(H@H#R./S!7 :O
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MKD@D(]!""&3G6 9B$A%D B!<2$"U5$ BH0"W6,H +=2:;&Q2]F#\R6>0=3X
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M1*R7R1W?WZO7RI,>F9F%K(L_,_/:U*&^NX=W=C_2QODGN+;'&I_VK4D,/+:
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MYW@DF3OIZ@;2JQ6W3[B^M4]9B#I;4T.) H;'!;+<!,08%2 :%L/UY42J!8I
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M+KI;"_A54+544#5=39P:)66($M$H *H4Y<@D2E$@+AA+*!>&K&TROB[Y=$'
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M38WDOM1BMJC6\\L6I%UV$O& #/M7D>2RL S["H >'8#>3=&(1(@G3GODK0E
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MBAAI"3-<2&(93I1YF@3\J8<':JI]Q(<&M8]^B/KV)]KX]O6TOKU%&N>?SG(
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M( <[X-O*X%CT42U%P_:JV;U#VP/@%O' -:.2,XL86/2,.&P ;I7FQK>VQRU
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M8,WXO0H04'$I$)R[(7VSKW>(!>?.RX_/P^9QA=T %CKLRLE4=?VI#_5OL.W
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M73&/E0NKYZ7-]O:'28LKB>.;QZ7;A+7G']1^>Y*6)]5YC#F/Q"@-"]TZI:G
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ME":P?7C>=!HH_Q.Y[%&2_2@0"V5,:EL(S@J.Q$_1Z0Z/Y+MQ>_T8#5J<U2@
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M-([!^KSG*@;G#B/#E#J,D)^(J8X94_VQF*CT;.JZ/ID&T4Q0)HV(T5C2->G
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M16UL@4MA$AMYAU"4="H39_M,>"@H"%,B"L9DKGQ\E\VX6.:-LR*$4PDXWR?
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M!9B;Y)ZNRI>;!^K[U5;%@V3=9#__-AZG6:'D_)QC=S >I@&WQGOI)>+1CLC
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M;3B:JG\R&?7CV23$$_PX?#>D(&8P(2W3$S^]'DR01)GTK%/.*F' %[1 *T&
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MM6QW=.QB+V7;:6>][F>.9A:68@2F<FW$+47M'Y(AZAQS-CYBV'G5]\?:/N]
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M<ZVI:,!'HR 4F2D&\C:[UNW'MT>]M\.M._L.7VPI7+EEYG6I-PVGC0M(QZY
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M)<?J0OI?OU]R?UZ-\+_/+F)A<I\DZL) 2$T#D\L"SH@"/N=H-,]:QM95ME>
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MEFQES#^N_XEAC'_]T_\'4$L#!!0    ( &V)J585]9FZB7 ! %S* 0 4
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M#+_K A'XI0ODZ.^ZT$!^\I"D^<E[>]-W?KK?]=GZIW939P'6+2WL- S _%>
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M9*"7V1+A@,0..E""BP)<]))7([@W)7AMU#(O)>3PQ>M:I(;Q3CA:>N$@PZ8
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M^9/M7]KJ!Z$C_">=)];+;:MQ1[@8 MR6(CPP:)!6XB>MYX_;M[]F_;/X#PV
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M=S8V]]Z]W++7%Z1[, 3Q>JX][#?.ZGD6E.T\32H9L\%]V-L8_O!R;D:_B]5
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M?YH*1/#@ES6@'T:_VBW9]-A-+1"A[7/K^\*)-3!2J94/Z18X>M-W4\S%O*C
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MYWL ZB33M_JDXZ9"?LWVO*]E7#E8E1<QU[<_#T_7F0R?5GF[Y$%^37H ^ET
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M)VYS*.GIYV(%&R69*/<$E<+1\KO<N3D3M1,:1U89=XC<%S[,>3B2:0KJ%FB
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MM63>HXWL:M(<#.D)F/R!NN=7%^ 6EW__+YISZD13@X!\SA!]<OT <#[@6M,
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M/+P9EX@@79*G]%/II$+MSQ_5[T0;1KP,$,6?-(%9G5S%-X7P;I?,]E<>_3K
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M8\5.[5K_ROZ1R/28L%'^<EB/Y>+Z;LQ$DO^:58"S8FI1T=O2N7%S]5V;];G
M,-&I<__LQ6DXI5SY>TYO4@G4X5[XM8;@8K\1TQA>+2.L'&^B"2((SH>Z-\GZ
MM*/P]/9C"6^,FZ7L5>4A;YRCU7*W9#DN[PIUP1-44F,,E_4G5'ZB($R&J"U%
M9I<:3<T:,A@ W3KG,H@;OR9_D'"[3!_@3V"/,1FBI&F=7*L1&T1T3_CE8&.N
M1BI>RU# XUT$[7\U51.<=$<>A0T:OJQ)T,E6ZL@N57S9T6,F)EC;U;M@4SBH
M<L*OYVX@;AZN+>V=N'T^L4HZYIW3BTP-D4R>,W<&;WRB''I(U*Q>J+E[CX\_
M^FQ8VT&Q3=%-LB #<'4$A5[G'H(OGC'[[27"I#WG?IN)8'^;B>R(4O>9>E"P
MFTC_HRZ4BJK$*AY<VUKFXEFCVH-VS9IVT4[D1_L>I8:1,!A=WX3N#C.@Q'4Z
M?ZK+C@GRP<A 'JCDF_XQO**WK3+XO9W"4[9\,5#VU4(]O"S4?IX8NEO;NJ/A
M3B$IW4>G'\=H%2NM+C)#S8KHB]R  (SQD\)VX1?Z??&K?WZY_'[ZL$N/1_#K
M]];7(\-!YT69BB@-1AVOIR91>YEK/DTGV^DR>E!AP#9!J2G5]<FC.U'%/"R?
MP,F<5?HHSK _>$;*:<6WL,,J,NNDZ+4P(HF@T+(G5-I8,5A4M,6C-"./.;[+
M7UM6'Q:B+BS^R7?RP@L5(1;NWAA(G^M?50,L1DJJYX+C_F\2QZ?A35[4:>:I
MF5&SJ7C[RI,^JDZ7L*3(AK&LA*H&RZ-3-3?Z<*,&]T6T$Y"B;?D92F89'E6*
MB;W;Z1@!7SOJ_#),$=@*327C<%#R&A!+X]+,(XDF>:+D1E\]E*YF64"V>G-;
MBQ[*>[#7@D]>'_E*NX=2&(%_73-^%_?*K4,>D0MUR:/%$28=Z6Y(,@-PUR>*
M>:*I6(DR+K&!XD?9];Y286F@#X2[@U;@5EX7<#E/7NAB,_CE# /@\4*=_F2'
M0 1#Z/IVJ;1'&:AY^3W:5)166Z@OI0;>L;=J?A2R&4M[.'#W;Z6)+\D"83RA
M^$?UCCVHAJ'+7": @,2FYT?53-*L=D-2\[:A%>24J&.()7;0SI.]:=((/6B
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M"CY5D\44D4.O(26BV0'H=]0J)@KN0E*1WYZ&HQ^ B5/@!'!.8"<!V-VM.Y&
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M>QTG;O]0'4I#'>FN]Z;-6;^$J*@MBC?4?-=(0EJ-*>8H]0RI*(!?K\JWZVR
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M4O$^1*' 7\7=-E??IIUO-5)V.HLMOGEV:_7B9 T >!D@:*G!]WZO/%Y?KR]
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M.9."H\ [L>T4E3VPR[(Z-949J(3 R^#9U7^)"Z7TQW3$Q#[G/V ,O$\RCP'
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M[RV<,:A']Y"_*\=*G8.B7N4=#[(IJC35HWXC]/,S UE,\W=G)OHKKX.<).E
M!_QJ@A;A"*V*XB)N;KR&)D? ;'B?_-7)\/,0+^3!S4@;R=K1%%$>79G2W<;@
M-)X]KRXIL9GO*NAM4ST*;*#Y%L65 <C=I",WP2F"\Z&6)2S,+W\@1?B-D#C(
MHFKA8(/%:4TG@\Z[A1<]JTU[\U=GSJ"UQ6F2->Y_S"M^ZH<YEGO<]3@]P[N[
MAU8%IR]/H>7KS_D+1C, TFAQN/#GQ*6.)O?!AH;#>['&*D(!LJ;?335E6P3W
M!62/S;RG9SJW*X^/-QYKN'@5='-BEJ-T-W0>BE>G4C4D3!>@:>:F;+EA=.'>
MQ[W>>#?K94B])(2$N"T^+_>U*70,O'X??](:W(-80"R"61= <0T;>!"6APMT
MVT\4*VUNU2_X@=/;G?7G8,FQQWVS;I-F1WF^.Q*/W>T[NZ>&>!IB_-ZZ1>S.
M#F+@1V#4<N'OM!0*A.ZN0G=S[)K.\+>NJWP9@IE.VGX\H$4^4\Q?QZ9T*6#]
MX^?0CXW'\QR*'\\M; F>_FR!5\S>-@4ZJD1)<7]UNL4DFSX():O)\O6!'EX(
M63"ZH2V?HM>=\F1<NCY;:\'<^*%2@J>%_D'FI:[*R>9N[#4!8?= ">,L3#9&
MV/A_L??>04VV6]]HK%A!145 B J""HATJ1%1 E(B(B @(""]23>41$%!:NBA
MAR("TD1 I$9$"+V%7J4DH9>$ED)RPN.S]W[W_L[,.=]\WSGSSIDSS/T'DWON
MLJZU?NNWUGVMM;(L;Y" D6E-$2]37UJGY4TM<&P;%2.ATJA\.VQ.Y_N]FD1<
MD&VBN%KDQPM65\ZH\ILVI2O$8*[>/<=_.D V8&^<N7!,+I0:_96V0:SJVZJR
MJ*!AB/W'I*A262++USY4KE_)R.8Z?MX_6#$>*5F=!GKGZ"9:0[VYPN]KP'9X
MN_/ (K"+^9?[G7R&@A4SK1@N: ?)PF]YB':977%04ANZ8.%0OK7II(L0+$5_
M -Z?EE]6/W7@<M37G78QJ[LX\P&O;BO+%47)+R^76IBK;\*VM'81V(5)J<TO
MAG)WC$[%^;5:.WJB12=:;?*,TS"2\N(\57SYIXIZXP*D9>OWZW1*ND8[!;0$
M[,Q;;NE(PGDPB43+*D'.X0)AHD%T[0@Y!'\2)$26>% U5%& I=88>XZ<.<.E
M_M*>W[9B8OP]KRQGQSU#MTVCRY3Q[(N7DM0V@=!57BOJ<?*A_:8E<VOM\5])
MHOA;8]#9KOSF9X5IL@MR?H&N"P]^^ZSF;L^=!WY]$PG60QG>7.$)7%;JIIX-
M?&CH*14KZ+T.'@=](*/>+%*_ (X<_>'!^6[G3UMJ"Y@SB1"K$)C+8]"5;H/U
M*[-46>B$OXI*.K'U+"K=389\X_AVZ_US21DBOP8=-BEW-_"I+Q0Z_6KH;!]H
M^_UL0:RTBIY1!\@5LO<34N?H4X'L5W#59[P-<6T(>=VB4QJDCA;;_3HR9@2[
M_J#/HC3WW5=>T@)B;)%Z:!8B!^_RI/N3/[9?C/^\0 >7^KP]&F;[Z4E=U7.3
MI#F6B1/6SR6?S79[AP]2O4>-(C*OAL,?N)#B4?%*+TB"Z;5+!$XC%VEHS3.2
M</AX0?X4Q.,  \#_:!G \X;;6M/\$O$\D9(&RW[B(JT.H?Q"U87.I?X+K*AC
M=/_I8JE@@FI-=NW[%T.T4H^""UYV*\4B.!7M340_E732C/N-8M,:_+<W*K#\
M.FO,6W( VX3+J&._4O]_"X3]W_$O8V!3E$8+;/N$[8(CZSTBY<!%"QQ<#SM"
MI;<D%_9>XE;;O>YMFSF.>OG5\2LQH]##$8*LV:RN-!TQ!N"1R][.,&VT,Q#?
M4L ]EB:]W:U3%M<(-5?POEC&FL^OR7/)[P/+.9$$V42U1PH-I>MPK7I-DDAN
M:FTV#B$]W&,$37E4WO_[L4.3<Z;A:Y0G3F4M=7GVI]HJ++77WC*_X50O[FZ(
M7]/7YV$QN<(ZD/-16ESMIUJ>/$O5,WSV.(#),6]<.?N0-@1S)I\C$+M)HETP
MM>\ALXC[_80P;>B!H\:"+D_Z3"BD]]'UJ?-BD,@K:*GM^C?SGM [P.GHDD5F
MH+4;"FU^MK0O#>OT![1?I%Q<>A5;8BT"SUTBNAC=HWZ]1E^VAXOB_O,'YI;!
MMHD:Q8T=PQD:52FC/"H7P0IA/]QAA1MJB7S@.U6\S_%1I)1Z/1K&%W@+9EE4
M&:NP(O;,20K0)%FDJO+EV*IZ@*K\8;>GJ*];5]T-4*KFM=YL);Z**_4\3A;]
M@PII;.L:='XR\.T\%?-W'K833HH!DB)AIK1=8CO@:E_M3O9]3!O]I9#6CLOG
MB0N'RV_#K([/H<N+HG/[+X-;\74?M]TY'*87+I=2K.B;#,"#O53,8]@)**I=
M;BW6<\^@C6Z-M>KSG#@W753!??P])X]OP"W.9V?:?D3]"#C.(N,:%57:NJZE
MCQ1($2ZUNBP>D@4"!D2;VUKS*I.&$AD $;^Q+#*VK?)3NV&OX+F?6IINF:-J
MUH_!-^:>Z 6_7?9NZ3IH$9:4,83K(40ZJN:PD]986K;@3(V) R6;FM%FB+P1
M!(3H7;6UV+X!R<$7?2.FS2PE3M=O5L<^MI6]J3\_DMD>/HL\#ONP#!MH&C6R
M)6"&$NF.U8&[XSH^SOK+$Z%H&3A!B0'@,S#I$6$ 9/UJ;$PLVW5R<E,M0F W
M-V?Z0^?>#A1-?&?2-_\*]8_0+SWX[!\^1+^Q,7KCANMI9['%("P)H4)WF5B%
MW<?W$CG0,!5XESQTC#3[7'I4$JQ.K'CWN9H!2%FU%)@<=]1T/8$PLCA]_^:8
M19-RL0Y*P?4T>4>1Y055/F_%,9Y-DV5 H@7*2L*1<E<-<*)S0]'PZ[3J=#.B
M:<(5N_O?BHH@X'IT/'@'R?Y8/U[A*:# [+TJ.;<]P? T<KQ&L+1\(BFLL9%K
M37 164N/5,D>$,^UW[?'=K@$7)8I:P;@AF1O'G2IXQOE^==,7QY>T)39A*[+
M^-AUD_=><_>4J9KB':^MHB@J!2M*HWU>CG?+.EBGN\#CLC0H%'T'+0TG_$Z'
MDKA-[.#QU490(-@^:PGIP#-8<&WW<_IC99UA%O/^NYT)(J=4B1-$^B"3\++F
M*C9J %D5"5 &X!=F9:?^Q%!M8PDT^PG*D"10X5^R.*1:R960J8"40+\15^NP
ME3^QDE3ZX4/&NN$6IR>[1#O?3=Z/(]0G?B*W_Z/NYS.(<&(+V,NTCQ@XLL)9
M;.JT=I\97%>KZC?H]T^\=*'IM2W3II>_5QR5_%3V0O9$IS3[E"C_K1#R?PE=
M!RG&3%V=FLO&E[2$[5E,BCZAMHS&%Y<!SQI(+VOE_$2\* OAWM-L[X4$7_>N
M-:M,%NWPLDLD1-XW8_NXM[,.X[3&K6,L2L:ZR3_@((043 ,H--Z]: ]'5H=_
M.RINSP \J1' #W17"L1(;6MBE\P;Y=?\T<.\/32,S>X#2NDY4*<\9A,1N'JJ
MT3?8HA#8!4J (Z<2Q8[5+LUU\G4TL6.#9NA]LC8AWI*A;HIJ%-371L%3,<%\
MVJQE99+5#88;S;!UT=]01."L2X<H>:<$!ZN/G8"R&/;[!>=):>H_$>LOIVP=
M>M<A:)16L,0%OVTU.Z3I;USK8LL _-@!)W>E@\^N4K*W*>@1/V Z, 5(VD\_
MF,5IN,*+H/!-0L+*8B<^[4S%1-:5O?RAT/9CW$];WCI\L4S:K;C3VK)*GG+P
M%2I97HJ;;CI TQGW\T%\*)'I@OIV[6\%W]L/RE\PC]Y^&D(@;0[4Z="ZA;@>
MDT"!)'T4$<''H:V>Z-9H.:,U,J@*<4<NR:5=07Y6F%+9-AM37SB&76Q-4+K_
MO$-Q;X,*3ARAGK7TM\D?&5V4\QR7V>;HO=X4OU)3&*UU/I23/Z(_JNU'P#%)
MV<_74.;O9F.NZ5P)_,X7?:SPU$1H_2WF S0P#X=@DF\[A "\97B#UDIL*KO$
M%PX8+4KUM"Z'<W*X']_XS)-XH:-O44$"'/VZQ%$QF2<GN/D7R/\ /1W4N<,
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MGR.RE7J)?C52ZL@WX(40-/;F<4!TY]9%2T65?\O)[.YWN:B$B:()_+644*@
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M/AN'M[&3XQD IW8()4BV8(4MSQ=ER@"\K=RM=UEBJZ)H)._T_=5#<Y_28!B
MPC&"&3FL#[2:[;+OE55:J$P^PBFKN,$ >  ##:O]./4G9WS5IZLKDC4<4NPN
M&OM^2/P8W?).O%H\2OGPT[/8\\VJ_&=L@U<,:#.B--QS8'+"Q2DDW:\V<HH$
MU I*X"">"2LR_E5QNP[P_>&%:/ HD(O>8Z):H-6PB!"MVD:_5"S@R3R;V^5P
MAQM(0.QF]GOBY89JW(^O_J.Z?!?'-'IF3-V:PXP3CQC0LXO=G3(H;'4;W?L1
M;:0% _">J?:BW:>Z_%:6T"0$ T#^:U;GNE@O?%%:N "TX[;#X;+,I!6V"TPJ
M$+7_7KUT6^#'_0T6EJ9N)-/8.28X!'=QS=4GQ.)JCJ^MJ>4*/'O\Y0%+@6Q6
MWJH:YXT'+6_DOH]V/I=,M$D1Q +4=V'U",))DBCI9 <P&>8YY+>!-^RHCJR0
M?;W2R,Y34;URNOS>IEI,J()/6JLL&A-^_]I5<F,Y%2QJ:W\==7,2/"=W8.[2
M;:T?JG:CSMD%DV-VR5KON_+S3>]&=D/*0PCI!HH7[\Z>ZO!_\RM*1GAC-EW]
MV(]SD"M'8M?]67*9<'*->:@N>CGX.Y&-\QZ>%+V"]);6C]6=Y$[Y,,<R7.1^
M>;&4M40%,<([T,I[]<U0T@?0-64H/'5?N\5!HI?@$7ZQA5 W >>SDY-&+=^Z
M)H^_.A""H!2Z#5N%D[D]?2;;!N;1Z*8;T.C*;N3H#W'GNN&"M6[R#V#;BK<I
MK1N4]+O5!H>ZUN3N.'3^JHMH25'Z <>Z V<Q-^-I;&SX#A&O>U<;^^N8\F:C
MB@HXV>"K5'@02X_NA>X>LIF>W,OH5%G9[^=3?YMI=#L,P*!O/WREZA.\M;FC
MCF,'Q1*V3:6+=V]ET23_9O?>M%D;NAJD#4([Z@B:&^YDS::V^DYE*R;OMR("
M;;&,;R_G3/QS,%\NW9WI)(R$.H#;;7WH14YW]RSZLA+["H%FWTTII:(NXXTQ
M2DPAIMYDWCIYOTE*9?=>KTL9M^%>[Z[_FMXRA.8PS52XO5^H^JJ/_EM_."S!
M@>X&9UZ6A63) !P\B>BOJL?"O8'NI,H*X$8NBH*;YG3/]&]GQO:[3$4E,:/B
M-\69#(#@BCN;R=Y4TRK\MR\#P 6F<XC6BX[Y8>O'_Y!C$AM!E*RQWW37*6R-
M\L%O/G,S&,_CLD,&%<*(S41MB54@^1>*W):":E-\Q,8''5TT+FG7TH>//Y<R
MV30.,89F<\<>BC4\XP'B^L?^CJO=:[Z(E_Z?%=/$ F5KQ4$+;*_IB->[D97;
M?8.+HY3!T>VV&:%V^9887XWOS]4OEZIE1O?^O<.03W).=^5+8N*YD"_0"WZ&
M?SX"$%UH^!UZF0$*/JO$-"U/C>=MO0R CQ+(O97JN@\4_DR@\.;X7>R,.OS_
M2@.HSP)=76LZM17899&/M?7U22++*U>?$#6$"R^</>^L(08X$"+9=B9NCN_L
MRV66%$8?D]K77( )P+L\Z(]DHD!W& #<"]MOZ:AXN-CU&%^4EFW"Z/?+Q9:2
M\X+ >J,M@7O2S\=MRUPQ[TA ]QG3"2_!N2VSQ#=[DR9[V$50%Z7>O_M]F=BT
M"?8";![>Q0WONI>+)T0/M4V:UVZ![BC$NER6"U,;B'U<:@0^/5^\W/@26=*D
M"G(\A;5??^U6VE*_L.Q2#FR3@Y^\NK<JAM[,[C/+,O7=\D]*1/QK<('I=?(>
M62R;_AIFNJBD5W=VS$&_H40AO_#+9-_>^77^-Y!<P>$H;UVS\O-A7ZSOYCC'
MCK(V84:K=4.-U5S8)T3[H4!1.;A"-3[D,]G!<, /76RHGNO )=+_S2@M/ MQ
M?KT4K*L5<6Q16K',]QR_,$C!ID&!\WJD1<XY95[S6S_[*1IT5P-2$*1UK;.(
M6Z>N^@Y9M\.Q&I2B$\%G#!T^MFK\19JHTYKSFJ2S70;4#?L5G.AC9B7_8MOY
MFWCTWOB>^ XOF(9%5U.G>M2NO%'.DP^04-T[/'DK"EK0[F.3ZE=1 M4U"A[J
MJVTR=\V=PE3X"WWH<-2OXW304XPDWVC93T=3BB2E[MJ$^C:_"-R 2TZZ$>MS
MYA#24$0;5_5&?VU%WKC=T,L31QV@)]R-Z.UO6R&O5#W.1$4=]H39#=K9Y'0K
M2% RU$!'96)<]P?5=1VFOT#=A'D@A)]W+RR8)7J=L^L*MT69?#N*[^VNNZ@V
M-*G9.#@[\WY'$?W%)),,ZUD/V<1=H+^:!'WT,ZLDY_HWX*9202F\QK1$HG0N
MP4P,G2>"R?QHI]9@C:Y[Y2_TNL"T_'IR<&B0\XBU,)@_3ZY^>,71).E3@E^:
M+.M7Y#T0]^FI;AL\" ],0DO2I@K(0YW(3VMZ R\_-U><&;M7L5GT^S[DTBSW
M@<WD4OXUU]DS$2R$XKZ5RQ.9Z88D[KCZ>QZ'6F R+\@R1_0G)WVKIBLJ@C12
M4I(N"OF^CJN-49N[E74K0)V_Y\#0^6:!!P!AY#*8-H.B37>B8OBP^YWVA?GJ
M2=E'OO?4EMXYI_QQ1]V:NV \,L,#46'F.6#OZ6>:2/0/&X%86N8<TOW,$9MJ
MV<=K4V^VZD^K#_X[2?91R8H$1OJE94^0 SN-!M+?9@V7"!4]VM8+O;[^^-EJ
M9\^-?,$7QUM5!52#5KC2]$6D__ID+9>&2F;*C;3>DN5;Q$TT>V#\V2V<W&T4
M$L [7N3XN=!/11-<"_W2E+$$BL6GE3( A^_<YKHQM8FC;X,VS!;,4NA>- QI
M"J^:Y6FF0"[0(8G\MN@)JPH)XC5Y<$;T4A9O2X:UGUCSP:R;)']O.WO/LMEN
M"0F\%^]TB]\E?:V?6C1TUB09:=JK4/,I-S_/86=[U#/@247RHEZHF#)=]]0Y
M29$:2( A$7,9VO)&<0Y+<>OU2-%B4>WSD#\R;9DUHFS^,OVLL6KI%29QTDE=
MD':BN!^],8VY[(H[ ]@YH)Y^M#^EPV>@,J&VK@0:NMG7?0];7"%49@1;'!1(
MVB'?;#S[DG4[3=LU\/Q7C3AEP=\BM$8ST^?V,I7)[\<HR/TI!>Z")'4A#LO-
MV+1+YVD-,=9NX@JMY;>%S3Z9D59*1"4G7]*Z2,;@A]CR=AX!3K5%%VOHW&/_
M^L\?:<T.U/O& (H-[73Y#E+:=/X# _!)AKX),BK3IXS]6[Z?M@CO>D3.@LO0
M?>FVBUBUEVI22VGB'8/9BQ1+_T>WE0"%5_9DZ[&8X$N\D*[TOL7(W/*R#@9
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MC\$[O?\9G]S=Z=.AS0:3*3M!'2KVN!OQPS>0!'&\UVB<+/A)'5XM*M]:39@
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MZ!4[7TU.L;[Q4TY'1MQ%33]RUS< LOAPND5.[\P;D8\S2JD*\'*\((*L@)$
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M9O_I^VK"74I]E).+#)HFQ+.![-Z0[B!*B7H3,KQ@+&]2:[&Y9J?74IS4FL=
M5Z&>)_L\]O1M1SL.1%7DE^>A"#D;6145X<9TN9+4UUFO@;K\MFD[40N&6SK:
M(EHDW!GE (;:09JB9Q"U7][=IF+$DT>MJC>J\0O]Z810Y%V?[?9%1%^KO-L"
MIT<UOI -P5[JK=S"H;&-N[/;M(UX[JJSZUMD"$H$:J*"EQ,?6MG>V*>4Q*G9
M(77/YD(=LFZVI=F^!$FTN6+3L3,M6OI\JFEY;)K^;8!A6&)YRJ-118&#N'E0
M ?Y+;DSAU*+^[KX$/42S2=8'LBJI?4OX$^;4,XLMS,$*5WN>/9PL-]GBF-E
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M4V\,/D>U77B6R9N+5]Z4LIA:;!-_;CY7@6B/N;]3^8[EB^7?#.P_7OX1<0
MI=8$6=)XB MM(UV] (W78<16<#$>I]*.F(;5/"N]A0D&8& Z?@MU=.F<EJ_'
MK)@SMO<@\<"/;HD00\7>W(TDJ%Y%UX:#@I)$:,;^E;FPC.@=/U%<6%L )! >
M,]DF)W;VSYTY+ T3@:>NACC="1U0!::Z<*WN 7<&VH;U&LY3"NZ.&B>?UEQN
MO->S:40Z;')$MM:Z:Q?&./)0Y,T)BY<-U+0-;_-&X,8H*E7A#@  2<#O]P)R
M.33?=)-1K0-L^K^GVM>Y)H9'=UR6NE/N;+4>G4B4]N\2E\=_Z@^JB^;=.@LJ
M_+LVU6)Z_>L.;&UE)\P-B[MS3WO*;Q!_/[]]SD/T3O,G'VDC9HJ[I^MT'9=
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M%%Y4=.H6J.@PB#&+40[<MSI;(DH2O4-/<C1K,JG3EBK?V]!8.)WKMX!P$XJ
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M*1Z+(F1]G6:W35 ?>03^/-.>Q%>_N(HP)@FG^.AM97B;)_>\6C87[]#CH8%
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M9>5J>*KX_ U8[V%#1V?:FLTLD:^'99472I&!/@1T:K-0Z-\BRCRT1Y+<#."
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M. #Y1$G12JZAOG;(2)C\]5\H:K>+<IGBRK6TB[G>SO&HH\/_">LGGA_=QOD
M;3WM&?XZ&#-*,;%T\E-:^X,'Q;=2BBG]0G=;EQ1=NJ0[M(865\29[+T_O,BD
ML0%*UTL!/ ]POF2>O9FLL^#L6<.QU-N-79<I+IMYNBP#F16_N8VHL'-WW3@
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MM7YWEQ:=6=MKNR>X!NX*JJ)!,30NZ([68HI]2=!;^AA6)(?. SB8&GFB4RV
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MT_[I<8LV6(V5:F>7;\TG90A)KZCUX$?@K%-_*NO)A&8A_EL\]/]6$WLP]K\
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M^9MXI"*?"2KB"(4(>HQ)I?Y1#-,XC&&$ DD$3FG"F;'KHQ<)4Y,-%1.0:"Y
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M*^(+#E:+O/WUYWM%?_$+T(T)M)*G*R6OV;#3[?8C;J;!]4=QI*I'NA%6W;@
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M(1!0*$,B_=B7G*?F4;<]B9C:,= 0#9XKJC?)/+7?JJ@)!U*<);Q,%ZC'63$
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MSND;]PYM*'AW+MX&FZB'.7Z]*#-NKI.VZNM!F\X3<1 3&D$_P;I*21K"5+
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M?UBW-]%E!>M2H."QX4_W$9!:YCU7M5^4Y"7ZUKGF6!W2BN6>ETBF"VEYHS3
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MR$(A4B_6/@%B<^ YHVQJQ]G&D-77]0VYE<^M2S_X4A%O&=SE;CG-#J^++-+
M1Y.C];$^2IQCZ>B@<$?7J,> <SA?"GGW$_0(]FA,I3^6\]6CN%GH.\[L6:B/
M];/(G]7Q\$Z(8B:59&8"^3#V4PH13Q-(E!4"F4]2%@0>%<2\:9O)C%,3N:U9
M_UP1K2,T:JKKJXZB)AQ(8>H2,8?>(.;"-: CN4AJ>L&:X/H^KH'RW0!06L0\
MN(9TI%B&NX>L &)>.[;S[<"&UFWW7?U&2I#IYD=S78)7QS-T/NCJKSJ*Y8E\
MU\+E"O!5%?/0?/L%F0MG,0TV.!^-53 ::+P8!!N^MF(+K%Z\3 >!3D%T'2;]
M[2G+JQ',?!JI[[&(\E@=)3&!B"8(XC0,89#ZS,<12J@0E@5@+LF/C1 8I[1,
MPX[:U\L<,*(^H?E8KJ]!/QQ'SK"I? P3<(^9>L<ZF-21'1M4INDR&V.-)])K
MX3Q>IN56&V/97'=R<$/4A6ZC6F+,!+!4=I^NT@8#GX80H3"!*:(1%(E,/)]%
M.*)6_KEQR9^:1=D2-Y%;*;M/8:2+J<$6> *'K_'=U!J$:9ZU@ZSA5&ZH[(B?
MUFDZR,(XOZ?J1T6_\_*#*%^3XN%COGS.N."OOO^N:+I9O,L6RDK2_E6F;.W*
M^3KS<<B$SP(82$8A(H)"$OD"AA$GG)!(_]&FEK+YU%;GU CUEG47-*9(!RLM
MI)0(DBW-@*R)MCNL+-;![* 9!MV!#PD-K*8:M&3K ^'GWVN4?P%KXL'U:9BM
MQ;H]8HY$LL7$HXI3>T!>BL(>(_2XKGFE!KN5UX]*5C+R7I"BOA=Z39XR+0O>
MOZX[0EW?YZ*2OTV0M_ %YH&,(4>20"2I!U/.0YBPR),!]3P<&37D/H.&J2G@
MF@L=%M[P 1I&*@]'PTK3X0RL.;&XD>BY4 ;7/</#/[#D,T#^"B@^KG;P/QVL
M[VPA+"Z+AE^0D:Z/^B^,H^N@\Y \>D'4<^CQKHS.XWWK$NG,H?IIUR\4]P\K
M/>:MK+3_XG95%J7ZC#0A;28D8D1Z+$AT1+/V)T4^)-2+H? 8HGX8QWX<V?B3
M; F8VH'TIJG46_E_"K#<4&Q9F==Z)<RT["'Q'?C$V7&7U,1K65>3#SKT7X%V
M)8;(7>V+HB/]VWKZ4;7PON"\U,5[C]/3$:^39C^))_6Y/A#MJUC>Y^3Q>E4^
M+'-=E.?Z<;E:E/Z,1HR$H?1A% NEA8>I;JA:=55E:2Q9B#S?JAJYX;Q3$W05
MV3H\I:$;/-6$7P&R)AV0BG9++[CA.ABZK]VC.[3?N0)V0S+XV *[H1I<'P?6
MWD-L!Y,KUZ[AK./Z9.V@V'&F6K[>OZ;J0BWI]P]"ZV!)Q'R/018E'"*"8H@3
MS" .J$]01!@/C0([]PT^-;'3TF;MK]Q"C$OA)4SG^[)(*ADN):2"Z%0%$B<8
M82&H59>]WHB-UFLO<X*;F<SMB\; @G5-UA50A+DMY/J278>E6M=#CUZ,]253
M^\JM[CS3PQWZ89F7#XVAVW2::OPWH6!I1)"$*='[5(<LJ)]2J Q+&F,9!P@;
M-:\_/LW49%Q%:.N_L7"2'<;1P"'I!)VA;UNZP("VBUP/=^)AI"P\ADX0&\DI
MV!,Y.\??24".^O8.OSV>^^XD!UL>NO];WK?VR(UKVWW/KQ"0(&<&:-Z($L5'
M @3H\6.N$X_=L3UG<#$?"GRV*Z>ZJF]5M<=]?WU(/>I=*E)%J>43X)QQNRV)
M>R^*2WSLO?;EJ[OJP<WU1U-M[]6O)42%)CBSTQ1",H HUX!1*@!4!&+.L,Y%
MD([ <1-C(T%GH=O:J6P,U7$[ M!OYG(=+#VSWSXB/4@>G?<^FO;:40,#JZR=
M<_!83^WLE9VEB-RZ;W57Y>,TFCDR)Y!A94"JI!W7NI1',QI GJ:"()::S.M(
MM[V9L8WMQLHF.RE8@>@4E'XC_'J >A[E&VSNFLRM/H2'6C"(ISITJI&A)8=:
M'#VA-]1V==>-&B<#[L3<WUKS7BWFZ^G\:3J_KU5D%_/5+]HLEKJZ[@O_KE=O
MOJ^7W+8QG?/E\[NU?EA]L.[:.ZWKMJ7[=W,[1O5J/4%$I3FS;,$I5 !A0@ U
MD@'$,PCMS$#P-"B^K4=;Q[8I4KF0B-(?MW7];;IRL;U.!KI6;E\[_T+W2OKK
M;*@@)*Y$(3.%[>)<$\ TQD 61BFC&9%:AFWRC:.S!]DS_-$ZVW>?;11=V/NV
M757OMBQBDCB23[:N)EM?F_ZMKR_=O4GVW4L:_V+N_O7>"=$V$_NS=."]R=XA
M/][J[+_)*XZM3ZN48V(7$05Q^J8XM;,"P@$CI@#(I) ;+2%58;E>/XQ _"E!
M>%U:'!B%<[4&_ ^A^KYKY-\:S??;]7HY%4]K-Q=VRA%W?%GN&?803C.8^/M8
MY-[#!=Y[DW2_6^I'/G5)KWJ^TK=S]7']52\K,:-F:0T-(A)Q!0J%*$ RHX!1
M*8 N!&'*R3^0H) 7CS;'QBBUR8FN;*YRZ!?.[#!"\8';CUDB@]@SQ33XU>:6
M\)4&)Y7%/6QS!  4B5Y\6AR49P(@."2<D%L[SERJ(Y/7BP<^G4\,E&F::@P$
M),BN;X4$7&(.%":D@)*[C8Z@R<KNT\?&)K5QJ^3/RKY ?<=]Y#PG(EWQZ'ON
MX0U%^+3BE,NQ9A)[SQYV\G#*K:/YPLF+.N]A+C5?Z=>Z^O/=O.2"32&LBA0F
M3&M>$"0!$3EVBPP.!,\0H,9(2I"0!=:3N;YW<F7>>U0>#7N]S*QZF7>;[^^=
MKCYLO+0N>%/)!VKO_:%8\ VVU5,:FOS4F/RS2U:NX-R67KQM![;+%DX 3O%V
M8WP:'7IC)0"($WLD(7=WK$#%EW/[K-6=7I:+_"_Z^_H7Z\,_)H8AE$F[/G%$
M Y!*!1!%P8"1PN0DSSDS0<7QSK8TMLF$RT%O-DEGY2:I-;E*B0FL.'466S^^
MB8)8SQ33V+C%*/G3V9F4AL:L'W4)C%C%HLZV,VQEJ$ON'I6!NGA#ATC2-T_+
MQ:/>C^@CK!!IAB#@A&N[L("6%S3!()6$4F2R%$OF'4-ZHH&QT4%E8D PY"G0
MV@=\#"CZ'N>E==?$B)Z")2 Z]$IX!HH+#84I+""T!8/64-!3]PT7!-IB]5[X
M9]MUW28WK[71R^6^#%.C)O_\:F87%%,SU4X_7M9;A1G-408S#60N#$"R2 'G
MH@!4:0AS P5B:<BD)]B"L;%?XT B=R7;.L69A?>&WS2I5XQ[IM4-O'N*>!OK
M;Y*M_=79>^Q-W<[@19INA;<_Z#2L,SR'T[/N#^I&?:Z=I?YJFYI^JT_1[;KF
MH_G"O]N_S9Y<HO?=8ED*T^T<3'Y9G(F@P47.8 HY2+5R)]XL!_;=1H *F1IF
M4D$9"HF-BVQ?$&T.EB0H=YU,W%HRC#%C=Z(?G[Y@U_3,MGN>)7N!4&4.H\L&
ML%[>)!L_D]K1H]/[WN.@>NJ%2+0=V[I!2;TG: \IOZ]FPCX(2D\G;^9K^Y5Y
M.YWIY2N^UO>+Y?-$$8.19@AD*%4 ";N,9THBP')M3,HA3KE7#,*9YX]M'EN9
MF)0V)HV1?FQ\#L%V-HV 2]]+^B!(O GL@N,G"&BEY;_<+[[]-WMGQ3WVARWE
MG'O>()1QP9EFR%^ZK,/6VYU>FL7RP94J*66"RX"E6A_X[Y8.+#/\_FB90WZ=
MZF_;R$G'%XYI?N/+^^E\5>^S8$.Q*NQBECA]2V2D A22#!"C\XSB0E&&O??L
M8EHV-IK8\2T1I0+YJI2/653NV3^;0[,ZT/VA\B9@'RQJQWKL*[Y4=_7,7KL]
M56G%5T(_M6=)[5KB?$LVSNV<>M;3O]J_+CN:47LR8"OTI7ITH#W43_LEVA[;
MA^1-\M?7J?R:?+..)T^NL_FFL\^-UEB%VOKHB-:-W*@-#K<#W =.>UO'O330
MK^*G*U0J)Y(QS"DC0&:EI#YF@*&\ %#DTGZK-57(Z\/<J?6Q?7PW@I2\%J04
MSDJWB_)@A_6Q FA9)*;Z=6!EF+!.8G:6Q'-# &:9!"A+&;#K(P((Q,HHEM$"
MX[#J?+UUTS#5]$JSDK\.N^L%>XA)2!!5()6" [NLS0#%0@'.4J(0))#H;#+7
MZY?JG4VTW'K0G@$OWS-^6XZ]C8>>)Z&!$KJE^<.KYNZA-K!D;M7V*/5R]V#I
M*I:[_Y"A2]:5__EB6[V=JSO[9GZP[VH=Q<X)A91H!G1F[,P"PQ0(@;3]<G%*
M%%69ED$*1WT8.;8)2&EIXDSMFDC01T_Z4>A+]T_/3!O2-0/6<[N,W8M7;6LQ
M\0>IS789Y'@5V#S:"B/Y4@-G^3SY_;-3W\QAJKF=I=H)*K+30B R.U\UA=N?
MQ44NA9<XU?:18R/0W^=EC>W/:[[VE?_8P:>=Z+IYW3,M_?[AW9<WKY//7VZ_
MO/E\/2$=^]AR7%)?7+%'_9<M<>P\:I!A?FQZ,RA/_$O'7(6'Q]GB6>O/>OEM
M*O7I0?YA,7=;@;H:R:LR$&/WWU\M5NL/B_6_Z?4G+1?W<Z<A7A59?+M8UK]R
MU\$)3!5%!>5 \0("1%VY0Z((P @+GJLTER8H2WM8\\=&#7\<KDD?2ZN3A?UK
MO87K=GN7VG&M6Z#N!1Q*ZW8R797IXM)1S'J1"'=U@T%@9L:P;Y+?#&Z\[T?/
M)'JRX._V6UT&/E9.-W6 G9?VM^OD6:^3K:,W=2G@4HEJQ]F(62@OTD>Q4EN&
M-7[8?)D7Z9BC))R7L:);R<Q_+)IJ:*>+_;&"L3RWGS[HPH201CG@5$J .7;5
M?JDFT$M!P+.]L7VPG,6[=?^N*WMY"6R/@_RX$/;,Z9?0ZUBT\A*,804J(\(Y
M7#'**V$-KCWI"=*E.I.7'C-H34E/GP[K1_K>UH&/W\V5?>RZC!15^GO].F?$
MY#EE#/!<8E=Q'0*FTP)DA$*-)<4:^L=MG6QB;*R[-3(IK0R@A],0>A#KU<#T
MS*6'F'3ASM/@!-#EU2 -Q)#>+U 8$;:ZW\I]I^\<CNY:+=]CN/8K.];>6*Q6
ME;SGO9[+YULIET]\=KM^Q9?+9_O+O_/9DYX(E'-..0/"Q:$CC"B@!>2 0H90
M:J @6 65X_!I=6S45UIIU[BS.BTLN+28']9^FQ'1$>R9(YV]R8[!26UQQ&H>
M(8C$*O#AU>:P-3]"8#@J Q)T<\?*(+.R+[4ZO?JN!?@F/-6"%HH"30LGYIMK
M(##F@+G5+B4HS8J@3&^_9L?&.=766Q56N[?A6NMR!E82\8/>CX'B _K2VYAO
M+F :7G@D"*)8A4C\&AVV,$D0$$>%2L+N[D9+ORXM]]TM%V:ZGN0R-X86!'"3
M,X!<I53A<JM%D<-,&5,@M[/FGTR]\^P@@AD@$;HTS=6(,*%%QW8!\V.,CC#T
M3 L5 G?M" 0/_1.^1AK?NT\>=!"?<.EPI)ZZ)#P=]K.63\OI^OG-=_G5L;.+
M\9AD@N@4:B=K(*1=@A@#F,@P*"!4BE&>$K_3WG,-C.[+7]N8-$8FSDK_C-B3
M(+:/TQC0]/T-#T,E*"FVS?5.6;$G'SA86FR;.[MYL:W7=<UE_Z3OITZN?[XN
MWSM)<VEG[1H@2B% (K.#5S$.*$62"HD0R[VT*L\U,+;!6Z=N;XT,'+PG0;P\
M>*^%IN?!&XA*AXSVTZY?D=)^\,"!<]I/NW.<U'[FNIZBW<^%9M;Y?#O!]P=!
M^F^^ZZ6<KO3=<BKUQ"[CT]R2@EW1(V2)(4. (6F YM(P:H1,"S*I@I ^K_G2
M,S=H(.M#1M6A#_T-L":W>C>/B*_+N"UA7Y%Y&;>U,$W:KHO$<6E&:C&;\>7*
M_:I*.0K,.!KJC>%8&*Q8!@K#,4"LR(#0L@"Y1D87BA1Y1NLWYLW<4W)]M.]+
MX\&+O"W:%7OY8=\3O]7H"'M^P VP/3W#':<3\9R<W"BK OL^-DG]>WES1VEV
M#0))"<& B2!Q^VRHW)!(5H\K721N5P1GD$1NOEM2R:L/DTSERC & 3%.02#%
M!'!E!%!:&<CS#$*4AR25O/HPML7.JW]]]^$V+)G$XM).TMV\[9D_VQT-3B+9
M^G9U$HE]U*!))%O3#Y-(=OZEX_)#?M7J::8_FFIM\\=4Z=?3E9PM5D]+_7'^
MJU[<+_GCUZF\=54WWB_F]^^GW^SH+:MMO)N[((EO4_7$9V\72SNRYZ]*RZ9Z
M]<MS]>/SMLX#YBED*=' (+O\0$@I("1+ 1-<$:D+D\NP(EP#&C\V&FA\=Q-'
M^QJM%K.I<H<V[G#!SAB=6/+CS"WZ72D\5YSTL9EOW&]0X;.D'#>.H0/GED.^
M-IX3S)&^#'W/,G?>@ZV[B9UF;AU.2H]O$N<S*)VNBQRY\D=;OY/:\63CN7M=
M:M^3/[^48J^]5#-YB;Z+-=L<TO1AIYPOT"E'\\Z7L*';E_23_J;G3[HIX.UJ
MY_XQ77]]];1:+Q[T\LWW6N/6F6;_I[[P[Q-&&)124J DI #9.2H0KHP,%BEG
MC&L%#0V34NI@10B9#2.HY+2G5WP6&O#7I0<,DPJF%GQA: I0(000B!> ,(KL
ME 3A/$QQK&?\AYA95&+M\Z8/DF7E4O]]X?>=[QGAGC_7M?6)H]NDL3_YRSJ0
M-!ZXR*A&;[UQPNFPQ_O<7@%AI*]F%PL&_?A= ='A-^R:1W4]$+Y5RKZUJU?V
MQX_++XN_YA-(&41*9\ 88S\U.>: TRP'ILA$@1@RBGC%E+>T,38BJP] :SMO
M$F>IQ3%QMH8>#A\#ZGL^?!5,PQP1AR'4X:#X+ 97G!4?/W/@X^*S3AV?&)^_
M-%;)Y#I;HA)PM0RB5W=54:J)0")'65H 6: ,(,$SP(4@0*4Y% 5).0VK?![0
M]M@(H=:X7CL3NQ7M"@'>;SK3$YP]$\>94LHUP*71R=T%@",44KX(56_5E,^W
M_,(EE2]"<KFN\N5'=,CH_6TZGSX\/33*D:]F?/JP<H=)?&Y7X^_F=CWO]*I?
M+:ICH=_X\X?%NOS;1,,<&HESH*5=("-HR8NZU5K!%4OMDHW:N8MWVF]W.\;&
M9K4GR7PCLBI+9Y+UUSJNH'+K^6]NGZ_V*Y&U8\D#?T[FB[73#5H]&3.54[<_
MO%Y45P3DTE[1L^T4.6!_]4R735=M]7 K/Y*-(\G&DZ1Q);&^E*H^KX;KD( ,
MZ&$ZYF6*+#R<'UI7C:I8E1:NQ[XU1_N*QP^7R'T]!GO9WA$>UVTNORF^4"=6
MK6[%JMPDF'",(3$Y!IA)!I#,<\"(H$!C*0W4U!1"ALS<S[8TMB_;MBI-G7>Y
M^N]AT_3SF/I-RJ,@U?,W90M28V3R9V-FQ*.YBU!$FF*?;V?0"?5%=P^GSY=O
M"-_#*VG%\Y4]NGY$KVAI5]2W\JRWG3:2]I\TV/;120=V-XU.7]#M\W*GRZB[
M]]/U]+Z<1-5:-QH1 E-F )'V"X-4B@'7$@/#H$BUI%R$Q>*<:6=LGY;:S&1K
M9]B7Y1R<?M^5""#U/&2/\8FHH>8)0Z0ORKE6!OV>7'#U\&MRZ?)N'/!:B[6=
MP:Z7Y5*JC..9($0%@=2 HL"NU);D0!C(0*XRR3*9L=SPD/%_HHVQC?W=4*DR
M%,HV^I XPY.MY:LZT"FPU,4IB/TXX4K@>N:#(\R^=,(LF"):4(E$#Z=:&)0:
M6EP\I(6V2SO&_;J2@%\7,WO'ZLV_/TW7SUV*<$\(265!. 64:^(4&37@TAB@
MC>9&,@UE@4*D.^*8%40\ ZA^5!$U90Y7[=M__<\T@^1_E(&Y:\_"VY&[3DNA
MC<0&I-H@@%*6VP] E@*F19%K([*,L@X)H8-WX'#YGK]LDCH%G[G-H!?IMRPK
MN"A2" S5!J!,%$!DIK#C#AII!#,RY<%IF2_4:_UG7;ZIIK,OV6%^TX#ANZ#O
MF<..0W]+*I=NDHU32>U5LNN6VRC?=RQI/(L8;!X5Z5AAY'&,&C9 /"J01Z'?
M<9_>;9KTED^7I0KCN_GCTWKU7G_3L[Q>\F-,30$) A)#2\1*$F#'A *I41G4
M&BE+S2$KJ):VQK:2*FU+\@0DGZ?W\ZF92I=I]/M\(59Z^:T<R943883;AK8?
MBT;"L&=J=%8FI9DW-4XW20-I_-T6#TPBD5A;2X,RDX?+AW3C<TLW#GFUR<ZS
MG'5G?Y([N6U42<L7!00BS31 !8).]M#2B2YXYJ2>11ZDN]K6V-A8Y&XYG<OI
MH\LQ<!$1NY:'\48KPG[$$0NWWD]4=LR\22I#DS_K/WO)S?-!)A)_M#8U*('X
M.'W((%[W=!,V^/+'1"DA4^$F&CD1+G?:+M<SG .WA,\5)B0-$S;X\L?8Z. +
MG_[%/4?^#C#MX[N;NSV/XB^W[_ZX_1!/VF#KW-72!O91@TH;;$T_E#;8^9>P
M0;-:KIMHGGKNB'*C""(0P%0P@#@K@*""@UQCFAHL28J]]!"/GCRV(50;YS>&
MCG%J'TI7>=_SB&H"+./-GL]ZV_:MLS?M?.?LW[8#[/AY@XRSLVXTP^W\!5U3
M4[[IN87T^8_%\A_OYG?+A=2KU0>]_F@^:;<ZU*N)P<*0C!MWX@CM!RV7]EM&
M,T!Y)@SG3%,1E'3KT>;81JJSU&5,/"X7]RXU*#0-Y3+(?O/>R-#U/,PWUMXD
M#8"UQ3>)2QJWRXC&ZIAI)]X014LWN=SBP&DFWA <IY?XW]J+\,)V)6B8%"FQ
M*VQDD%UK,ZP!-X@ 0E118*TY5UG$7/_1KKN;''2?DL#7(>['07W@V#,1>:3Q
M)W_VLAP/!6N8A/T76J:'@A&8FA]+&N:SOG=Q&Y_THSNXF-]O0GM)EE/(40HT
M<Q.AU FU,U?YA$,&[2RIP&$1_N<:&AL#U78F&T-]@H3#H/4\=8T 6-_GJ%VP
M"C\4O0!$K&/.<\T,>W!YP=FCH\A+UW>C!;OL6BS+<\TZ4L!(!<MJ#8*0#""<
M*4 SITCD=O=<L7&&30@='#8P-AHX..J?7CKJ]T/1;^1?@TW?(_Y$Y,3P81+G
M (K$!$>/'Y0!SCEW./+/7M<UZI*O2[GDC^;M=,[G<LIG=XM5.07??+G2/"74
MCG@ LS0'""H&!(0(J"*5DC,MI/#:Z0]I=&S,L+'9+>DW5B>-V=VG"SX=X#EU
MB QK[Z1R-:(=(JW\(8H61^71Y,!14OX@',= !=S;52OLC5WIW-MOR*_+Q5]V
M[5-EMT\4I"++!++3$$HL"U'MJG]P(+$J-%1VJI*S,+VPD^V,C7AJ1:S&UJ0R
MMLGY#U4-.PUM.[]$!*QG2NF(50?]L%8DKM 0._W<@77$6IT[UA)KO_R*(E3B
M<GD'<::\@YV,?K.S(ZT.BCO\ZHIDO;8<MHFNFDAI>04[)3*66U[)N#O[,0+(
M'$N99L:@U'2L0S6( R'C[_^/4E3#O#>(J%2;K  0Y>[EX>X,GU% TR+-L9#8
MU33L4HUJI&_-BQ:D^B=Y9SPG\J-\"_I>#L0J3G63;/P?NC+5H'T6LSC5,(8/
M7Y]JT XY6:)J6 NNC)#YQ/_ZS3YW:1=U![$;J3)*PY0!6NC43I*PG205+M%/
ML=Q C$4:EEIRN<FQK<.LH<E#8VG'X)CS^/I]&.*BUC.A[X3&..PV]@X1&',1
MG]AQ,><;?)FPF(L G(V*N7QG-Y(YG0U7QWE"R?+,8 TT-AH@B R@FDA06&8A
MI;!<%D0O;8V-C5A"STW"T?4CEUB8]4PK9^#J(4W-!Y!(/-+:U* ,XN/T(7=X
MW=,U5>WA8;HN)5UNY\J%Q-@6]%Q.]6I;=6ES3J)Y;CAW9:&5*0!"E  A* 5(
M4<8X1##%*"QW+:#UL?'*CO%ER;T]\W<KLW4]N@KK&S\2Z@WQGEDI)M@=$N(Z
M@!8M0RZD[8%3YCK <IQ#U^4AUY8^/8SO>3<WB^5#N7ZTB\;J'RM)+RR=K!%-
M 2F$)3JB)&#04IY&M@FI<\A,6,!>N UC([Y=A;#C6+4=-V[*_:3ZBDXB:UUZ
MS',/L-]^Z'LSKY<NN***9S"(T8MQ^EOP0C4U@R$Z7QHS_%%7BJ%LJ7BUC?77
MN6(BRW* );+4B+5=5%+M=,M3EK&,HS0/"EMJ;6UL)+A5]$A^T]S96G[#.LJ?
MG,37C\BBH=8S9>T MF-I3SD37J#$UD YV=;+J*"TN7U6!Z7UIHY:U-6N^^J3
MGKE2Y5\67_AWEV_A8ETM;[U=+,L=^E\.-_$G7&2X8!0!(:D""$IE5YJ$@!P2
MA+BAG&3Y9*[ORZ<&:%9WM,=K'+%J'!U9U=^8:MQ)EI4_+DQXS;^7:4FU2XG]
M,KC2KJ \N4U6>KV>:57+4";<'8<$DE;G/O7CLUZ[:"!)[<J%&U<6+=FQ_>;T
MX>KVP"JBX/:5*,92Y.YJQK"2W5>"=:3I?>WSNI'M^RD7T]ET;9?.=BE]K*8W
M01DDF5). ;QP$S8% <.J )QGT$B.[3)7AFCW7FHP:,XVF"KO;&MUN9442Z7W
M(OQ^_!<3U)YY[OT!DF_:40LF,5\H(I'5Q>8&)25?YP_)Q_N^\.CQ+TON^.OS
M\X-8S":L("17) <RUQP@!BD0)"T A+DVG*>:"Z_<M:,GCVVI5QN75-;Y1X3O
MP]4^^J\"H>=A[NE_4)3W25\[Q77O/VFP2.Z3#NS&;I^^H&O*QMOI3%>5ZB88
MI2G-!0=4(>)$+13@6:& 3I%B0J2I@EX[TJ<>/K:A5R<<. /K4IJA"1D[P%T>
M@=? T?,@#$"B0[K%L<M7Y%CL/&S@Q(IC-XZS*4Y<TW%S=+'4T_OYJZ?E4L_E
MLQWO=AHOW3S^5SZ=OU^L5K_/EYK/IO^AU41G)J4NF)V;PE4TSAF@.E5 8)JB
M(B,<$]CL9WCNE@8TWV'[HN_MT\KZ1'^77]WJ-YE9@UM"U:[O <_=U-BH#K2Y
M6L/9V)WL&)XXRY.?G.T_WR1;\R/NMG8 +=;F:TC3P^[%=@#E:&NVRS.N* _T
M23_:-_(K7^D[IU+''S[I!]N0$\!X6G]=+%T[VVMN'YQP)YQ(DA&*B01N&P&@
M3&G 1$J 8)+GA4"4VG:"TM>[FC*VZ4OI2;+<F%F)__&'&_N[VIN$;]S9O9"7
M#G6H7M*M"SW/S ?IF+Z/SLL^V5J8W#5]LG$DV7JR>^%M>Y]T*TMR%9PQ2Y%T
M,V3X\B-7 7:RY,AU3^R:$B*K$V,^<Q%0BWFY([S:+W"RW25NLE>V1P6K25J0
MU* "@A2F"" D4D )%P 1QG.M<JZR0$W5:TT:)?V",OVG/NDJ\QG+#=]58!)C
MA [S(]EANZ%GLMUQ)JF\J8[ 5D?J1J^GLZ?U])M.WABC99F_<N&P+&I>2RS,
MH^6]7&W0P'DQL0 \SIN)]N0PII[S]7+R9?I0/;>DDCIOL*FGK3E55&5 T(P
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MW_CR'[J,CJT2P#]K^]HWI3M?V96W78_7=01O5RN]7FU+M&\JM$\*.[FD3%.
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M"+144DI34,B"CE5/-3(V0JEL3!HCDS\K,P,+G9R$TX]+K@6I9_((QB>8*MH
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MEWH=MM]"NB!@HZPG8(?8TJI-_UNS.U4>!![O8:UZ$JOI"E_,G:&0YH??P^D
MSLG=EB[/B56;:9,\4@_C[2Z)UBSG5 '"*;,T5PC D9+ T)P+@])4P5#=+,^F
M1T=P7]W65ZG QTL%LW(D[HBT>H8==^@$/Z+K!]J>*>Y,1:=M,E/S7>ECBR4<
ML=[*/)UM^(7K/5T"Y'+AIXM/N%*BYY0TG6;<I$:F@#*" :(( JY2"H0B::8R
M2V"FFS;/#Z'V5]D:+!O=BJ@O!<7!J7?2J<T<1@CU$B*Q-7=&H/5WV>FS*COQ
MM?[J&57S-97$2)T*""3#%"!3<$!3G0%F_YO"'"+.BJ DR[W'CXT.ZE5#UZ.=
M ^S\:* [(GWOQWJ#$9[^>-+G6'F/^P\?-N'QI&-'F8ZGK^HV8.\6R_*T>;TY
MVCEQQE-'#B*"$<^U<M6'($ 0VX\^2J7]U.<&4:XRG'F=Q'1H>VQ#O38]X>N=
MR)/D-SL-LR:'UW4,Z04_7N@)VYY)XR*L/=15ZX!4)*H):7E0'NH R2%)=7E$
M-P;[I)W@N59- G@]3"32I(#"4A0G!""[2@%4B,*I"R.2I\+D*.BTZ'0S8^.E
MQLJD,3.,A\Y@Z4<YUR/4,[L<@=,#F[2#$(DXSC0R*$>T.WI(!Q>N[GB0I._=
M-^&3?G1D,[]_-S>+Y4,9/??>-O9NK1]6$Z$SQI1@0!NG'<Q- 013!<!9GE-(
M-$,H*/;,I]&QL4)M<S+=VAIX7N2#M.<9463\^CX7JJ';V)OL&)S\Z4Q.2IMC
MG@,%0!3K[,>GR6'/>P) .#KC";FWXT;'P^-L\:QUG<UV.H;WPZ(LWZ)5&:Z[
M*FO.[?[[J\5J_6&Q_C=M36V4U4L%O#I^=\)Q#H6RDQA%6&8G,7D.&%$$2$,-
M*:B!!0DBKT&L'AO[[14-*)-5@"B/<^5NZH+^[G[V3'8?]BWPW D:6]\.<6+?
MIEFZ\;7).:E\N$F<D_9?U\FS=L3>^'F3W#XLGF)6.ART2V+M?PUB\[#;:D-V
MP]%NW:"-CRV1\^^E5^_F=WHY7:@)U#@UF4! %DYH/\_MHIRG D@H*->&%GF>
M3^;ZWI7%\9R.#V2Z%_&QBOAV'>CQ9&VU>JJS,8>M4![:Z9[K@C%UY#];&F4%
M@8OVJ$#X$7(D3W?;Z+,@#\S^)\ES/-T9PV4RGFD_6CS+YM05*\QD+B#("J@!
MLFLLEVTD[$]:H%1BHB6[,IQEK,?7IT,U.AYFMV'<.<!EA,?<74&+$=W26\3<
M^99>.K;E<DS<Y5LZ: &[7:./9C\3XC?^??KP]/#+8KE<_%7%W-E_<2Q6A>.]
MM?[<*GN#Y2\^VURV^FTZ=_=9)OLH99DK)?4D+33+-<= 978ZC"AT&B:B $@J
MG:-,"B&\:F$.8NW8B.MNL;:=/N6VTYH0UZD3*"X]3D3C2R)KGV]*V9+%QI\
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M#>DW?.E2_U9W>MELQ$SE[5R]GLZ>G$33_HYFRK+<K9$ I5P#E",&6,[M;*?
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M.!(WV69W7-;S[G?O!H^.<Y^-Q#HR.*K5>[; L*:;S)I(GFDP2CH"-9F\4)@
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M$*+]1GD7->,&AT/ JY'D._"T_K*8+Y=O%_,R74UXY%)EBCBX8XEB#Y*(QX#
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MDI"$1)=<TN2)Y]8%'WN2.&XI6]^ 'E#9'9CH"[?HU>PK;K4P,9AX%(C L)#
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MP82,<;P^%N,FFA^XZF @I36;9=T<CIORM-L%&1E#'2B@DJ9>WI6<F!.> 7G
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M[FGWON8"^0Q3$MQ',*5.:O*& I.,"FA_=SGSJ$-J':SN2MNXEF@(#-ULI3:
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MS+YX"P7KE7TE$2)MY*"5L\P05ZGY!(;=*-LM3\P> \@&5$D'0*NR69X9U^W
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M-"[Z0K&3NB_%M9_.?WL_SAXRG,[WE& '.O_PMXEUKBB+$4H4"90T"-X80JE
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M:T(Y:PN6>"<CT4(&SWWFU(A>8>; (J.#X5S[30=0YMB@^'!S<SOI%G<[6Z#
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MK&I)#*A18A!'6ZQ64OA:L2T&5@K)C:0)R,#B/1W)2%-AB5E[OV8]#??!6EM
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M2FN'E,=8QE^X17P@$M(IN\[T1($80C4 Q@28"(W#91I)(&KC,F,\F[(B<Z8
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M6+N#[E,:WME!]S&6L7]KG\_Y9P!GF6=1X-))(O'4(^"2<0,>:X@=.5! F&"
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MW=_E/F)U[X=<Y3%\5N8_<#OY+U!+ P04    " !MB:E65VK4(_@$  "@&
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M5TP:)D2N\.RZ%%J+9&#H=V6*AI#$%<P"<=E='6G[?;O7:9E3K<:CK*:UXNK
M:Q<'7D?3^WUMN^L]W.O:WH-]GY/J]^R^U_[J8KLMVSOL[B36*1Q1.@/=K7 /
MO6RT&G="W,#/KL&K USI71/U[GE<9-]_5Q77%%.DTNW:K$+^(X,Z)5OHEY7\
M_PG6\[TVGH>*YZ</#;? /OT=NB/H6[7$EY?1-7 :GQU:Q4O$9(P )6).H4;R
M!!RSVW;XN07^PQ9X MAW6^6=K@'NK[I3Y/H;Y<R#=]$W2IT[U]F9*._S!Y+%
MQ*B[=\']D5!%+>%^G$*6R*I</SSEH;+JP=ORZEG>W1>_(AS]#5!+ P04
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MRQ\4COX%4$L! A0#%     @ ;8FI5MO[G1'Z<P$ K&(0 !$
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M<BTR,#(S,#,S,5]G,2YJ<&=02P$"% ,4    " !MB:E6+*U_"Q^K  !J#@<
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M,C,S,S$M97@S,3(N:'1M4$L! A0#%     @ ;8FI5K!>%E%%"   .S<  !4
M             ( !T5,$ &YA='(R,#(S,S,Q+65X,S$S+FAT;5!+ 0(4 Q0
M   ( &V)J597:M0C^ 0  * 8   5              "  4E<! !N871R,C R
M,S,S,2UE>#,R,2YH=&U02P$"% ,4    " !NB:E6+%^; @,%  "_&   %0
M            @ %T800 ;F%T<C(P,C,S,S$M97@S,C(N:'1M4$L! A0#%
M  @ ;HFI5HN*>OL$!0  JQ@  !4              ( !JF8$ &YA='(R,#(S
C,S,Q+65X,S(S+FAT;5!+!08     #0 - %X#  #A:P0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
